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Abstract 
The E. coli glucuronylsynthase is a glycosynthase enzyme derived from E. coli 
-glucuronidase.  It catalyses the conjugation of a glucopyranuronic acid unit to 
an alcohol acceptor.  These glucuronide conjugates are important markers for 
doping in sports drug testing and drug metabolism in pharmaceutical trials.  Up 
till now, the optimal glucuronylsynthase reaction conditions were unknown 
which may have reduced the previously reported yields. 
This thesis covers the development and optimisation of the 
glucuronylsynthase-mediated glucuronylation reaction.  This was achieved by 
determining the enzyme kinetics associated with the glucuronylsynthase 
enzyme and devising a synthetic strategy to overcome the water solubility 
issues associated with steroidal substrates. 
HPLC-UV was used to monitor and quantitate the components of the 
glucuronylsynthase reaction required for enzyme kinetic analysis.  This HPLC 
assay was used to determine the kinetic parameters (Km, kcat) of the -D-
glucuronyl fluoride 51 donor and a range of acceptor substrates.  Substrate 
inhibition and product inhibition were observed during these kinetic 
investigations and inhibition constants are determined in each case. 
The optimised glucuronylsynthase-mediated reaction conditions were also 
determined using HPLC-UV.  Different variations (pH, temperature, enzyme 
concentration, substrate concentration/equivalents) were altered and their effect 
on enzyme activity and product yield determined by HPLC-UV.  Improved 
reaction rates and yield were observed in the glucuronylsynthase reactions 
involving phenol 52 and DHEA O-(carboxymethyl)oxime 116 when applying 
optimised conditions. 
To overcome the poor water solubility of steroidal substrates, 
carboxymethoxylamine 115 was condensed to the ketone of DHEA 55 and 
testosterone 7 to synthesise ionisable oxime analogues with greatly enhanced 
water solubility.  This provided greater yields of the steroid glucuronide 
conjugates compared to the direct glucuronylsynthesis of the parent steroids.  
Greater enzyme efficiency was also achieved due to more concentrated 
 vii 
reaction volumes being used.  The oxime moiety was cleaved under mild 
titanium(III) hydrolysis to complete the synthesis of the steroid glucuronide 
conjugate in high overall yields in three steps.  Application of this steroid 
solubilisation strategy on a half gram scale was demonstrated. 
A solid-phase extraction procedure was adapted to a small library of steroids 
to isolate a variety of purified steroid glucuronides.  This screen illustrated the 
broad application of the enzyme and served as a trial for a larger screen of 
substrates.  The combination of the optimised methodology and screening 
procedures sets the foundation to expand the substrate repertoire for the 
glucuronylsynthase reaction. 
Upon reviewing the glucuronylsynthase procedure and alternate means of 
glucuronylation, the glucuronylsynthase procedure compares well, and is better 
than these alternative procedures in many ways.  This includes an experimental 
procedure that is easy to set-up, mild and applicable to a broad range of 
substrates. Other attributes include a short and simple donor synthesis and the 
absence of by-products (to date) which allows high isolated yields and purity. 
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 Nomenclature 
This thesis follows the nomenclature outlined by the IUPAC guidelines.  
However, a summary of the carbohydrate and steroid nomenclature used in this 
thesis is provided below. 
Carbohydrate nomenclature 
The numbering for monosaccharides begins at the aldehyde carbon if drawn 
in a Fisher projection (Figure i).  The symbols “D” and “L” refers to the 
configuration of the highest-numbered centre of chirality (which usually forms 
the bridging oxygen in the cyclic form.  When the oxygen is positioned to the 
right of the Fisher projection (as drawn on C5 of Figure i), the carbohydrate is 
classed as a “D” sugar.  The “L” sugar is the enantiomer of the “D” sugar. 
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Figure i.  Numbering of straight-chain and cyclic D-glucuronic acid. 
The stereochemistry at the C1 carbon (anomeric carbon) is defined by the 
Greek letter “” or “” depending on its stereochemistry relative to the highest-
numbered stereogenic centre in the Fisher projection.  Substituents with a cis 
arrangement to the highest-numbered centre of chirality are classed -anomers, 
whereas a trans arrangement provides the -anomer (Figure i).  The remaining 
stereocentres are also assessed by their relative stereochemistry (cis/trans) to 
the highest-numbered centre of chirality.  However, the amalgamation of their 
stereochemistry is defined by trivial names.  For example, the name glucose is 
given to the monosaccharide with the stereochemistry 2-cis,3-trans,4-cis 
relative stereochemistry to the C5 carbon 
The term “pyran” refers to the 6-membered cyclic configuration.  When a 
carboxylic acid replaces the primary alcohol on the C6 of glucose, the 
systematic names change from glucose to glucuronic acid, glucoside to 
glucosiduronic acid, and glucosyl to glucosyluronic acid.  Furthermore, the 
xvi 
 carboxylate anion and esters of glucuronic acid are referred to as glucuronates.  
For simplicity reasons, the term glucopyranosiduronic acid will be shortened to 
glucuronide and glucosyluronic acid shortened to glucuronyl. 
Steroid nomenclature 
The numbering of positions and rings of steroids is depicted in Figure ii.  With 
the structure drawn as depicted in Figure ii, any substituents drawn below the 
plane of paper (dashed bonds) are termed  (alpha) whilst substituents drawn 
above the plane of paper (thick wedge) are termed  (beta). 
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Figure ii.  Numbering of the positions and rings of the steroid backbone. 
There are names given to some core steroid nuclei (Figure iii).  These names 
are used to describe the backbone of the steroid structure which is then 
modified to include the functional groups attached to that backbone analogous 
to standard IUPAC hydrocarbon nomenclature.  A small range of steroid nuclei 
consisting of various C17 side-chains also exist (e.g. pregnane, cholane, 
cholestane, etc) but are excluded from this nomenclature summary as they will 
not be mentioned in this thesis. 
IUPAC name: 17-hydroxyandrost-4-en-3-one
common name: testosterone
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Figure iii.  a) Some common steroid nuclei and b) examples of their use. 
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~ Chapter 1 ~  
Introduction
Introduction 
1.1 Drug metabolism 
Exogenous and endogenous molecules are eliminated from the body 
principally by excretion in urine.  The hydrophilicity of a molecule is a major 
factor determining its rate of elimination from the body via urine - an aqueous 
medium.  Hydrophilic drugs such as amphetamines, which possess a 
protonated amine at physiological pH, can be excreted in urine without 
undergoing metabolism.  However, hydrophobic compounds, such as steroids, 
are less likely to enter into the aqueous medium and will remain in the body.  
These molecules will undergo metabolism by the body to increase the drug’s 
hydrophilicity and allow renal excretion.  This process is commonly known as 
biotransformation. 
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Scheme 1.1: Metabolism of codeine 1 to morphine 2 and its respective glucuronide 
metabolites (4 and 5). 
Biotransformation can occur throughout the body, but the vast majority is 
carried out at the smooth endoplasmic reticulum of the liver cells (hepatocytes).  
Hydrophobic drugs can diffuse through the hepatocyte cell walls where they can 
be acted upon by an array of metabolising enzymes.  There exist two classes of 
biotransformation.  The first class is known as phase I metabolism and involves 
the chemical modification of the parent compound by such means as oxidation, 
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reduction and/or hydrolysis.  For example, codeine 1 is metabolised by the 
cytochrome P450 enzyme (CYP2D6) to the more bioactive morphine 2 
molecule (Scheme 1.1). 
The second class of biotransformation, phase II, involves the conjugation of a 
drug to an endogenous molecule.  The three primary conjugates are 
D-glucuronic acid 3, sulfate, and glutathione.  At physiological pH, these 
molecules   are   charged,   so   upon   conjugation   they    enhance  the  drug’s  
hydrophilicity, leading to its excretion from the body.  The most common phase 
II conjugation is with D-glucuronic acid (Figure 1.1) 3 (pKa 2.96), known as 
glucuronylation.  Glucuronylation in humans is catalysed by uridine 5’-
diphosphoglucuronosyltransferases (UGTs): a super-family of enzymes, 
comprised of many isoforms.1  UGTs are able to conjugate activated glucuronic 
acid to an array of functional groups including alcohols, carboxylic acids, 
amines and thiols.  Morphine 2 can undergo phase II metabolism by UGT2B7 
(an isoform of UGT), on its phenol or hydroxyl substituent to form two different 
glucuronide metabolites: morphine-3-glucuronide 4 and morphine-6-glucuronide 
5 respectively (Scheme 1.1).2  
O
HO
HO
HO
OH
O O
HO
HO
HO
O
O
OH
H
pKa 2.96
3OH  
Figure 1.1: The pKa of D-glucuronic acid 3.3
1.2 Glucuronides in sports drug testing.  
The use of drugs in an attempt to enhance sporting performance is known as 
“doping”.  The World Anti-Doping Agency (WADA) was formed in 1998 to unify 
the standards on drug analysis following a large police drug raid at the Tour de 
France that exposed the degree of doping in sport.  Its mission is to create a 
“level playing field” in sports, and educate athletes about the health risks 
involved with doping.  Sport drug testing laboratories, such as the Australian 
Sports Drug Testing Laboratory (ASDTL) at the National Measurement Institute, 
screen for performance-enhancing drugs using the standards set down by 
WADA. 
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Testing is predominately performed on urine samples in which most 
hydrophobic performance-enhancing drugs would have undergone phase I 
and/or phase II metabolism.  Drugs such as anabolic androgenic steroids are 
predominately excreted as glucuronide metabolites.4  Direct analysis of these 
glucuronides proves difficult.  Due to their instability towards heat, gas 
chromatography – mass spectroscopy (GC-MS) cannot be directly applied for 
analysis.  Liquid chromatography – mass spectroscopy (LC-MS) avoids the 
heat, but requires an additional liquid-phase micro-extraction sample clean-up 
prior to analysis.5  Additionally, there is not always a glucuronide reference 
material available to validate LC-MS results.  Therefore, the most commonly 
adopted protocol (Scheme 1.2) involves hydrolysis of the metabolites (such as 
testosterone -D-glucuronide 6) back to the parent compound (testosterone 7), 
utilising E. coli -glucuronidase, then derivatisation to the corresponding silyl 
ether 8 and analysis by gas chromatography/mass spectrometry using electron 
impact ionisation (GC-EIMS).6 
O
O
testosterone-D-glucuronide 6
OHO
OH
OH
O
O
OH
O
-glucuronidase
Testosterone 7
1) Solid-phase extraction
2) Derivatisation
OTMS
TMSO
TMS-derivatised testosterone 8
GC-MS analysis
TMS = trimethylsilyl
- Gluc 3
 
Scheme 1.2.  Steps required for the analysis of steroid glucuronides by GC-MS. 
An inefficient work-up, such as an incomplete enzymatic hydrolysis, reduces 
the quantity of detectable hydrolysed drug and provides the laboratories with an 
underestimate of the degree of doping found from the athlete’s urine sample.  
To solve this problem, known quantities of glucuronide reference materials (in 
particular isotope-labelled materials) can be added at the initial step and then 
4 
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5 
utilised to monitor the loss of material associated with each work-up step.  The 
extent of the loss can provide information on the original concentration of 
metabolites prior to the work-up procedures.  This provides the drug testing 
laboratory with a more accurate account of the degree of doping. 
1.3 Glucuronides in pharmaceutics. 
All new pharmaceutical drugs must undergo various clinical trials before they 
can be approved by the respective pharmaceutical advisory board to be sold as 
a treatment.   One of the trials each drug must pass is the toxicity assessment.  
The toxicity assessment examines how the parent compound is absorbed, 
metabolised and excreted, and aims to identify toxic effects in a broad range of 
situations.7  This study is required for various reasons.  The first, and most 
important reason, is to assess any potential health risks that a drug, or any of its 
metabolites, may have on the body.  The second reason is to assess a drug’s 
pharmacokinetics which refers to the study of a drug’s distribution throughout 
the body.  It considers the half-life of the drug, its blood-lipid distribution (known 
as volume of distribution), the best means of administration, as well as its 
elimination or clearance from the body.  Pharmacokinetics is vital in determining 
the maximum tolerated (toxic) dose, minimum therapeutic dose, and to design 
an effective dose regime (i.e. single dose or repeated doses over time). 
In order to study the elimination or clearance of a drug from the body, 
extensive investigation must be undertaken to characterise and quantify every 
possible metabolite.  As the drug under investigation is a new compound, no 
information or reference materials would be available for its metabolites.  This 
investigation would be simplified if reference metabolites, such as glucuronides, 
could be obtained and be used as a comparison in their studies. 
Codeine 1 is a well-characterised drug in terms of pharmacokinetics.  Codeine 
1 is converted to the more bioactive morphine 2 through phase I metabolism.  
Morphine 2 can then undergo glucuronylation to form two different glucuronide 
metabolites (Scheme 1.1).  Glucuronylation of the phenol produces morphine-3-
glucuronide 4, which accounts for two-thirds of morphine 2 recovered in urine.8  
Morphine-3-glucuronide 4 is a potent antagonist of morphine 2 and so 
accumulation of this metabolite reduces the efficacy of morphine 2.9  
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Glucuronylation of the hydroxyl substituent produces morphine-6-glucuronide 5, 
which is present at 10% of the concentration of morphine-3-glucuronide 4 in 
plasma.8  Morphine-6-glucuronide 5 is pharmacologically active and displays 
greater agonistic properties for the 1 opioid receptor than morphine 2 itself, 
increasing the efficacy of morphine 2.8  The example case- study of codeine 1 
highlights the importance of metabolite monitoring in clinical trials.  By 
quantifying the metabolites and their associated bioactivity, a therapeutic dose 
regime can be accurately designed. 
1.4 Glucuronides in agriculture. 
Monitoring of agricultural products is an ever-increasing field due to continual 
pressure placed on the standards required for the food we eat.  In an attempt to 
increase cattle size, some farmers feed their cattle muscle-building androgens, 
or estrogens (that direct the body’s resources into muscle development instead 
of the reproductive cycle).  In 1988, the European Union (EU) placed a ban on 
the importation of hormone-treated meat.  Concerns rose that the hormone-
packed meat may disrupt the hormone levels of its consumers.  Additionally, 
EU-funded studies have raised the concern that hormones are metabolised by 
cattle and the urine-excreted metabolites can run-off and contaminate 
waterways and/or other food sources.10  This ban has increased the demand for 
hormone glucuronide reference materials as EU importers screen meat for 
evidence of hormone-enhanced cattle.  Similarly, cattle exporters, such as 
Australia and the USA, need to screen their exports to Europe to ensure 
hormone concentrations are below the EU standards to avoid costly rejections.  
Glucuronide metabolites are monitored in these screens. 
Another area of concern in agriculture is the presence of pesticide and 
herbicide residues.  Pesticides are sprayed on the crops that cattle eat, as well 
as directly onto the cattle to treat parasites.  These pesticides can also run-off to 
contaminate other food sources and waterways.  As a result, meat, vegetation 
and waterways are screened for pesticides and their associated metabolites 
(such as glucuronides).  Agencies such as Australia’s National Measurement 
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Institute monitor these levels to ensure that the public are not exposed to high 
levels of these toxic compounds. 
1.5 Current methods of glucuronylation 
It is apparent from sections 1.1-1.4 that the monitoring of glucuronides is 
important in a wide variety of fields.  Glucuronide standards are an essential 
commodity in the validation of glucuronide metabolites.  However, these 
standards are often difficult and/or expensive to obtain, if they exist at all.  The 
underlying reason is the absence of an efficient glycosylation method.11  Low 
yields are frequently obtained due to the low reactivity between the glycosyl 
donor and the glycosyl acceptor (such as the secondary alcohol functions in the 
steroid moiety). 
One of the oldest and still most commonly utilised glucuronylation procedures 
is the Koenigs-Knorr method (Scheme 1.3).12  It involves the glucuronylation of 
an acceptor alcohol/phenol (e.g. estrone 9) with a protected -glycosyl halide 
(e.g. methyl 2,3,4-tri-O-acetyl--D-glucopyranosyluronate bromide 10) in the 
presence of a heavy metal salt, Lewis acid or phase-transfer catalyst.13-20  
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Scheme 1.3: Methyl 2,3,4-tri-O-acetyl--D-glucopyranosyluronate bromide (10) is 
coupled to estrone (9) via Koenigs-Knorr method.  Subsequent deacetylation of the 
protected estrone glucuronide (11) produces the estrone 3--D-glucuronide (12).  
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There are many disadvantages associated with the Koenigs-Knorr method.  
Of most concern is the likely formation of by-products.  The majority of Koenigs-
Knorr reactions are only stereoselective due to the multiple pathways possible 
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in the reaction (Scheme 1.4).21  The protected -glucuronide product 13 can 
form from the SN2 mechanism with the -glucuronyl halide 10 (Path A) or 
through a SN1 mechanism that occurs via an oxocarbenium intermediate 14 
(Path B). The -glucuronide product 15 can occur as a result of a SN1 
mechanism (Path B) or via a -glucuronyl halide intermediate 16 (Path C).  
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Scheme 1.4.  The mechanistic pathways for the Koenigs-Knorr reaction.  Substituents 
at the 3, 4, and 5-position are omitted for clarity. 
The use of acyl-protecting groups helps stabilise the glucuronyl halide 10 and 
promotes -glucuronide product 13 formation through anchimeric assistance 
(Path D).22  However, this anchimeric assistance provides additional pathways 
that lead to an ortho ester by-product 17 (Path E).  This ortho ester 17 can be 
isolated or may hydrolyse upon acid work-up to yield an anomeric mixture of 
glucuronide product 13 & 15 (Path F) and/or the 2-deacetylated by-product 18 
(Path G). 
Another drawback to the Koenigs-Knorr reaction is the poor reactivity of the 
glycosyl halides which require harsh reaction conditions and activation by metal 
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salts which are generally toxic, expensive and moisture-sensitive.  Lastly, 
reactions are performed with protected glucuronyl donors 10, so the additional 
hydrolysis step required to remove the protecting groups will reduce the overall 
yield of the glucuronide conjugates. 
Since the discovery of the Koenigs-Knorr reaction in 1901, there has been a 
development of several novel chemical-based glucuronylation reactions.  They 
are somewhat related to the Koenigs-Knorr reaction with the most significant 
variation involving the use of alternative glucuronyl donors.  The substitution of 
the glycosyl halide 10 for a trichloroacetimidate 19 may achieve high 
glycosylation yields under mild Lewis acid catalysis (Scheme 1.5a).11,18,23-27  
Alternatively, the 1-hydroxyl glucuronyl donor 20 can be converted to the 
activated 1-O-silylated glucuronyl donor 21 in situ by the addition of 
trimethylsilyl triflate (Scheme 1.5b).11,18,28  Another strategy for glucuronide 
synthesis is to use the above-mentioned glycosylating methods with a glucose 
unit.  The corresponding glucoside is then selectively oxidised using TEMPO to 
its consequent glucuronide.29,30  Glucuronides yielding O-acyl linkages have 
also been synthesised by using either the Mitsunobu reaction31,32 or through a 
direct and selective esterification33.  These variations have improved yields and 
expanded the range of glucuronylation procedures available to synthetic 
chemists. 
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Scheme 1.5. The glucuronylation of 3,17-dihydroxy-5-androstane 17-acetate with a) 
trichloroacetimidate (19) provides preferentially the -glucuronide product (13) whereas 
b) the triflate procedure produces predominately -glucuronide product (15).18 
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Enzyme-mediated glucuronylation avoids the stringent reaction conditions of 
the Koenigs-Knorr method (and its variants) and utilises unprotected and 
activated glucuronic acid substrates to allow a one-step glucuronylation.  The 
wild-type glucuronidase enzyme can be used by exploiting its transglycosylation 
mechanism (detailed in a later chapter in Scheme 1.8).34-37  A glucuronyl donor 
is generally a glucuronide with a good beta-linked leaving unit such as 4-
nitrophenol.  The glucuronyl acceptor is required in high concentrations to 
compete with water for the glycosyl-enzyme intermediate but improvements to 
the glucuronyl donor have been made in this area with the development of 
chemical rescue38 and glycosyl azides.39  The major drawback to this procedure 
is that the transglycosylation product is also a substrate for hydrolysis which 
often results in low yields.  
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Scheme 1.6: UGT-mediated glucuronylation of estradiol (24). 
The UGTs are a family of eukaryotic membrane-bound enzymes that catalyse 
the transfer of the glucuronic acid moiety of uridine 5’-diphospho--D-glucuronic 
acid (UDP-glucuronic acid) 22 to a variety of acceptors.  For example, estradiol 
3--D-glucuronide 23 has been synthesised by the UGT-mediated 
glucuronylation of estradiol 24 (Scheme 1.6).40  Its existence as a membrane-
bound enzyme causes difficulty in its expression and the practicality of its 
application in reactions.  Animal sacrifice is often required to obtain the UGT 
enzymes.  Additionally, many isoforms of UGTs exist, for example the reported 
number UDP-glucuronosyltransferase isoforms for humans is fifteen and for rats 
it is fourteen.41,42  Each isoform exhibits substrate specificity for a different class 
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of drug/steroid.  However, all isoforms require the addition of UDP-glucuronic 
acid 22 as the glucuronyl donor, which is an unstable and expensive substrate.  
These factors combine to form a very costly and time-consuming 
glucuronylation.  However, the mild, one-step reaction and stereospecific 
outcome of enzyme-mediated glucuronylation makes it an attractive method. 
1.6 -Glucuronidase enzyme 
The -glucuronidase enzyme (E.C. 3.2.1.31) belongs to a class of glycoside 
hydrolysing enzymes known as glycosidases.  They exist in a range of animals 
(e.g. humans, dogs, rats), plants (e.g. rye, rhubarb, tobacco) and micro-
organisms (e.g. Escherichia coli, Clostridium, Staphylococcus).43,44  The 
species of interest in this study is Escherichia coli (E. coli).  Escherichia coli has 
a fully defined genome45 and well-established handling procedures, so genome 
manipulation, cell growth and protein expression are well understood. 
The E. coli -glucuronidase exists as a homotetramer with each subunit 
consisting of 603 amino acids and weighing 68.5 kDa each.46  Investigations 
have proven that the enzyme has optimal activity at pH 7.5.47  The activity of the 
enzyme (Units) and enzyme kinetics (Km and Vmax) can be measured by the 
hydrolysis of p-nitrophenyl -D-glucuronide 25 (Scheme 1.7).48  The released p-
nitrophenolate  26 absorbs strongly in the visible light spectrum (405 nm) and 
can be monitored over time by spectrophotometry. 
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Scheme 1.7: The hydrolysis of p-nitrophenyl--D-glucuronide (25) by -glucuronidase 
(GUS). 
The crystal structure for E. coli -glucuronidase was not available at the time 
this study was performed.  A model has been proposed by Matsumura et. al. 
using the known human -glucuronidase crystal structure.49  It is a reasonable 
comparison to make considering the orthologue is ~50% identical in amino acid 
sequence and exhibits identical activity (Km 0.2 mM E. coli.50 vs. 0.2 mM 
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human51 for p-nitrophenyl--D-glucuronide 25).  The model depicts several 
amino acid residues that may form the binding pocket inside the active site that 
may be responsible for the enzyme’s specificity for glucuronides.  
Intermolecular hydrogen bonding to the glucuronic acid residue is observed 
through aspartic acid 163 (D163), tyrosine 468 (Y468), tryptophan 549 (W549), 
arginine 562 (R562), and asparagine 566 (N566).  Additionally, the close 
proximity of the protonated lysine 568 (K568) residue to the glucuronyl 
carboxylate may provide an ionic interaction that defines the enzyme’s high 
specificity for glucuronides.  Two glutamate residues (E504 and E413) are in 
close range of the anomeric carbon. 
 
Figure 1.2: The hypothesised binding of glucuronic acid 3 to the active site of E. coli -
glucuronidase.  This model has been adapted from Matsumura and Ellington’s model of 
E. coli based on the human sequence and quaternary structure.49  Fine lines indicate 
intermolecular hydrogen bonding within 3Å. 
The mechanism of action for -glucuronidase (Scheme 1.8) has been well 
characterised and is analogous for both prokaryotes and eukaryotes.52  The 
active site consists of two strategically positioned glutamic acid residues: the 
glutamate 504 residue (E504) and the glutamate 413 residue (E413).  These 
work mutually to provide general acid/base and nucleophilic catalysis via a SN2-
like mechanism with a transition state demonstrating substantial oxocarbenium-
ion-like character.  The mechanism begins with an SN2 nucleophilic attack by 
the carboxylate anion of E504 on the anomeric carbon of the glucuronide 27.  
This is catalysed by E413 which acts as a general acid and protonates the 
departing glycosidic oxygen of 27. 
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Scheme 1.8: -glucuronidase mechanism of action. 
This mechanism also has SN1 character due to the oxygen in the ring 
donating electrons to the electron-deficient anomeric carbon of 28.  Departure 
of the aglycon residue results in -glycosyl enzyme intermediate 29.  Water 
enters the active site and performs a nucleophilic attack on the anomeric carbon 
to displace the E504 residue in another SN1/SN2 hybrid mechanism 30.  This is 
catalysed by the E413 carboxylate anion which acts as a general base.  D-
Glucuronic acid 3 is released from 31 with overall retention of configuration and 
the enzyme prepared for another cycle of hydrolysis. 
The mechanism (Scheme 1.8) is completely reversible which means the 
nucleophilic attack on the anomeric carbon in the glycosyl enzyme intermediate 
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29 by an alcohol can generate a -transglycosylated product.  However, this 
transglycosylated product will not accumulate, as it is a substrate for -
glucuronidase, and will eventually undergo the hydrolysis mechanism. 
1.7 Glycosynthases and the genetically-modified -
glucuronidase enzyme 
In 1998, Withers et al. reported the first of what would be a series of 
engineered -glycosidase enzymes that could synthesise -glycosidic 
linkages.53  Because of their ability to synthesise -glycosidic linkages in the 
absence of the reversing hydrolytic pathway they were dubbed 
“glycosynthases”.53  Through site-directed mutagenesis, the nucleophilic 
glutamate residue E358 of the -glycosidase enzyme from Agrobacterium sp. 
was converted to alanine.  The result was a mutant enzyme that was unable to 
function via the normal hydrolytic pathway.  However, when the mutant enzyme 
was supplied with -D-glucosyl fluoride donor 32 and an appropriate glucoside 
acceptor residue, the fluoride was displaced and a 1→4 -glycosylation 
occurred to produce oligosaccharides (such as cellobiosides 33 or longer-
chained oligosaccharides) (Scheme 1.9).     
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Scheme 1.9: Mechanism of action for the Agrobacterium sp. -glycosynthase. 
The -D-glucosyl fluoride-enzyme complex mimics the glycosyl enzyme 
intermediate (i.e. analogous to 29) by providing a good leaving group during 
glycosylation.  The reverse mechanism (fluorination) is essentially absent since 
the fluoride ion is not bound strongly to the enzyme and will be dispersed into 
the medium following glycosylation.  Additionally, the newly formed glycoside 33 
has a poor anomeric leaving group and will not be displaced by poor 
nucleophiles such as a fluoride ion. 
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Since the Agrobacterium sp. glycosynthase in 1998, a variety of 
glycosynthases from a range of -glycosidases have been developed by 
numerous groups from around the world.54-56  The mutants thus far have been 
utilised to synthesise oligosaccharides (such as 33).  Of particular importance to 
this project is a recently engineered enzyme, E. coli -glucuronidase, which was 
developed as a glycosynthase (or more specifically – a glucuronylsynthase) but 
failed to catalyse oligosaccharide synthesis in preliminary trials with a range of 
carbohydrate acceptors.  
Withers developed four E. coli -glucuronidase mutants to be utilised in this 
project.  The glucuronylsynthase enzymes were prepared through the site-
directed mutagenesis of the native E. coli -glucuronidase gene.  The 
nucleophilic glutamate residue (E504) was replaced by either an alanine 
(E504A), glycine (E504G), or serine (E504S) residue.  The fourth mutant is a 
wild-type (WT) species prepared from the unmodified native -glucuronidase 
gene (i.e. retention of the E504 glutamate residue).  All differ from native -
glucuronidase due to an added poly-histidine tag.  -Glucuronidase-deficient 
strains of E. coli were transformed with plasmids bearing the codon of one of 
the four genetically-modified -glucuronidase enzymes. 
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Scheme 1.10. General mechanism for the E. coli -glucuronylsynthase 
The mechanism of the E. coli -glucuronylsynthase (Scheme 1.10) is 
anticipated to operate analogously to the common mechanism of other 
glycosynthases.  Hence, the substitution of the nucleophilic E504 residue to a 
non-nucleophilic residue disables the hydrolytic pathway.  Upon addition of the 
glycosyl fluoride, the glycosyl-enzyme intermediate is imitated (analogous to 
29).  The E413 residue still exists to fulfil its role as a general acid-base which 
aids glucuronylation.  The absence of the hydrolytic pathway means the 
glucuronide products can accumulate. 
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1.8 Early results 
The investigation of enzyme-mediated glucuronylation of biologically important 
alcohols began in early 2005 by Dr. Malcolm McLeod of the University of 
Sydney, in collaboration with Prof. Steven G. Withers of the University of British 
Columbia in Canada.  Following the unsuccessful oligosaccharide synthesis by 
the glucuronylsynthases, their research focused on discovering what sort of 
aglycons would be susceptible to glucuronylation by the glucuronylsynthase 
enzyme.  This study incorporated the development of a library of acceptor 
compounds that were screened to identify “hits” in the Jan screen.  The Jan 
screen (Scheme 1.11) involved the inactivation of the WT -glucuronidase 
enzyme with 2-deoxy-2-fluoro--D-glucuronyl fluoride 34.  Transglycosylation of 
the inactivated -glucuronidase enzyme 35 with an accepting alcohol re-
activates the -glucuronidase enzyme 36.  Formation of reactivated -
glucuronidase enzyme 36 was monitored by the release of the p-nitrophenolate 
26 chromophore from the hydrolysis of p-nitrophenyl -D-glucuronide (pNPG) 
25.  A successful transglycosylation was a promising first step that suggested 
the acceptor alcohol may undergo glucuronylation in a glucuronylsynthase 
reaction.  
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Scheme 1.11: Successful transglycosylation in a Jan Screening. 
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Twelve (37 -50) out of the ninety-six alcohols screened gave significant 
enzyme reactivation after one hour (Figure 1.3).57  The alcohols 2-
methylcyclohexanol (38 and 39) and 4-methylcyclohexanol (40 and 41) were 
used as a diastereomeric mixture.  None of the 54 carbohydrates trialled 
showed any evidence of reactivation.  The twelve alcohol substrates (37-50) 
were trialled in small scale glucuronylation reactions with the three 
glucuronylsynthase (E504A, E504G and E504S) and -D-glucuronyl fluoride 51.  
The formation of glucuronides was monitored by TLC and the products were 
confirmed by LC-MS. 
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Figure 1.3: Successful hits from the Jan screening of the WT.  
In late 2005, three glycosynthases (E504A, E504G, and E504S) were 
successfully expressed and isolated at the University of Sydney.58  McLeod’s 
small scale glucuronylation reactions were successfully repeated and confirmed 
by LC-MS.  The small scale study also determined that the glycine mutant 
(E504G) was the more active mutant.  This observation is hypothesised to be 
due to the absence of a side chain on the glycine residue.  Additional 
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candidates for glucuronylation were also trialled, including a range of phenols 
(52 -54) and steroids (7, 9, 55 -62; Figure 1.4).58 
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Figure 1.4: Additional substrates trialled in glucuronylsynthase reactions. 
Phenol 52 was more reactive than p-cresol 53 which was more reactive than 
p-nitrophenol 54.  It is speculated that the pKa of phenols plays a role in its 
nucleophilicity and therefore reactivity.  Alternatively, the binding site of the 
enzyme may not accommodate a negatively-charged acceptor and therefore 
prohibit the phenolate ion from entering the binding site. 
The 3-hydroxy steroids (55 and 56) showed a good aptitude towards 
glucuronylation by the E504G glucuronylsynthase.  The 17-hydroxy steroids (7 
and 57) showed moderate propensity towards glucuronylation with the E504G 
enzyme.  Surprisingly, the 3,17-dihydroxy steroids (58 and 59) displayed no 
formation of mono or di-glucuronide products.  Progesterone analogues with 
variously positioned alcohols (60, 61 and 62) and estrone 9 showed no spots by 
TLC but tentative signals by electron spray ionisation mass spectrometry (ESI-
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MS).  The difference in reactivity was rationalised as steric hindrance for the 
17-hydroxy and progesterone analogues and poor nucleophilicity by estrone 9.  
No reasonable rationale could be offered for the dihydroxy steroids. 
The twelve alcohols (37-50) identified by McLeod plus phenol 52 and 
dehydroepiandrosterone (DHEA) 55 were scaled up on a 20 mg scale so that a 
yield can be determined and thorough characterisation could be performed on 
the glucuronide products (63 -77, Table 1.1). 
Table 1.1: Alcohols subjected to glucuronylation by glucuronylsynthase. 
OHO
FHO
HO
O
O
+ ROH OHO
HO
HO
O
O
OR
+ HF(aq)
E504G
Phosphate buffer,
pH 7.5, RT,
3-5 days51 63-77  
Entry R (product no.) Additivea Yield (%)  Entry R (product no.) Additive Yield (%)b 
a 63  
- 60 i 
71
O
 
- 84 (38) 
b 
64
 
A 
 
66c 
j 
72O  
B 39 
c 
65  
A 37c k 
73F  
- 40 
d 
66  
A 44 l 
74  
B 67 
e 
67
 
B 53 m 
75
 
B 42 (30) 
f 
68  
- 93 n 
76  
- 13 
g 
69  
- 47 
h 
70  
A 71 
 
o 
77
O
 
-d  
Cd 
5 
26 
a Reactions were performed using -D-glucuronyl fluoride 51 (1.2 equiv.), E504G 
glucuronylsynthase (0.1 mg mL-1) in 50 mM sodium phosphate buffer, pH 7.5 unless 
otherwise stated.  Reaction additives include A: DMSO (12.5% v/v), B: DMSO (25% v/v), C: 
DDM (2.2% w/v).  b Yield in parentheses denotes the yield obtained from the alanine 
glucuronylsynthase (E504A) under analogous reaction conditions.  c Product was 
isolated as a mixture of diastereomers.  d Saturated acceptor (1.4 mg mL-1), E504G (0.2 
mg mL-1) and 100 mM sodium phosphate buffer, pH 7.5 was used. 
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Dimethylsulfoxide (DMSO) was required as a co-solvent to dissolve the more 
hydrophobic alcohols (entries b, c, d, e, h, j, l, m), yet the enzyme showed 
robust qualities by remaining active in DMSO concentrations of up to 25% v/v 
(entries e, j, l, m).  The steroid DHEA 55 was only sparsely soluble in DMSO, so 
the detergent n-dodecyl -maltoside (DDM) was utilised to avoid a significant 
drop in activity by subjecting the enzyme to higher concentrations of DMSO.  
Although complete dissolution was still not attained, DDM was better at 
dissolving DHEA 55 without the denaturing effects DMSO poses at greater 
concentrations. 
An initial investigation into the optimised glucuronylsynthase reaction 
conditions was also visited prior to this research.58  Using the WT enzyme as a 
model system, a range of co-solvents and detergents (at various 
concentrations) were investigated as additives to aid the solubility of 
hydrophobic substrates.58  The effect that each additive had on the hydrolysis of 
p-nitrophenyl--D-glucuronide 25 (Scheme 1.7) in relation to the control sample 
(no additives) suggested their affect with glucuronylsynthases.  This study 
suggested DMSO, DDM and Amidosulfobetaine-14 (ASB-14) had the least 
impact on reducing enzyme activity.  Whilst this study is a good indication to the 
relative affect these additives may have on the glucuronylsynthases, their actual 
effect is still undetermined.  An assay is required to monitor the activity of the 
glucuronylsynthase so that a direct correlation can be drawn between the 
experimental variables and enzymatic activity. 
1.9 Project proposal 
Following on from my Honours research, the ultimate goal for this research 
will be to identify the optimal reaction conditions to maximise product yield for 
the glucuronylsynthase reactions.  To attain this goal, an assay to quantitatively 
measure the kinetics and activity of the glucuronylsynthase enzyme will need to 
be developed.  The ideal assay would directly detect product formation in a 
continuous manner.  The experimental variables of pH, concentration and 
temperature will be optimised to achieve the maximum yield. 
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Another objective will be aiming at broadening the application of the 
glucuronylsynthase reactions.  In the past, the glucuronides of simple acceptor 
substrates (identified from the Jan screen) have been synthesised to establish 
the functionality of the glucuronylsynthase.  By demonstrating the enzyme’s 
application in industries, such as the pharmaceutical industry, it will expand the 
potential use in the synthesis of phase II glucuronide metabolites.  The ultimate 
role of this enzyme is for the synthesis of steroid glucuronides which are in high 
demand in the sports testing laboratories.  The development of high yielding 
reactions with steroids, that rival the alternate means of glucuronylation, is 
essential for the future applications of this enzyme. 
The development of a direct assay will assist in observing the enzyme kinetics 
and provide the information required to seek the optimal reaction conditions.  
Success with a range of steroid and pharmaceutical substrates will demonstrate 
the diversity of this technique’s application.  A combination of high yielding 
glucuronylation and universal application will see the glucuronylsynthase 
enzyme become an asset in the industrial synthesis of glucuronide metabolites. 
 22 
~ Chapter 2 ~       
The 
glucuronylsynthase 
system
The glucuronylsynthase system 
23 
2.1 Overview 
The primary development of the glucuronylsynthase methodology has been 
researched and successfully applied to the glucuronylation of a library of simple 
alcohols and a select range of steroids (Table 1.1).57,58 The methodology was 
developed from general chemical and biochemical procedures as well as those 
reported for other glycosynthase systems.  A more thorough investigation into 
the methodology may improve reaction yields and provide a greater 
understanding of the glucuronylsynthase system.  The optimisation of the 
glucuronylsynthase system was performed at all levels: from the expression of 
the glucuronylsynthase enzyme and the synthesis of the -D-glucuronyl fluoride 
51 donor through to the reaction conditions of the glucuronylsynthase reactions. 
2.2 The recombinant E. coli. 
The construction of the glucuronylsynthase gene was developed in the 
Wither’s group through site-directed mutagenesis of the E. coli -D-
glucuronidase enzyme.57  The glucuronylsynthase enzyme was expressed from 
a gene sub cloned into a Novagen® pET-28a(+) vector (Figure 2.1) at the NdeI 
and XhoI cloning sites.57  The pET-28a(+) vector also carries the kanamycin 78 
resistance gene, T7lac promoter, and an N-terminal His-Tag extension.  The -
glucuronidase deficient E. coli lysogenic cell line GMS407(DE3) was used to 
host this plasmid to ensure glucuronylsynthase expression that was free of wild-
type activity.59  
Using this expression system, the glucuronylsynthase enzyme has been 
achieved in good yields (~40 mg L-1 culture).58  However, for each step of the 
expression (e.g. transformation, cell lysis), alternative biochemical techniques 
are available.  It was of particular interest if an alternative technique may 
provide a more efficient and higher yielding method to obtain the 
glucuronylsynthase enzyme.  The optimum expression, isolation and purification 
techniques for the glucuronylsynthase enzyme are discussed. 
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Figure 2.1.  pET-28a(+) vector map reproduced from Novagen.60 
2.2.1 Transformation 
The first step of the glucuronylsynthase expression involved the 
transformation of the E. coli cells with the pET-28a vector bearing the 
glucuronylsynthase gene.  Two common procedures were available to perform 
this feat.  The first method was a chemical heat–shock transformation.61,62  
Upon an instant rise in temperature (4 C to 42 C) in a calcium-rich media, the 
plasmid penetrates the host cells.  This method was the original transformation 
procedure used, prior to this research, to transform the host strain with the 
vector. 
An alternative technique is electroporation which also achieved successful 
transformation.  An electric current is used to increase the permeability of the 
bacteria cell wall and allow plasmid penetration.63  By visual observation, both 
transformation procedures achieved transformation with equivalent efficiency.  
The choice of transformation procedure is therefore at the researcher’s 
discretion. 
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2.2.2 Selection 
Following transformation, the successful transformants must be identified and 
isolated.  Selection of the transformed E. coli was performed on Luria Burtani 
(LB) agar media containing kanamycin 78 and 5-bromo-4-chloro-3-indolyl β-D-
glucuronide (X-gluc) 79.  Kanamycin 78 is an aminoglycoside antibiotic that 
inhibits the 30s ribosomal subunit and prevents translation of protein.  The pET-
28a(+) carries the gene for kanamycin kinase, an enzyme capable of 
deactivating kanamycin 78 through phosphorylation to allow the host cell to 
survive in the presence of this antibiotic.  A selection process was achieved by 
growing cells in kanamycin-enriched media whereby only successful 
transformants bearing kanamycin 78 resistance survived.  
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Figure 2.2. The aminoglycoside antibiotic kanamycin 78 
In the presence of wild-type -glucuronidase, X-Gluc 79 is hydrolysed to the 
enol 5-bromo-4-chloroindoxyl and, through dimerisation and oxidation (in the 
presence of oxygen), forms the blue (max = 615nm) 5,5’-dibromo-4,4’-dichloro-
indigo dye 80 (Scheme 2.1).  As a result, any cells expressing wild-type -
glucuronidase would grow with blue discolouration.  X-Gluc 79 therefore 
provided a second selection process based on glucuronidase functionality.  
Successful transformation of the glucuronylsynthases into the GMS407(DE3) 
strain produced white colonies that survived on LB media containing kanamycin 
78 and X-gluc 79.   
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Scheme 2.1.  Use of X-gluc 79 for the selection of functional -glucuronidase (GUS). 
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2.2.3 Induction 
Once the successful transformants had 
been identified, a culture was grown 
from a single colony, and the over-
expression of the glucuronylsynthase 
enzyme was commenced.  The pET-
28a(+) plasmid regulates the expression 
of glucuronylsynthase using an 
amalgamation of two well-characterised 
transcription regulators: the lac operon 
(specifically lacUV5) and the strong T7 
bacteriophage transcription system 
(Figure 2.3).  The lac operon acts as an 
expression “brake” and is derived from 
the regulation of -galactosidase.64 
The lac repressor protein, a tetrameric 
DNA binding protein, is expressed from 
the lacI gene from the genome and the 
plasmid. It binds to the lac operator site 
(lacO) present in the DE3 gene of the 
genome (T7 RNA polymerase 
expression) and the T7 promoter on the 
plasmid (glucuronylsynthase 
expression).  
 
When bound, the lac repressor protein 
represses T7 RNA polymerase 
expression at the genome and blocks 
the binding of any polymerase to the 
plasmid (“brake” applied), preventing 
transcription of the glucuronylsynthase 
gene. 
Figure 2.3 The induction of the 
pET-28a(+) vector in λDE3 lysogens.  
Image reproduced from Novagen.65 
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Isopropyl -D-1-thiogalacto-pyranoside (IPTG) 81 (Figure 2.4) binds to the 
repressor protein, altering its conformation and releasing it from the lacO sites 
to allow expression of the T7 RNA polymerase 
(“brake” lifted).  T7 RNA polymerase expressed from the DE3 gene (in the E. 
coli genome) will strongly bind to the un-repressed T7 promoter region on the 
plasmid and subsequently transcribe the glucuronylsynthase gene. 
O
HO
HO
OH
S
OH
  
Figure 2.4.  Isopropyl -D-1-thiogalactopyranoside (IPTG) 81 
The T7 transcription system is derived from the T7 bacteriophage, a bacterial 
virus.  The T7 RNA polymerase is highly selective and active such that when 
cells are fully induced, almost all of the cell’s resources are converted to 
targeted gene expression; the desired product can comprise more than 50% of 
the total cell protein a few hours after induction.65  Its high selectivity and 
activity makes it an expression “accelerator”.  The removal of the lac repressor 
protein combined with the strong binding of the T7 RNA polymerase 
metaphorically “lifts the brake and applies the acceleration” to over-express the 
glucuronylsynthase enzyme. 
From the selection plates (kanamycin 78 and X-gluc 79), 0.5 L cultures were 
grown in LB media containing kanamycin 78, and cells were induced with IPTG 
81 once the optical density (OD600nm) reached ~0.7.  An aliquot from each 
culture was taken prior to and after induction (Figure 2.5) and subjected to 
sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE), a 
technique that resolves protein based on molecular weight.  Over-expression of 
the glucuronylsynthase gene was confirmed by an intense band in the post-
induction sample coinciding with the mass of the enzyme (68.5 kDa).  Post-
induced cells were centrifuged and the cell pellet stored at -80 C until needed. 
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Figure 2.5.  SDS-PAGE gel from 
glucuronylsynthase induction. Lane 1 is 
a protein standard marker with indicated 
band sizes; lane 2 is the cell culture pre-
induction; lane 3 is the cell culture 3 h 
after IPTG 81 induction; lane 4 is the 
purified protein. 
2.2.4 Purification 
The final step of the glucuronylsynthase production involved the isolation of 
the pure enzyme from the bacterial cells.  The pET-28a(+) plasmid encodes for 
a hexa-histidine extension (His-tag) and thrombin recognition site on the N-
terminus of the expressed enzyme.  This protein fusion link was exploited in 
the enzyme’s purification.  The nitrogen in the imidazole ring of histidine 
coordinates strongly to nickel (II) ions (Figure 2.6) to allow affinity-based 
purification.   
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Figure 2.6: Poly-histidine tail co-ordinated to Ni2+ ions. 
Purification began by first lysing the bacterial cells.  Previously, cellular 
disruption was performed by a series of freeze-thaw cycles in liquid nitrogen.57  
Having recently gained access to a French pressure cell press, the yields on 
glucuronylsynthase enzyme have risen from 18 mg of protein per gram of cells 
(utilising freeze-thaw) to 20-25 mg of protein per gram of cells (French press).  
The over-expression of glucuronylsynthase is therefore calculated to be at 
least 2.5% w/w of cell mass. 
The crude cell extract was loaded onto a HisTrapTM column (GE Healthcare) 
consisting of nickel sepharose media.  The column was washed with a 
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buffered saline solution containing a dilute concentration of imidazole.  
Glucuronylsynthase bound tightly to the resin-bound nickel due to its poly-
histidine tail whilst the remainder of the cell extract was washed from the 
column.  This could be visualised by a strong UV absorption during this 
washing step.  Imidazole also binds strongly to nickel and competes with the 
histidine residues.  The concentration of imidazole was slowly increased over a 
gradient to displace glucuronylsynthase from the HistrapTM column.  Amicon® 
centrifugation filter units were used to concentrate the enzyme fractions and 
change the eluting solution to phosphate buffer by ultrafiltration.  The 
centrifugation filter units have a molecular weight cut-off of 10 kDa allowing the 
glucuronylsynthase (68 kDa) to remain in the cartridge. 
A thrombin recognition sequence exists in the linker region between the poly-
histidine tail and the enzyme.  Thrombin is highly specific endo-peptidase and 
can be used for the cleavage of the poly-histidine tag from the enzyme.  This is 
useful in cases where the poly-histidine tail may hinder enzyme activity and/or 
infer incorrect structural conformation.66,67  Fortunately, previous studies on the 
His-tagged wild-type glucuronidase showed no impediment on wild-type 
activity.58   As a result, the glucuronylsynthase was used with the His-tag still 
appended. 
2.2.5 Plasmid amplification 
A fresh transformation was performed for every batch of enzyme expressed 
and stocks of plasmid were needed to avoid the laborious steps involved in re-
cloning another plasmid.  NEB5 strain of E. coli was used to host the 
amplification due to its genotype giving it high permeability and low plasmid 
degradation.  It contains genotypes such as recA1 (a recombination deficiency 
to avoid recombination of homologous sequences into the bacterial genome), 
endA1 (elimination of non-specific endonuclease expression) and hsdR17 
(removal of a native restriction enzyme to avoid foreign DNA degradation).  
The NEB5 cells were transformed via electroporation and grown to a 2 mL 
culture from a single transformed colony.  The plasmid was extracted from the 
cell pellet using a QIAprep Spin Miniprep Kit (Qiagen) to yield 100 L of 
plasmid. 
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The isolated plasmid was sequenced to ensure the infallible duplication of 
the plasmid and the glucuronylsynthase gene.  A single digestion (XhoI) and 
double digestion (NdeI and XhoI) was performed on the plasmid at the gene 
insertion sites with the digestion fragments analysed by SDS-PAGE (Figure 
2.7).  For the single digestion, a single band was observed ~7 kB 
corresponding to the pET28a(+) plasmid (~5.4 kB) bearing the 
glucuronylsynthase gene (~1.8 kB).  For the double digestion, two bands were 
observed.  One band is observed at 6 kB and corresponds to the empty pET-
28a(+) plasmid (~5.4 kB) and the other band occurs at 1.8 kB which 
corresponds well with the glucuronylsynthase gene (~1.8 kB).  Sequencing the 
plasmid has confirmed that the glucuronylsynthase gene still exists in the 
plasmid for future transformations. 
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Figure 2.7: SDS-
PAGE of the double 
digestion (lane 2) and 
single digestion (lane 
3) of the pET-28a 
plasmid against a 1 kB 
DNA ladder standard 
(Lane 1).    
2.3 Glucuronylsynthase crystal structure 
From the introduction, the -glucuronidase enzyme is used extensively in 
industry and molecular biology.  Yet, despite its widespread application, at the 
time of this publication, no crystal structure has been obtained.  A model has 
been proposed by Matsumura et. al. using the known human -glucuronidase 
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crystal structure (Figure 1.2).49  Whilst this model predicts the amino acid 
residues that may participate in binding of the glucuronic acid moiety, the 
residues responsible for the variation of aglycon substrate specificity are not 
known.  It may also be difficult to use this model to rationalise aglycon 
specificity considering the different roles that -glucuronidase plays in humans 
versus E. coli.  Human -glucuronidase has a specific role of hydrolysing the -
linked D-glucuronic acid 3 residues from the non-reducing termini of 
glycosaminoglycans oligosaccharides.68  In E. coli, -glucuronidase has a 
universal role of removing -glucuronic acid 3 residues from almost any 
metabolite as an energy source for the cell.  The universal role of E. coli 
-glucuronidase suggests the tertiary structure of the aglycon binding region 
would differ from the human -glucuronidase structure.  The crystal structure of 
the E. coli b-glucuronidase would provide more information behind the 
promiscuous activity of this enzyme and, in future, allow the evaluation of 
changes involved in mutagenic studies, such as site-direct mutagenesis and 
directed evolution. 
An attempt to grow a crystal of glucuronylsynthase was performed with a 
library of known crystallising conditions.  A series of microbatch crystallisations 
in 96-well plates were performed using Hampton Research® Crystal ScreenTM 
(Hampton Research, Laguna Hills, CA), Hampton Research® Index ScreenTM 
(Hampton Research, Laguna Hills, CA) and QIAGEN® PEGS SuiteTM (QIAGEN 
Sciences, Germantown, MD). For each crystallising solution, three wells were 
used.  The first well contained the enzyme only, the second well contained the 
enzyme and -D-glucuronyl fluoride 51 and the third well contained the 
enzyme and p-nitrophenyl--D-glucuronide 25.  Screens were conducted with 
-D-glucuronyl fluoride 51 and p-nitrophenyl--D-glucuronide 25 in the hope of 
a obtaining a substrate-bound crystal. 
Out of the 864 crystallising conditions trialled, only ten conditions displayed 
possible crystal formation (crystal photographs are attached in section 7.2.16).  
Out of this ten, two crystallising solutions exhibited crystals in more than one 
well.  In the presence of Tris (0.1 M, pH 6.9), mono-sodium phosphate 
monohydrate (0.49 M), and di-potassium phosphate (0.91 M), rod-clusters 
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were observed for the enzyme in the presence of -D-glucuronyl fluoride 51 
and p-nitrophenyl -D-glucuronide 25.  In the presence of tri-ammonium citrate 
(1.8 M, pH 7.0), plate-like crystals were observed in the wells containing the 
glucuronylsynthase alone and in the presence of -D-glucuronyl fluoride 51. 
Table 2.1: Formulation for the scaled up crystallisation attempts of glucuronylsynthase. 
Conditions 
Crystal 
attempt Crystallising formulation E
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Tris (0.1 M, pH 9.6), NaH2PO4.H2O  
(0.45-0.55 M), K2HPO4 (0.75–1 M) 
   
2 
Na2HPO4 (0.175-0.225 M), 
PEG 3350 (16-26% w/v) 
   
3 
Mg(HCO2)2 (0.175-0.225 M), 
PEG 3350 (16-26% w/v) 
   
4 
HEPES (0.075-0.125 M, pH 7.5), 
PEG 3350 (19-29% w/v) 
   
5 
Tris (0.1 M, pH 8.5), CaCl2.H2O 
(0.175-0.225 M), PEG 400 (24-34% w/v) 
   
The growth of crystals large enough for x-ray diffraction was attempted using 
the hanging-drop method in 24-well plates.  Out of the ten promising 
crystallising conditions, five crystallising solutions were selected and repeated 
on a larger scale (Table 2.1).  This selection was based on the appearance of 
crystals grown in the microbatch crystallisation screen.  Eighteen wells were 
used to crystallise the enzyme using various ratios of the crystallisation 
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formulation.  The remaining 6 wells were omitted of enzyme in a blank run to 
rule out inorganic crystallisation.  No crystals were observed from any of the 
scaled up crystallisations.  Repeating the conditions using batch crystallisation 
(as used in the screens) might be more successful.  The tri-ammonium citrate 
was not trialled in the scaled up crystallisations as the formula consisted of a 
single component.  Given the results in the crystallisation screen, it should be 
investigated in future attempts by varying the concentration or pH of the 
solution. 
The methodology for glucuronylsynthase expression has been investigated 
and improved with only a slight modification from the initial protocol used.  A 
40% improvement in enzyme yield was seen when the cell lysis method was 
altered from a freeze-thaw technique to a French-cell press technique.  
However, the appropriate crystallisation condition to grow sizable crystals for x-
ray crystal analysis is still under investigation.  With the development of the 
methodology for glucuronylsynthase expression complete, the methodology for 
the -D-glucuronyl fluoride 51 donor synthesis was optimised. 
2.4 Synthesis of the ammonium 1-deoxy-1-fluoro 
-D-glucopyranuronate (-D-glucuronyl fluoride) 
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Scheme 2.2: Synthesis of -D-glucuronyl fluoride 51 
The ammonium 1-deoxy-1-fluoro -D-glucopyranuronate (-D-glucuronyl 
fluoride) 51 required for glucuronylsynthase reactions has previously been 
synthesised (Scheme 2.2).58  With each attempt at the synthesis, some 
reaction yields have improved and the conditions for these optimised reactions 
are detailed in the experimental.  To summarise the synthetic sequence, 
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D-glucose 82 is selectively per-acetylated as the -anomer 83, then fluorinated 
with hydrogen fluoride at room temperature.  The -anomer 84 is the 
thermodynamic product in the fluorination reaction.69  A simple trans-
esterification with methoxide removes the acetyl groups which is followed by a 
selective TEMPO oxidation of the primary alcohol of 32. 
A TEMPO oxidation is usually performed in the presence of stoichiometric 
sodium chlorite and catalytic sodium hypochlorite to avoid chlorination by-
products which tend to occur with aromatic substrates.70  With no aromaticity in 
the molecule, the TEMPO oxidation was conducted with stoichiometric quantity 
of sodium hypochlorite and in the absence of sodium chlorite.  No chlorinated 
by-products were observed.  Purification was achieved by ion-exchange 
chromatography with Dowex® anion exchange resin and ammonium 
bicarbonate.  The fractions were combined and lyophilised on a freeze-drier 
until most of the ammonium bicarbonate had decomposed. 
Crystallisation was achieved with 70% aqueous ethanol with acetone 
required in some cases to aid crystallisation.  The X-ray crystal structure was 
obtained (Figure 2.8) and shows the relative stereochemistry of the sugar 51.  
The crystal unit depicts an extensive network of hydrogen bonding exists 
between the species (omitted in Figure 2.8 for clarity). 
  
Figure 2.8.  Crystal structure of 1-deoxy-1-fluoro -D-glucopyranuronate 51 anion with 
labelling of selected atoms.  Anisotropic displacement ellipsoids show 30% probability 
levels.  Hydrogen atoms are drawn as circles with small radii. The CIF is reported in 
appendix 2. 
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The synthesis of the ammonium 1-deoxy-1-fluoro -D-glucopyranuronate (-
D-glucuronyl fluoride) 51 has not been altered from its previous synthetic 
sequence.  However, improvements to the work-up procedures, particularly in 
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the isolation of the final -D-glucuronyl fluoride 51, have improved the overall 
yield of the glycosyl donor.  The -D-glucuronyl fluoride 51 can be synthesised 
in 39% from D-glucose 82 or 69% from the penta-acetylated glucose 83.  The 
single crystal x-ray structure obtained for -D-glucuronyl fluoride 51 validates 
the synthesis and relative stereochemistry of this molecule. 
The core components of the glucuronylsynthase reaction are the 
glucuronylsynthase enzyme and -D-glucuronyl fluoride 51.  The protocols 
outlining their optimised production have been outlined for the 
glucuronylsynthase methodology.  The next agenda was to optimise and 
improve yields in the glucuronylsynthase reactions and expand the substrate 
repertoire for this enzyme. 
2.5 Expanding the scope of the glucuronylsynthase 
methodology 
2.5.1 Defining the glucuronylsynthase reaction protocol 
In the past, glucuronylsynthase reactions were performed with no formalised 
protocol to follow.  The substrate would be used as concentrated as possible 
with DMSO to aid solubility where required.  It was time to research the 
optimised conditions and define the reaction protocol for the 
glucuronylsynthase reaction.  A selection of the alcohols subjected to 
glucuronylsynthesis during my Honours research (Table 1.1) were retested 
with different reaction conditions to verify reproducibility and improved yields.  
A range of results were achieved consisting of both improved and inferior 
yields (Table 2.2).  In each case, double the glucuronylsynthase concentration 
(0.2 mg mL-1) of my Honours research (0.1 mg mL-1) was used unless 
otherwise stated. 
Some reactions were performed with multiple variations making it difficult to 
pinpoint the exact variable responsible for the reaction yield.  However, there 
were a couple of trends that stood out.  When DDM is used to aid solubility, the 
yield is improved in most cases (trans-4-methylcyclohexonol 41 being the 
exception).  This may be due to reduced enzyme inactivation especially when 
the detergent is substituted for harsh co-solvents like DMSO.   
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Table 2.2. Revised glucuronylsynthase reactions. 
OHO
FHO
HO
O
O
OHO
OH
HO
O
O
O
0.2 mg mL-1 E504G
pH 7.5, RT R
+
1.2 equiv
HO R + HF(aq)
 
R 
Previous 
yield (%)a 
New yield 
(%)a Altered conditions 
 
67b 41 
half the substrate concentration, 
E504G increased to 0.4 mg mL-1, 
DMSO concentration reduced to 5% 
 
37b 60 
half the substrate concentration, 
DMSO concentration reduced to 10% 
 
44c 21 25% DMSO replaced by 0.5% DDM 
 
47 58 none 
O
 
84 64 double the substrate concentration 
F
 
40 50 
quarter the substrate concentration, 
0.5% DDM used 
O
 
39c 45 
half the substrate concentration, 
25% DMSO replaced by 2% DDM 
 
42c 48 25% DMSO replaced by 1% DDM 
 
13 31 E504G increased to 0.4 mg mL-1 
a Reactions were performed using -D-glucuronyl fluoride 51 (1.2 equiv.), E504G 
glucuronylsynthase (0.1 mg mL-1) in 50 mM sodium phosphate buffer, pH 7.5 unless otherwise 
stated. b 12.5% DMSO used.  c 25% DMSO used. 
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Increasing enzyme concentration also seemed to improve the yield for cis-2-
methylcyclohexanol 38 and phenol 52.  The improvement in yield is likely due 
to more enzyme available to turnover such a slow reaction.  It is also 
interesting to see that by doubling the concentration of 3-methoxybenzyl 
alcohol 47 we reduce the yield by 20%, yet when we reduce the concentration, 
such as for 4-fluorobenzyl alcohol 50 or 4-methoxybenzyl alcohol 48, an 
improved yield is observed.  Standard Michaelis-Menten enzyme kinetics 
predicts that an increase to the substrate concentration should increase the 
rate of reaction (limited to the enzyme’s maximum velocity) which would be 
advantageous to the yield.  However, this is not the case and with the optimum 
reaction variables still undetermined, a glucuronylsynthase reaction protocol 
could not be defined.   An enzyme kinetic study was required to better assess 
the individual reaction variables.  But before an enzyme kinetic study was 
undertaken, the scope of the glucuronylsynthase methodology was explored 
with the demonstration of reaction scalability. 
2.5.2 Scalability of glucuronylsynthase 
The most contemporary procedure for glucuronide synthesis incorporates 
uridine 5’-diphosphoglucuronosyltransferases (UGTs) to catalyse 
glucuronylation.40  However, its existence as a membrane-bound enzyme 
causes difficulty in its expression and the practicality of its application in 
reactions.  Typically, reactions involving UGTs are restricted to <10 mg scales. 
The glucuronylsynthase enzyme exists as globular homotetramer; allowing 
ease of handling and large-scale expression.  In past investigations, 
glucuronylsynthase reactions were performed on 20 mg scales for analytical 
purposes.58  To assess the application of glucuronylsynthase on a large scale 
reaction, 5 mg of enzyme was used to convert 300 mg (2.5 mmol) of 2-
phenylethanol 45 to its corresponding glucuronide 68 (Scheme 2.3) in 96% 
yield (718 mg).  This yield is equivalent to that obtained with a 20 mg scale 
reaction (93%) and was achieved with only 0.003 mol% of enzyme. 
The capability to scale up the reaction (fifteen fold in this case) with no 
change in yield illustrates the practicality of large scale glucuronylsynthase 
reactions for application in industry.  With glucuronylsynthase reaction 
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scalability successfully demonstrated, it was time to expand the scope of the 
glucuronylsynthase methodology by investigating the enantioselectivity of the 
glucuronylsynthase enzyme. 
OHO
FHO
HO
O
O
OHO
OH
HO
O
O
O
0.2 mg mL-1 E504G
pH 7.5, RT
+ + HF(aq)
HO
45
300 mg
51 68
716 mg (96%)  
Scheme 2.3.  Large scale glucuronylsynthesis of 2-phenylethanol 45. 
2.5.3 Enantioselectivity of the glucuronylsynthase enzyme 
A large range of enzymes are known to be enantioselective.  Whilst no 
literature exists on the stereoselectivity of native -glucuronidase, it would be 
an interesting study to determine if the glucuronylsynthase has any preference 
towards one enantiomer of a chiral acceptor.  Reviewing the fifteen substrates 
explored during my Honours research (Table 1.1), two substrates (cis-2-
methylcyclohexanol 38 and trans-2-methylcyclohexanol 39) were reacted as a 
mixture of enantiomers (Figure 2.9).  In previous studies, the glucuronide of 
trans-2-methylcyclohexanol 39 was synthesised in the highest yield out of the 
two substrates (Table 1.1).  As a result, the enantioselectivity of the 
glucuronylsynthase enzyme towards trans-2-methylcyclohexanol 39 was 
examined in more depth through the use of a Mosher’s auxiliary in an attempt 
to identify and quantify the enantiomers. 
(R)
(R)
OH
(S)
(S)
HO
( S)
(R)
OH
(S)
(R)
HO
R,R-39 S,S-39R,S-38 S,R-38  
Figure 2.9: The enantiomers of cis-2-methylcyclohexanol 38 and trans-2-
methylcyclohexanol 39. 
To begin, the enantiomeric ratio of the commercially-supplied trans alcohol 
39 was determined.  Excess (S)-(+)--methoxy--trifluoromethylphenylacetyl 
chloride 85 was generated in situ then added to the trans-alcohol 39 to create 
a diastereomeric mixture of the trans-2-methylcyclohexyl (R)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (trans Mosher ester) 86 (Scheme 2.4).71 
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Scheme 2.4: The Mosher esterification of (±)-trans-2-methylcyclohexanol 39. 
The chemical shift relating to the methyl on the cyclohexyl ring is resolved by 
1H NMR and was used to quantify each diastereomer (Figure 2.10).  For the 
trans Mosher esters 86, one methyl shift occurs at 0.94 ppm and the other at 
0.78 ppm.   The NMR analysis showed an equivalent ratio of diastereomers for 
the trans Mosher esters 86 which suggested that the trans 2-
methylcyclohexanol 39 was supplied as a 1:1 mixture of enantiomers. 
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Figure 2.10: 1H NMR spectrum (300 MHz, CDCl3) of the trans Mosher esters 86 made 
from commercial trans-2-methylcyclohexanol 39. 
The methyl resonance in the 1H NMR was also used to determine the 
absolute configuration of the trans Mosher esters 86.  Analysing the Dale-
Mosher model for the trans Mosher esters 86, it is predicted that the methyl of 
the S,S-trans Mosher ester R,S,S-86 would exist further upfield from the 
methyl of the R,R-trans Mosher esters ester R,R,R-86 due to the shielding by 
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the phenyl ring (Figure 2.11).72  This model suggests that the methyl 
resonance at 0.94 ppm should be assigned as the R,R-trans Mosher ester 
R,R,R-86 and the 0.78 ppm as the R,S,S-trans Mosher ester R,S,S-86.  
However, this is not consistent with literature, which assigns the methyl of 
R,S,S-86 further downfield relative to the R,R,R-86 methyl resonance.73,74  The 
assignment of the trans Mosher esters 86 in the literature were based on the 
optical rotation of the alcohol 39 prior to esterification.  An extensive 13C study 
on Mosher esters by Lemière noted that the Mosher’s ester for 2-substituted 
cyclohexanols did not fit the Dale-Mosher model.75  The proximity of the methyl 
group to the Mosher’s auxiliary is hypothesised to impose steric interactions 
that distort the Dale-Mosher conformation. 
(S)
(S)
H
O( R)
O
CH3
H
F3C
O ( R)
( R)
H
O( R)
O
F3C
O H3C
HCH3CH3
R,S,S-86 R,R,R-86  
Figure 2.11.  Dale-Mosher conformations of (R)-MTPA esters of trans-2-
methylcyclohexanols 86. 
In light of this literature inconsistency, we hoped to determine the absolute 
configuration of the trans Mosher esters 86 by separating them by HPLC, 
removing the Mosher auxiliary and assigning the absolute configuration of the 
trans-alcohol 39 based on optical rotation.  Normal phase HPLC was used on 
the trans Mosher esters 86 but baseline separation could not be achieved 
(Figure 2.12).  Attempts at isolating the two diastereomers 86 by preparative 
HPLC was unsuccessful with the two isomers co-eluting from the column.  
Alternative HPLC conditions need to be further investigated so that the 
diastereomers 86 can be isolated.  As a result of this, the literature data 
reported by Hirata was used to assign the absolute configuration of the trans 
Mosher esters 86.73 
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 Figure 2.12: HPLC chromatogram (260 nm) of the trans Mosher ester 86 made from 
commercial supply. 
A glucuronylsynthase reaction was performed on the racemic mixture of 
trans-2-methylcyclohexanol 39 with the glucuronide product 64 isolated from 
flash chromatography in 35% yield (Scheme 2.5).  The 1H NMR illustrated a 
clear selectivity for the reaction of one enantiomer over the other (Figure 2.13 
and Figure 2.14).  There is a significant shift in some of the pyranose protons 
(Figure 2.13).  The H12 and H11 protons are clearly separated and have a 
chemical shift difference (Δδ) of 0.022 ppm and 0.029 ppm respectively.  The 
H10 and H9 protons also show diastereomeric resonances, however the extent 
of their separation is obstructed.  The H1 proton of the two diastereomeric 
glucuronides 64 achieves baseline separation.  However, the environment for 
the major isomer is obscured by the H9 environment.  
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Scheme 2.5.  Glucuronylsynthase reaction on racemic trans-2-methylcyclohexanol 39. 
The majority of the alkyl protons in the cyclohexanyl ring appear as broad 
multiplets in the 1H NMR spectrum (Figure 2.14).  The exception to this being 
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the two doublets that correspond to the methyl protons (H7).  The two 
resonances (Δδ = 0.064 ppm) provide an estimated diastereomeric ratio of 1.0 
: 4.0.  Unfortunately, another proton environment arises between these two 
peaks which did not allow baseline integration of the two environments.  
However, another set of isolated diastereomeric resonances were present in 
the spectrum.  The H2 protons appear at ~2.1 ppm and are separated (Δδ = 
0.051 ppm) with baseline separation.  The ratio of their integration provided a 
diastereomeric ratio (1.0 : 4.2.) equivalent to that calculated for the methyl (H7) 
environments.  
 
Figure 2.13. 4.5-3.0 ppm region of the 1H NMR (800 MHz, MeOD) spectrum of trans-2-
methylcyclohexyl -D-glucuronide 64 depicting the diastereomeric protons in the 
pyranosyl ring. 
 
Figure 2.14.  2.2-0.85 ppm region of the 1H NMR spectrum of trans-2-methylcyclohexyl 
-D-glucuronide 64 depicting the diastereomeric protons in the cyclohexanyl ring. 
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The 1H NMR of trans-2-methylcyclohexyl -D-glucuronide 64 provides the 
diastereomeric ratio of the reaction, but no information regarding the absolute 
configuration of the major diastereomer.  To determine the stereochemistry of 
the major diastereomer, the purified glucuronide 64 was dissolved in 
phosphate buffer and subjected to enzymatic hydrolysis by wild-type -
glucuronidase (Scheme 2.6).  The free trans-alcohol 39 aglycon was extracted 
with ethyl acetate to yield 67% recovery from the glucuronide 64.  The 
unaccounted mass (5.8 mg, 33%) was likely due to the evaporation of the 
volatile alcohol 39 during the drying process.  The aglycons were converted to 
the trans Mosher esters 86 under analogous conditions used for the starting 
material.  Unfortunately, there was not enough material to make the (S)-
Mosher ester as well. 
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Scheme 2.6.  Mosher's esterification of the glucuronide aglycons (39). 
The 1H NMR spectrum for the trans Mosher esters 86 of the hydrolysed 
product 39 showed a significant difference in the integration of the methyl 
chemical shifts.  The methyl shift at 0.94 ppm predominates over the other 
methyl shift just visible at 0.78 ppm (Figure 2.15).  Whilst the NMR spectrum is 
not clean enough to accurately integrate the two methyl environments, visually 
there is a dramatic decrease in one of the diastereomeric species. 
The difference of the two diastereomeric methyl shifts (Δδ = δ[(R)-MTPA 
ester of (+)-alcohol] – δ[(R)-MTPA ester of (-)-alcohol]) was equal to the Δδ 
value of 0.161 reported by Hirata.73  The major methyl peak at 0.94 ppm 
implies that the R,S,S-trans Mosher ester R,S,S-86 is the major diastereomer 
and therefore the (1S,2S)-trans-2-methylcyclohexyl -D-glucuronide S,S-64 
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was the major product (4 : 1) from the glucuronylsynthesis of a racemic mixture 
of trans-2-methylcyclohexanol 39  (Scheme 2.5).  
 
Figure 2.15: 1H NMR spectrum (300 MHz) of the trans Mosher esters 86 made from the 
hydrolysed product 39. 
Future investigations should aim at isolating and characterising the individual 
trans Mosher esters 86 and determining the rotation of the hydrolysed alcohols 
39.  Most concerning in this study was the low conversion (11%) of hydrolysed 
alcohol 39 converted to the trans Mosher esters 86.  Such a low yield with a 1 : 
4 ratio of alcohols 39 could produce the expected minor Mosher's ester as the 
major product through kinetic resolution.  This uncertainty could be avoided in 
future studies by the synthesis and analysis of the (S)-Mosher esters. 
A repeat study using an alternative racemic substrate would also be 
insightful.  From the experience gained in this study, a non-volatile substrate 
would be recommended so that it can be sufficiently dried without loss to 
evaporation.  This would allow more accurate determination of sample mass 
and may also improve yields, especially in the esterification step whereby 
water decomposes the MTPA acid chloride 85. 
This glucuronylsynthase enantioselectivity would arise from different reaction 
rates between the two enantiomers which is based on the substrate fitting in 
the active site of the enzyme.  This provides some information about the 
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binding pocket of glucuronylsynthase and -glucuronidase.  Generating a list of 
diastereomeric ratios from a library of enantiomers would be useful in mapping 
out the space of the binding pocket and deducing structure-activity 
relationships. 
This enantiomeric study has proven that the glucuronylsynthase enzyme is 
selective for one enantiomer of trans-2-methylcyclohexanol 39 over the other.  
This is the first reported study detailing the enantioselectivity of -
glucuronidase.  The diastereomeric glucuronides 64 were produced in a 
glucuronylsynthase reaction in a 1 : 4 ratio.  However, with the possibility of 
kinetic resolution during the esterification, the major diastereomer could not be 
definitely assigned as the (1S,2S)-trans-2-methylcyclohexanyl -D-glucuronide 
S,S-64.  Whilst not selective enough for synthetic purposes, this enantiomeric 
study has expanded the scope of the glucuronylsynthase methodology.  The 
development of the glucuronylsynthase methodology was continued by 
expanding the substrate library for this enzyme. 
2.5.4 Novel substrates for glucuronylsynthesis 
Up until this point, the glucuronylsynthase has successfully attached a 
glucuronyl residue to a selection of simple alcohols and a small library of 
steroids.  But for the glucuronylsynthase enzyme to be implemented in 
industry, it needs to accommodate larger and structurally more complex 
molecules. 
As discussed in the introduction (chapter 1.1), enzymes in our body convert 
codeine 1 into morphine 2 and then subsequently one of two morphine 
glucuronides (Scheme 1.1).  Codeine 1, morphine 2 and chloramphenicol 87 
were generously donated by the National Measurement Institute to trial with 
the glucuronylsynthase enzyme.  Morphine 2 and its methylated analogue, 
codeine 1, have analgesic properties whilst chloramphenicol 87 is an antibiotic.  
Morphine 2 and chloramphenicol 87 are synthetically interesting substrates 
due to the presence of two possible sites of glucuronylation.  The trends from 
previous studies predict the more reactive and less hindered alcohols are 
favoured.  Hence, the allylic alcohol of morphine 2 and the primary alcohol of 
chloramphenicol 87 are predicted to be the probable sites of glucuronylation. 
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Unfortunately, no product could be seen by TLC for all three substrates.  This 
observation was supported by a negative result in the electron-spray ionisation 
mass spectrum (ESI-MS).  Perhaps under optimised conditions, the 
glucuronide product(s) would be observed. 
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Figure 2.16.  Pharmaceutical substrates trialled with the glucuronylsynthase. 
The mechanism of glucuronylsynthase is essentially an enzyme-mediated 
SN2-like nucleophilic reaction (Scheme 1.10).  It was of great interest to 
determine if an alternative class of nucleophiles would react in a similar 
manner.  Given the impressive yield of 2-phenylethanol 45, identical reaction 
conditions were tested on 2-phenylethylamine 88 and 2-phenylethanethiol 89 
(Figure 2.17).  Unfortunately the respective N-linked and S-linked glucuronides 
could not be visualised by TLC or confirmed by ESI-MS. 
OH NH2 SH
2-phenylethanol
45
2-phenylethylamine
88
2-phenylethanethiol
89  
Figure 2.17.  Different classes of substrates attempted with the glucuronylsynthase 
enzyme 
The reaction with 2-phenylethanethiol 89 went cloudy suggesting probable 
protein denaturation.  Thiols are reducing agents and at such a high 
concentration (100 mM) may have reduced the disulfide bonds of cysteine to 
cause protein denaturation.  Comparing the pKa of the three substrates, 2-
phenylethanol 45 (~16), 2-phenylethylamine 88 (30-40, protonated 10-11) and 
2-phenylethanethiol 89 (10-11), the amine would be charged at the reaction pH 
of 7.5.  The ammonium species has no lone pairs and is no longer a 
nucleophile for the reaction.  Furthermore, if the N-glycoside was formed, the 
corresponding hemiacetal may be unstable in aqueous solution and hydrolyse 
readily.  This means that phenylethylamine 88 may act as a donor despite no 
product formation observed.  So it is proposed that alcohols and phenols are 
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the only class of nucleophiles capable of reacting at the active site of 
glucuronylsynthase.  For this particular example, the thiol 89  proved to be too 
reactive and caused enzyme inactivation whilst no glucuronide product was 
observed for the cationic amine species 88.  This result meant that the 
glucuronylsynthase substrate library could not be expanded to include the use 
of alternative nucleophiles or the pharmaceutical substrates demonstrated in 
this study. 
Optimisation and expansion of the glucuronylsynthase methodology has 
been discussed in this chapter.  The production of the glucuronylsynthase 
enzyme and synthesis of -D-glucuronyl fluoride 51 has been optimised and 
both can be achieved in high yields.  Expanding the scope of the 
glucuronylsynthase enzyme was demonstrated with a large scale synthesis of 
2-phenylethanol 45 and the enantioselectivity towards trans 2-
methylcyclohexanol 39 arising from kinetic resolution.  Unfortunately, attempts 
at expanding the substrate repertoire of glucuronylsynthase were unsuccessful 
at this point of time.  The glucuronylsynthesis of few pharmaceutical substrates 
did not produce any products.  Furthermore, attempts at improving yields of 
known glucuronylsynthase reactions produced both positive and negative 
results.  A more thorough investigation of these reactions through an enzyme 
kinetic study may shed some light on improving the yields of 
glucuronylsynthase reactions. 
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Enzyme kinetics 
3.1 Introduction to enzyme kinetics 
Before the details of the assay development are discussed, it is essential that 
the fundamentals of enzyme kinetics are known and that the assumptions that 
will be made in this research are outlined. 
3.1.1 The Michaelis-Menten equation 
In 1913, Michaelis and Menten proposed that the mechanism of an enzyme 
be represented by a reversible first step prior to product formation (Scheme 
3.1).76  This equilibrium is assumed to occur fast enough to be represented by 
an equilibrium constant for substrate dissociation (KD).  The instantaneous 
concentrations of enzyme (e) and substrate (a) can be calculated 
stoichiometrically from their initial concentrations minus the concentration of 
the enzyme-substrate complex (x).  Respectively, e = e0 – x and a = a0 – x.  
The concentration of the enzyme-substrate complex (x) is assumed to be 
limited by the concentration of enzyme (e0) with the substrate concentration 
(a0) usually much greater than e0 and therefore much greater than x.  So the 
concentration of the substrate can be assumed as a = a0 with good accuracy. 
k1
k -1
E + A EA E + P
e0-x a x p
k2 KD =
(e0 - x) a
x
 
Scheme 3.1. Michaelis-Menten's enzyme mechanism.  Font in italics represent the 
terms used in the kinetic equations. 
Arranging the dissociation constant in terms of x: 
x =
a e0
KD + a            ( 1 ) 
The second step of the reaction is a simple first-order reaction determined 
from the concentration of enzyme-substrate complex (x) and the reaction rate 
constant k2.  Its rate is given by: 
v = k2x =
k2 a e0
KD + a      ( 2 ) 
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Briggs and Haldane (1925) extended this work by re-defining the change in 
the enzyme-substrate complex concentration (x) in terms of substrate 
dissociation and the rate of product formation (k2).  It can be defined as: 
dx
dt = k1 e a - k -1 x - k2 x     ( 3 ) 
Briggs and Haldane proposed that a steady state would be reached during 
the reaction in which the concentration of intermediate was constant.77 This 
means that dx/dt = 0: 
k1(e0-x)a - k -1x - k2x = 0             ( 4 ) 
Re-arranged in terms of substrate-enzyme complex concentration (x): 
k1 e0 a
k-1 + k2 + k1 ax =           ( 5 ) 
The reaction rate (v) for product formation is a simple first-order reaction 
dependent on the concentration of the substrate-enzyme complex 
concentration (x) with a rate constant of k2.  Substituting (5) for x: 
k1 k2 e0 a
k-1 + k2 + k1 av = k2 x =
k2 e0 a
+ ak -1 + k2k1
=
  ( 6 ) 
Equation (6) may be re-written in its more general form as the Michaelis-
Menten equation: 
kcat e0 a
Km + av =
Vmax a
Km + aor     ( 7 ) 
where kcat is the catalytic constant, Km is the Michaelis constant and Vmax is 
the limiting rate.  The rate equation (7) is almost identical to the equation 
derived by Michaelis and Menten (equation 2) with the exception of the 
constants used in the denominator (i.e. KD vs. Km).  The latter is seen as an 
improvement to the original Michaelis-Menten approach and has been adopted 
into kinetic analyses ever since. 
The Vmax is the product of kcat and e0 (Vmax = kcat x e0) and is dependent on 
enzyme concentration (e0).  The catalytic constant (kcat) is equal to k2 for 
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simple mechanisms obeying Michaelis kinetics.  As the concentration of 
substrate A approaches infinity (a → ∞), the velocity of the reaction 
approaches Vmax (v → Vmax): 
kcat e0 a
Km + av =
as a 
a >>> Km
kcat e0 a
av = kcat e0=              ( 8 ) 
Similarly, Km is a fundamental property of the enzyme and equates to (k-1 + 
k2)/k1 under simple single substrate kinetics.  Via mathematical means, it has 
been proven to be the concentration of substrate required to achieve half the 
limiting rate: 
kcat e0 a
a + av =when a = Km, =
kcat e0
2 = ½ Vmax     ( 9 ) 
The curve defined by equation (7) is a rectangular hyperbola that spans from 
the origin to the asymptote v = Vmax (Figure 3.1). 
Initial slope = Vmax/Km
Vmax
Km a
v
0
½Vmax
 
Figure 3.1.  Dependence of initial rate v on the substance concentration a for a 
reaction obeying the Michaelis-Menten equation. 
At the initial tangent to this curve, where the concentration of substrate (a) is 
small, the velocity (v) is directly proportional to the substrate concentration (a): 
Vmax a
Km
as a  
a <<< Km
kcat e0 a
Kmv
 =
        ( 10 ) 
The gradient of this initial slope is therefore determined by the parameters 
Vmax/Km.  The term Vmax is dependent on enzyme concentration (Vmax = kcat x 
e0) and so dividing by the initial enzyme concentration determines the 
fundamental parameter kcat/Km.  The parameter kcat/Km is given the term 
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specificity constant and it indicates how well a substrate is turned-over by the 
enzyme.  Substrates that have low Km values and/or high turnover numbers 
(large kcat values) will have a high specificity constant which results in a steep 
initial slope for the initial velocity vs. concentration plot for a given e0 value.  
The specificity constant provides the means of contrasting the specificities of 
different substrates for an enzyme. 
The kcat, Km and kcat/Km constants are not dependent on reaction variables 
such as enzyme/substrate concentration and are therefore fundamental 
parameters that define an enzyme reacting with a given substrate.  These 
parameters will be determined in the enzyme kinetic study to profile and better 
understand the mechanism of the glucuronylsynthase enzyme.  The Michaelis-
Menten equation (7) has been derived to analyse the enzyme kinetics for a 
single-substrate reaction.  The glucuronylsynthase reaction is a two-substrate 
reaction which follows more complicated rate equations. 
3.1.2 Two-substrate kinetics 
The glucuronylsynthase reaction is a two-substrate reaction (Scheme 3.2) 
which has a mechanism more complicated than the initial mechanism 
proposed by Michaelis and Menten (Scheme 3.1).  In general terms, there are 
three different mechanisms proposed for enzymatic reactions containing two 
substrates that will be discussed in this review.  In fact, the actual number of 
mechanisms observed in nature is much greater as many variations are 
observed to occur.78  
OHO
HO
HO
O
O
F
A
+ ROH
glucuronylsynthase OHO
HO
HO
O
O
Q
ORHF(aq) +
B E P  
Scheme 3.2.  The bimolecular glucuronylsynthase reaction with letter assignments for 
schematic representations. 
The first mechanism is known as the “ordered bi bi” reaction according to 
Cleland nomenclature or compulsory-order ternary complex mechanism 
(Scheme 3.3).79  In this mechanism, the substrates must enter in a specific 
sequence and the products also released in a specific order. 
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Scheme 3.3.  Ordered bi bi enzyme mechanism. 
Using King-Altman analysis80, the complex rate equation in terms of kinetic 
constants can be derived for the ordered bi bi mechanism.  For initial reaction 
rates, the concentration of products is deemed negligible such that P = Q = 0.  
The rate equation in terms of kinetic constants takes the form:81 
v = Vmax a b
KiA KmB + KmB a + KmA b + a b       ( 11 ) 
where Vmax is the limiting velocity of the enzyme, a and b are the 
concentration of the two substrates, KmA and KmB are the Michaelis constants 
for the respective substrates and K iA is the true dissociation constant of A 
(k-1/k1). 
The second type of mechanism is the ”random bi bi” mechanism according to 
Cleland nomenclature or random-order ternary complex mechanism (Scheme 
3.4).79  In this mechanism, the substrates can bind to the enzyme in any order 
and products can also be released in any order. 
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Scheme 3.4.  Random bi bi mechanism.81 
  The scheme depicts the dissociation constant for each complex formed 
rather than rates.  The King-Altamann analysis of this mechanism is lengthy 
and for simplicity, its basic rate equation given in terms of kinetic constants 
is:81 
V+ab
K iAKmB
- V -pq
KmPK iQ
1 +
a
K iA
b
K iB
p
K iP
q
K iQ
ab
K iAKmB
pq
KmPK iQ+ + + + +
v =
  ( 12 ) 
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When the initial rate is monitored, the concentration of products (p and q) are 
assumed negligible (p = q = 0) and the rate equation conveniently simplifies to 
the same rate equation (11) used for the ordered bi bi mechanism. 
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The third general mechanism is the “ping pong” mechanism according to 
Cleland nomenclature or substituted enzyme mechanism.  In this mechanism 
(Scheme 3.5), the first product leaves before the second substrate binds and 
the enzyme goes through an activated intermediate (F).  This mechanism 
describes the hydrolysis mechanism of the wild-type glycosidase (Scheme 1.8) 
whereby the glycosyl-enzyme intermediate (29) can be labelled the activated 
intermediate (F).  On mechanistic grounds, it is expected that the 
glycosynthase proceeds by the binding of the two substrates prior to the first 
product release (Scheme 1.9).54  The glycosynthase does not become involved 
as an activated intermediate and only mediates a single substitution with 
inversion of stereochemistry.  As a result, this mechanism will not be 
considered and its rate equation will not be presented. 
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Scheme 3.5.  The ping pong mechanism 
Equation (11) can be re-arranged to make the concentration of substrate A 
(a) a factor (equation 13).  If the concentration of substrate B (b) is kept 
constant, the congregation of constants can be combined to give apparent 
kinetic parameters and the relationship takes the form of the single substrate 
Michaelis-Menten equation: 
v =
K iA KmB + KmA b
KmB + b
Vmax b
KmB + b
a
+ a
V maxapp a
KmAapp + a
=
        ( 13 ) 
The apparent values are an approximation to the actual Vmax and KmA 
values.   The Vmaxapp is proportional to the true value of Vmax with respect to 
b/(KmB+b).  As KmB must be greater than zero, it suggests that the Vmaxapp will 
always be an underestimate of the true value of Vmax (Vmaxapp < Vmax) for all 
moderate values of b.  Kmapp is defined by multiple parameters and can be 
either an overestimation or underestimation of the true Km.82  
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However, if the concentration of substrate B is large (b > 10 x Km), the terms 
in equation (11) that do not contain b are assumed negligible (i.e. K iAKmB and 
KmBa << b).81  Equation (11) will simplify down to a simple pseudo-single 
substrate Michaelis-Menten model with true kinetic parameters: 
Vmax a
KmA + a
=From (11), v =
Vmax a b
b (KmA + a)      ( 14 ) 
The parallel equation can be used to find the kinetic parameters for substrate 
B when the concentration of substrate A (a) is saturating. 
3.1.3 Practical aspects of kinetic studies. 
It is valuable to describe the practical aspects of enzyme kinetics so that 
accurate results can be achieved and translated in terms of the theory 
discussed.  The monitoring of the initial rate of the reaction is crucial for 
determining the kinetic parameters using the rate equations discussed.  At the 
initial rate of the reaction, the concentration of the product and change in 
substrate concentration is deemed negligible.  These assumptions were 
factored into the derivation of the rate equation. 
The enzyme activity is dependent on several experimental factors.  These 
include temperature, pH and enzyme concentration.  These factors need to be 
identical for each reaction monitored so that changes in the reaction rate are 
solely due to substrate concentration.  When considering the pH for a reaction 
to monitor, the enzyme’s optimum pH should be used if known.  Enzymes tend 
to have bell-shaped activity vs. pH curves (Figure 3.2).81  If the reaction is 
performed on the slope of this bell-curve, the slightest pH difference can cause 
a significant shift in activity. 
enzyme
activity
pH  
Figure 3.2.  The typical enzyme activity vs. pH bell-curve.  Dotted lines represent the 
large change in activity in response to a small change in pH on the slope of the curve. 
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Enzyme activity is usually proportional to temperature, but some enzymes 
may be unstable at certain temperatures.  A constant temperature that is 
stable for the enzyme must be used throughout the kinetic study. 
The enzyme stability can also be a factor of enzyme concentration.  Many 
enzymes are more stable at high concentrations than at low, in a phenomenon 
known as enzyme inactivation.81  Some enzymes form quaternary structures 
(e.g. by -glucuronidase forms a homotetramer) which often provide a greater 
enzyme stability.83-85  Enzyme activity may differ between the monomeric and 
associated forms through allosteric-like regulation between the subunits.86,87 At 
low concentrations of enzyme, the enzyme may be in equilibria between its 
monomeric and quaternary forms which could cause deviations from the 
linearity in activity.  The linear relationship between enzyme activity and 
enzyme concentration should be demonstrated to prove enzyme inactivation is 
not an issue.  However, if present, the enzyme concentration needs to be 
identical in every assay so that the initial rates can be accurately compared. 
The initial rate can be monitored using one of three possible assays.  A 
continuous assay involves the reaction being continuously monitored by an 
automated recording apparatus.  This is the preferred method as the reaction 
remains untouched throughout the assay.  However, it can sometimes be 
difficult to incorporate the required reaction conditions with the recording 
apparatus, for example reactions requiring extreme temperatures or pressures.  
A discontinuous assay is performed when portions of the reaction are removed 
at intervals and analysed to determine the extent of the reaction.  This assay 
can tolerate reactions with more demanding reaction conditions as aliquots are 
removed from the reaction vessel to be analysed.  However, the removal (and 
possible dilution) of samples can introduce errors to the kinetic experiment 
through instrumental and human error.  The final assay is the coupled assay 
which is only used when a continuous or discontinuous assay is not possible.  
It involves monitoring a reaction that occurs in response to the product(s) 
formed in the enzyme reaction of interest (Scheme 3.6).  This is an indirect 
determination of product formation (B) and uses the assumption that the 
reaction rate of the coupled reaction (k2) is faster than the enzyme reaction of 
interest (k1). 
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Scheme 3.6.  The coupled assay 
The direct or indirect monitoring of product is also an important aspect.  An 
assay that directly monitors product formation is ideal as it eliminates side 
reactions that may contribute to the component that is monitored.  Monitoring 
the release of fluoride ions in the glycosynthase reactions is an example of 
monitoring indirect product formation.  The release of fluoride ions can 
attributed to multiple side-reactions such as the hydrolysis of the glycosyl 
donor (Scheme 3.7a).    A blank reaction in the absence of alcohol acceptor 
would need to be performed for each reaction to account for glycosyl fluoride 
donor hydrolysis. 
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Scheme 3.7. The release of fluoride ion from glucosyl fluoride 32 by a) hydrolysis and 
b) oligomerisation. 
Additionally, any oligomer formation, which can occur for most 
glycosynthases, would also contribute towards the fluoride concentration 
(Scheme 3.7b).  The presence of multiple acceptors and donors with different 
affinities would complicate the kinetic analysis.  Whilst oligomerisation has not 
been observed with glucuronylsynthase, the preparation of blank reactions 
essentially doubles the work load.58  Ultimately, the direct observation of the 
glucuronide product would simplify the kinetic analysis and eliminate the need 
to perform additional controlled reactions.  These theoretical and practical 
aspects were considered in the search for an assay to monitor the 
glucuronylsynthase reactions. 
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3.2 Glycosynthase kinetic assays 
3.2.1 Introduction 
The glucuronylsynthase reactions performed with varied reaction conditions 
(Table 2.2) illustrated unusual trends in yield.  It was obvious that a more 
systematic study behind the effect of each of these variations needed to be 
implemented.  This would involve elucidating the kinetic parameters for the 
substrates used, the catalytic rates of the reactions and the effect each 
reaction variable had on these parameters.  The first step of the enzyme 
kinetic study was to identify a suitable assay.  For the wild-type -
glucuronidase enzyme, a simple continuous chromogenic assay is used to 
assess enzymatic activity.  A chromophore is cleaved from its glucuronyl 
residue by the enzyme which can be detected spectrophotometrically (Scheme 
3.8a).  The reverse chromo-ablative reaction (Scheme 3.8b) could be utilised 
for glucuronylsynthase except past examples have shown low reactivity 
towards phenols with the reaction rate being many magnitudes lower than the 
wild-type counter-part.  Furthermore, the substrates tested would have to 
contain a chromophore, which is absent in most of the substrates used to date.  
The kinetic parameters of other glycosynthases have been determined 
primarily by fluoride-selective potentiometry. 
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Scheme 3.8.  a) Hydrolysis of p-nitrophenyl -D-glucuronide 25 by wild-type 
glucuronidase and b) glucuronylsynthesis of p-nitrophenyl--D-glucuronide 25 by 
glucuronylsynthase. 
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3.2.2 Fluoride-selective potentiometry 
There are many different types of glycosynthases developed from a range of 
different organisms utilising a plethora of sugar donors and acceptors.  
However, there is one aspect that is common to all and that is the release of 
fluoride from the glycosyl fluoride donor.  It is for this reason that fluoride-
selective potentiometry is the most commonly utilised assay for glycosynthase 
reactions.88-98 
The latest fluoride selective electrodes do not suffer significant interference 
from other anions and will detect fluoride concentrations in the low micromolar 
range (1.0 x 10-6 M).99-102  Nevertheless, there are multiple drawbacks 
associated with this method that should be addressed.  As discussed in the 
practical aspects of an assay (refer to section 3.1.3), the monitoring of fluoride 
is an indirect measurement of product formation which would require additional 
testing of blank reactions.  The main concern with ion selective electrodes is 
the degree of drift over time, with most electrodes requiring recalibration every 
2 hours.  This is adequate time to determine initial velocities but means 
monitoring a glucuronylsynthase reaction over days would require constant 
recalibration and introduce errors.  Further to this, the calibration curve is not 
always linear over the concentration range monitored and estimations may be 
needed which introduce further errors. 
Another major disadvantage of fluoride selective potentiometry is response 
time in reading low concentrations of fluoride ions.  Some procedures 
recommend up to a minute to obtain an accurate reading which is unsuitable 
for kinetic studies where the fluoride concentration is continuously changing.  A 
work around would involve removing aliquots of the reaction in a discontinuous 
manner.  This would provide further problems as an adequate volume 
(generally millilitres) is required to cover the probehead.  This means either a 
dilution is required, reducing the detection limit of the assay, or large aliquots 
of a sizeable reaction would need to be taken.   
 Another factor of concern is the incompatibility of the probe with certain 
solvents which may dissolve the membrane of the junction.  Unlike the majority 
of glycosynthases which operate with highly hydrophilic donors and acceptors, 
the glucuronylsynthase functions with lipophilic acceptors i.e. alkyl alcohols, 
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benzyl alcohols and steroids.  The effect of detergents or co-solvents to aid 
solubility needed to be tested but their implementation may cause damage to 
the electrode. 
Fluoride selective potentiometry has been successfully applied to many 
glycosynthase kinetic studies, but the drawbacks and errors disclosed here 
suggest an alternative assay was required.  So a different glycosynthase assay 
was explored. 
3.3 1H NMR assay 
3.3.1 General discussion 
No glycosynthase assays to date have reported the use of NMR as a means 
of detection.  With a Bruker 800 MHz NMR spectrometer at my disposal, 
proton NMR spectroscopy could be used to identify and quantify the various 
reaction components in a time-efficient manner with most samples requiring 
only a single scan.  Multiple samples were analysed simultaneously in a 
continuous assay through the use of an autosampler while the temperature 
was maintained at 21 C by a probe heater. 
The glucuronylsynthesis of 2-phenylethanol 45 was used to initiate the study 
due to its high yield and water solubility.  The glucuronylsynthase enzyme was 
used at five times its normal concentration (1.0 mg mL-1) so that an 
appreciable reaction rate was observed.  By using the “Jump and Return” 
sequence, developed by Plateau and Guéron, the samples did not have to be 
prepared in completely deuterated materials.103  Only 10% deuterium oxide 
was required in the final solution for locking purposes, making sample 
preparation quick and simple.  Seven reactions were analysed simultaneously; 
differing only by substrate concentration to ensure all factors, such as enzyme 
activity, were identical for the kinetic study. 
  The acquired spectrum resembles a sine curve with an inflexion point at the 
water peak to suppress its presence (Figure 3.3).  Baseline correction and 
peak integrations were applied at the regions 5.9-5.4 ppm (anomeric proton of 
-D-glucuronyl fluoride 51), 4.5-4.3 ppm (anomeric proton of the glucuronide 
product 68) and 3.1-2.7 ppm (benzylic protons of 2-phenylethanol 45 and the 
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glucuronide product 68).  The benzylic protons of 2-phenylethanol 45 and the 
glucuronide 68 are isolated in the spectra and their combined integration 
remains constant throughout the reaction.  The integration of this region was 
therefore used as an internal standard in the integration of the 1H NMR 
spectra.  
 
Figure 3.3: Stacked 1H NMR spectra for a single glucuronylsynthesis reaction of 2-
phenylethanol 45 (100 mM) with -D-glucuronyl fluoride 51 (2.4 mM) and E504G 
(1 mg mL-1) over a 2 h timescale.  Spectra are colour-coded as black: t = 0 min, red: t = 
26 min, green: t = 51.5 min, blue: t = 75.5 min, purple: t = 98 min, navy blue: t = 124 min.  
The respective regions have been labelled with text or represented by a red-highlighted 
proton. 
3.3.2 Kinetics of -D-glucuronyl fluoride 51 
An enzyme kinetic study was initiated by first determining the kinetic 
parameters for the -D-glucuronyl fluoride 51 donor.  The concentration of 2-
phenylethanol 45 was kept constant at 100 mM – the limit of its solubility in a 
phosphate buffered solution.  Because of this restricted solubility, the enzyme 
was not saturated with 2-phenylethanol 45 and meant that only the apparent 
kinetic parameters could be determined for -D-glucuronyl fluoride 51 
according to equation (13).  Seven reactions with varied concentrations of -D-
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glucuronyl fluoride 51 (500 mM, 239 mM, 119 mM, 59.7 mM, 23.9 mM, 11.9 
mM and 2.40 mM) were used.  It was remarkable to see the time course plots 
(product formation vs. time) display equivalent velocities (Figure 3.4).  The 
initial velocities were linear (R2 > 0.98) in the region below 10% conversion.  
The reaction containing 2.4 mM -D-glucuronyl fluoride 51 went to completion 
within the two hour timescale.  This can be observed in Figure 3.4 by a plateau 
of product formation. 
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Figure 3.4: Time course plots of varying -D-glucuronyl fluoride 51 donor with 
constant glucuronylsynthase (1.0 mg mL-1) and sub-saturating 2-phenylethanol 45 
acceptor (100 mM)  obtained by 800 MHz 1H NMR experiments (21 °C, 50 mM phosphate 
buffer, pH 7.5, 10% D2O).  Linear plots are lines of best fit for the initial velocity (<10% 
conversion).  R2 values for the initial velocity were calculated using linear regression 
analysis. 
When the initial velocities of these reactions are plotted against the -D-
glucuronyl fluoride 51 concentration, it provided a horizontal straight line in the 
initial velocity vs. concentration plot (Figure 3.5).  This suggested the 
glucuronylsynthase was approaching the Vmaxapp in this range of -D-
glucuronyl fluoride 51 concentrations tested and that the Kmapp for -D-
glucuronyl fluoride 51 is below the lowest concentration (2.4 mM) tested.  This 
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is not unusual with strong affinities being reported for glycosynthases such as 
Humicola insolens endoglucanase E197A (0.87 mM)90, Bacillus licheniformis 
1,3-1,4--glucanase (1.36 mM)104 and Streptomyces sp. -glucosidase (1.7 
mM)105 towards their -glycosyl fluoride donor. 
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Figure 3.5.  Initial velocity vs. concentration plot of varying -D-glucuronyl fluoride 51 
donor with constant sub-saturating 2-phenylethanol 45 acceptor (100 mM) and 
glucuronylsynthase (1.0 mg mL-1) obtained by 800 MHz 1H NMR experiments (21 °C, 50 
mM phosphate buffer, pH 7.5, 10% D2O). 
A repeat of this assay with lower -D-glucuronyl fluoride 51 concentrations 
(50 M, 100 M, 250 M, 500 M, 1 mM and 2.5 mM) was performed but no 
conclusions could be reached due to the poor signal-to-noise ratio at these 
dilute concentrations.  The results from this study suggest that the apparent 
Michaelis constant (Kmapp) is less than 2.4 mM which is below the detection 
limit of the NMR technology used.  In contrast, it appears the apparent limiting 
velocity (Vmaxapp) of the reaction was approached in the concentration range 
explored.  The initial velocities of the reactions monitored appear to form the 
plateau of the initial velocities vs. concentration plot suggesting an 
approximate Vmaxapp of 21 nmol min-1 [mg protein]-1. 
3.3.3 Kinetics of 2-phenylethanol 45 
NMR studies were then used to instigate the kinetic study of the acceptor 
alcohol, 2-phenylethanol 45. The concentration of -D-glucuronyl fluoride 51 
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was kept constant at 100 mM.  From the kinetic study of -D-glucuronyl 
fluoride 51 (refer to section 3.3.2), the proposed Kmapp (and Km) is less than 2.4 
mM so the enzyme would have been saturated at this concentration.  This 
saturating concentration of -D-glucuronyl fluoride 51 would provide the 
conditions (a >> Km) that determine the true kinetic parameters for 2-
phenylethanol 45 according to equation (14).   Seven samples with varied 
concentrations of 2-phenylethanol 45 (100 mM, 75 mM, 50 mM, 25 mM, 10 
mM, 5 mM and 1 mM) were used.  Unlike the velocities observed in the -D-
glucuronyl fluoride 51 study, the initial velocities for 2-phenylethanol 45 varied 
with substrate concentration (Figure 3.6).  After 2 hours, the product was only 
just visible in the NMR spectrum for the reaction containing 1 mM of 2-
phenylethanol 45.  This once again highlights the poor sensitivity of this 
technique.  Nevertheless, good linear regression values were achieved for the 
more concentrated samples. 
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Figure 3.6.  Time course plots of varying 2-phenylethanol 45 acceptor with constant 
glucuronylsynthase (1.0 mg mL-1) and saturating -D-glucuronyl fluoride 51 acceptor 
(100 mM)  obtained by 800 MHz 1H NMR experiments (21 °C, 50 mM phosphate buffer, pH 
7.5, 10% D2O).  Linear plots are lines of best fit for the initial velocity (<4% conversion).  
R2 values for the initial velocity were calculated using to linear regression analysis. 
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Plotting the velocities against the 2-phenylethanol 45 concentrations 
produces a hyperbolic curve indicative of Michaelis-Menten kinetics (Figure 
3.7).  Data fitting software was used to estimate the Michaelis-Menten 
parameters.  The Michaelis constant (Km) for 2-phenylethanol 45 was 
extrapolated as 109.5 mM and the limiting velocity (Vmax) as 29.7 nmol min-1 
[mg protein]-1.  The affinity for 2-phenylethanol 45 (with saturating -D-
glucuronyl fluoride 51) is quite weak in comparison to the proposed sub-
millimolar -D-glucuronyl fluoride 51 binding affinity.  In fact, according to the 
estimated kinetic values, the Michaelis constant (Km 109.5 mM) is never 
reached due to the insolubility of this substrate at higher concentrations.  So at 
the best, the extrapolated value is still only an approximation of the real Km.  
The Vmax was extrapolated as 29.7 nmol min-1, which is larger than the Vmaxapp 
(21 nmol min-1 [mg protein]-1) estimated from the -D-glucuronyl fluoride 51 
study.  This is expected considering Vmaxapp is an underestimation of the true 
value of Vmax (refer to section 3.1.2). The Vmax equates to a very slow catalytic 
turnover (kcat) of 0.034 s-1. 
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Figure 3.7.  Initial velocity vs. concentration plot of varying 2-phenylethanol 45 
acceptor with constant saturating -D-glucuronyl fluoride 51 donor (100 mM) and 
glucuronylsynthase (1.0 mg mL-1) obtained by 800 MHz 1H NMR experiments (21 °C, 50 
mM phosphate buffer, pH 7.5, 10% D2O).  Curve represents Michaelis-Menten fit from 
extrapolated parameters (Km 109.5 mM, Vmax 29.7 nmol min-1 [mg protein]-1). 
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Taking the slope of the initial velocities vs. concentration plot at low 
concentrations, the substrate specificity (kcat/Km) was determined as 0.30 
M-1 s-1.  This value, when compared to the substrate specificity values of other 
alcohol acceptors with glucuronylsynthase, will give a relative indication of how 
well each substrate is recognised and how efficiently it is converted to its 
glucuronide by the enzyme. 
3.3.4 Conclusion 
Proton NMR has been proven to be a practical means of monitoring the 
glucuronylsynthase reaction in a continuous manner.  The anomeric protons of 
the reaction components are generally isolated and can be integrated to 
quantify the conversion of a reaction.  The successful application of this assay 
was applied to 2-phenylethanol 45.  It was determined to bind weakly to the 
glucuronylsynthase (Km 109.5 mM) under conditions of saturating glucuronyl 
donor 51 and incapable of approaching its limiting velocity (Vmax 29.7 nmol 
min-1 [mg protein]-1) due to solubility restraints.  The -D-glucuronyl fluoride 51 
donor is predicted to bind tightly the glucuronylsynthase enzyme (Km < 2.4 
mM) but a value was not determined due to the poor sensitivity of this 
technique.  The proton NMR assay is applicable to glucuronylsynthase 
reactions and may be extended to other glycosynthase reactions.  With the 
current NMR technology, the assay is limited to binding affinities down to the 
millimolar region.  
3.4 Isothermal titration calorimetry 
3.4.1 Background 
Isothermal titration calorimetry (ITC) is not used to establish kinetic 
parameters but does determine the thermodynamic parameters associated 
with a ligand binding to its host.  It uses heat measurement to indicate the 
extent to which a ligand-binding site is saturated.  The technique is relatively 
new, with the first applications conducted 44 years ago to solve chemical 
equilibra.106  It was followed closely by the first biochemical binding study and 
enzyme kinetic study.107,108  However, it is not until possibly the past decade 
that the calorimetric technology has become suitable for the routine use in 
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characterising the thermodynamics of biochemical interactions.109,110  Current 
ITC technology is sensitive enough to detect 0.1 cal (10 cal accurately).111  
This allows the determination of binding constants as large as 108-109 M-1. 
ITC works by the incremental addition of ligand or substrate into a solution of 
the enzyme in a constant temperature (isothermal) cell.  Heat is applied or 
removed to retain a constant temperature and this energy applied or withdrawn 
is directly proportional to the amount of binding.  As the system reaches 
saturation, the heat signal diminishes until only heats of dilution are observed.  
The optimised binding data for a single-site binding enzyme should resemble a 
sigmoidal curve that follows the equation: 
q = v H et KA a1 + KA a           ( 15 ) 
where q is the heat produced/absorbed, v is the volume of the cell, ΔH is the 
binding enthalpy per mole of the ligand, et is the total enzyme concentration, 
KA is the binding constant and a is the concentration of ligand.112  The shape of 
the sigmoidal curve is greatly affected by the size of the enzyme concentration 
(et) and the binding constant (KA) in a parameter termed as the “c” value.109  
The “c” value is defined as the enzyme concentration multiplied by the binding 
constant (c = et x KA).  A “c” value of 0 provides a horizontal line, and as “c” 
increases, the sigmoidal curve emerges until c → ∞, which has a vertical 
inflexion like a step (Figure 3.8).  For the accurate determination of the binding 
constant KA, a “c” value of 10-100 is recommended. 
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Figure 3.8.  Simulated binding 
isotherms for various values of the 
parameter c.  The desirable curvature 
(c = 100) is depicted as continuous 
curve. 
 
67 
Enzyme kinetics 
3.4.2 Binding constant of -D-glucuronyl fluoride 51 
The substrate (-D-glucuronyl fluoride 51) was dissolved in an identical batch 
of phosphate buffer used to dialyse the enzyme to eliminate heats of ionisation 
(or protonation) caused by different salt and pH levels.  It was degassed prior 
to its addition to the ITC syringe.  The enzyme concentration was determined 
by spectroscopic methods and degassed prior to its addition to the isothermal 
cell set at 21 C.  Beginning with a glucuronylsynthase concentration of 50 M 
(3.4 mg mL-1), titration with different concentrations of -D-glucuronyl fluoride 
51 was performed until the correct curvature in the thermogram was 
obtained.109  The ideal sigmoidal curvature was never obtained with only the 
latter half of the sigmoidal curve (demonstrating binding-site saturation) only 
ever achieved.  When lower concentrations of -D-glucuronyl fluoride 51 were 
added, the binding site did not achieve saturation and the slow initial uptake 
(giving rise to a sigmoidal curve) was still not observed. The best curvature 
was achieved with 3 mM of -D-glucuronyl fluoride 51, which provided data 
points that approached saturating conditions (Figure 3.9).  
 a) 
 
 
Figure 3.9.  a) ITC data of E504G (50 
M) titrated with -D-glucuronyl fluoride 
51 (3 mM) at 21 C with heat of dilution 
experiments subtracted and b) the 
nonlinear regression analysis.  
 b) 
A repeat of this titration was performed with the absence of enzyme to 
determine temperature changes contributed from heat of dilution.  The 
negative energy applied to the system implies that the binding of -D-
68 
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glucuronyl fluoride 51 to glucuronylsynthase is an exothermic event.  Non-
linear regression fits of this data to equation (15) provided large errors with the 
binding constant (KA) calculated as 1130 ± 2770 M-1.  Taking the inverse of 
this value, we obtain a dissociation constant (KD) of 0.2 ± 0.4 mM. 
One of the major causes for this error was from the poor signal response 
provided by the system.  The maximum signal (5 cal s-1) obtained from 
titration did not pass the recommended threshold for accuracy of 10 cal s-1.  
So the titration was repeated with 125 M (8.5 mg mL-1) of glucuronylsynthase 
and 6.7 mM -D-glucuronyl fluoride 51.  An identical thermogram was obtained 
with larger responses (Figure 3.10).  The non-linear regression fit had smaller 
errors and calculates the binding constant (KA) as 780 ± 30 M-1. 
 a) 
 
Figure 3.10.  a) ITC data of E504G 
(125 M) titrated with -D-glucuronyl 
fluoride 51 donor (6.7 mM) at 21 C with 
heat of dilution experiments subtracted 
and b) the nonlinear regression 
analysis. 
 b) 
 
Taking the inverse of this value, we obtain a dissociation constant (KD) of 
1.28 ± 0.03 mM.  The dissociation constant (KD) is an approximation of the 
Michaelis constant (Km) with the actual Km being of greater value for a single 
substrate mechanism.113  However, Cook and Cleland demonstrate how the 
dissociation constant (KD) can be greater or smaller estimation of the real Km 
value in a two substrate mechanism.82  This implied that the Km of -D-
glucuronyl fluoride 51 resides in the low mM region in line with the previously 
mentioned glycosynthase literature examples.90,104,105  However, the accuracy 
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of this value is questionable given the “c” parameter for this titration (c = 0.1) is 
below the recommended “c” values of 10-100.  From these figures, a titration 
using glucuronylsynthase one hundred times more concentrated (850 mg mL-1) 
is required for an acceptable result.  Such a concentrated sample is unviable 
and an alternative assay was required to determine the binding affinity of -D-
glucuronyl fluoride 51. 
3.4.3 Binding constant for 2-phenylethyl -D-glucuronide 68 
The glucuronide products formed in the glucuronylsynthase reactions are 
substrates for the wild-type glucuronidase.  With glucuronylsynthase differing 
from glucuronidase by a single amino acid, it is likely that the glucuronide 
product may have some affinity towards the glucuronylsynthase binding site.  
To determine the extent of this equilibrium, the 2-phenylethyl -D-glucuronide 
68 was titrated against glucuronylsynthase (48.5 M) using ITC.  Titrating with 
a millimolar solution produced a titration curve that depicted no trace of 
saturation even occurring.  The titration was stopped prematurely and repeated 
with a 10 mM solution of 2-phenylethyl -D-glucuronide 68.  This showed some 
sign of saturation occurring, but the signal response was too low (<0.2 cal s-1) 
so the titration was also stopped prematurely.  In contrast, when a 100 mM 
concentration of 2-phenylethyl -D-glucuronide 68 was titrated against 
glucuronylsynthase, an endothermic thermogram was observed.  This 
suggested that the response from substrate binding was still not measurable 
and that only the heat of dilution was providing a response.  A heat of dilution 
control experiment would have provided the net calorimetric response that 
substrate binding exerted.  However, this was not performed due to the small 
overall response in the titrations (~ 5 cal s-1) suggesting the response from 
substrate binding was still minute.  Whilst inconclusive, this study implies that 
the binding affinity of 2-phenylethyl -D-glucuronide 68 to glucuronylsynthase is 
very weak and that a highly concentrated batch of enzyme (>30 mg mL-1) 
would be required to obtain an adequate response required to determine the 
binding constant (KA). 
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Figure 3.11.  Raw ITC data of E504G (48.5 M) titrated with 2-phenylethyl -D-
glucuronide  68 at a) 1 mM; b) 10 mM; and c) 100 mM at 21 C. 
3.4.4 Conclusions 
Isothermal titration calorimetry demonstrated the saturation of 
glucuronylsynthase with -D-glucuronyl fluoride 51 by measuring the heat 
associated with its exothermic binding interaction.  A binding constant (KA) of 
780 ± 30 M-1 was calculated from its titration.  However, the accuracy of this 
value is questionable given the signal response and the “c” value (0.1) were 
both below their recommended thresholds.  From the data obtained, 
glucuronylsynthase would be required at one hundred times the concentration 
for an acceptable binding constant result.  Such a concentration is unfeasible, 
and even if possible, demands high quantities of precious enzyme.  The 
titration of 2-phenylethyl -D-glucuronide 68 encountered equivalent threshold 
problems.  No binding constant was calculated due to low signal response. 
Complications are envisaged for the binding of the acceptor alcohols to 
glucuronylsynthase.  Under a 2-substrate enzyme system, two possible models 
could exist: the random-order ternary-complex mechanism or the compulsory-
order ternary complex mechanism (refer to section 3.1.2).  In each case, the 
binding would be different with and without the presence of -D-glucuronyl 
fluoride 51.  In the presence of -D-glucuronyl fluoride 51 and the acceptor 
alcohol, a glucuronylsynthase reaction will produce a glucuronide product, 
fluoride ion and a proton.  These products may alter the binding studies by 
binding to the enzyme or alter the reaction temperature through the heat of 
reaction, dilution and/or ionisation.  Heat from reactions have been monitored 
by ITC to determine enzymatic parameters, but requires reaction completion 
within 30-60 min.111  Well outside the timeframe required for a 
glucuronylsynthase reaction (days). 
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A repeat of the binding study using glucuronylsynthase as concentrated as 
possible may provide adequate results for the binding of -D-glucuronyl 
fluoride 51 and the glucuronide products, but is unlikely to define the binding 
constant for the acceptor alcohols.  Furthermore, the sample preparation was 
an arduous task to eliminate interference resulting from heat of dilutions.  
Overall, ITC appeared to be an unsuitable assay for the glucuronylsynthase 
system. 
3.5 HPLC-UV 
3.5.1 Background 
HPLC has been successfully applied in literature as a means to determine 
the enzyme kinetics of glycosynthases.104,105,114  HPLC is a discontinuous 
assay by definition, as samples are removed from the reaction over intervals.  
However, HPLC in conjunction with an autosampler provides automation that 
can be associated with a continuously sampled assay.  Multiple detectors are 
available to directly monitor and quantify the product(s) of the reactions.  As 
discussed previously (refer to section 3.1.3), this simplifies kinetic analysis by 
focusing on the reaction of interest. 
Yang et al utilised LC-MS to determine the kinetic parameters of their 
glycosynthase.115  A past group member attempted to repeat the LC-MS work 
with the glucuronylsynthase.116  His work was successful in that the individual 
reaction components could be separated and identified by ESI-MS, but the 
response of the ESI was easily interfered by variations in buffer concentration 
making it difficult to accurately quantify the reaction components.  This 
procedure is extremely sensitive with the reaction mixture being too 
concentrated for a direct injection.  Aliquots had to be manually removed from 
the reaction and diluted prior to LC-MS analysis which introduces numerous 
means for errors to occur. 
A repeat of the assay using HPLC with a photodiode array detector (PDA) 
was developed to eliminate the interferences encountered with the ESI-MS 
detector.  The reaction was directly injected without dilution from a thermostat-
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controlled autosampler to eliminate human error and provide efficiency through 
automation. 
3.5.2 Development of the HPLC-UV assay 
Initial studies looked at the development of an assay that would separate the 
components in the 2-phenylethanol 45 glucuronylsynthase reaction.  A solution 
containing 2-phenylethanol 45, -D-glucuronyl fluoride 51 and 2-phenylethyl -
D-glucuronide 68 was used to simulate the glucuronylsynthase reaction and to 
hone in on the optimised conditions.  An isocratic mobile phase of 23% 
aqueous acetonitrile containing 0.1% trifluoroacetic acid provided adequate 
separation of the reaction components within a 10 min run time.  The 
trifluoroacetic acid was important to achieve good resolution on the C18 
column by ensuring the protonation of the glucuronide.  Pure samples of 2-
phenylethanol 45, -D-glucuronyl fluoride 51 and 2-phenylethyl -D-glucuronide 
68 were analysed by the HPLC assay to verify retention times (ret).  The -D-
glucuronyl fluoride 51 was UV silent, but the 2-phenylethanol 45 (ret 7.2 min) 
and 2-phenylethyl -D-glucuronide 68 (ret 4.2 min) had an UV maximum at 260 
nm. 
3.5.3 Internal standard 
To perform an accurate comparison between each injection, an internal 
standard was introduced to the glucuronylsynthase reaction.  A library of 
potential internal standards was created from simple chemicals found within 
the lab and were assessed on 3 factors.  The first selection criterion was to 
omit any alcohols or phenols to avoid any chance of glucuronylation.  The 
second requirement was the presence of UV activity to allow PDA detection.  
The final condition needed a retention time within (or close to) the 10 min run 
time developed for the 2-phenylethanol 45 glucuronylsynthase reaction without 
overlapping the peaks of interest.  Nineteen compounds were subjected to the 
HPLC assay with their retention time and UV maxima reported in Table 7.1. 
Six compounds (1,2-naphthoquinone-4-sulfuric acid 90, 2-methoxybenzoic 
acid 91, 4-methoxybenzoic acid 92, 3,4-dimethoxybenzoic acid 93, 2-
nitrobenzoic acid 94 and 3-nitrobenzoic acid 95) satisfied all of the previously 
mentioned requirements. 
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The 2-methoxybenzoic acid 91 was chosen as the potential internal standard 
due to its retention time approximately midway between the two peaks of 
interest.  A study was then performed to ensure no change in enzymatic 
activity was observed as a result of 2-methoxybenzoic acid 91 being present in 
the glucuronylsynthase reaction.  A solution of 2-phenylethanol 45 (100 mM) 
and -D-glucuronyl fluoride 51 (100 mM) was divided into two HPLC vials.  To 
the first vial, 2-methoxybenzoic acid 91 (final concentration 1 mM) was added 
and to the second vial, an equal volume of phosphate buffer (the control).  An 
equal aliquot of enzyme was added to each and the reaction monitored 
simultaneously by the developed HPLC assay.  The glucuronide product peak 
area was plotted against time for both reactions (Figure 3.12) with a linear 
relationship (R2 > 0.99) observed over the studied time frame for each 
reaction. 
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Figure 3.12.  Reaction profiles for the glucuronylsynthase reaction between 2-
phenylethanol 45 acceptor (100 mM) with α-D-glucuronyl fluoride 51 donor (100 mM) in 
the presence of 2-methoxybenzoic acid 91 ( ) and its absence ( ) (21 C in 100 mM 
phosphate buffer, pH 7.5).  Linear plots and R2 values were calculated using linear 
regression analysis. 
The reaction without 2-methoxybenzoic acid 91 (the control) provided an 
initial velocity of 15,865 arbitrary units (au) min-1 whilst the reaction containing 
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1 mM 2-methoxybenzoic acid 91 (internal standard) provided an initial velocity 
of 15,401 au min-1 (97% of control).  When the data points for the reaction with 
2-methoxybenzoic acid 91 are corrected for the internal standard, the linear 
regression value improves even further to a value of 0.9999.  This 
demonstrates the positive effect an internal standard has on data accuracy.  
The small deviation in velocity (<3% of control) was considered low and so 2-
methoxybenzoic acid 91 was deemed not to effect the glucuronylsynthesis of 
2-phenylethanol 45.  Due to its intense absorption at 296 nm, retention time 
and inert nature, 2-methoxybenzoic acid 91 was used as an internal standard, 
at a concentration of 0.5 mM, in all the following HPLC assays. 
The HPLC assay is a quick and simple assay for the glucuronylsynthase 
enzyme.  Temperature and injection times are all automated due to a 
thermostat-controlled autosampler which also allows the possibility to monitor 
multiple reactions at once.  The optimised conditions (23% aqueous 
acetonitrile + 0.1% trifluoroacetic acid) have provided a quick 10 min run time 
for the 2-phenylethanol 45 example.  An internal standard, 2-methoxybenzoic 
acid 91, was identified and proven not to interfere with the reaction.  The 
HPLC-UV assay had been successfully developed for the kinetic investigations 
on glucuronylsynthase. 
3.5.4 Kinetics of -D-glucuronyl fluoride 51 
The commencement of enzyme kinetics focused on the kinetic parameters of 
the -D-glucuronyl fluoride 51 donor.  The first step in determining the kinetic 
parameters for -D-glucuronyl fluoride 51 was to develop a calibration curve to 
relate the glucuronide product concentration with UV response.  The 2-
phenylethyl -D-glucuronide 68 was synthesised by glucuronylsynthesis and 
standard solutions were made between 0 - 50 M in 100 mM phosphate buffer, 
pH 7.5 with 0.5 mM internal standard. 
Initially, an injection volume of 5 L was used, but the signal-to-noise ratio 
was poor for dilute samples so the injection volume was increased to 25 L.  
However, the area of the glucuronide peak did not increase proportionally by 
five fold, and the solvent front appeared larger with the increasing 
concentration of glucuronide standard.  It appeared that the 0.1% 
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trifluoroacetic acid in the mobile phase was not strong enough to buffer the 25 
L injection.  As a result, a large portion of the glucuronide product 68 
remained de-protonated, which did not retain on the reverse-phase column 
and was subsequently eluted with the solvent front.  To overcome this 
problem, the 0.1% trifluoroacetic acid in the mobile phase was replaced with 
100 mM phosphate buffer at pH 2.  This new solvent system imposed no 
change in retention time for the individual reaction components and was strong 
enough to buffer the large 25 L injections.  Furthermore, using phosphate 
buffer over trifluoroacetic acid allowed spectral monitoring down to 210 nm 
which was otherwise masked by the trifluoroacetic acid absorbance.  The 
absorbance at 211 nm was stronger than the absorbance at 260 nm for 2-
phenylethanol 45, which improved the sensitivity of the assay.  The 
absorbance at 211 nm is due to the carboxylic acid functionality.  This meant 
that the glucuronylsynthase reactions of UV silent alcohols could now be 
monitored by the developed HPLC assay. 
The calibration curve of 2-phenylethyl -D-glucuronide 68 was obtained by 
the injection of known concentrations (0 - 50 M) to the improved HPLC assay.  
A linear response (R2 > 0.99) in peak area, with respect to the 2-phenylethyl -
D-glucuronide 68 concentration, was observed (Figure 7.2).  The calibration 
curves, for the glucuronides of all the substrates tested in the HPLC kinetic 
study, were obtained in an identical fashion. 
Kinetic measurements for -D-glucuronyl fluoride 51 were commenced with a 
fixed, kinetically sub-saturating concentration of 2-phenylethanol 45 acceptor 
(107 mM) due to limited solubility of this substrate in the aqueous buffer.  
Fourteen separate reactions with various concentrations of -D-glucuronyl 
fluoride 51 (0-100 M) were monitored with the HPLC assay at 21 C.  The 
reactions rates varied with concentration and when plotted against the 
concentration of -D-glucuronyl fluoride 51, it resembled a curve expected for 
Michaelis-Menten kinetics (Figure 3.13). 
Attempts to fit this data to the two-substrate kinetic model (equation 11), 
using Kleidograph data-fitting software, produced large errors.  It is 
recommended that many more data points are required to extrapolate accurate 
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values from an equation with four unknown parameters.  Given that the 
concentration of 2-phenylethanol 45 concentration remains constant 
throughout the study, the data points were fitted to the simplified two substrate 
rate equation (13).  This resulted in the elucidation of apparent kinetic 
parameters with significantly lower errors than the previous fit.  The Kmapp was 
calculated as 15.0  1.1 M and is low relative to other glycosynthase 
enzymes.91,92,105,115  The Vmaxapp was extrapolated as 20.3 nmol min-1 [mg 
protein]-1 which denotes a slow kcatapp of 0.023 ± 0.001 s-1. 
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Figure 3.13. Initial velocity vs. concentration plot of varying α-D-glucuronyl fluoride 51 
donor with constant sub-saturating (107 mM) 2-phenylethanol 45 acceptor (21 °C, 100 
mM phosphate buffer, pH 7.5).  The line represents the data fitted (least-squares) to the 
Michaelis-Menten equation. 
The apparent substrate specificity was determined from the initial slope of 
the initial velocity vs. concentration curve where substrate concentration is low 
as indicated in equation (10).  The apparent kcat/Km from the initial slope was 
determined as 1.0 x 103 M 1 s-1 which is comparable to other glycosynthases 
with their glycosyl donor that range in literature from 0.003-1050 M-1 s-1. 88-97  
The glucuronylsynthase enzyme exhibited strong and highly specific binding of 
its glycosyl donor, but demonstrated a turnover much lower than 
glycosynthase examples in the literature.  The low kcat for this reaction leaves 
considerable scope for improving the catalytic efficiency of this enzyme 
system. 
77 
Enzyme kinetics 
3.5.5 Kinetics of 2-phenylethanol 45 
An analogous study to the previous one was used to determine the kinetic 
parameters of 2-phenylethanol 45.  The concentration of -D-glucuronyl 
fluoride 51 was kept at a constant concentration of 1 mM which is greater than 
ten times Kmapp  as recommended by kinetic literature (>66 x Kmapp = 15 M).  
By definition, the enzyme is considered saturated with -D-glucuronyl fluoride 
51 and the two substrate rate equation (11) can be simplified to the pseudo-
single substrate model (equation 14).  Consequently, the true kinetic 
parameters for 2-phenylethanol 45 could be determined. 
Ten reactions with a varied concentration of 2-phenylethanol 45 (0-107 mM) 
were analysed with the HPLC assay.  Under these conditions the acceptor 
alcohol did not saturate the enzyme due to the limited aqueous solubility of the 
acceptor alcohol.  Nevertheless, when the initial velocities were plotted against 
the concentration of 2-phenylethanol 45 acceptor, the beginning of a curve 
depicting Michaelis-Menten kinetics was observed (Figure 3.14).  The 
magnitude and curvature of this curve was very similar to the initial velocity vs. 
concentration curve obtained from the NMR kinetics of 2-phenylethanol 45 
(Figure 3.7). 
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Figure 3.14. Initial velocity vs. concentration plot of varying 2-phenylethanol 45 
acceptor with constant saturating (1 mM) α-D-glucuronyl fluoride 51 donor (21 C, 100 
mM phosphate buffer, pH 7.5).  Continuous line represents data fitted (least squares) to 
the pseudo-single substrate rate equation (14) and the broken line represents the initial 
slope of the curve used for kcat/Km calculations (n = 5) with its linear regression analysis 
denoted as R2. 
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Fitting the data to the pseudo-single substrate model (equation 14), a Km of 
140  10 mM and a Vmax of 42.8 nmol min-1 [mg protein]-1 denoting a kcat of 
0.049 ± 0.003 s-1.  The kinetic parameters were of similar magnitude to that 
determined by NMR experiments (Km 109.5 mM, kcat 0.034 s-1) obtained at the 
same temperature, but using 100 mM of -D-glucuronyl fluoride 51.  Similar to 
the NMR experiments, the calculated Km (144 mM) is never reached due to 
solubility restrictions and its accuracy questionable as it is an extrapolated 
value. 
This large difference in binding affinity provides information regarding the 
enzyme mechanism.  A literature survey compiled by Davis et al revealed that 
the Michaelis-Menten ratio (KmB/KmA) strongly correlates to either ordered or 
random bi bi mechanisms.117  Their survey suggested that a threshold of 
KmB/KmA > 10 denotes an ordered bi bi reaction.  The binding affinity ratio for 
2-phenylethanol 45 (Km = 144 mM) and -D-glucuronyl fluoride 51 (Kmapp = 15 
mM) is calculated as 9600 suggesting that the glucuronylsynthase reaction 
operates via an ordered bi bi mechanism.  Despite the -D-glucuronyl fluoride 
51 parameter being an apparent value, it is improbable that the true Michaelis-
Menten constant would alter the ratio to within the threshold of 10 reported by 
Davis et al. 
 The Vmaxapp is an underestimation of the Vmax (refer to section 3.1.2) and by 
definition, the kcatapp is an underestimation of the true kcat value.  It is therefore 
no surprise that the kcat determined in this kinetic study is of similar magnitude 
but slightly greater than the kcatapp of 0.023 s-1 determined in the -D-glucuronyl 
fluoride 51 kinetic study. Assuming saturating donor and acceptor 
concentrations, the kcatapp or turnover number for this system is low relative to 
other glycosynthases. 
The slope of the initial velocity vs. concentration plot (Figure 3.14) provided 
an estimated substrate specificity (kcat/Km) of 0.30 M-1 s-1.  This value is 
identical to the substrate specificity value determined from the NMR kinetic 
study.  The similar results produced from the NMR and HPLC assays for the 2-
phenylethanol 45 glucuronylsynthase reaction helps validate the kinetic 
parameters determined for 2-phenylethanol 45.  However, the HPLC assay is 
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easier to perform and provided greater sensitivity which was essential in 
successfully determining the kinetic parameters of -D-glucuronyl fluoride 51.  
The HPLC assay was then used to determine the kinetic parameters of other 
alcohol acceptors. 
3.5.6 Kinetics of 3-methoxybenzyl alcohol 47 
The expansion of the enzyme kinetic investigation with glucuronylsynthase 
was continued with 3-methoxybenzyl alcohol 47 due to its reasonable solubility 
in water.  To commence, a calibration curve was created so that the 3-
methoxybenzyl -D-glucuronide 71 concentration could be related to UV 
response. 
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Figure 3.15. Initial velocity vs. concentration plot of varying 3-methoxybenzyl alcohol 
47 acceptor with constant saturating (1 mM) -D-glucuronyl fluoride 51 donor (21 °C, 100 
mM phosphate buffer, pH 7.5). Broken line represents the initial slope of the curve used 
for kcat/Km calculations (n = 5) with its linear regression analysis denoted as R2. 
Eleven reactions were monitored at 21 C with a saturating concentration of 
-D-glucuronyl fluoride 51 (1 mM) and varied concentrations (0 – 107 mM) of 
3-methoxybenzyl alcohol 47.  The initial velocities of these reactions were 
plotted against their respective concentration of 3-methoxybenzyl alcohol 47, 
but Michaelis-Menten kinetics were not observed (Figure 3.15).  The data at 
low substrate concentrations resembled Michaelis-Menten kinetics, but the 
initial velocity at higher concentrations appeared to drop off.  The entire 
experiment was repeated only to achieve identical results.  The reduction in 
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initial velocity at high substrate concentrations is indicative of substrate 
inhibition.  In light of this discovery, the enzyme mechanism had to be re-
modelled to incorporate substrate inhibition. 
Considering the single substrate mechanism, a second substrate molecule 
(A) may bind to the enzyme-substrate complex (EA) to produce the inactive 
complex AEA (Scheme 3.9). 
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Scheme 3.9.  Single substrate mechanism with substrate inhibition 
As the concentration of A increases, the enzyme-substrate complex is 
pushed down an additional dead-end pathway that reduces the concentration 
of EA and lowers the velocity of product formation.  The rate equation for this 
model is as follows: 
Vmax a
Km + a + a2 / Ksi
v =
    ( 16 ) 
where Ksi is the equilibrium constant of the substrate inhibition pathway 
(k-3/k3) and Vmax and Km satisfy the usual definitions of the Michaelis-Menten 
parameters.  As the concentration of A (a) becomes large, the effect of the 
term a2 reduces the reaction velocity towards zero rather than Vmax.  This term 
creates a decrease in velocity at higher substrate concentrations instead of a 
plateau of velocity associated with standard Michaelis-Menten kinetics.  The 
maximum of the initial velocity vs. concentration curve for a system with 
substrate inhibition occurs at a2 = KmKsi.81  The equation also shows that at 
low concentrations of A (Ksi > a, therefore a2/Ksi → 0), the rate equation 
simplifies to Michaelis-Menten kinetics.  The same occurs if only weak 
inhibition exists (Ksi >> a, therefore a2/Ksi → 0). 
The glucuronylsynthase has been proposed to operate via the ordered bi bi 
mechanism whereby substrate inhibition is denoted by a dead-end pathway 
(Scheme 3.10). 
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Scheme 3.10.  The ordered bi bi mechanism with a dead-end path.  A dead-end step 
(interconversion of EQ to EBQ in this example) is always at equilibrium in the steady 
state. 
A two-substrate model that undergoes substrate inhibition by substrate B 
follows the rate equation:81 
Vmax a b
KiA KmB + KmB a + KmA b + a b + a b2 / KsiB)
v =
       ( 17 ) 
where a and b are the concentrations of substrates A and B, Km and Vmax are 
defined as the Michaelis-Menten constants, K iA is the substrate dissociation 
constant (k-1/k1) and KsiB is the strength of inhibition by substrate B which 
approximates (but does not equal) to k-5/k5.  Parallel to the single substrate 
equation, the term b2 drives the velocity towards zero at high concentrations of 
B instead of Vmax. 
Taking out the factor a from the denominator, we get: 
v =
+ KmB +
K iA KmB
a
KmA b
a + b +a
b2
KsiB
Vmax a b
    ( 18 ) 
From (18), it can be shown in saturating conditions of a, the two-substrate 
equation with substrate inhibition simplifies to the single substrate equation 
with substrate inhibition: 
Vmax b
KmB + b + b2 / KsiB
v =
As a 
K iA KmB
a
KmA b
a&
 0, so
       ( 19 ) 
The 3-methoxybenzyl alcohol 47 glucuronylsynthase reaction monitored by 
HPLC contained a saturating concentration of -D-glucuronyl fluoride 51.  
Therefore, rate equation (19) was used to model the data and determine the 
kinetic parameters for 3-methoxybenzyl alcohol 47.  The data appears to fit 
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well to the equation (R2 > 0.97), but considerable errors (45-66%) were found 
with the kinetic parameters.  The Km was determined as 43 ± 25 mM, the Vmax 
as 64 ± 29 nmol min-1 [mg protein]-1 and the Ksi was 41 ± 27 mM.  The weak 
binding affinity once again demonstrated the stronger binding affinity of the 
carbohydrate moiety in glucuronides.  The ratio KmB/KmAapp was calculated as 
287 which supports an ordered bi bi mechanism. 
The calculated Vmax equates to a slow catalytic turnover (kcat) of 0.073 s-1.  
Conversely, only a third of this velocity was ever observed with a maximum 
observed velocity of 20 nmol-1 min-1 [mg protein]-1 (kcat = 0.023 s-1) from the 
initial velocity vs. concentration plot (Figure 3.15).  This velocity occurred at 55 
mM which corresponded well with the calculated concentration (a2 = KmKsi) of 
42 mM. 
The substrate specificity (kcat/Km) was calculated as 1.8 M-1 s-1 using the 
calculated parameters.  Given the error associated with these values, the slope 
of the initial velocity vs. concentration curve at very low substrate concentration 
was used.  A substrate specificity of 1.3 M-1 s-1 was determined which 
corresponds well with the calculated value.  The kcat/Km value for 3-
methoxybenzyl alcohol 47 (1.3 M-1 s-1) is greater than 2-phenylethanol 45 (0.3 
M-1 s-1) which implies 3-methoxybenzyl alcohol 47 is favoured as a substrate 
by the glucuronylsynthase enzyme. 
The calculated strength of inhibition (Ksi) is less than the Michaelis-Menten 
constant suggesting that 3-methoxybenzyl alcohol 47 provides greater binding 
through inhibition rather than reaction turnover.  However, this can not be 
affirmed given the large errors associated with both of these kinetic 
parameters.  It is recommended that more data points are acquired to 
accurately fit the data to the rate equation which consists of 3 unknown kinetic 
parameters.  Alternatively, the proposed model does not correspond to the 
actual mechanism associated with this system.  The adoption of alternate 
model of inhibition may lead to a better fit to the data. 
3.5.7 Kinetics of 4-fluorobenzyl alcohol 50 
The kinetic parameters of another acceptor alcohol were explored with 4-
fluorobenzyl alcohol 50 subjected to HPLC enzyme kinetics.  Once again, the 
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glucuronide standard was synthesised by glucuronylsynthesis and used to 
generate a calibration curve for 4-fluorobenzyl -D-glucuronide 73.  Twelve 
reactions were monitored at 21 C with a saturating concentration of -D-
glucuronyl fluoride 51 (1 mM) and varied concentrations (0 – 107 mM) of 4-
fluorobenzyl alcohol 50.  The initial velocities of these reactions were plotted 
against their respective concentration of 4-fluorobenzyl alcohol 50, to resemble 
a curve similar to that obtained for 3-methoxybenzyl alcohol 47.  The curve 
also showed substrate inhibition at high substrate concentrations (Figure 3.16). 
The -D-glucuronyl fluoride 51 was used at a saturating concentration so the 
pseudo-single substrate with substrate inhibition rate equation (equation 19) 
was used to model the data.  A good fit (R2 > 0.98) was obtained for the curve, 
but once again the errors associated with the kinetic parameters were still 
unacceptable (33-46%).  The Vmax was calculated as 27 ± 9 nmol min-1 [mg 
protein]-1, the Km as 45 ± 19 mM and the Ksi as 24 ± 11 mM.  The calculated 
Vmax provides a catalytic turnover of kcat 0.031 s-1.  However only 0.0085 s-1 
was observed at a concentration of 37 mM of 4-fluorobenzyl alcohol 50.  The 
theoretical concentration of maximum velocity (a2 = KmKsi) of 33 mM agreed 
closely to the observed value. 
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Figure 3.16. Initial velocity vs. concentration plot of varying 4-fluorobenzyl alcohol 50 
acceptor with constant saturating (1 mM) -D-glucuronyl fluoride 51 donor (21 °C, 100 
mM phosphate buffer, pH 7.5). Broken line represents the initial slope of the curve used 
for kcat/Km calculations (n = 4) with its linear regression analysis denoted as R2. 
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The large KmB/KmAapp ratio of 3000 once again denotes an ordered bi bi 
system for the glucuronylsynthase reaction.  Using the slope of the kinetic 
curve at very low substrate concentration, the substrate specificity (kcat/Km) 
was determined as 0.62 M-1 s-1.  The substrate specificity determined from the 
calculated kinetic parameters is 0.69 M-1 s-1 and agrees closely to the 
observed value.  This substrate specificity value suggests the 4-fluorobenzyl 
alcohol 50 is more favoured by the glucuronylsynthase enzyme than 2-
phenylethanol 45 but not as favoured as 3-methoxybenzyl alcohol 47. 
Once again, the strength of inhibition (Ksi 24 mM) is smaller than the 
Michaelis-Menten constant (Km 45 mM) which suggests inhibitory binding is 
greater than productive binding.  But this is a tentative result given the large 
errors associated with both kinetic parameters once again.  These errors 
demonstrate the inaccuracies associated with fitting a small set of data to a 
complex rate equation with so many unknowns.  Alternatively, the proposed 
model (Scheme 3.10) may need to be altered to suit the true mechanism for 
the glucuronylsynthase system and lead to a better fit to the data.  But with all 
the datasets tested so far being restricted by the solubility of the acceptor 
substrate solubility, the study was continued by exploring the kinetics of the 
more water soluble substrate, phenol 52. 
3.5.8 Kinetics of phenol 52 
The alcohol substrates tested thus far have had poor water solubility and a 
full picture of the kinetic curve is yet to be obtained.  Phenol 52 has been 
shown to form glucuronides with the glucuronylsynthase and has a greater 
solubility in water than all of the acceptor alcohols tested so far.  Furthermore, 
the yields obtained from phenol 52 in glucuronylsynthase reactions are 
significantly smaller than achieved for accepter alcohols.  The kinetic 
parameters for phenol 52 were explored in the hope of obtaining a kinetic 
curve over a greater substrate concentration and to understand phenol’s 
moderate glucuronide yield. 
A calibration curve was developed for phenyl -D-glucuronide 76 in an 
identical fashion as previous kinetic studies.  The less hydrophobic product 
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meant the solvent system had to be altered to 18% acetonitrile in 100 mM 
sodium phosphate buffer, pH 2.0 to provide a retention time of 4.2 min. 
Fourteen glucuronylsynthase reactions were monitored by the altered HPLC 
assay (18% acetonitrile) at 21 C.  The -D-glucuronyl fluoride 51 was used at 
a saturating concentration of 1 mM and phenol 52 was varied (0-240 mM).  
When the initial velocity was plotted against the concentration of phenol 52, the 
presence of substrate inhibition was again observed (Figure 3.17).  This time 
however, a large enough concentration of substrate was achievable to 
visualise complete reaction inhibition. 
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Figure 3.17.  Initial velocity vs. concentration plot of varying phenol 52 acceptor with 
constant saturating (1 mM) -D-glucuronyl fluoride 51 donor (21 °C, 100 mM phosphate 
buffer, pH 7.5).  Broken line represents the initial slope of the curve used for kcat/Km 
calculations (n = 5) with its linear regression analysis denoted as R2. 
An attempt to fit this data to the pseudo-single substrate model with substrate 
inhibition (equation 19) was a little less accurate (R2 > 0.95) than attempts with 
previous acceptor alcohols.  The extrapolated kinetic parameters comprised of 
high errors (10-80%) with the Vmax estimated as 5 ± 4 nmol min-1 [mg protein]-1, 
the Km as 20 ± 2 mM and the Ksi as 34 ± 9 mM.  The large KmB/KmAapp ratio 
(1,333) is consistent with an ordered bi-bi mechanism. 
The catalytic turnover is kcat 0.0061 s-1 from the calculated Vmax value.  As 
anticipated from experimental observations, this was the slowest 
glucuronylsynthase reaction monitored.  The maximum observed catalytic 
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turnover was only half of the theoretical turnover with a value of 0.0030 s-1.  
This occurred at a concentration of 30 mM which corresponds well with 
calculated concentration (a2 = KmKsi) of 26 mM. 
The substrate specificity (kcat/Km) determined from the slope of the kinetic 
curve at very low substrate concentration was 0.22 M-1 s-1 which is similar with 
the value of 0.31 M-1 s-1 determined from the calculated kinetic parameters.  
The Michaelis-Menten constant (Km) is the lowest reported for the acceptor 
species yet the catalytic turnover is the slowest of the acceptor species.  It is 
evident that the slow catalytic turnover of phenol 52 is responsible for it be the 
less favoured substrate for the glucuronylsynthase enzyme in terms of 
substrate specificity.  The sluggish reaction rate and low substrate specificity is 
likely the cause of the low yields associated with the glucuronylsynthesis of 
phenol 52. 
3.5.9 Conclusions 
The kinetic parameters of the -D-glucuronyl fluoride 51 donor and a few of 
the acceptor alcohols have been successfully determined by HPLC kinetic 
studies (Table 3.1).  The data demonstrated pseudo-single substrate 
Michaelis-Menten kinetics for the reaction between -D-glucuronyl fluoride 51 
donor and 2-phenylethanol 45.  For -D-glucuronyl fluoride 51, the 
concentration of 2-phenylethanol 45 was kept at a constant, sub-saturating 
concentration so that apparent kinetic parameters were determined.  For the 
acceptor aglycons, the -D-glucuronyl fluoride 51 was kept at a constant, 
saturating concentration so estimates of the true kinetic parameters were 
determined (Table 3.2).  With the exception of 2-phenylethanol 45, the 
acceptor alcohols demonstrated substrate inhibition.  Attempts of fitting the 
data to a pseudo-single substrate model with substrate inhibition returned large 
errors.  Either more data points are needed to solve the multiple unknown 
parameters in the complex rate equation or an alternative model needs to be 
derived to fit the glucuronylsynthase mechanism.  Despite the large errors 
associated with the calculated kinetic parameters (Table 3.2), they do provide 
a reasonable estimation especially with regards to the substrate specificity 
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constants.  The calculated values matched those determined from the slope 
very closely.  The Km values on the other hand, were less reliable. 
Table 3.1.  Summary of observed kinetic parameters for the substrates of 
glucuronylsynthase at 21 C in 50 mM sodium phosphate, pH 7.5. 
Substrate 
Max kcat 
(s-1) 
Concentration at 
max v0 (mM) 
kcat/Km 
(M-1 s-1)a 
-D-glucuronyl fluoride 51 0.020b N/Ac 1.0 x 103 
2-phenylethanol 45 0.021 N/Ac 0.30  0.02 
3-methoxybenzyl alcohol 47 0.023d 55 d 1.3  0.09 
4-fluorobenzyl alcohol 50 0.0085 d 37 d 0.62  0.04 
phenol 52 0.0030 d 30 d 0.22  0.01 
a) determined from the slope of the initial velocity vs. concentration plot at low 
substrate concentration.  Errors were determined using linear regression analysis; b) 
apparent kinetic parameter; c) maximum v0 never achieved; d) substrate inhibition 
observed. 
Table 3.2.  Summary of calculated kinetic parameters from data fitting for the substrates 
of glucuronylsynthase at 21 C in 50 mM sodium phosphate, pH 7.5.  Errors were 
determined using a non-linear regression analysis. 
Substrate Km (mM) Ksi (mM) kcat(s-1) Conc. at max 
v0 (mM)d 
kcat/Km 
(M-1 s-1) 
-D-glucuronyl 
fluoride 51a 0.015  0.001 N/A 0.023  0.01 N/A 1500 
2-phenylethanol 45b 140  10 N/A 0.049 ± 0.003 N/A 0.34 
3-methoxybenzyl 
alcohol 47c 43 ± 23 41 ± 27 0.073 ± 0.03 42 1.7 
4-fluorobenzyl 
alcohol 50c 45 ± 19 24 ± 11 0.031 ± 0.01 33 0.69 
phenol 52c 20 ± 2 34 ± 9 0.0061 ± 0.005 26 0.31 
a) apparent parameters calculated from the pseudo-single substrate model (equation 
13); b) parameters calculated from the pseudo-single substrate model (equation 14), c)  
parameters calculated from the pseudo-single substrate model with substrate inhibition 
(equation 16); d) calculated from a2 = KmKsi 
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The significant difference in estimated Michaelis constants (Km) observed for 
the -D-glucuronyl fluoride 51 donor and 2-phenylethanol 45 acceptor 
substrates is noteworthy.  Despite the degree of error associated with the 
remaining acceptors, their approximated Km values are still three orders of 
magnitude greater than the -D-glucuronyl fluoride 51 donor.  This may reflect 
the binding interactions for glucuronide substrates at the WT β-glucuronidase 
and the role of this enzyme in E. coli, the producing organism.  Escherichia coli 
is an enteric organism that employs a glucuronide transporter/β-glucuronidase 
enzyme system to harvest the glucuronide residue as a carbon source from 
biliary metabolites excreted in the gut.118  These glucuronide conjugates are 
formed from a wide variety of xenobiotic and some endogenous compounds.  
For this reason the primary recognition of the glucuronide conjugate by β-
glucuronidase is expected for the target carbohydrate moiety over the variable 
aglycon portion.  The kinetic data reported for β-glucuronidase mediated 
hydrolysis provides some support for this analysis.  A Km 0.2 mM was reported 
for the E. coli β-glucuronidase mediated hydrolysis of p-nitrophenyl--D-
glucuronide 25 and estriol 3--D-glucuronide that contain significantly different 
aglycon residues.119  The substrate promiscuity of this enzyme has been 
exploited in the field of analytical chemistry for the de-conjugation of 
glucuronide metabolites.  For the glucuronylsynthase, this is reflected in tight 
binding and a low apparent Km for the -D-glucuronyl fluoride 51 donor (Kmapp 
15.0  1.1 M) and weaker binding and a much higher estimated Km for the 
alcohol acceptors (Km > 20 mM).  As for the catalytic rate of the enzyme, it is 
possibly at the lower end of the range in the glycosynthase family. 
The kinetic properties of 2-phenylethanol 45 are interesting.  The absence of 
substrate inhibition (in the concentrations studied) may be linked to the high 
yields associated with its glucuronylsynthesis.  These high yields are achieved 
despite the 2-phenylethanol 45 being one of the least preferred substrates 
according to substrate specificity (kcat/Km) values (Table 3.1).  This goes 
against the trend expressed by the other aglycons whereby their 
glucuronylsynthesis yields parallel their substrate specificity values (Table 3.3). 
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Table 3.3.  Correlation of substrate specificity values and glucuronylsynthesis yields 
Substrate 
kcat/Km 
(M-1 s-1)a 
Yield from glucuronylation 
reaction (%)b 
2-phenylethanol 45 0.30  0.02 96c 
3-methoxybenzyl alcohol 47 1.3  0.09 84d 
4-fluorobenzyl alcohol 50 0.62  0.04 40c 
phenol 52 0.22  0.01 13c 
a determined from the initial slope of the initial velocity vs. concentration plot. b 
reaction conditions: 1.2 equiv -D-glucuronyl fluoride 51, 0.2 mg mL-1 E504G, RT, 50 mM 
sodium phosphate buffer, pH 7.5. c substrate concentration 100 mM. d substrate 
concentration 50 mM. 
Using the substrate at its maximum concentration does not increase the 
catalytic turnover for the majority of acceptor alcohols due to substrate 
inhibition.  This provides a rationale for one of the trends observed in the series 
of glucuronylsynthase reactions listed earlier in the research (Table 2.2).  It 
was observed that when the substrate concentration was increased from 50 
mM to 100 mM for 3-methoxybenzyl alcohol 47, the yield is reduced.  
Conversely, when the concentrations of 4-fluorobenzyl alcohol 50 and 4-
methoxybenzyl alcohol 48 were reduced in the reactions, an improved yield 
was obtained.  It is proposed that substrate inhibition may have been hindering 
these reactions which caused the discrepancies in yields.  If a more dilute 
substrate concentration was used, the effect of substrate inhibition would be 
reduced.  This would increase the initial velocity of the reaction which may lead 
to improved glucuronide yields.  Another strategy of improving the 
glucuronylsynthase yields may lie in optimising other reaction variables. 
3.6 Reaction optimisation 
In an attempt to improve the catalytic activity and yield in the 
glucuronylsynthase reactions, a selection of reaction variables were altered 
and their effect on reaction velocity and yield were monitored by HPLC. 
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3.6.1 Effect of pH 
The effect of pH on the hydrolysis mechanism of the WT glucuronidase has 
been reported.120  An optimal pH range of 5-8.5 was determined with an 
optimum of ~7.  However, the mechanism of glucuronylsynthase is different 
and an alternative pH may favour this reaction.  
The effect of pH was studied using the glucuronylsynthase reaction with 2-
phenylethanol 45.  Nine identical reactions were set up with a sub-saturating 
concentration of 2-phenylethanol 45 and saturating concentration of -D-
glucuronyl fluoride 51.  The pH of each reaction was varied by one pH unit 
over a wide range of pH values (3.0 - 11.0).  The initial velocity of the reactions 
was monitored at 21 C and then the reactions were incubated without 
agitation at 21 C for 5 days before another injection was made to determine 
the reaction yield. 
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Figure 3.18. Dependence of initial rate (v0; solid bars) and final yield (%, lined bars) on 
pH for reaction of 2-phenylethanol 45 acceptor (100 mM) and α-D-glucuronyl fluoride 51 
donor (1 mM), (21 °C, 50 mM buffer). 
An equivalent initial velocity was observed over the pH range 6-9 (Figure 
3.18) which shares an equivalent optimum range reported for the wildtype -
glucuronidase.  An average velocity of 18.3 nmol min-1 [mg protein]-1 was 
observed over this range which is the equivalent velocity observed in the 
kinetic study of 2-phenylethanol 45 with identical concentrations but a pH of 
7.5 (Figure 3.14).  Reduced activity is observed at pH 5 and 10 with no product 
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formation observed outside of this pH range suggesting the enzyme is inactive 
or has denatured. 
After 5 days, the reactions in the pH range of 5-9 all achieved equivalent 
yields (93-98%).  It is interesting to see that the reaction at pH 5 achieved the 
same yield as the reactions in the optimum pH range despite it having a 
reduced initial velocity.  The other slow reaction at pH 10 only achieves a yield 
of 45%.  The reactions that showed no initial activity (pH 3, 4 and 11) also 
produced no product after 5 days confirming absolutely no detectable enzyme 
activity at these pH levels.  Like the wild-type glucuronidase, the 
glucuronylsynthase has a broad pH range with an equivalent pH optimum of 7-
8.  The glucuronylsynthase reactions are already performed at pH 7.5 so no 
further optimisation could be achieved by altering the pH.  Progress was then 
made at optimising another reaction variable. 
3.6.2 Effect of temperature. 
An increased temperature is known to increase reaction rates of both 
enzymatic and non-enzymatic processes.  However, thermal stability can be an 
issue for substrates, products or the enzyme.  The glucuronylsynthase reaction 
was evaluated at several temperatures (4, 11, 18, 24, 30, 37 °C) at a 
saturating concentration of α-D-glucuronyl fluoride 51 donor (90 mM) and sub-
saturating concentration of 3-methoxybenzyl alcohol 47 acceptor (89 mM).  
With the reaction of 2-phenylethanol 45 achieving near quantitative conversion, 
the acceptor alcohol was substituted to 3-methoxybenzyl alcohol 47 (a lower 
yielding glucuronide) to determine if increasing temperature had a positive 
effect on yield.  A reduced enzyme concentration (0.02 mg mL-1), relative to 
typical synthesis experiments (0.2 mg mL-1), was used to allow the observation 
of initial rates and more keenly assess the influence temperature had on 
overall yield. 
Similar to the pH investigation, two measurements of enzyme activity were 
taken for each temperature value.   Firstly, the initial rate (v0) of reaction was 
determined and as expected showed an increase of initial rate with 
temperature (Figure 3.19a).  The reactions were incubated in the HPLC 
thermostatted autosampler at their respective temperature during their analysis 
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before being transferred to their thermostat-controlled storage.  The reactions 
were incubated for 13 days at their respective temperature and analysed once 
again by HPLC after day 4 and day 13 to assess the yield of product formed 
(Figure 3.19b). 
A yield of 1-10% only is achieved due to enzyme concentration being a tenth 
of what is typically used in a synthetic application.  It is worthy to note the 
increase in yield even after day 13 which demonstrates the ruggedness of this 
enzyme.  However, the reactions maintained at 30 °C and 37 °C gave similar 
yields after 13 days suggesting that the higher initial reaction rate observed at 
the higher temperature is attenuated over time by a higher rate of enzyme 
inactivation.   
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Figure 3.19.  Dependence of a) initial rate (v0) and b) yield (%) on temperature for 
reaction of 3-methoxybenzyl alcohol 47 acceptor (89 mM) and α-D-glucuronyl fluoride 51 
donor (90 mM), (50 mM sodium phosphate buffer, pH 7.5). 
Previously, the glucuronylsynthase reactions have been performed at room 
temperature over 3-5 days.  But according to the results of this investigation, a 
3 fold increase in velocity is achieved if the reaction is performed at 37 C 
rather than at 24 C.  Looking at the activity over time, the enzyme is very 
stable at 37 C over the length of time required for a glucuronylsynthase 
reaction (4 days).  It is only if extended reaction times are required that 
enzyme inactivation may become an issue.  It was therefore determined that 
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glucuronylsynthase reactions should be incubated at 37 C to promote faster 
reactions that may lead to improved yields. 
The low yields observed in these reactions were due to the low concentration 
of enzyme used.  But there was no evidence to suggest that the activity 
observed in the kinetic assays was proportional to the activity in a synthetic 
application given the tremendous difference (10-fold) in enzyme concentration 
used.  It was obvious that an enzyme concentration study was necessary. 
3.6.3 Effect of enzyme concentration on enzyme activity 
The E. coli -glucuronidase quaternary structure is comprised of four 
identical subunits (homotetramer).120  The formation of a quaternary structure 
is enzyme concentration dependent which can lead to deviations in activity 
through its association-dissociation equilibria or allosteric regulation.  An 
investigation to determine the linearity between enzyme activity assayed in the 
kinetic experiments and the synthetic applications, where concentrations vary 
by over 10 times, was completed. 
The measurement of enzyme activity in response to enzyme concentration 
was determined using the glucuronylsynthesis of 2-phenylethanol 45 (94 mM) 
with the α-D-glucuronyl fluoride 51 donor (1 mM) in the presence of various 
concentrations of glucuronylsynthase (0.026 - 1.93 mg mL-1).  A perfectly linear 
response (R2 > 0.99) in relation to enzyme concentration was observed for the 
absolute reaction velocity (Figure 3.20, ).  This suggested that no variation in 
the enzyme’s activity, as a result of allosteric regulation, was observed in the 
concentration ranges studied.  Comparing the relative velocities with respect to 
enzyme concentration, an equivalent velocity of 17 nmol min-1 [mg protein]-1 is 
observed throughout (Figure 3.20, ) demonstrating the catalytic equivalence 
across all enzyme concentrations. 
  The results of this study show that the activity demonstrated in the kinetic 
experiments can be compared to those conducted on a synthetic scale.  With 
most of the reaction variables now investigated, it was of great interest to see 
what effect these optimised conditions had on a synthetic application. 
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Figure 3.20.  Dependence of initial rate on glucuronylsynthase concentration for the 
reaction of 2-phenylethanol 45 acceptor (94 mM) and α-D-glucuronyl fluoride 51 donor (1 
mM) in 50 mM phosphate buffer, pH 7.5 at 21 C. The initial velocity is shown as 
absolute velocity ( ) as M min-1 and relative velocity ( ) to the amount of enzyme 
(nmol min-1 [mg protein]-1).  R2 was determined using linear regression analysis. 
3.6.4Optimised synthesis of phenyl -D-glucuronide 76 
The optimum reaction conditions have been determined for most of the 
reaction variables (substrate and enzyme concentration, pH and temperature).  
These optimum conditions were combined and used in the glucuronylsynthesis 
of phenol 52.  The previous glucuronylsynthesis of phenol 52 obtained the 
phenyl -D-glucuronide 76 in only 13% yield.58  This yield was obtained by 
reacting 100 mM of phenol 52 in the presence of 0.1 mg mL-1 of 
glucuronylsynthase at room temperature (~25 C).  Alterations to this reaction 
included the dilution of phenol 52 to 40 mM, incubating the reaction at 30 C 
and using five times the concentration of glucuronylsynthase.  According to the 
plot of initial velocity vs. phenol concentration (Figure 3.17), a reaction with 40 
mM phenol 52 has twice the velocity of a reaction performed with 100 mM of 
phenol 52 due to substrate inhibition at higher concentrations.  Using these 
optimised conditions, the phenyl -D-glucuronide 76 was obtained in 43% yield; 
over three times the yield from the un-optimised reaction.  A review of 
previously synthesised glucuronides is yet to be completed.  Given the 
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remarkable improvement in yield for the synthesis with phenol 52, a review of 
other alcohol acceptors is warranted. 
3.6.5 Summaries and conclusions 
Improving the catalytic turnover and overall yield in the interim has been 
achieved by understanding the kinetic behaviour of the substrates and 
scrutinising the reaction variables (pH, temperature, and enzyme 
concentration).  The glucuronylsynthase is robust and kept full activity over a 
wide range of pHs (6-9).  Thermal stability is also noteworthy with improved 
activity achieved at higher temperatures and very little enzyme inactivation 
observed.  Reactions at 37 C are now recommended to achieve reactions 
rates three times that of the preceding reactions performed at room 
temperature.  Enzyme concentration dependent allosteric regulation has also 
been ruled out with an identical catalytic rate observed across all 
concentrations of enzyme.  Combining these optimised conditions for the 
glucuronylsynthase reaction of phenol 52, the yield of the glucuronide product 
was improved three-fold.  Further studies are needed to assess the 
improvements on both previous and new acceptor alcohols.  Of particular 
interest is the reaction with steroids, a fundamental goal of this project. 
3.7 High-throughput assays 
In addition to an enzyme kinetic assay, a high-throughput assay for 
glucuronylsynthase activity was also investigated.  This research was 
performed in conjunction with a molecular biologist with the aim of developing 
a screen suitable for directed evolution. 
Directed evolution is not uncommon amongst glycosynthases.  To date, there 
have been four types of high throughput screening applied to glycosynthases.  
These include chemical complementation, enzyme-coupled 
spectrophotometry, pH-dependent assays and enzyme-linked immunosorbent 
assay (ELISA). 
3.7.1 Chemical complementation 
Chemical complementation was developed by the Cornish group and 
involves transcriptional modification brought about by glycosynthase 
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activity.121-123  In their system, a molecule of dexamethasone is linked to a 
molecule of methotrexate via an oligosaccharide linkage (Figure 3.21).  The 
oligosaccharide linkage is formed via a glycosynthase reaction with a 
genetically-modified endo-glucosidase.  Dihydrofolate reductase binds to the 
methotrexate moiety and the glucocorticoid receptor binds to the 
dexamethasone moiety.  The dihydrofolate reductase is fused to a DNA 
binging domain, which binds to a specific DNA binding site upstream from the 
LEU2 gene.  The glucocorticoid receptor is fused to an activation domain 
which up-regulates the transcription of the LEU2 genes.  When the 
oligosaccharide linker is fused through a glycosynthase reaction, the activation 
domain is “locked” in position to promote the transcription of the LEU2 gene.  
The LEU2 gene is an essential gene in the biosynthesis of leucine and its up-
regulation allows cells to grow in leucine-deficient media.  A novel selection 
criterion is achieved by relating glycosynthase activity to cell survival.  This 
makes this assay a high throughput selection as opposed to a screen as only 
mutants with appreciable glycosynthase activity will survive. 
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Figure 3.21.  Cornish’s chemical complementation model.  Formation of the glycosidic 
bond via a glycosynthase reaction up-regulates LEU2 transcription. 
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Chemical complementation is an ingenious and complex model as a high 
throughput selection for glycosynthase activity.  Unfortunately, the system 
relies on oligosaccharide formation through the use of an endo-glycosynthase.  
The -glucuronidase enzyme (and therefore the glucuronylsynthase enzyme) 
is an exo-glycosidase meaning it can only cleave (form) glycosidic bonds at the 
terminal glycoside.  This makes chemical complementation unsuitable for the 
glucuronylsynthase high throughput screen. 
3.7.2 Enzyme-coupled spectrophotometric assay 
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Scheme 3.11.  An example of a glycosynthase reaction coupled with endo-cellulase to 
hydrolyse the 4-nitrophenolate (26) chromophore in an enzyme-coupled high 
throughput glycosynthase screen.  n = 1 or 2.124 
The enzyme-coupled spectrophotometric assay was developed in the 
Withers group and is based on the hydrolysis of a fluorescent or colorimetric 
tag from the glycosynthase product.96,124  It involves the reaction of a glycosyl 
fluoride donor with a glycoside acceptor bearing a chromophore.  An endo-
glycosidase, that recognises the newly formed oligosaccharide, hydrolyses the 
glycosidic bond linking the chromophore which can be measured 
spectrophotometrically (Scheme 3.11).  The hydrolysis step is usually of many 
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magnitudes faster than the glycosynthase step, so the glycosynthesis is the 
rate-determining step.  The rate of fluorescence or colour formation is therefore 
directly related to the glycosynthase activity. 
Similar to chemical complementation, this assay relies on the formation of an 
oligosaccharide which has not been observed for the glucuronylsynthase 
enzyme.  Further to this, the only known enzyme to cleave oligosaccharides 
bearing glucuronyl residues is chondroitinase.125  Chondroitinase cleaves the 
1-4 linkage between hexosamines and glucuronic acid 3 residues of the 
polysaccharide chondroitin via an elimination mechanism (Scheme 3.12).126  
Chondroitinase is unlikely to be coupled with the glucuronylsynthase enzyme 
as the glucuronylsynthase product would have to contain a 4-O-linked 
chromophore.  This product would be improbable to synthesise from a 
glucuronylsynthase reaction and the absence of the hexosamine means it is 
highly unlikely to be recognised by chondroitinase.  This makes the enzyme-
coupled assay unsuitable for the glucuronylsynthase high throughput screen. 
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Scheme 3.12.  The general reaction of chondroitinase. 
3.7.3 “Chromo-ablative” Assay 
Spectrophotometric assays are sensitive and simple to run and typically 
involve the hydrolysis of a masked chromophore.  The spectrophotometric 
assay can not be applied directly to the glucuronylsynthase system due to it 
being a glycosidic-bond forming reaction.  Nor can it be applied in an indirect 
manner such as the enzyme-coupled assay mentioned previously.  But the 
reverse reaction that removes the spectrophotometric signal through bond 
formation is applicable.  The glucuronylsynthase activity would be monitored 
by the quenching of fluorescence or removal of colour via glucuronide 
conjugation.  Being the reverse reaction to the chromogenic (colour-producing) 
assay, we coined the term chromo-ablative (colour-destroying) assay. 
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Figure 3.22. a) spectrophotometric assay of glucuronidase by the release of a 
chromophore and b) chromo-ablative assay of glucuronylsynthase through the 
quenching of a chromophore.  Some examples of chromophores are given for R. 
Fluorescein 96, p-nitrophenol 54, 7-hydroxy-4-methylumbelliferone 97 and 6-
bromo-2-naphthol 98 are known chromophores (Figure 3.22) that were 
subjected to small scale glucuronylsynthesis to verify that the glucuronide is 
formed.  The 7-hydroxy-4-methylumbelliferone 97 dye was synthesised in-
house via a Pechmann condensation with resorcinol 99 (Scheme 3.13).127  A 
new spot was visualised on TLC for the glucuronylsynthesis of 7-hydroxy-4-
methylumbelliferone 97 and 6-bromo-2-naphthol 98 only.  All four crude 
reactions were also analysed by LC-MS ESI with a strong signal corresponding 
to the correct mass for the glucuronide conjugates of 7-hydroxy-4-
methylumbelliferone 97 and 6-bromo-2-naphthol 98 only. 
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Scheme 3.13. Synthesis of 7-hydroxy-4-methylumbelliferone 97 via a Pechmann 
condensation. 
The 4-methylumbellifer-7-yl -D-glucuronide 100 and 6-bromo-2-naphthyl -
D-glucuronide 101 were synthesised on a larger scale and obtained in good 
yields (41% and 69% respectively) when compared to the yield obtained from 
100 
Enzyme kinetics 
phenol 52 (31%, Table 2.2).  A chromo-ablative assay was initiated by first 
determining the excitation and emission maximum for 7-hydroxy-4-
methylumbelliferone 97 (λex = 389 nm, λem = 447 nm) and 6-bromo-2-naphthol 
98 (λex = 257 nm, λem = 367 nm) in phosphate buffer, pH 7.5 under ambient 
conditions.  Calibration curves of the two chromophores were obtained and 
were near linear (R2 > 0.94) up to their solubility limit.  Individual 
glucuronylsynthase reactions on the two chromophores were performed inside 
quartz cuvettes and monitored by fluorescence every ten minutes over 2 days 
in a continuous assay.  Blank reactions lacking glucuronylsynthase were also 
performed to verify fluorescent quenching was due to the glucuronylsynthase 
reaction.  After twelve hours, the fluorescence of 7-hydroxy-4-
methylumbelliferone 97 had been quenched by 80% through its 
glucuronylsynthase-mediated conjugation with -D-glucuronyl fluoride 51 
(Figure 3.23).  An unusual rise in fluorescence was observed over the first hour 
for 6-bromo-2-naphthol 98 (Figure 3.24).  A likely cause may be due to 
inadequate mixing of the substrate.  Nevertheless, an equivalent quenching of 
fluorescence was observed over time, albeit at a lower rate than 7-hydroxy-4-
methylumbelliferone 97.  The concentration of 7-hydroxy-4-methyl-
umbelliferone 97 (0.5 mM) was 2.5 times that of 6-bromo-2-naphthol 98 (0.2 
mM) which may partially account for the variation in reaction rates.  
 
Figure 3.23.  In vitro fluorescent monitoring of 7-hydroxy-4-methylumbelliferone 97 in 
a glucuronylsynthase reaction.  
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Figure 3.24.  In vitro fluorescent monitoring of 6-bromo-2-naphthol 98 in a 
glucuronylsynthase reaction. 
In vitro, the chromo-ablative assays were successfully proven to work due to 
high concentrations of purified enzyme available.  However, the assays were 
never trialled in vivo.  The screens would be performed with cell lysate which 
contains dilute concentrations of crude glucuronylsynthase.  This would 
suggest significantly slower reactions would be observed which may introduce 
errors such as false positives through signal drifting.  Additionally, the assay 
relies on monitoring the small reduction of fluorescence from an initially intense 
source of fluorescence.  This is difficult to measure compared to measuring the 
small development of fluorescence from an environment free of fluorescence.  
As a final point, directed evolution may only result in the evolution of a new 
glucuronylsynthase specific towards 7-hydroxy-4-methylumbelliferone 97 or 6-
bromo-2-naphthol 98.  Improved glycosynthase activity in the directed 
evolution screens would not necessarily suggest improved universal 
glycosynthase activity e.g. towards steroids.  So this assay was placed aside 
for a more universal screening assay to be developed. 
3.7.4 Fluoride-selective assay 
Fluoride selective potentiometry is the most common glycosynthase kinetic 
assay, primarily for its universal application in all glycosynthases regardless of 
the acceptor alcohol or products formed.  Its application on a high throughput 
screen, however, would be impractical.  Fortunately, there are alternative 
means to detect fluoride ions.  Fluoride binds strongly to tetravalent zirconium 
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and ligand-exchange assays have been developed for the detection of 
fluoride.128-130  The complex of zirconium (IV) and flavonol emits a blue 
fluorescence (λem 460 nm) that can be quenched in the presence of fluoride 
ions via ligand exchange in a chromo-ablative manner.131  The earlier flavonol-
zirconium methods required low pHs and organic solvents to promote 
hydrogen bonding and dissolve the hydrophobic flavonol ligand.  Such 
conditions would mean an inconvenient discontinuous assay.  Recently, the 
highly water-soluble 2’-sulfoflavonol 102 was used as the zirconium(IV) ligand 
in neutral, aqueous conditions (Scheme 3.14).132  This work was investigated 
as possible high throughput screening assay for glucuronylsynthase with 
expansion to all glycosynthases. 
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Scheme 3.14.  Ligand exchange reaction of Zr–EDTA–flavonol with fluoride ion. 
The 2’-sulfoflavonol 102 was synthesised from o-hydroxyacetophenone 103 
and sodium 2-formylbenzenesulfonate 104 via an Aldol condensation followed 
by an oxidative cyclisation of the 2’-hydroxychalcone-2-sulfonate 105 (Scheme 
3.15). The final flavonol 102 product was isolated as the potassium salt from 
reverse-phase flash chromatography. 
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Scheme 3.15.  Synthesis of 2'-sulfoflavonol 102 
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The Zr-EDTA-flavonol complex 106 was created in situ during the high 
throughput screening in the molecular biology lab.  The assay was able to 
detect the release of fluoride ions down to 200 nM, with the in vitro 
experiments showing an appreciable decrease in fluorescence over time.133  
Unfortunately, when the assay was applied with cell lysate, it appeared that the 
non-enzymatic hydrolysis of the -D-glucuronyl fluoride 51 donor (Scheme 
3.7a) was increased in the cell lysate and interfered with the assay.  The 
minute amount of glucuronylsynthase activity in the mutants made it difficult to 
set apart a positive result from background hydrolysis.133  This assay is a novel 
means of high throughput screening applicable to all glycosynthases where a 
glycosyl fluoride donor is utilised and an appreciable catalytic turnover is 
achieved.  This assay was inadequate for the current glucuronylsynthase 
activity and alternative assays were explored until a more active generation of 
mutants were created. 
3.7.5 pH-Dependent assay 
The pH-dependent assay was developed by Shoham et al and is a universal 
assay applicable to all glycosynthases.134  It exploits the fact that hydrogen 
fluoride is produced from all glycosynthase reactions so that when little to no 
buffer is applied, the pH of the reaction will drop.  Using common pH 
indicators, the reaction progress can be monitored by eye or more accurately 
through spectrophotometry (Scheme 3.16).  This assay was explored as a 
glucuronylsynthase high throughput assay using 1 mM phosphate buffer and 
Methyl Red 107 as the pH indicator.  The assay was successful in vitro, but 
when applied with cell lysate, the same problems experienced with the 
zirconium flavonol assay were encountered.  The minute amount of 
glycosynthase activity in the mutants made it difficult to set apart a positive 
result from background hydrolysis.133  Furthermore, there was a lag time before 
the pH started to drop due to additional buffering from the cell lysate.  The 
assay reported by Shoham et al was successful for their glycosynthase system 
due to an appreciable parent glycosynthase activity (kcat 1.3 s-1).  This catalytic 
turnover is over 50 times faster than the fastest reported glucuronylsynthase 
reaction (kcat 0.023 s-1 involving 3-methoxybenzyl alcohol 47).   An appreciable 
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glucuronylsynthase activity needs to be achieved by initial directed evolution 
studies before this assay is viable as a glucuronylsynthase high throughput 
assay. 
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Scheme 3.16. Detection of HF production in the glucuronylsynthase by Methyl 
Red 107. 
3.7.6 ELISA assay 
An enzyme-linked immunosorbent assay (ELISA) relies on the recognition of 
the glycosynthase products by a specifically developed anti-body.  An enzyme-
coupled assay would then be used to detect anti-body binding.  This assay 
was demonstrated by Withers and Hancock for their glycosynthase-inspired 
glycophospholipid-synthesising enzyme.91,135  The glycophospholipid-
synthesising enzyme attaches the glycosyl donor to a membrane-attached 
acceptor (Scheme 3.17).  Cholera toxin B subunit (CTB) is added which 
specifically binds to the membrane-bound glycophospholipid products.  The 
plates are washed and mouse anti-CTB is added to bind to the CTB.  The 
plates are washed once again and rabbit anti mouse antibody fused with 
horseradish peroxidase binds to the mouse anti-body.   The horse radish 
peroxidase will oxidise 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS) in the presence of peroxide which can be measured at 405 nm. 
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Scheme 3.17.  ELISA assay for the glycophospholipid synthesising glycosynthase.  
CTB = Cholera toxin B subunit, HRP = horseradish peroxidase, ABTS = 2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid). 
The glycophospholipid synthesising glycosynthase shares similar attributes 
to the glucuronylsynthase enzyme: both attach a glycosyl fluoride donor to a 
variety of non-carbohydrate acceptors.  The ELISA assay may be applicable to 
the glucuronylsynthase system.  ELISA assays have already been developed 
for a small library of steroid glucuronides, including pregnanediol 3-
glucuronide,136 pregnanetriol 3-glucuronide,137 and estrone 3--D-glucuronide 
12138.  Unfortunately no highly specific ELISA assays seem to exist for the 
glucuronides of anabolic steroids such as testosterone 7, nandrolone and 
tetrahydrogestrinone.  Although previous work in the group has seen the 
development of an ELISA assay for the detection of non-conjugated anabolic 
steroids.139,140  It is plausible to develop an ELISA assay, similar to Withers and 
Hancock, whereby an antibody fused with horseradish peroxidase binds to 
another antibody that is selective for a steroid glucuronide of choice.  The 
development of such an ELISA assay is complex task as it requires the 
development of antibodies and so more simple assays were considered first. 
3.7.7 Conclusions 
Multiple high through-put screening assays have been mentioned and, at the 
time of this publication, are currently undergoing trials with cell lysate.  Some 
screens, such as the pH-dependent and fluoride-selective assays failed when 
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the assay was performed with cell lysate.  This is likely due to the low 
glucuronylsynthase activity in cell lysate.  This is not due to the enzyme 
concentration in the cell, but due to the slow catalytic turnover of the enzyme.  
However, options are still open with the chromo-ablative and ELISA assay yet 
to be trialled with cell lysate.  The chromo-ablative assay has been developed 
in vitro but the ELISA assay is still a concept.  The 1H NMR and HPLC assays 
developed for kinetic investigations are unsuitable for high throughput 
screening due to the arduous task of preparing such a large sample set.  The 
search for a successful high through-put screen is on-going. 
3.8 Conclusions from enzyme kinetics 
A HPLC assay was developed to monitor the kinetics of the 
glucuronylsynthase reactions.  Unlike the ITC and 1H NMR assays, the 
samples did not have to be prepared in a special manner for analysis and 
provided the greatest sensitivity of all the kinetic assays attempted.  The 
results from the kinetic investigation (Table 3.1 and Table 3.2) found that -D-
glucuronyl fluoride 51 bound strongly to the glucuronylsynthase enzyme (Kmapp 
15 M) whilst the accepter alcohols exhibited weak binding (Km > 20 mM).  
This large difference in Michaelis constants reflects the binding interactions of 
the wild-type -glucuronidase enzyme whereby the preferential recognition of 
the carbohydrate residue allows the hydrolysis of D-glucuronic acid 3 from a 
wide variety of aglycons. 
This large difference in Michaelis-Menten constants also suggested that the 
glucuronylsynthase operated under an ordered bi bi enzyme mechanism.  The 
rate equation for this model fitted the kinetic data very well for -D-glucuronyl 
fluoride 51 and 2-phenylethanol 45.  However, the kinetic investigation of 3-
methoxybenzyl alcohol 47, 4-fluorobenzyl alcohol 50 and phenol 52 showed 
substrate inhibition.  An attempt at fitting the data to a model with substrate 
inhibition generated kinetic parameters with a moderate degree of uncertainty.  
Either more data points are required to accurately solve the multiple unknown 
kinetic parameters of the current model or an alternative model needs to be 
derived for the glucuronylsynthase system. 
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The catalytic turnovers determined from the kinetic study are less than 
desirable (kcat < 0.023 s-1 observed).  The low catalytic turnover suggested the 
application of directed evolution to more active glucuronylsynthase enzyme.  A 
range of high-throughput screens were proposed for the study but the poor 
activity of the current glucuronylsynthase made it difficult to monitor the 
enzyme activity in cell lysate by the chromo-ablative, pH-dependent and 
fluoride-selective assays.  Alternative options are still available (for example, 
the ELISA assay) and work, in conjunction with a molecular biologist, is still on-
going. 
The activity of the glucuronylsynthase was improved marginally through the 
optimisation study of the reaction variables.  Increasing the temperature of the 
glucuronylsynthase reactions to 37 C will increase the reaction rate three fold.  
No improvement in activity could be achieved by pH with the optimum pH (pH 
7.5) was already used in reaction.  A linear relationship was observed between 
enzyme activity and enzyme concentration, ruling out any deviations of activity 
as a result of quaternary structure equilibria or allosteric regulation.  With the 
optimised reaction conditions determined and a better understanding of the 
glucuronylsynthase mechanism (i.e. substrate inhibition is possible), the 
research was redirected back towards expanding the repertoire of the 
glucuronylsynthase library.  With the ultimate goal of this research to 
synthesise steroid glucuronides for analytic standards; the investigation of 
steroidal substrates was commenced.  
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4.1 Introduction 
An initial attempt at expanding the glucuronylsynthase methodology was 
unrewarding.  Unsystematic modifications to the variables of the 
glucuronylsynthase reaction were performed in the hope identifying a trend 
(refer to section 2.5.1).  Furthermore, novel substrates were subjected to 
glucuronylsynthase reactions with no known experimental protocol to follow 
(refer to section 2.5.4).  A deeper understanding of the glucuronylsynthase 
reaction was gained from enzyme kinetic studies.  The kinetic aspects of the 
enzyme, recognition of substrate inhibition and optimum reaction variables 
were determined from this systematic approach. 
With this knowledge in hand, the extension of the glucuronylsynthase 
methodology was recommenced by expanding the substrate library once 
again.  With the ultimate goal of synthesising steroid glucuronides as analytical 
standards, the glucuronylsynthase methodology for steroids was explored. 
Previous attempts at synthesising steroid glucuronides via 
glucuronylsynthase reactions produced low yields and identified the low water 
solubility of the steroidal substrates as a major issue.58  The solubility of 
steroids in the aqueous media will be addressed in this study along with the 
optimised conditions to achieve high yields of steroid glucuronide conjugates 
from glucuronylsynthase reactions. 
4.2 Glucuronylsynthesis of steroids 
The majority of the glucuronylsynthase research performed to date has 
investigated simple alcohols.  The only steroid glucuronide isolated in milligram 
quantities prior to this research has been that derived from DHEA 55.57    
DHEA 55 is very hydrophobic and had to be dissolved in 2% w/v of the 
detergent DDM to synthesise the DHEA -D-glucuronide 77 in 26% yield 
(Scheme 4.1). This yield was low but still significant considering literature 
states that the Koenigs-Knorr procedure yields 77 in 20% yield over two 
steps.20  The glucuronylsynthase achieved the desired product 77 in a mild, 
single step reaction that allowed essentially complete recovery of starting 
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material 55.  Further to this, it was performed prior to the knowledge of the 
optimised glucuronylsynthase conditions. 
A few additional steroids were subjected to small scale glucuronylsynthesis 
prior to this research and demonstrated likely product formation in accordance 
to the ESI-MS analysis.58  Due to the scale of these reactions, the glucuronide 
products of epiandrosterone 56, testosterone 7, and nandrolone 108 could not 
be confirmed by a complete characterisation nor could a yield be placed on 
these reactions.  To commence the steroid methodology study, it was of great 
importance to determine the yield of these glucuronylsynthase reactions and 
confirm the glucuronide products from these reactions. 
  On a 40 mg scale, epiandrosterone 56 yielded 21% of the glucuronide 
product 109 using identical reaction conditions to that applied to the DHEA 55 
synthetic scale glucuronylsynthesis (Scheme 4.1).  Under the mild conditions, 
the unconsumed epiandrosterone 56 was essentially fully recovered (76%).  
This yield is similar to the yield obtained from DHEA 55 (26%); which is 
consistent given their structural similarities. 
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Scheme 4.1.  Glucuronylsynthesis of a selection of steroids 
The glucuronide formation of the 17-hydroxy steroids was less obvious in 
the small scale investigation and this was consistent with low yields obtained 
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by the preparative scale reactions.  The glucuronides of testosterone 7 and 
nandrolone 108 were obtained in 12% and 6% respectively (Scheme 4.1).  
Nandrolone 108 was completely soluble at 10 mM with 2% DDM whilst 
testosterone 7 was not fully dissolved at 5 mM in 2% DDM.  It appears that 
increased solubility did not necessarily provide a greater yield as only half the 
yield of nandrolone -D-glucuronide 110 (6%) was formed in comparison to 
testosterone -D-glucuronide 6 (12%).  Two possibilities are hypothesised.  
The first theory is that the small structural difference of the methyl group is 
playing an important role in the correct binding in the enzyme.  For example, 
the A ring of nandrolone 108 is subtly more planar than testosterone 7.  This 
may encourage the incorrect binding of the less sterically-demanding A ring 
into the binding site instead of the D ring required for a glucuronylsynthase 
reaction to take place. 
The alternative hypothesis relates to the findings of the kinetic experiments 
(chapter 3.5).  Substrate inhibition was discovered for the majority of acceptor 
alcohols tested in the kinetic studies.  The nandrolone 108 concentration (10 
mM) was almost double the concentration of the other steroids (5-6 mM) and 
so the presence of substrate inhibition may have affected the yield of the 
glucuronylsynthase reaction. 
Which ever the cause for the reduced yield, there was one factor that all 
reactions suffered from.  All reactions were very dilute due to the poor water 
solubility of steroids.  The dilute reactions meant greater quantities of precious 
enzyme were needed to achieve enzyme concentrations that provided an 
appreciable reaction rate.  A more concentrated reaction would require less 
enzyme, but may encounter substrate inhibition if existing for this class of 
substrates.  This could be explored through HPLC kinetic assays; however the 
first step was to discover a suitable method of making the steroids more 
soluble in water. 
The detergent DDM was used to aid in the solubility of the steroid in the 
above examples.  It was used to prevent the denaturing effects associated with 
the use of co-solvents as determined in previous studies.58  This study also 
detailed that DMSO is deemed the best co-solvent due to its conservation of 
enzyme activity and enzyme stability over time.  So a glucuronylsynthase 
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reaction with DHEA 55 using DMSO as a co-solvent was performed to 
compare its use against the detergent DDM.  DHEA 55 was not very soluble in 
the DMSO solution with only a 5 mM concentration achievable with a 25% v/v 
DMSO solution.  Nevertheless, this was subjected to glucuronylsynthesis, 
using analogous reaction conditions applied to the DDM reaction, to achieve 
the DHEA -D-glucuronide 77 in 17% yield.  The high concentration of 
detergents and co-solvents required to get the steroid even slightly more 
concentrated is a trade-off against enzyme inactivation.  It was concluded that 
additives did not significantly aid the solubility of the steroids.  An alternative 
approach may be to temporarily modify the steroid to make itself more water 
soluble. 
4.3 DHEA derivatives 
Improving the aqueous solubility of steroids with additives proved futile so a 
new strategy to install a modifier onto the steroid might prove more successful.  
This modifier would have to increase the aqueous solubility of the steroid 
without hindering the glucuronylsynthase reaction and be easily cleaved in the 
presence of a glucuronide moiety.    The chemical modification of steroids to 
improve water solubility has already been reported previously with an example 
demonstrating the interconversion of the alcohol in DHEA 55 to an ionisable 
species.141  In this example, DHEA 55 was made over 50 times more soluble in 
a saline solution by coupling glycine to the alcohol of DHEA 55 (Scheme 4.2).  
The primary amine of the glycine 3-DHEA ester 111 is easily protonated to 
create an ionised species that enhances water solubility. 
O
HO
DHEA 55
(0.026 mg mL-1)
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O
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(1.38 mg mL-1)
1. BocNHCH2COOH,
DCC/DMAP, DCM
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Scheme 4.2.  Improved solubility of DHEA 55 through the esterification with glycine.141 
A similar concept was envisaged for this research that would leave the 
alcohol untouched for glucuronylsynthase reactions by manipulating an 
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alternative region of the steroid.  Using DHEA 55 as the model substrate, its 
only functionality aside from the alcohol is an alkene bond and a ketone.  
Modification of the ketone seemed the best choice given it is positioned on the 
opposite side of the steroid to the point of glucuronylation, and the large choice 
of ketone derivatives available. 
A simple, mild and reversible reaction is the condensation of a primary amine 
with a ketone to form an imine product.142  The imine is usually hydrolysed 
under aqueous acidic conditions to reform the ketone.  Imines alone are too 
labile and would hydrolyse in situ in the aqueous media of the 
glucuronylsynthase reactions.  Hydrazones and oximes, on the other hand, are 
made in a similar manner but are more resistant towards hydrolysis.  
Hydrazone and oxime analogues were synthesised in the hope of improving 
the water solubility of DHEA 55. 
4.3.1 Hydrazone analogues of DHEA 55 
Hydrazone analogues of DHEA 55 were synthesised in the hope that the 
nitrogen alpha to the imine instils resistance to hydrolysis and solubility through 
a cationic species (Figure 4.1). 
N
NH2
R2R1
N
NH3
R2R1pKa 4-5
H
 
Figure 4.1.  Cationic species of hydrazone.143 
DHEA 55 was refluxed with hydrazine to yield the DHEA hydrazone 112 in 
81% (Scheme 4.3).144  The NMR spectra (attached in example spectra) for the 
DHEA hydrazone 112 looked very similar to the DHEA 55 spectra with some 
minor differences.  A broad singlet is present at 4.76 ppm which was assigned 
to the NH2 protons in the 1H spectrum (d6-DMSO).  The interconversion of the 
ketone to a hydrazone is observed as an upfield shift in the 13C spectrum with 
the C17 carbon going from a carbonyl (221 ppm) to an imine (166 ppm). 
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Scheme 4.3.  Synthesis of DHEA hydrazone analogues 112. 
A second hydrazone analogue of DHEA 55 was synthesised using 2’-pyridyl 
hydrazine using identical reaction conditions.  The DHEA 2’-pyridylhydrazone 
analogue 113 was obtained in 74% yield as a single diastereomer.  This 
isomer is assumed to be the E-isomer due to steric interactions associated with 
the methyl at the C13 position.  There is no previously reported data for the 
DHEA 2’-pyridylhydrazone 113 with this synthesis being the first reported.  The 
1H and 13C NMR spectra (attached in example spectra) exhibited only one 
diastereomer.  The introduction of the hydrazone is evident by the clearly 
defined aromatic segment in the 1H and 13C spectra and the upfield shift of the 
C17 carbon to 163 ppm.  The addition of the 2’-pyridyl group to DHEA 55 was 
expected to aid solubility by introducing a heteroatom that could undergo 
hydrogen-bonding.  The substitution of benzene rings for pyridine is a common 
strategy in reducing the lipophilicity of drugs in medicinal chemistry.  In 
addition, pyridine has a pKa of 5.2 suggesting that a small proportion of the 
protonated form may exist in the glucuronylsynthase reaction pH of 7.5 and 
enhance this analogue’s solubility in water. 
The solubility of DHEA 55 and its analogues were determined by the 
continuous dilution of a known sample at room temperature until complete 
dissolution was determined by eye.  DHEA 55 had a low solubility of 0.02 mM 
in 100 mM phosphate buffer, pH 7.5.  Formation of the DHEA hydrazone 112 
improved the solubility of DHEA 55 five fold to 0.1 mM whereas the DHEA 2’-
pyridylhydrazone 113 was only soluble to 0.05 mM.  It was concluded that the 
hydrophobicity of the aromatic ring  and low pKa value was responsible for its 
lack of solubility.  With only minor enhancements to the solubility of DHEA 
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produced by the hydrazone groups, the synthesis of oxime analogues was 
investigated. 
4.3.2 Oximes analogues of DHEA 55 
The successful synthesis of DHEA hydrazones provided DHEA analogues 
that did not show significantly enhanced solubility.  The synthesis of some 
DHEA oxime analogues were investigated in the hope of greater success.  The 
first synthesised DHEA oxime analogue was the simple unsubstituted DHEA 
oxime 114 (NMR spectra attached in example spectra).  DHEA 55 was added 
to a basic solution of hydroxylamine to produce the DHEA oxime 114 (Scheme 
4.4) in a 52% yield as a mixture of E and Z diastereomers (1.9 : 1.0 
respectively).145 
O
HO
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HO
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HONH2.HCl,
NaOAc, MeOH,
4 °C, 2 h
52%
N
HO
HO
Z-114E-114
DHEA 55 1.9 : 1.0  
Scheme 4.4.  Synthesis of DHEA oxime 114 
The assignment of the isomers was based on the IR spectrum which was 
compared to work performed by Göndös et al.146  Göndös separated the two 
isomers on alumina and provides the melting points and IR spectra of both 
isomers.  In his publication, the stereochemistry of each isomer was 
determined via the Beckmann rearrangement which leads to two different and 
easily distinguishable lactams (Scheme 4.5). 
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Scheme 4.5. Beckmann rearrangement on the DHEA oxime 114 diastereomers 
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The O-H stretch in the IR is 3250 cm-1 for the E-isomer and 3310 cm-1 for the 
Z-isomer.  The imine stretch (C=N) is reported as 1671 cm-1 for the E-isomer 
and 1636 cm-1 for the Z-isomer.  The IR spectrum of the diastereomeric 
mixture of DHEA oximes 114 we synthesised gave an O-H stretch at 3252 cm-1 
and a C=N stretch at 1679 cm-1 which strongly suggested that the E-isomer E-
114 was the predominant isomer. 
A second oxime analogue was synthesised with a similar ionisable functional 
group strategy that was applied to the hydrazone synthesis.  DHEA 55 was 
reacted with carboxymethoxylamine hemihydrochloride 115 to form the DHEA 
O-(carboxymethyl)oxime 116.  The carboxylic acid attached to the end of this 
oxime has a pKa of ~2-3 meaning the carboxylate anion would prevail and 
provide enhanced water solubility in the glucuronylsynthase reactions 
performed at pH 7.5. 
First attempts at the oxime synthesis involved refluxing the two substrates in 
pyridine for 5 hours but only yielded 59% of the DHEA O-
(carboxymethyl)oxime 116 (Scheme 4.6).140  The yield is reasonable, but when 
it is considered that two more steps are yet to follow (i.e. glucuronylation and 
de-oximation), a low yield at the start of a linear sequence would vastly reduce 
the overall yield of synthesising DHEA -D-glucuronide 77.  An alternative 
synthesis was attempted that involved the addition of pyrrolidine to DHEA 55 
prior to the addition of carboxymethoxylamine hemihydrochloride 115.147  The 
pyrrolidine activated the carbonyl as an iminium intermediate 117 which reacts 
more readily with the carboxymethoxylamine hemihydrochloride 115 (Scheme 
4.6).  This two-step, one pot reaction produced the DHEA O-
(carboxymethyl)oxime 116 in 88% yield over the two steps as a single 
diastereomer. 
There is limited characterisation data reported for this oxime 116 with the 
exception of the optical rotation which matched the measured rotation 
perfectly.148  The NMR data fits perfectly with the proposed structure of DHEA 
O-(carboxymethyl)oxime 116.  Parallel with the other synthesised DHEA 
analogues, the 1H spectrum of the DHEA O-(carboxymethyl)oxime 116 
(attached in the example spectra) looks similar to the DHEA 55 NMR spectrum 
except with an added oxime environment.  A large singlet at 4.42 ppm, 
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integrating to two protons, corresponded to the methylene of the newly 
installed oxime.  The 13C spectrum depicted the correct number of carbon 
signals and included new peaks at 171 ppm and 70 ppm respectively assigned 
to the carboxylic acid and methylene carbon of the oxime moiety. 
O
HO
HCl.H2NOCH2CO2H,
pyr, 80 °C, N2, 5 h
59%
pyrrolidine, MeOH
dark, 4 °C, N2, 1h
N
HO
O
O
OH
N
HO
HCl.H2NOCH2CO2H,
pyrrolidine, MeOH,
dark, , N2, 6 h
88% over 2 steps
DHEA 55 DHEA (O-carboxymethyl)oxime 116
DHEA pyrrolidinium imine 117  
Scheme 4.6.  Synthesis of DHEA O-(carboxymethyl)oxime 116. 
The solubility of these DHEA oxime analogues in 100 mM phosphate buffer, 
pH 7.5 was tested against DHEA 55 and the hydrazone analogues.  The 
DHEA oxime 114 displayed the same solubility (0.05 mM) as the DHEA 2’-
pyridylhydrazone 113.  The DHEA oxime 114 does not become ionised like the 
DHEA hydrazone 112 which may compromise its water solubility.  The DHEA 
O-(carboxymethyl)oxime 116 was soluble at 2 mM which was the best 
solubility enhancement result observed.  This was a hundred-fold improvement 
on the solubility of DHEA 55.  It was of great interest to see if this more soluble 
DHEA analogue was prone to glucuronylation in a glucuronylsynthase 
reaction. 
4.3.3 Glucuronylsynthesis of DHEA O-(carboxymethyl)oxime 116 
The development of a range of DHEA 55 analogues with improved water 
solubility was hoped to replace the high concentration of detergents and co-
solvents and the harsh, denaturing effects they impose on the 
glucuronylsynthase enzyme.  The DHEA O-(carboxymethyl)oxime 116 was the 
most soluble of these analogues and its participation in a glucuronylsynthase 
reaction was explored. 
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The glucuronylsynthase reaction was performed on a 2 mM concentration of 
DHEA O-(carboxymethyl)oxime 116 using 0.4 mg mL-1 of the 
glucuronylsynthase enzyme at room temperature.  Elevated temperatures 
were not used for this reaction so a direct comparison could be made between 
the glucuronylsynthesis of DHEA 55 (Scheme 4.1) which was also performed 
at room temperature.  A new spot was observed by TLC after an hour, but after 
a couple of days, the reaction seemed to have stopped.  Uncertain if the -D-
glucuronyl fluoride 51 had degraded, another equivalent was added.  To our 
amazement, the DHEA O-(carboxymethyl)oxime -D-glucuronide 118 was 
isolated in an impressive 76% yield after 4 days (Scheme 4.7).  This was over 
three times that reported from the best DHEA 55 glucuronylsynthase reaction. 
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Scheme 4.7. Glucuronylsynthase reaction of DHEA O-(carboxymethyl)oxime 116 
With no previous report of this glucuronide reported in literature, a thorough 
characterisation of this compound was undertaken.  High resolution mass 
spectrometry reported a peak at m/z 536.2495 which is consistent with the 
formula C27H38NO10 that corresponds to the parent molecule minus a proton.  
A peak at m/z of 558.2302 was also observed that can be assigned as the di-
anion of the molecule plus a sodium cation (C27H37NO10Na). 
Comparing the IR spectrum of DHEA O-(carboxymethyl)oxime 116 to its 
glucuronide 118, subtle changes in absorption confirm glucuronide 
conjugation.  Most noticeable is the more intense and broad absorption at 
3423 cm-1 corresponding with the additional O-H stretches from the glucuronyl 
residue.  The additional carboxylic acid from the glucuronyl residue produces a 
broader carbonyl stretch that peaks at 1745 cm-1 as opposed to the 1680 cm-1 
produced from the combined C=N and C=O stretches of the DHEA O-
(carboxymethyl)oxime 116.  But possibly the most information is provided in 
119 
Steroid solubilisation strategy 
the NMR spectra (Figure 4.2).  The alkenic proton occurs at 5.51 ppm and the 
oxime methylene protons occur as a singlet at 4.38 ppm.  The glucuronosyl 
protons integrate correctly and appear in the 3-4 ppm region.  The anomeric 
glucuronyl proton is observed as a doublet at 4.59 ppm with a coupling 
constant of 7.3 Hz consistent with axial-axial coupling with the adjacent proton.  
This coupling interaction implies an alpha-positioned proton which confirms a 
beta-linked glucuronide product.  The 13C spectrum was also consistent with 
glucuronide conjugation due to the appearance of 6 new carbon environments.  
The carboxylic acid carbon of the glucuronide appears at 178.4 ppm, the 
anomeric carbon at 101.2 ppm, and the remaining 4 glucuronyl carbons 
occurring in the region 80.6-73.9 ppm. 
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Figure 4.2.  1H NMR spectrum (800 MHz, D2O) of DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 (Full page spectrum attached in example spectra). 
To authenticate the synthesis of the proposed glucuronide 118 and remove 
any doubts of stereochemistry, crystals of the DHEA O-(carboxymethyl)oxime 
-D-glucuronide 118 were grown for single x-ray crystal analysis.  Successful 
recrystallisation of the DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
from ethyl acetate, methanol, and water formed translucent crystals upon 
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cooling overnight at 4 C.  The di-sodium salt of DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 was determined (Figure 4.3).  The 
relative stereochemistry was consistent with spectral data and shows the E-
configuration of the oxime substituent and the -linked glycosidic bond.  
 
Figure 4.3.  Crystal structure of one DHEA O-(carboxymethyl)oxime -D-glucuronide 
118 di-anion molecule with labelling of selected atoms.  Anisotropic displacement 
ellipsoids show 30% probability levels. Hydrogen atoms are drawn as circles with small 
radii.  The CIF file is reported in appendix 2. 
Given the impressive yield of 76% for the DHEA O-(carboxymethyl)oxime 
116 glucuronylsynthase reaction, the reaction was repeated on a larger scale 
to prove the practicality of large scale glucuronylsynthase reactions with 
steroids.  A large scale glucuronylsynthase reaction has already been 
demonstrated on 2-phenylethanol 45, but a large scale steroid reaction would 
demonstrate the practical applications of this enzyme and surmount the 
limitations of alternative means of enzymatic glucuronylation.  A reaction with 
0.5 g of DHEA O-(carboxymethyl)oxime 116 was prepared, but due to an 
unforeseen low expression batch of glucuronylsynthase, the DHEA analogue 
116  had to be used at a more concentrated level.  This was to ensure enzyme 
concentrations were high enough to sufficiently convert the large amount of 
material in a reasonable time.  A concentration of 4 mM of DHEA O-
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(carboxymethyl)oxime 116 was achieved by the addition of 5% v/v DMSO.  
After swirling for 4 days at room temperature, only 0.3 g (41%) of the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 was obtained. 
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Scheme 4.8.  Large scale glucuronylsynthase reaction on DHEA O-
(carboxymethyl)oxime 116. 
There were three possible factors that could be associated with this drop in 
yield.  The first factor was the concentration of DHEA O-(carboxymethyl)oxime 
116.  The large scale reaction had twice the concentration of aglycon, than the 
previous reaction.  If substrate inhibition exists for DHEA O-
(carboxymethyl)oxime 116, then the large scale reaction could have suffered 
reduced reaction rates that resulted in a lower yield.  The equivalent of -D-
glucuronyl fluoride 51 was also different in each reaction.  Unlike the first 
reaction, an additional equivalent of -D-glucuronyl fluoride 51 was not added 
to the large scale reaction.  And the final factor is the addition of DMSO as an 
additive to the large scale reaction.  The effect of co-solvents and detergents 
on the activity and stability of the WT -glucuronidase has been explored, but 
no studies have been directed to the glucuronylsynthase enzyme.  In order to 
determine the effect that each of these three factors place on the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reactions, it was necessary to 
revisit the HPLC kinetics.  However, with copious quantities of the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 in hand, the discovery of a de-
oximating procedure was deemed more important.  Without an efficient de-
oximation step, the synthesis sequence would have hit a dead end and the 
optimisation of the glucuronylsynthase step would be futile. 
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4.4 De-oximation of the O-(carboxymethyl)oxime 
The appendage of carboxymethoxylamine 115 to DHEA 55 created the 
oxime analogue 116 that has vastly improved solubility in water.  The DHEA O-
(carboxymethyl)oxime 116 was successfully converted to its glucuronide 118 in 
76% yield under un-optimised conditions.  The final step of the improved 
steroid solubilisation strategy was to cleave the oxime to reform the ketone of 
DHEA 55 in the presence of the attached glucuronide residue.  To begin this 
study, de-oximation of DHEA O-(carboxymethyl)oxime 116 was tried first 
before attempting de-oximation of the subsequent glucuronide. 
4.4.1 De-oximation of DHEA O-(carboxymethyl)oxime 116 
A long list of oxime cleavage procedures exist with the majority operating 
through an acid/metal activated hydrolysis or reduction/oxidation of the oxime.  
With the ultimate goal of removing the oxime from DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 (Scheme 4.9), the reaction 
procedure needed to be mild so it did not hydrolyse the glycosidic bond of the 
glucuronide.  As a result, the use of strong acids was cast aside in fear they 
would degrade the labile glucuronide moiety.  The conditions would also need 
to be selective to avoid any side reactions with other functional groups present 
in the molecule such as the alcohols on the glucuronide or the alkene in DHEA 
55.  Oxidative cleavage seemed an unlikely procedure in light of these 
concerns. 
Many of the de-oximation procedures use non-polar organic solvents as the 
reaction solvent.  With the exception of only a few polar organic solvents, such 
as methanol and DMSO, the DHEA O-(carboxymethyl)oxime -D-glucuronide 
118 is water soluble.  The ideal procedure would be a mild and stereoselective 
procedure, preferably performed in an aqueous media. 
An acid-mediated hydrolysis is the most commonly used procedure but 
refluxing is generally required to achieve higher yields even with unsubstituted 
oximes.149  The combination of heat and acid would surely degrade the 
glucuronide 118 and may also lead to by-products through the Beckmann 
rearrangement (see Scheme 4.5 for an example).150  A metal-mediated 
hydrolysis was hoped to provide improved activation to avoid unnecessary 
Steroid solubilisation strategy 
heating.  Cupric chloride is commonly utilised for the hydrolysis of hydrazones 
in an aqueous media with good yields obtained within hours of reaction at 
room temperature.151-153  It has also been used in the hydrolysis of oximes, but 
to a lesser effect.154  Given the mild, aqueous reaction conditions, this was 
attempted in the de-oximation of DHEA O-(carboxymethyl)oxime 116 (Scheme 
4.9A).  After 24 hours of stirring DHEA O-(carboxymethyl)oxime 116 in the 
presence of 50 mM cupric chloride in phosphate buffer at pH 7.5, no new spots 
were observed by TLC. 
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Scheme 4.9.  De-oximation of the DHEA O-(carboxymethyl)oxime 116. 
The hydrolysis of the oxime was then attempted with an aqueous solution of 
molybdenum hexacarbonyl.155  Molybdenum hexacarbonyl had previously 
been used in the cleavage of isoxazolidines156, but only recently been proven 
to mediate oxime hydrolysis.155  The procedure recommended refluxing in 
aqueous acetonitrile, but to commence, the molybdenum hexacarbonyl was 
stirred in a pH 7.5 buffered solution of the DHEA O-(carboxymethyl)oxime 116 
(Scheme 4.9B).  After 3 hours, no new spots were observed by TLC, so 
acetonitrile was added to aid solubility of the DHEA O-(carboxymethyl)oxime 
116 and possibly the molybdenum reagent also.  After 24 hours, no new 
products were observed by TLC.  The published procedure only reported 
yields for the unsubstituted oximes upon refluxing.155  So it was no surprise 
that our attempt of de-oximating a substituted oxime at room temperature 
would fail.  The discovery of a hydrolysis procedure without heating was 
preferential and so an alternative procedure was explored. 
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Iron(III) nitrate has also been reported as a mild oxidant for deoximation.157-162  
In some instances, it was used in a solvent-free system which may reduce the 
possibility of hydrolysis occurring to the glucuronide.  The solvent-free method 
reported by Firouzabadi et al was attempted (Scheme 4.9C).160  It involved 
stirring a dry mixture of iron(III) nitrate nonahydrate (0.5 equiv) and 
phosphotungstic acid hexahydrate (0.5 equiv) with the oxime (1 equiv).  After 
an hour, a sample of the stirring dry powder was dissolved in chloroform and 
analysed by TLC.  No new spots were observed, so the solvent-free reaction 
was heated to 40 C with stirring.  The reaction was analysed by TLC once 
again after 24 hours and showed no evidence of DHEA 55 formation.  The 
published procedure only reports yields for the unsubstituted oxime and 
observes the release of a red gas.  It appears that iron(III) nitrate oxidises the 
unsubstituted oxime ultimately to nitrogen dioxide which is replaced with water 
to reform the carbonyl.  Unfortunately, iron(III) nitrate was too mild to 
oxidatively cleave the O-(carboxymethyl)oxime.  It appeared that the search for 
a mild de-oximation procedure would have to be refined to substituted oximes. 
Corey and Richman published a mild de-oximation procedure with chromous 
acetate.163  The procedure is reported to work better on oxime acetates than 
the unsubstituted oxime.  Unfortunately, alkyl oximes (such as our oxime) 
required heating in order to react.  Heating in the presence of a Lewis acid 
(Cr2+) may hydrolyse the glycosidic bond of the glucuronide.  It seemed most 
published procedures for substituted oxime removal required harsh reaction 
conditions; or at least harsh in respect to our substrate.  These were conditions 
we had hoped to avoid. 
Timms and Wildsmith developed a mild de-oximation procedure using 
titanium(III) chloride during their synthesis of erythromycylamine.164  Whilst 
their paper reports the de-oximation of an unsubstituted oxime, their procedure 
has also been effective against substituted oximes.165  A 20 mg reaction of the 
DHEA O-(carboxymethyl)oxime 116 was attempted according to the 
procedure.  Upon addition of the solution of titanium(III) chloride, the reaction 
solution turned immediately black-violet and the reaction left to stir at room 
temperature under a nitrogen atmosphere.  The reaction was conveniently 
followed by a colour change with the reaction solution fading to a light blue and 
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the formation of titanium dioxide observed as a white precipitate.  After an 
hour, a complete conversion to DHEA 55 was observed by TLC but only 33% 
was isolated upon work-up.  The remaining mass was unaccounted for and 
possibly lost during workup.  Nevertheless, this was the first de-oximation 
observed, with the product isolated matching the spectral data for DHEA 55. 
Timms describes how the anhydrous reaction yields the imine intermediate 
implying a reductive N-O cleavage is achieved from titanium(III) chloride 
(Scheme 4.10).164  This suggests that two titanium (III) atoms are oxidised in 
the process.  With the exception of the imine 119, the intermediates of this 
reaction have not been isolated, and a detailed mechanism is unknown.  The 
reaction solution is buffered at an acidic pH with acetate to ensure the 
titanium(III) does not readily undergo oxidation with oxygen and the imine 
product 119 formed is hydrolysed to its corresponding ketone 55.   
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Scheme 4.10.  De-oximation of DHEA O-(carboxymethyl)oxime 116 and its imine 
intermediate 119. 
The successful de-oximation of DHEA O-(carboxymethyl)oxime 116 was 
achieved using titanium(III) chloride under mild conditions that avoided the use 
of heat or strong inorganic acids.  Next it was time to attempt the de-oximation 
of the oxime in the presence of the glucuronyl residue. 
4.4.2 De-oximation of the DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
The DHEA O-(carboxymethyl)oxime 116 was synthesised as more soluble 
analogue of DHEA 55 which resulted in superior yields in the 
glucuronylsynthase reactions.  However, the DHEA O-(carboxymethyl)oxime 
-D-glucuronide 118 is not a glucuronide metabolite of interest.  The cleavage 
of the oxime functionality would restore the ketone to produce the DHEA -D-
glucuronide 77 which is a metabolite of interest.  Titanium(III) chloride was 
shown to successfully cleave the oxime from DHEA O-(carboxymethyl)oxime 
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116, so the procedure was attempted in the presence of the glucuronyl 
residue. 
The addition of a solution of titanium(III) chloride to an acetate buffered 
solution of the DHEA O-(carboxymethyl)oxime -D-glucuronide 118 produced a 
violet-black solution that progressively lightened over time.  After an hour, a 
single spot was observed on TLC that matched the retention factor of DHEA -
D-glucuronide 77.  The reaction mixture was also run against DHEA 55 and 
DHEA O-(carboxymethyl)oxime 116 standards on the TLC to assess if any 
glucuronide degradation had occurred.  To our delight, no spots were observed 
for these degradation products.  After purification, a quantitative yield was 
achieved for this de-oximation (Scheme 4.11). 
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Scheme 4.11.  De-oximation of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
Characterisation of the de-oximated product matched the spectral data for 
DHEA -D-glucuronide 77.  High resolution mass spectrometry value matched 
the calculated value with a difference of only 0.9 ppm.  The 1H NMR spectrum 
(Figure 4.4) is missing the singlet which corresponded to the two methylene 
protons of the O-(carboxymethyl)oxime moiety in the 4-5 ppm region.  All 
glucuronide protons are accounted for with the anomeric proton present as a 
doublet (J 7.7 Hz) at 4.45 ppm, the proton adjacent to the glucuronyl carboxylic 
acid present as a doublet (J 9.6 Hz) at 3.80 ppm and the remaining protons as 
triplets in the 3.7-3.1 ppm region.  With the exception of the doublet at 5.43 
ppm (J 4.2 Hz) corresponding to the alkene, the steroidal protons are difficult 
to assign, but integrate correctly.  The 13C spectrum provided good evidence of 
ketone regeneration with the C17 carbon shifting almost 50 ppm downfield 
from an oxime (177 ppm) to the ketone (226 ppm).  The signals for the 
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carboxylic acid and methylene carbons from the oxime moiety were absent 
from this spectrum. 
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Figure 4.4.  1H NMR spectrum (800 MHz, MeOD) for the de-oximated product: DHEA -
D-glucuronide 77 (full page spectrum attached in example spectra). 
The quantitative yield for the de-oximation step provides a high yield overall 
for the 3 step solubility strategy (Scheme 4.12).  A total yield of 67% was 
achieved over the three steps which provided an improvement in yield of over 
2.5 times the best yield obtained from the direct glucuronylsynthesis of DHEA 
55.  The 3 step sequence is a vast improvement on the reported Koenigs-
Knorr procedure which provides a yield of only 20% over two steps.20  With the 
successful application to DHEA 55, it would be of great interest to expand the 
strategy to other steroids with alternative functional arrangements.  A good 
example would be testosterone 7 whose glucuronide 6 was only obtained in 
12% yield from direct glucuronylsynthesis.  This yield is likely attributed to a 
combination of poor water solubility and the more sterically-hindered position 
of the alcohol on the C17 carbon.  Of particular interest for testosterone 7 is 
whether the three step sequence will succeed with an unsaturated ketone.  But 
before other steroids are studied with the three step solubility sequence, it 
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seems appropriate that the optimised conditions of this sequence be 
determined first. 
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Scheme 4.12.  The 3 step solubility strategy for DHEA 55. 
The lowest yield in the three step sequence was the glucuronylsynthase 
reaction.  The two attempts at this reaction had only a couple of varied reaction 
conditions which caused a large difference in the yield obtained (35% 
difference).  With the exception of scale, the only difference between the two 
reactions was the equivalents of -D-glucuronyl fluoride 51, the concentration 
of the DHEA O-(carboxymethyl)oxime 116 and the addition of DMSO to aid 
solubility.  The HPLC assay could be used to investigate the effect that these 3 
factors have on the glucuronylsynthesis of DHEA O-(carboxymethyl)oxime 116 
which may improve the overall yield of the 3 step sequence. 
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4.5 Investigation the reaction variables of the DHEA 
O-(carboxymethyl)oxime glucuronylsynthase reaction. 
The glucuronylsynthesis of DHEA O-(carboxymethyl)oxime 116 has been 
performed twice with two very different yields obtained (76% versus 41%).  It 
was of great interest to understand what reaction variables caused such a 
change in yield and whether the conditions could be optimised to improve the 
yield further.  The three factors, other than scale, that differed between the two 
reactions were the substrate concentration of DHEA O-(carboxymethyl)oxime 
116 and -D-glucuronyl fluoride 51 and the presence of DMSO.  A study on 
each of these factors was performed using the HPLC kinetic assay.  The 
kinetic parameters of DHEA O-(carboxymethyl)oxime 116 were determined 
first.  A comparison of the kinetic parameters of DHEA O-
(carboxymethyl)oxime 116 will be made against the simple acceptor alcohols 
tested previously in the HPLC kinetic study.  Of particular interest, is the 
existence of substrate inhibition present in many of the other acceptor 
alcohols.  
4.5.1 Kinetic parameters of DHEA O-(carboxymethyl)oxime 116 
The kinetic parameters of DHEA O-(carboxymethyl)oxime 116 were explored 
by the developed HPLC assay (chapter 3.5).  The calibration curve for DHEA 
O-(carboxymethyl)oxime -D-glucuronide 118 was generated between 0-10 M 
using previously synthesised material. Due to the hydrophobicity of DHEA O-
(carboxymethyl)oxime 116 relative to previous substrates, the concentration of 
acetonitrile in the HPLC mobile phase had to be increased to 30% v/v.  With 
this altered mobile phase, the glucuronide 118 had a retention time of 5.7 min.  
Thirteen reactions were monitored at 21 C with a saturating concentration of 
-D-glucuronyl fluoride 51 (1 mM) and varied concentrations (0 – 1.95 mM) of 
DHEA O-(carboxymethyl)oxime 116.  The initial velocities of these reactions 
were plotted against their respective concentration of DHEA O-
(carboxymethyl)oxime 116, to develop a curve that showed substrate inhibition 
at high substrate concentrations (Figure 3.16). 
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Figure 4.5. Initial velocity vs. concentration plot of varying DHEA O-
(carboxymethyl)oxime 116 acceptor with constant saturating (1 mM) -D-glucuronyl 
fluoride 51 donor (21 °C, 100 mM phosphate buffer, pH 7.5).  Broken line represents the 
initial slope of the curve used for kcat/Km calculations (n = 3) with its linear regression 
analysis denoted as R2. 
Fitting the data to the substrate inhibition kinetic model (refer to section 3.5.6, 
equation 19), a good fit (R2 > 0.97) is obtained for the curve, but the errors 
associated with the kinetic parameters were large (100-280%).  The Vmax was 
extrapolated as 32 ± 87 nmol min-1 [mg protein]-1, the Km as 7 ± 19 mM and the 
Ksi was 0.1 ± 0.1 mM.  The Vmax equates to a kcat of 0.037 s-1 which is fast 
relative to the other aglycons studied (Table 3.2).  The calculated substrate 
specificity (kcat/Km) of 5.3 M-1 s-1 is over three times greater than the substrate 
specificity calculated for 3-methoxybenzyl alcohol 47. 
Due to substrate inhibition, the maximum observed velocity occurs at 0.55 
mM and provides a maximum velocity of 1.3 nmol min-1 [mg protein]-1 which 
equates to a kcat of 1.4 x 10-3 s-1.  Using the initial slope of the kinetic curve at 
very low substrate concentration, the substrate specificity constant (kcat/Km) 
was determined as 4.3 M-1 s-1.  This observed value is only marginally lower 
than the calculated specificity constant and is the highest specificity constant 
reported for the glucuronylsynthase enzyme so far.  The kcat of the substrate 
falls in line with other aglycons studied suggesting that the higher substrate 
specificity arises from a lower Km value.  The larger surface area of the DHEA 
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O-(carboxymethyl)oxime 116 molecule may provide more favourable 
interactions with the enzyme binding site which helps lower the Km value. 
The substrate inhibition may be a factor as to why the large scale DHEA O-
(carboxymethyl)oxime 116 reaction of 4 mM provided a lower yield then the 
higher yielding 2 mM reaction.  In the large scale reaction, the reaction velocity 
is more hindered by substrate inhibition on an account of DHEA O-
(carboxymethyl)oxime 116 being more concentrated.  A lower turnover means 
less product is formed over time.  So it is likely that by doubling the 
concentration of DHEA O-(carboxymethyl)oxime 116, the yield of glucuronide 
118 was reduced.  Next it was time to determine what effect the -D-glucuronyl 
fluoride 51 concentration had on the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction.   
4.5.2 Equivalents of -D-glucuronyl fluoride 51 
A second equivalent of -D-glucuronyl fluoride 51 was added to the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction that achieved a yield of 
76%.  To observe if this extra equivalent had any effect on the yield, a series of 
identical DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase reactions 
with various equivalents of -D-glucuronyl fluoride 51 were monitored by the 
HPLC assay over 40 hours at 37 C.  One equivalent of -D-glucuronyl fluoride 
51 produced a 48% yield in 40 hours which is similar to the yield (41%) 
achieved in the large scale reaction with only one equivalent of -D-glucuronyl 
fluoride 51.  What is strange about this particular reaction profile is that after 14 
hours, the reaction appeared to halt.  This was observed as a plateau in 
product formation after 14 hours (Figure 4.6).  The addition of two equivalents 
of -D-glucuronyl fluoride 51 produced a yield of 77% which coincidently 
matched the yield (76%) of the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction where an additional equivalent was added midway 
through the reaction.  A third, fourth and fifth equivalent of -D-glucuronyl 
fluoride 51 was also monitored and we were delighted to observe near 
quantitative conversion (98%) of DHEA O-(carboxymethyl)oxime 116 to its 
glucuronide 118.  This was a drastic improvement in yield for the 
glucuronylsynthesis of DHEA O-(carboxymethyl)oxime 116.  This meant that 
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the overall yield for DHEA -D-glucuronide 77 in the three step steroid solubility 
sequence (Scheme 4.12) could be upgraded from 67% to 86% over three 
steps. 
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Figure 4.6.  Reaction yield (%) against time for reaction of DHEA O-
(carboxymethyl)oxime 116 acceptor (1.4 mM) and varying equivalents of α-D-glucuronyl 
fluoride 51 donor (37 °C, 100 mM phosphate buffer, pH 7.5). 
Initially there were concerns of the quality of the -D-glucuronyl fluoride 51 
synthesised, despite characterisation validating purity.  However, doubling the 
equivalents of -D-glucuronyl fluoride 51 did not lead to a doubling of the yield.  
An uncertainty existed on the stability of the -D-glucuronyl fluoride 51 in these 
reactions over time.  During the synthesis of -D-glucuronyl fluoride 51, it was 
observed that this glycosyl fluoride was particularly sensitive to heat with 
discolouration observed within only a couple of hours of heating at 40 C.  It 
was proposed that by heating the reaction at 37 C to improve 
glucuronylsynthase activity, it was at the cost of increased -D-glucuronyl 
fluoride 51 degradation.  The concentration of -D-glucuronyl fluoride 51 could 
not be measured by the reversed phase HPLC assay, so its degradation could 
not be monitored. 
4.5.3 Non-enzymatic hydrolysis of the -D-glucuronyl fluoride 51 
A 1H NMR kinetic experiment was performed to determine the extent of -D-
glucuronyl fluoride 51 degradation (Figure 4.7).  The degradation of -D-
133 
Steroid solubilisation strategy 
glucuronyl fluoride 51 involves the non-enzymatic hydrolysis to glucuronic acid 
3 (analogous to Scheme 3.7a).  Both anomers of glucuronic acid 3 were 
observed in the 1H NMR spectrum. The anomeric proton of -D-glucuronyl 
fluoride 51 was observed as a doublet of doublets over the region 5.8-5.9 ppm.  
The anomeric protons of the hydrolysis products, -glucuronic acid -3 and -
glucuronic acid -3, were observed at 5.4 ppm and 5.6 ppm respectively. 
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Figure 4.7.  1H NMR analysis of -D-glucuronyl fluoride 51 non-enzymatic hydrolysis at 
37 ºC in D2O (500 MHz).  Signals correspond to -D-glucuronyl fluoride 51 (doublet of 
doublets), -D-glucuronic acid -3 (singlet) and -D-glucuronic acid -3 (doublet). 
A 130 mM solution of -D-glucuronyl fluoride 51 was made with D2O, and 
scanned every hour over 21 hours at a probe temperature of 37 C.  By eye, it 
is difficult to observe the -D-glucuronyl fluoride 51 peaks shrinking, but the 
formation of the glucuronic acid 3 anomers is evident.  Plotting the peak 
integration over time, a linear degradation is observed at a rate of 0.6 mol h-1 
(Figure 4.8).  The non-enzymatic hydrolysis of the glycosyl fluoride donor has 
been reported in other glycosynthase studies in which all state a first-order 
hydrolysis.104,166,167  Assuming the same ordered kinetics apply to -D-
glucuronyl fluoride 51, a hydrolysis rate constant (kH) of 1.3 x 10-6 s-1 is 
calculated.  This is of equivalent magnitude to the other reported non-
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enzymatic hydrolysis of glycosyl fluorides.  This hydrolysis rate is 1000-fold 
lower than the kcat of the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction (1.4 x 10-3 s-1) suggesting that something else was 
responsible for slowing the reaction.  This suggested the operation of 
competitive product inhibition increasing over the course of the reaction, a 
phenomenon that could be overcome with increasing concentrations of α-D-
glucuronyl fluoride 51 donor. 
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Figure 4.8.  The rate of non-enzymatic hydrolysis of -D-glucuronyl fluoride 51 ( ) 
and the rate of formation of the glucuronic acid anomers (-D-glucuronic acid 3  and 
-D-glucuronic acid 3 ) as a percentage of total components.  R2 values were 
calculated using linear regression analysis. 
4.6 Product inhibition 
Competitive product inhibition is suspected of causing incomplete conversion 
of DHEA O-(carboxymethyl)oxime 116 into its glucuronide 118.  This is 
credible considering the glucuronide products are the natural substrate of the 
original WT -glucuronidase enzyme from which glucuronylsynthase was 
engineered.  Furthermore, this inhibition appears to be overcome by the 
addition of excess -D-glucuronyl fluoride 51 which signifies its competitive 
nature.    An investigation to verify the existence of product inhibition and its 
magnitude in the glucuronylsynthase reactions was performed. 
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4.6.1 A review of product inhibition 
For a single-substrate system, there are two pure forms of inhibition that can 
be applied to an enzyme.  The first is competitive inhibition, whereby the 
inhibitor will compete with the substrate for the active site of the enzyme 
(Figure 4.9).  The formation of E.I is a dead-end complex; therefore its 
concentration is given by a true equilibrium constant termed the competitive 
inhibitor constant (K ic).  This equilibrium would be observed by an increase in 
the Km, but not the limiting velocity (Vmax), as a higher substrate concentration 
is seen to overcome the inhibition. 
A + E.I
K ic
A + E
+
I
A.E
k1
E + P
k-1
k2
 
Figure 4.9.  Schematic diagram of a single substrate system undergoing competitive 
inhibition. A = substrate, I = inhibitor and E = enzyme. 
The second form of inhibition is uncompetitive inhibition, which 
mechanistically is the converse of competitive inhibition. The inhibitor is binds 
to the enzyme-substrate complex only and not the free enzyme (Figure 4.10).  
The formation of A.E.I is the dead-end complex in this system and similarly its 
concentration is given by a true equilibrium constant termed the uncompetitive 
inhibitor constant (K iu).  This equilibrium reduces the effective concentration of 
the enzyme-substrate complex (E.A) which forces more substrate to combine 
with the enzyme through Le Chatelier’s principle.  This is observed as an 
improvement in the binding affinity of the substrate to the enzyme (reduces 
Km).  But with the enzyme-substrate complex locked up with the inhibitor, the 
turnover is reduced (lower Vmax) regardless of how much substrate is added. 
A + E
A.E.I
A.E
+
I
K iu
k1
E + P
k-1
k2
 
Figure 4.10.  Schematic diagram of a single substrate system undergoing 
uncompetitive inhibition. A = substrate, I = inhibitor and E = enzyme. 
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Mixed inhibition is the common form of inhibition that arises from the 
combination of competitive and uncompetitive inhibition (Figure 4.11).  The 
schematic diagram in Figure 4.11 can be used generally to represent the two 
cases of inhibition based on the size of the equilibrium constants.  In 
competitive inhibition, K iu = ∞, so the complex A.E.I never forms.  In 
uncompetitive inhibition, K ic = ∞, so the complex E.I never forms.   
A + E.I
K ic
A + E
+
I
A.E.I
A.E
+
I
K iu
k1
E + P
k -1
k2
 
Figure 4.11.  Schematic diagram of a single substrate system undergoing mixed 
inhibition. A = substrate, I = inhibitor and E = enzyme. 
Non-competitive inhibition is a rare case of mixed inhibition whereby the 
inhibitor binds with equal affinity to the enzyme and enzyme-substrate complex 
at a different location to the active site.  This would be represented in Figure 
4.11 by the two inhibition constants being equal (K ic = K iu).  The non-
competitive inhibitor does not change how the substrate binds to the enzyme, 
so Km remains unchanged.  With binding affinity unchanged, there is no reason 
why mechanistically the substrate should not bind with the inhibitor-enzyme 
(E.I) complex to form A.E.I. This form of inhibition is observed as a reduction in 
the limiting rate (Vmax).  However, in most cases inhibition cases, K ic ≠ K iu and 
standard mixed inhibition is observed.  This mixed inhibition model (Figure 
4.11) is depicted by the single-substrate rate equation: 
Vmax a
Km (1 + 1/K ic) + a (1 + 1/K iu)v =       ( 20 ) 
In 1953, Dixon deduced a method to determine the extent of inhibition on 
enzymes using inverse plots.168  This was complemented by Cornish-Bowden’s 
graphical means of determining the type and extent of enzyme inhibition in 
1974 (Figure 4.12).169  Curves of the inverse velocity plotted against inhibitor 
concentration (Dixon plot) intersect at a common place when competitive 
inhibition exists.  The x-axis value of this intersection point represents the –K ic 
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value, the competitive inhibition constant.  If a similar approach is taken to the 
substrate concentration over velocity (a/v) vs. inhibition concentration (i) curve, 
a common intersect point is observed for uncompetitive inhibition.  The x-axis 
value of this intersection determines the uncompetitive inhibition constant (K iu).  
In the pure forms of these inhibitions, the curves will intersect in only one of the 
graphs (Dixon or a/v vs. i) with parallel curves observed in the other.  However, 
intersecting curves in both graphs (Dixon and a/v vs. i) is indicative of mixed 
inhibition.  Non-competitive inhibition is identified by the intersection of both 
graphs occurring on the x-axis. 
-K ic
1/v
i
a/v
i
competitive inhibition
1/v
i
uncompetitive inhibition
-K ic
1/v
i
mixed inhibition
-Kiu
a/v
i
-Kiu
a/v
i
-K ic=-K iu
1/v
i
pure non-competitive inhibition
-K iu=-K ic
a/v
i  
Figure 4.12. Characteristic plots for the different inhibition types and the 
determination of the inhibition constants K ic and K iu. 
 The use of inverse ordinate variables such 1/v0 used in the Dixon plot have 
long been known to distort the appearance of the experimental data to such a 
degree that the plot gives a false impression of the best-fit.170  The 
corresponding distortion applied by using a/v0 as an ordinate variable is much 
less.171  The uncompetitive inhibition parameter (K iu) can be determined with 
good confidence, but the accuracy of the competitive inhibition parameter (K ic) 
is questionable. 
Recently, Cornish-Bowden deduced the relationship between inhibition 
parameters and the inhibitor concentration that imposes 50% inhibition (i0.5) 
commonly referred to in biochemical and pharmacological applications.172  
Manipulation of the Michaelis-Menten equation incorporating the inhibition 
138 
Steroid solubilisation strategy 
parameters (equation 20), Cornish-Bowden et al defined the line in a plot of 
a/v0 against i as: 
a
v =
Km
Vmax
1 + iK ic
+ aVmax
1 + iKiu                          ( 21 ) 
where a is substrate concentration, v is the initial reaction velocity, Km is the 
Michaelis constant, Vmax is the limiting rate, i is the inhibitor concentration, K ic 
is the competitive inhibition constant and K iu is the uncompetitive inhibition 
constant. 
The plot of a/v vs. inhibition concentration (i) intersects the y-axis at a/v0 
where the velocity (v) is the uninhibited velocity (v0).  Being a reciprocal, 
doubling the value of the y-intercept gets the value for half the uninhibited 
velocity (2a/v0 = a/0.5v0).  Given that the i0.5 value is defined as the 
concentration of inhibitor required to reduce the reaction rate by half,  the 
inhibitor concentration (i) to achieve this 2a/v0 value, from the plot of a/v vs. 
inhibition concentration (i), is the i0.5 concentration (Figure 4.13).  Rather than 
attempting to solve equation 19 for the inhibitor concentration (i) that provides 
2a/v0, the simple geometrical proof regarding two congruent triangles 
demonstrates that the x-intercept is equal to –i0.5.  So for every plot of a/v 
against i, the x-intercept is the -i0.5 value for that specific concentration of 
substrate (a). 
a/v
2a/v
i0.5-i0.5
a/v
i0
Congruent
triangles
 
Figure 4.13.  Geometrical proof for determining i0.5 from the plot a/v vs. inhibitor 
concentration (i). 
Cornish-Bowden et al also devised a relationship between i0.5 and the 
normalised rate of the uninhibited reaction.172  A normalised rate is the ratio of 
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the uninhibited reaction rate over the limiting reaction rate (v0/Vmax).  Its 
relationship to the i0.5 value is defined as: 
1
i0.5
1
K ic
= + v0Vmax
1
Kiu
- 1K ic                                 ( 22 ) 
Thus a plot of the inverse i0.5 against the normalised rate of uninhibited 
reaction (v0/Vmax) has a y-intercept of 1/Kic.  This is reported to provide a more 
accurate determination of the competitive inhibition parameter than a Dixon 
plot.  This is because it is a secondary plot derived from the plot a/v versus i 
whereas the Dixon plot uses the less accurate inverse ordinate variable, 1/v.  
The slope of the secondary plot 1/i0.5 versus v0/Vmax (equation 22) is (1/K iu-
1/K ic) which indicates that the gradient is determined by the size of each 
inhibition constant.  As a result, the different types of inhibition can be 
determined by the angle of the slope (Figure 4.14).  This secondary plot 
provides the values for all inhibition parameters and has a slope that defines 
the different types of inhibition.  The implementation of this analysis will be 
presented in the inhibition studies. 
1 v0/V max
1/i0.5
1/K ic
pure competitive
slope = -1/K ic
Kiu = 
1 v0/Vmax
1/i0.5
1/K ic
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slope = 1/Kiu-1/Kic
Kiu > K ic
1 v0/V max
1/i0.5
1/Kic
pure non-competitive
slope = 0
K iu = K ic
1 v0/V max
1/i0.5
1/K ic
mixed-uncompetitive
slope = 1/Kiu-1/Kic
Kiu < K ic
1 v0/V max
1/i0.5
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0 0 0
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Figure 4.14.  Determination of the inhibition types and the inhibition constants from 
the dependence of 1/i0.5 on v0/Vmax 
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4.6.2 Determining the inhibition by DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 
A study of the amount of α-D-glucuronyl fluoride 51 donor added to the DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reaction suggested product 
inhibition may be preventing full conversion to the glucuronide 118.  The 
observation that the reaction seemed to stall when the concentration of DHEA 
O-(carboxymethyl)oxime -D-glucuronide 118 to α-D-glucuronyl fluoride 51 was 
approximately a 1:1 ratio was made.  Product inhibition was suggested from 
the improved yields through the addition of extra equivalents of α-D-glucuronyl 
fluoride 51 
To investigate this product inhibition, the initial velocity of a series of 
glucuronylsynthase reactions in the presence of increasing concentration of 
DHEA O-(carboxymethyl)oxime -D-glucuronide 118 would need to be 
determined.  However, monitoring the effect of product inhibition on the DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reaction would provide 
complications as the product peak would be masked by the large quantities of 
the same glucuronide added as an inhibitor to each reaction.  An attempt at 
monitoring a small change in the area of a large peak is less accurate than 
monitoring peaks developing from the baseline.  As a result, the proposed 
inhibition effect of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 was 
tested against the 2-phenylethanol 45 glucuronylsynthase reaction.  The 
glucuronylsynthesis of 2-phenylethanol 45 is free from substrate inhibition and 
was the fastest glucuronylsynthase reaction to monitor meaning a small effect 
on reaction velocity should be easier and more accurately detected.  
Furthermore, the retention time of the DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 does not co-elute with the 2-phenylethyl -D-glucuronide 68 
peak which was monitored to determine initial reaction velocity. 
Three series of 2-phenylethanol 45 glucuronylsynthase reactions were 
studied with 2-phenylethanol 45 at a fixed and sub-saturating concentration of 
88 mM and the α-D-glucuronyl fluoride 51 donor at concentrations near its 
Kmapp (5 M, 10 M and 20 M).  For each concentration of α-D-glucuronyl 
fluoride 51 used, six glucuronylsynthase reactions were performed in the 
Steroid solubilisation strategy 
presence of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 (0 – 101 M).  
A plot of the initial velocity of the 2-phenylethanol 45 glucuronylsynthase 
reaction against DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
concentration depicts a decrease in velocity as the glucuronide concentration 
is increased for all concentrations of α-D-glucuronyl fluoride 51 (Figure 4.15).  
The reduction in initial velocity as a result of DHEA O-(carboxymethyl)oxime -
D-glucuronide 118 concentration already suggested inhibition was taking place.  
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Figure 4.15.  Inhibitory effect of different DHEA O-(carboxymethyl)-oxime -D-
glucuronide 118 concentrations (0-101 M) on the initial rate (v0) of the 
glucuronylsynthase reaction involving sub-saturating 2-phenylethanol 45 (88 mM) and α-
D-glucuronyl fluoride 51 (5 M , 10 M , and 20 M ) at 21 °C in 100 mM phosphate 
buffer, pH 7.5 
Estimations of the inhibition parameters were calculated from Dixon and a/v 
vs. i plots (Figure 4.16).  The Dixon plot (Figure 4.16a) depicts the three series 
of 2-phenylethanol 45 reactions as linear plots (R2 > 0.97) that all intersect 
above the x-axis at approximately 73 M.  This denoted either competitive or 
mixed inhibition with a competitive inhibition parameter (K ic) of 73 ± 6 M.  The 
a/v versus i plot (Figure 4.16b) of the three series of 2-phenylethanol 45 
reactions also shows a linear relationship (R2 > 0.97) with a common point of 
intersect below 190 M.  This common intersect provides an uncompetitive 
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inhibition parameter (K iu) of 190 ± 2 M.  Intersecting curves on both plots 
denotes mixed predominately competitive inhibition. 
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Figure 4.16.  a) Dixon plot of 1/v against the concentration of DHEA O-
(carboxymethyl)oxime -D-glucuronide 118; and b) the plot of α-D-glucuronyl fluoride 51 
concentration over initial velocity ([-D-glucuronyl fluoride 51]/v) against the 
concentration of DHEA O-(carboxymethyl)oxime-D-glucuronide 118.  The 
glucuronylsynthase reaction involved sub-saturating 2-phenylethanol 45 (88 mM) and α-
D-glucuronyl fluoride 51 (5 M , 10 M , and 20 M ) at 21 °C in 100 mM phosphate 
buffer, pH 7.5.  R2 values were calculated using linear regression analysis. 
To provide a more accurate determination of the inhibition parameters, the 
i0.5 concentrations were determined from the x-axis intercepts of the a/v versus 
i plot (Figure 4.16b) and plotted against the normalised velocity (v0/Vmax) of 
their uninhibited reaction (Figure 4.17).  The plot has a negative slope that 
crosses the x-axis at a point greater than one which signifies mixed 
predominately competitive inhibition.  The competitive inhibition parameter (K ic) 
was determined from the inverse of the y-intercept which equated to 71 M.  
This value corresponds well with the K ic value of 73 M determined from the 
Dixon plot (Figure 4.16a).  The K ic value was substituted into the equation 
(1/K iu-1/K ic) that defines the slope of the curve to solve for K iu.172  K iu was 
determined to be 180 M which again agrees well with the value (190 M) 
determined from the a/v versus i plot (Figure 4.16b). 
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Figure 4.17.  The plot of 1/i0.5 vs. v/Vmax exhibiting mixed (predominantly competitive) 
inhibition by DHEA O-(carboxymethyl)oxime -D-glucuronide 118 in the 
glucuronylsynthase reaction involving sub-saturating 2-phenylethanol 45 (88 mM) and α-
D-glucuronyl fluoride 51 (5 M , 10 M , and 20 M ) at 21 °C in 100 mM phosphate 
buffer, pH 7.5.  R2 was calculated using linear regression analysis. 
The observation of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
inhibition in the 2-phenylethanol 45 glucuronylsynthase reaction strongly 
suggests that product inhibition is occurring in DHEA O-(carboxymethyl)oxime 
116 glucuronylsynthase reaction.  DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 exerts mixed inhibition to the glucuronylsynthase enzyme that 
is predominately through competitive inhibition.  The competitive inhibition 
parameter was determined as 73 M with the use of a Dixon plot and 71 M 
using the secondary plot of 1/i0.5 versus v/Vmax.  This is a moderately strong 
inhibition value that suggested that the binding affinity of the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 is much stronger than the binding 
affinity of DHEA O-(carboxymethyl)oxime 116 which was estimated in the 
millimolar range (refer to section 4.5.1).  Fortunately, the -D-glucuronyl 
fluoride 51 Kmapp 0.15 M is significantly lower which means a considerable 
amount of conversion can be achieved before the competitive product 
inhibition becomes a problem.  By keeping the concentration of -D-glucuronyl 
fluoride 51 high, by the addition of extra equivalents, the concentration does 
not approach Kmapp thus overcoming the effects of product inhibition.  A 
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significant amount of uncompetitive inhibition was also discovered and 
determined to be 190 M from the a/v versus i plot and 180 M using the 
secondary plot of 1/i0.5 versus v/Vmax.  The combination of the two inhibition 
types was able to stop the glucuronylsynthase reaction of DHEA O-
(carboxymethyl)oxime 116 at approximately 50% conversion in the presence of 
one equivalent of -D-glucuronyl fluoride 51.  The glucuronylsynthesis of 2-
phenylethanol 45 achieves 96% conversion with 1.2 equivalents of -D-
glucuronyl fluoride 51.  We were interested if product inhibition existed for this 
glucuronylsynthase reaction.  
4.6.3 Determining the inhibition by 2-phenylethyl -D-glucuronide 68 
Product inhibition of the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction is responsible for incomplete conversion to the 
glucuronide 118.  The hypothesis that glucuronide yield might be directly 
proportional to the strength of product inhibition was proposed.  The 
glucuronylsynthase reaction of 2-phenylethanol 45 achieves near quantitative 
yields with only one equivalent of -D-glucuronyl fluoride 51.  We were 
interested in whether product inhibition was present in this reaction, and if so, 
to what degree. 
The assay to measure the inhibition of 2-phenylethyl -D-glucuronide 68 was 
conducted for the DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase 
reaction.  The DHEA O-(carboxymethyl)oxime -D-glucuronide 118 produced 
in the reaction would not co-elute with the 2-phenylethyl -D-glucuronide 68 
added to the reaction mix.  Initially, a reaction of DHEA O-
(carboxymethyl)oxime 116 (0.6 mM; the concentration at the maximum 
observed velocity) with -D-glucuronyl fluoride 51 (20 M) was monitored with 
5 concentrations of 2-phenylethyl -D-glucuronide 68 in the micromolar range 
(0-100 M).  However, it appeared that the initial velocity did not reduce with 
an increase of 2-phenylethyl -D-glucuronide 68 concentration (Figure 4.18).  
So the investigation was repeated with the same DHEA O-
(carboxymethyl)oxime 116 reactions but with 2-phenylethyl -D-glucuronide 68 
concentrations in the millimolar range (0-100 mM).  Once again, a decrease in 
initial velocity was not observed with increasing 2-phenylethyl -D-glucuronide 
Steroid solubilisation strategy 
68 (Figure 4.18).  With no observed inhibition in these glucuronylsynthase 
reactions, it was deemed meaningless to assay the inhibition at alternative -
D-glucuronyl fluoride 51 concentrations. 
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Figure 4.18.  Effect of 2-phenylethyl -D-glucuronide 68 (0-100 mM) on the initial rate 
(v0) of the glucuronylsynthase reaction involving DHEA O-(carboxymethyl)oxime 116 
(0.6 mM) and α-D-glucuronyl fluoride 51 (20 M) at 21 °C in 100 mM phosphate buffer, pH 
7.5. 
An average velocity of 0.6 ± 0.2 nmol min-1 [mg protein]-1 was observed for 
all concentrations of 2-phenylethyl -D-glucuronide 68 up to 100 mM.  It 
appeared that inhibition is either non-existent or too small to be detected by the 
assay.  This is consistent with the findings from the ITC study (refer to section 
3.4.3).  In the ITC study, the 2-phenylethyl -D-glucuronide 68 was also found 
to bind very weakly to the enzyme. 
The -D-glucuronidase is a promiscuous enzyme that binds with a range of 
glucuronides in the micromolar, if not low millimolar range.  It can be assumed 
that with only a single amino acid change, an equivalent affinity to a range of 
glucuronides may be observed for the glucuronylsynthase.  The underlying 
reason why 2-phenylethyl -D-glucuronide 68 does not bind well and inhibit the 
glucuronylsynthase is a mystery.  Kinetic studies using the wild-type -
glucuronidase could be used to determine the kinetic parameters, but due to 
the absence of a visible chromophore, the assay would not be simple to 
perform.  Perhaps when a crystal structure is obtained of the E. coli -D-
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glucuronidase, or better yet, of the glucuronylsynthase, a structure-activity 
relationship can be devised. 
The absence of both product and substrate inhibition in the 2-phenylethanol 
45 glucuronylsynthase reaction may suggest why near quantitative yields can 
be achieved with only one equivalent of -D-glucuronyl fluoride 51.  In contrast, 
the glucuronylsynthesis of DHEA O-(carboxymethyl)oxime 116, where its 
glucuronide product 118 imposes strong inhibitory binding, only achieves 
~50% yield with one equivalent of α-D-glucuronyl fluoride 51.  It would be of 
considerable interest to determine if product inhibition exists in some of the 
other glucuronylsynthase reactions performed to date.  Further to this, if 
product inhibition is proven in these cases, what is the extent of the inhibition in 
these reactions?  And finally, is there a relationship between the strength of 
product inhibition and the yields obtained in these glucuronylsynthase 
reactions with one equivalent of α-D-glucuronyl fluoride 51? 
The discovery of mixed, predominately competitive product inhibition and the 
ability to overcome it with additional equivalents of α-D-glucuronyl fluoride 51 
has been a defining moment in the optimisation of the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction.  It has boosted the 
yield of the three step steroid solubilisation strategy by an additional 20%.  It 
was of great interest to see if the success of this 3-step solubility strategy could 
be extended to other classes of steroidal substrates such as testosterone 7. 
4.7 Solubility strategy with testosterone 
Testosterone 7 is a 17-hydroxy steroid which suffers from poor solubility 
and low yields (12%) in the direct glucuronylsynthase reaction.  It was hoped to 
overcome the issue of poor solubility and low yield by subjecting testosterone 7 
to the three step steroid solubilisation strategy.  Unlike DHEA 55, testosterone 
7 has an unsaturated ketone that is present in a range of steroids such as 
boldenone and gestrinone.  It was of particular interest to see if the steroid 
solubilisation strategy would work with unsaturated ketones. 
Steroid solubilisation strategy 
4.7.1 Oximation of testosterone 7 
The first step of the steroid solubility sequence was to attach the ionisable 
functional group onto testosterone 7.  The oximation of testosterone 7 with 
carboxymethoxylamine 115 was performed according to the procedure of 
Philomin.147  Activation of the unsaturated ketone with pyrrolidine was rapid 
with the yellow testosterone pyrrolidinium species formed within 5 minutes as 
reported in literature.  Refluxing this intermediate with carboxymethoxylamine 
hemihydrochloride 115 for an hour produced testosterone O-
(carboxymethyl)oxime 120 in 91% yield and as a mixture (1.0 : 1.7) of Z and E 
isomers (Scheme 4.13).  The ratio of isomers varied with each attempt at the 
synthesis with another attempt providing a yield of 65% and a Z : E ratio of 1.0 
: 4.9.  The major product (E-isomer) in each synthesis attempt was always the 
same isomer. 
The 17-ketone of DHEA 55 required an hour to form the pyrrolidinium 
intermediate 117, then over 6 hours to form the O-(carboxymethyl)oxime 116.  
The reaction with testosterone 7 was much more rapid with a reaction time of 
only 5 min for the pyrrolidinium formation and only an hour for the O-
(carboxymethyl)oxime 120 conversion.  The discrepancy in reaction rates is 
likely due to steric factors with the ketone of DHEA 55 being adjacent to a 
quaternary carbon. 
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Scheme 4.13. Oximation of testosterone 7 with carboxymethoxylamine 115. 
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Two distinct isomers were observed in the 1H NMR spectrum (Figure 4.19).  
The NMR data for the reaction yielding a Z : E ratio of 1.0 : 4.9 was used in the 
Steroid solubilisation strategy 
NMR analysis so that peaks could be easily assigned to each isomer based on 
signal intensity.  There were two signals for the oxymethylene protons of the 
O-(carboxymethyl)oxime moiety as a result of the two isomers.  The major 
isomer appears as a singlet at 4.54 ppm and the minor isomer at 4.51 ppm.  
The olefinic proton of the testosterone O-(carboxymethyl)oxime 120 isomers is 
present at 6.45 ppm for the minor isomer and 5.74 ppm for the major isomer.   
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Figure 4.19.  1H NMR (800 MHz, MeOD) of the diastereomeric mixture of testosterone 
O-(carboxymethyl)oxime 120 (full page spectrum attached in example spectra) 
Differentiation of the isomers could not be determined by NOESY 
experimentation.  The numerous studies on unsaturated oximes and 
testosterone oximes all report that the olefinic proton shifts downfield in the 1H 
NMR spectrum for the Z isomer relative to the E isomer.173-176  Assuming this is 
true for our system, the olefinic proton for the minor product appears furthest 
downfield suggesting that the E oxime was the major product.  This oxime 
group would be removed in the final step, so the stereochemistry of the 
testosterone O-(carboxymethyl)oxime 120 would have made no difference to 
the final product.  The only exception may be if the glucuronylsynthase enzyme 
was selective for one isomer over the other. 
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The 13C NMR spectrum (attached example spectra) contained 41 
environments as a result of the two isomers, with only a single carbon peak 
overlapping or obstructed.  Fortunately, the 1 : 5 ratio of the sample analysed 
allowed the individual peaks to be assigned to their respective isomer based 
on peak intensity.  The introduction of the O-(carboxymethyl)oxime moiety was 
verified by the addition of a carboxylic acid (174.07 and 173.99 ppm) and an 
oxymethylene (71.0 and 70.8 ppm) carbon resonance in the spectrum.  In 
addition, the C3 carbon of testosterone shifted upfield from 200 ppm as an 
unsaturated ketone 7 to 157 ppm as an unsaturated oxime. 
The melting point and optical rotation agreed with the literature.177  But these 
values would be dependent on the ratio of isomers present and this was not 
specified in previous work.  The high resolution mass spectroscopy ESI value 
matched the exact mass of the testosterone O-(carboxymethyl)oxime 120 
anion. 
The solubility of the testosterone O-(carboxymethyl)oxime 120 was tested 
against the solubility of testosterone 7 in 100 mM phosphate buffer at pH 7.5.  
Testosterone 7 appeared to dissolve at a concentration of 0.02 mM.  The 
testosterone O-(carboxymethyl)oxime 120 was completely dissolved at a 
concentration of 10 mM which is a 500-fold increase in solubility.  In contrast, 
only a 5 mM concentration of testosterone 7 was achieved when 2% DDM is 
used to aid solubility.  This concentration was doubled without the need of 
additives through the use of the ionisable oxime group.  Next it was time to see 
what this enhanced solubility had on the glucuronylsynthesis of testosterone 7. 
4.7.2 Testosterone O-(carboxymethyl)oxime 120 glucuronylsynthase reaction 
With testosterone O-(carboxymethyl)oxime 120 in hand, the testosterone 7 
analogue was subjected to glucuronylsynthesis using optimised conditions 
developed for the DHEA O-(carboxymethyl)oxime 116.  Testosterone O-
(carboxymethyl)oxime 120 (10 mM) was reacted with three equivalents of -D-
glucuronyl fluoride 51 and glucuronylsynthase (0.2 mg mL-1, Scheme 4.14).  
After four days at 30 C, the testosterone O-(carboxymethyl)oxime -D-
glucuronide 121 was isolated in a yield of 72% as a mixture of isomers.  This 
yield is six times the yield obtained from the direct glucuronylsynthesis of 
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testosterone 7 (12% yield).  In addition to this, 23% of unreacted testosterone 
O-(carboxymethyl)oxime 120 was recovered from the column making the total 
yield 94% based on recovered starting materials. 
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Scheme 4.14.  Glucuronylsynthase reaction on testosterone 
O-(carboxymethyl)oxime 120 
There is no previously reported synthesis or spectral data for testosterone O-
(carboxymethyl)oxime -D-glucuronide 121.  The high resolution mass 
spectrum exhibited a molecular anion consistent with the desired molecular 
formula C27H38NO10.  The infrared spectrum of the glucuronide 121 showed a 
broad absorption at 3370 cm-1 that corresponds to the alcohols of the installed 
glucuronyl residue.  An absorption at 1732 and 1630 cm-1 denotes the 
existence of carboxylic acid carbonyls and oxime carbons (C=N) respectively. 
The 1H NMR spectrum (Figure 4.20) depicts the existence of two glucuronide 
isomers resulting from the diastereomeric mixture of oximes.  The olefinic 
protons of the two isomers occur at 6.45 ppm (minor) and 5.71 ppm (major).  
The E isomer is once again the major isomer formed in a diastereomeric ratio 
2.0 : 1.0.  This ratio arises from the testosterone O-(carboxymethyl)oxime 120 
E : Z ratio of 1.7 : 1.0.  It appears the glucuronylsynthase had no strong 
selectivity of one isomer over the other.  The O-(carboxymethyl)oxime segment 
is also present as two singlets as a result of the two isomers.  The 
oxymethylene protons of this group appear at 4.54 ppm (major) and 4.52 ppm 
(minor). 
The protons of the installed glucuronide residue are present in the spectrum 
and integrate perfectly.  The spatial distance between the glucuronide and site 
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of isomerisation is large enough that the glucuronyl environments are 
accidentally equivalent for the two isomeric species.  The anomeric proton 
exists as a doublet at 4.38 ppm (J 7.2 Hz) whilst the remaining pyranose 
resonances appear in the 3-4 ppm region along with the steroidal H17 proton.  
The large coupling constant of the anomeric proton denotes axial-axial 
coupling with the adjacent proton which implies a -glycosidic bond has formed 
between the testosterone alcohol and the glucuronide residue. 
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Figure 4.20.  1H NMR (800 MHz, MeOD) of the diastereomeric mixture of testosterone 
O-(carboxymethyl)oxime -D-glucuronide 121. 
The 13C NMR spectrum was complex due to the existence of the two isomers 
but verified the introduction of the glucuronyl residue.  A total of 46 
environments were present in the spectrum with 8 carbons overlapping 
including the six glucuronyl carbons.  The glucuronyl resonances occur at 
172.7 ppm (carboxylic carbonyl), 105.1 ppm (anomeric) and 77.5, 76.6, 75.0 
and 73.2 ppm for the remaining carbons of the pyranose ring.  The 2 : 1 ratio of 
isomers allowed the carbon resonances to be assigned to their respective 
isomers based on their intensity. 
Attempts at recrystallising the testosterone O-(carboxymethyl)oxime -D-
glucuronide 121 were unsuccessful.  With limited time left for research, focus 
152 
Steroid solubilisation strategy 
was made towards the de-oximation of testosterone O-(carboxymethyl)oxime 
-D-glucuronide 121. 
4.7.3 De-oximation 
Testosterone 7 was oximated in high yields then subjected to 
glucuronylsynthesis in good yield to synthesise the testosterone O-
(carboxymethyl)oxime -D-glucuronide 121.  The final step of the steroid 
solubilisation strategy would be to remove the oxime to yield testosterone -D-
glucuronide 6. 
Testosterone O-(carboxymethyl)oxime -D-glucuronide 121 was subjected to 
the mild titanium(III) chloride conditions used on the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 (Scheme 4.15).  The de-oximation 
took longer than the hour taken to de-oximate the DHEA derivative 118 
possibly due to the extended conjugation present in testosterone O-
(carboxymethyl)oxime -D-glucuronide 121.  After 24 hours, the initial violet 
colour of the reaction had lightened to a greyish-blue and the reaction was 
worked-up.  Unreacted testosterone O-(carboxymethyl)oxime -D-glucuronide 
121 was recovered in 53% yield with testosterone -D-glucuronide 6 isolated in 
38% yield (81% brsm). 
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Scheme 4.15.  De-oximation of testosterone O-(carboxymethyl)oxime -D-
glucuronide 121. 
The high resolution mass spectrum of testosterone -D-glucuronide 6 
exhibited the molecular anion (m/z 463.2329) consistent with the desired 
molecular formula C25H35O8.  The IR depicts a broad absorbance at 3416 cm-1 
confirming the presence of the hydroxyl groups from the glucuronyl moiety.  
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The absorbance at 1666 cm-1 substantiates the reformation of the unsaturated 
ketone in the testosterone 7 moiety. 
The 1H NMR spectrum (Figure 4.21) confirms the oxime removal by the 
absence of the oxymethylene protons at 4.5 ppm and the formation of a single 
isomer once again.  The olefinic proton is represented by a singlet at 5.71 ppm 
which provides evidence that testosterone -D-glucuronide 6 was not over-
reduced to a saturated ketone.  Aqueous titanium(III) has been reported to 
reduce enedicarbonyl compounds to their saturated dicarbonyl form (Scheme 
4.16).178  But the spectral data confirms that only the unsaturated ketone is 
generated in this reaction. 
 
 
Figure 4.21.  1H NMR (800 MHz, MeOD) of testosterone -D-glucuronide 6. 
The glucuronyl moiety is also present with the anomeric proton appearing as 
a doublet at 4.36 ppm (J 7.8 Hz), the proton alpha to the carboxylic acid 
appearing at 3.52 ppm (J 8.7 Hz) and the remaining 3 pyranose protons 
appearing as triplets in the 3.5 - 3.2 ppm region.  Once again, the large 
coupling constant of the anomeric proton is indicative of a -glycosidic linkage 
of the glucuronyl residue.  
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Scheme 4.16. Reduction of an enedicarbonyl species by titanium(III) chloride.178 
The 13C NMR spectrum also confirms a single isomer as a result of oxime 
removal and shows 25 carbon environments consistent with the proposed 
structure.  The oxime cleavage was also confirmed by the absence of the 
carboxylic acid (174 ppm) and oxymethylene carbon (71 ppm) of the oxime 
moiety.  This is also confirmed by the downfield shift of the steroidal C3 carbon 
from 157 ppm as an oxime to 202 ppm as an unsaturated ketone. 
  The reaction time was not sufficient to completely convert the oxime 
glucuronide 121 to testosterone -D-glucuronide 6.  Given a longer reaction 
time, a greater yield could potentially have been generated.  Oxidation of 
titanium(III) was also observed over this extended reaction time which may 
have also contributed to lower conversions.  A greater excess of titanium(III) 
may be needed or its continuous addition over time may improve conversions. 
Alternately, improved reaction conditions such as the degassing of solvents, 
the use of argon gas or optimising the buffer concentration and pH may help 
reduce the degradation of titanium(III).  Nevertheless, the testosterone -D-
glucuronide 6 was synthesised from testosterone 7 in 25% over three steps 
(Scheme 4.17).  This is still over double the yield from the direct 
glucuronylsynthesis of testosterone 7 (12% yield) and an improvement on 
literature preparation via the Koenigs-Knorr procedure (17% over two steps).20  
Better yet, a yield of 69% over three steps is achieved if based on recovered 
starting materials. 
Little improvement is envisaged for the oximation and glucuronylsynthase 
step.  Unlike the near-quantitative glucuronylsynthesis of the DHEA O-
(carboxymethyl)oxime 116, the lower yield for testosterone O-
(carboxymethyl)oxime 120 must arise from the substrate not binding in the 
necessary way (perhaps from steric hindrance associated with neopentylic 
alcohol).  The de-oximation step is the lowest yielding step of the sequence 
and its optimisation will see a drastic improvement to the three step steroid 
solubilisation strategy for testosterone 7 and other steroids bearing 
unsaturated ketones.  
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Scheme 4.17. The three step solubility strategy for testosterone 7. 
4.8 Conclusions 
The expansion of the glucuronylsynthase library was branched into the field 
of steroidal substrates as glucuronyl acceptors.  The glucuronylsynthase 
enzyme was able to produce the glucuronides of a small range of steroid 
substrates by direct glucuronylsynthesis.  The best yield of 26% was achieved 
with DHEA 55 when 2% DDM was used to aid its solubility.  This yield was 
greater than the reported 20% yield of DHEA -D-glucuronide 77 obtained over 
two steps from the Koenigs-Knorr reaction.20 
High concentrations of additives to aid steroid solubility only seem to provide 
small improvements.  Improved solubility of DHEA 55 was investigated through 
the temporary interconversion of the ketone group to a hydrazone or oxime 
functionality.  Four DHEA analogues were synthesised, but the DHEA O-
(carboxymethyl)oxime 116 brought about the greatest solubility enhancement 
(100-fold the solubility of DHEA 55).  DHEA O-(carboxymethyl)oxime -D-
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glucuronide 118 was isolated in 76% from the glucuronylsynthase reaction of 
DHEA O-(carboxymethyl)oxime 116.  The cleavage of the oxime was achieved 
in quantitative yield from a mild, titanium(III) reduction.164  This three step 
sequence for obtaining DHEA -D-glucuronide 77 from DHEA 55 yielded 67% 
over three steps (Scheme 4.12).  This 3-step solubility strategy was also 
applied to the synthesis of testosterone -D-glucuronide 6 (Scheme 4.17).  The 
testosterone -D-glucuronide 6 was synthesised from testosterone 7 in 25% 
over three steps (69% brsm).   
The kinetics of the glucuronylsynthase enzyme with DHEA O-
(carboxymethyl)oxime 116 as a substrate were investigated with the HPLC 
assay.  Substrate inhibition was observed for this substrate which provided a 
calculated Km of 7 ± 19 mM and a kcat of 1.4 x 10-3 s-1.  Compared to the other 
alcohol accepters tested to date (Table 3.2), the Km for DHEA O-
(carboxymethyl)oxime 116 is the smallest reported whilst its catalytic turnover 
is the slowest.  The specificity constant (kcat/Km) was the largest exhibited for 
an acceptor alcohol tested so far with a value of 4.3 M-1 s-1.  It is hypothesised 
that the greater binding and specificity is due to the large size of the molecule 
available to make contact (bind) with the active site. 
A study on the equivalents of -D-glucuronyl fluoride 51 added to the DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reaction flagged the 
presence of product inhibition.  Using HPLC kinetic studies, DHEA O-
(carboxymethyl)oxime -D-glucuronide  118 was proven to be an inhibitor 
displaying mixed predominately competitive inhibition.  The competitive 
inhibition constant (K ic) was determined as 73 ± 6 M and the weaker 
uncompetitive inhibition constant (K iu) as 190 ± 2 M.  Conversely, 2-
phenylethyl -D-glucuronide 68 did not show any signs of inhibition.  The 
product inhibition in the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction was responsible for the moderate yields.  
Overcoming the product inhibition with extra equivalents of -D-glucuronyl 
fluoride 51 achieved near quantitive yields of the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 (98% with 5 equivalents of 51).  
This improvement in yield for the DHEA O-(carboxymethyl)oxime 116 
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glucuronylsynthase reaction improved the steroid solubilisation strategy for 
DHEA -D-glucuronide 77 synthesis to 86% over three steps. 
DHEA 55 and testosterone 7 were two examples that demonstrated the 
successful application of the steroid solubility sequence regardless of ketone 
position (3-keto and 17-keto shown), alcohol position (3- and 17- shown) or 
ketone type (saturated or ,-unsaturated shown).  As a result, this steroid 
solubilisation strategy is anticipated to be extended to a wide variety of 
saturated or unsaturated keto-steroids. 
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5.1 Introduction 
The glucuronylsynthase enzyme has proven to synthesise a select range of 
steroids with good to moderate yields.   The three step solubility strategy 
(chapters 4.3 and 4.7) has improved the yields of glucuronides for keto-
steroids.  To expand the steroid substrate repertoire for the 
glucuronylsynthase, a steroid screen is warranted. The application of the three 
step solubility sequence would be arduous and time-consuming task to apply 
in a screen and may not be applicable to some steroids (i.e. steroids without 
carbonyl functionality).  The three step solubility strategy could be used for a 
preparative glucuronide synthesis at a later stage if required.  To improve the 
solubility of the steroids in the screen, the use of additives to aid solubility were 
investigated by HPLC on the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction.  The design of a steroid substrate screen utilising 
solid phase extraction procedures will be discussed and some preliminary 
screening results will be presented. 
5.2 Effects of additives on the glucuronylsynthase 
reactions 
5.2.1 Effect of additives on glucuronylsynthase activity 
The effect of a selection of detergents and co-solvents has already been 
determined on the activity and stability of the WT -glucuronidase.58  DMSO 
and DDM were considered the best additives to use with the WT -
glucuronidase.  Differing by only one amino acid, it was assumed that the 
additives would have similar effects on the glucuronylsynthase enzyme.  But 
given the large reduction in yield as a consequence of using DMSO in the 
DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase reaction, it was 
important to investigate the effect that a selection of additives had on the 
glucuronylsynthase reactions. 
The DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase reaction rate is 
lower than most of the other acceptors (chapter 4.5).  So any decrease in 
velocity, as a result of an additive, would be more difficult to assess than a 
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change in a faster reaction, such as with 2-phenylethanol 45.  As a result, the 
effect of different additives on the initial velocity of the enzyme was determined 
at a saturating concentration of α-D-glucuronyl fluoride 51 donor (1 mM) and a 
high sub-saturating concentration of 2-phenylethanol 45 acceptor (94 mM).  
The co-solvents were tested at 5% and 10% v/v and included DMSO, ethanol 
(EtOH), tert-butanol (tBuOH), and glycerol.  The detergents were tested at 1% 
and 2% w/v and included n-dodecyl maltoside (DDM), Triton X-100 (TX-100) 
and Brij-56.  Also of interest was the protein extraction reagent BugBuster® 
which consists of a proprietary formulation of detergents and salts.  It is used 
for cell lysis in the directed evolution screens and we wanted to ensure that full 
enzyme activity was sustained in this solution.  It was tested at concentrations 
of 2% and 10% w/v which is equivalent to the concentration used in the 
screens and the supplied stock concentration respectively.  Given the length of 
time to complete this investigation (2 days), another reaction without additives 
(control 2) was performed at the end of the investigation to account for activity 
loss over this time. 
As expected, all the reactions with additives demonstrated a decrease in 
enzyme activity (Figure 5.1).  Detergents maintained the highest activity with 
similar activities exhibited for each and no velocities falling below 70% of the 
control (no additives).  The exception being the Bug Buster which was 
analysed at a greater concentration than the other detergents tested.  Co-
solvents were more detrimental to the enzyme albeit tert-butanol and glycerol 
which demonstrated enzymatic activities greater than 80% of the control.  
Based on the initial velocity of 2-phenylethanol 45, all detergents are suitable 
at either 1% or 2% w/v concentration.  If a co-solvent is used, glycerol is best 
suited at 5% or 10% v/v concentration or tert-butanol at 5% v/v concentration.  
DMSO essentially halved the initial rate of the 2-phenylethanol 45 
glucuronylsynthase reaction.  If an equivalent effect occurs with the DHEA O-
(carboxymethyl)oxime 116 reaction, it would help explain the reduction in yield 
of the large scale reaction containing DMSO. 
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Figure 5.1.  Effect of additives on the initial rate (v0, as a percentage of the initial 
velocity for the control) for reaction of 2-phenylethanol 45 acceptor (94 mM) and α-D-
glucuronyl fluoride 51 (21 C in 100 mM phosphate buffer, pH 7.5).   
5.2.2 Effect of additives on glucuronylsynthase yields 
In addition to knowing the effect of additives on the glucuronylsynthase 
activity, it was beneficial to investigate the stability of the glucuronylsynthase in 
these reactions over time.  The DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction was used to explore the effect of additives on its 
yield.  The study commenced with six identical 2 mM DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reactions prepared in HPLC 
vials that differed only by the additive.  These reactions included 5% tert-
butanol, 5% DMSO, 5% glycerol, 1% DDM, 1% TX-100 and one without 
additives (control).  Three equivalents of -D-glucuronyl fluoride 51 was used 
to overcome the product inhibition.  The reactions were monitored at 37 C 
over 60 hours with an injection taken every 5 hours (Figure 5.2). 
The reaction profiles of the reactions with additives looked very similar to the 
control reaction with the exception of 1% DDM and 5% tert-butanol.  The 
reaction containing 1% DDM was much slower than the other reactions 
resulting in a yield ~30% lower than the control.  The reaction containing 5% 
tert-butanol reaction exhibited a faster production of product and achieved a 
higher yield than the control reaction.  A decrease in glucuronide product 118 
was observed for all reactions over an extended time which may be due to 
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instrumental error or possible non-enzymatic hydrolysis occurring at these 
elevated temperatures (37 C). 
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Figure 5.2.  Reaction profiles for the reaction of DHEA O-(carboxymethyl)oxime (CMO-
DHEA) 116 acceptor (2 mM) and α-D-glucuronyl fluoride 51  donor (6 mM) with 
glucuronylsynthase (0.4 mg mL-1) in the presence of additive (37 °C, 100 mM phosphate 
buffer, pH 7.5).  The reaction progress is depicted in terms of concentration (mM) of 
DHEA O-(carboxymethyl)oxime -D-glucuronide 118 produced (left y-axis) and the yield 
(%) of the reaction (right y-axis). 
The purpose of using additives is to increase the concentration of DHEA O-
(carboxymethyl)oxime 116 and other steroids in the glucuronylsynthase 
reactions.  So the effect of the additives was monitored on a 5 mM reaction of 
DHEA O-(carboxymethyl)oxime 116 using the same concentration of 
glucuronylsynthase.  Six reactions of concentrated DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reactions were prepared in 
HPLC vials and monitored at 37 C over 60 hours with an injection taken every 
5 hours (Figure 5.3).  Given the enhanced effect of 5% tert-butanol, a 10% v/v 
tert-butanol solution was prepared and monitored with a 5 mM concentration of 
DHEA O-(carboxymethyl)oxime 116.  The remaining reactions contained 5% 
tert-butanol, 5% DMSO, 5% glycerol, 1% DDM, or 1% TX-100.  A control 
reaction could not be performed at 5 mM due to limitations in its solubility. 
Unfortunately, the HPLC vial containing the reaction with 1% TX-100 had its 
seal ruptured during the assay and at 37 C the solvent evaporated.    
Consequently, its results were omitted from the study.  Given the reaction of 2 
163 
Extension of the glucuronylsynthase methodology to other steroids 
mM DHEA O-(carboxymethyl)oxime 116 in the presence of 1% TX-100 yielded 
15% less product than the control, it was deemed unnecessary to repeat this 
reaction.  Evaluating the remainder of the additives, the reactions containing 
5% DMSO and 1% DDM had approximately a 20% improvement in the yield of 
DHEA O-(carboxymethyl)oxime -D-glucuronide 118.  The reactions containing 
tert-butanol and glycerol, exhibited similar yields achieved in the 2 mM DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reactions.  However there is 
little room for improvement with tert-butanol as the reactions containing 5% 
and 10% tert-butanol both achieved a 97% yield. 
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Figure 5.3.  Reaction profiles for the reaction of DHEA O-(carboxymethyl)oxime 116 
acceptor (5 mM) and α-D-glucuronyl fluoride 51 donor (15 mM) with glucuronylsynthase 
(0.4 mg mL-1) in the presence of additive (37 °C, 100 mM phosphate buffer, pH 7.5).  The 
reaction progress is depicted in terms of concentration (mM) of DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 produced (left y-axis) and the yield (%) of the 
reaction (right y-axis). 
The reaction rate in the presence of tert-butanol was clearly greater than in 
the presence of the other additives.  The concentration of tert-butanol seemed 
to have no effect on the reaction rate and yield of the glucuronylsynthase 
reaction.  The reaction profile for the 5 mM DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction in the presence of 5% and 10% tert-butanol were 
essentially identical. 
A general improvement in the yield of DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 was observed when the glucuronylsynthase reaction was 
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performed with a more concentrated solution of DHEA O-
(carboxymethyl)oxime 116.  To assess if the yield could be increased further, a 
study using a 10 mM solution of DHEA O-(carboxymethyl)oxime 116 was 
performed.  Unfortunately, only 10% tert-butanol was capable of achieving 
complete dissolution of a 10 mM solution of DHEA O-(carboxymethyl)oxime 
116.  A 76% yield of product was obtained after 60 hours, but it is worthy to 
note that the same concentration of enzyme (0.4 mg mL-1) was used in all the 
reaction profiles monitored.  Basic Michaelis-Menten kinetics states that 
velocity is not linear with substrate concentration (except at very low substrate 
concentrations) so a longer reaction time may still be required to process 
double the quantity of substrate in an equal volume of buffer. 
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Figure 5.4.  Reaction profiles (product formation, mM) for the reaction of DHEA O-
(carboxymethyl)oxime 116 acceptor (2 mM, 5 mM or 10 mM) and α-D-glucuronyl fluoride 
51 donor (3 equiv) with glucuronylsynthase (0.4 mg mL-1) in the presence of tert-butanol 
(0%, 5% and 10%) and 100 mM phosphate buffer, pH 7.5 at 37 °C.  Final reaction yields 
are displayed at the end of the curves. 
With no other 10 mM reactions to compare against, the reaction profile of the 
10 mM DHEA O-(carboxymethyl)oxime 116 reaction performed with 10% tert-
butanol was compared against the other reactions containing tert-butanol and 
the control (Figure 5.4).  When assessing the amount of product 118 formed, 
more glucuronide 118 is produced in the 10 mM DHEA O-
(carboxymethyl)oxime 116 reaction (7.6 mM of 118) than the 5 mM DHEA O-
(carboxymethyl)oxime 116 reaction (4.8 mM of 118) containing 10% tert-
butanol given the same amount of time and enzyme. 
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The reaction rate of the 10 mM DHEA O-(carboxymethyl)oxime 116 reaction 
is faster than the 5 mM reaction with the same 10% concentration of tert-
butanol.  A reaction with 2 mM DHEA O-(carboxymethyl)oxime 116 containing 
10% tert-butanol was performed for comparative reasons, but due to a seal 
rupture in its assay, a final yield was never obtained. 
The increasing reaction rate with increasing substrate concentration 
contradicts the notion of substrate inhibition observed in the DHEA O-
(carboxymethyl)oxime 116 kinetic study (refer to section 4.5.1).  If substrate 
inhibition exists, the reaction rate should be decreasing with increasing DHEA 
O-(carboxymethyl)oxime 116 concentration.  To better assess reaction rate, 
the initial velocity of each DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reaction was estimated from the reaction profiles (Figure 
5.5).  The initial velocity of the DHEA O-(carboxymethyl)oxime 116 at 37 C 
without additives is 3.3 nmol min-1 [mg protein]-1.  This initial velocity is almost 
five times the rate of the 2 mM DHEA O-(carboxymethyl)oxime 116 reaction 
performed at 21 C in the kinetic study.  All the additives, except tert-butanol, 
exhibited initial velocities (2.6 – 4.1 nmol min-1 [mg protein]-1) similar to this rate 
in both 2 mM and 5 mM DHEA O-(carboxymethyl)oxime 116 reactions. 
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Figure 5.5.  Estimated initial velocity (v0) for the reaction of DHEA O-
(carboxymethyl)oxime (CMO-DHEA) 116 acceptor (2 mM, 5 mM or 10 mM) and α-D-
glucuronyl fluoride 51 donor (3 equiv) with glucuronylsynthase (0.4 mg mL-1) in the 
presence of in the presence of additive (37 °C, 100 mM phosphate buffer, pH 7.5, n = 2).  
Numbers above the bars represent the initial velocity (nmol min-1 [mg protein]-1). 
As suggested in their reaction profiles, the reactions containing tert-butanol 
exhibited enhanced initial velocities.  The addition of 5% or 10% tert-butanol to 
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a 2 mM DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase reaction 
doubled the initial velocity of the reaction.  The initial velocity was improved 
further when the DHEA O-(carboxymethyl)oxime 116 concentration was 
increased.  A reaction with 5 mM of DHEA O-(carboxymethyl)oxime 116 had 
triple the initial velocity of the 2 mM control reaction for concentrations of 5% 
and 10%  tert-butanol.  Furthermore, the reaction with 10 mM of DHEA O-
(carboxymethyl)oxime 116, dissolved in 10% tert-butanol, had four times the 
initial velocity of the 2 mM control reaction. 
Just how much tert-butanol can be added to the reactions before the 
glucuronylsynthase activity and stability is compromised is unknown.  A future 
study that determines the limitation of tert-butanol concentration is needed as a 
greater tert-butanol concentration should provide a more concentrated steroid 
concentration.  A greater concentration may increase the reaction rate and 
yield for DHEA O-(carboxymethyl)oxime 116 which may possibly extend to 
other steroid substrates.   
This enhanced velocity with tert-butanol was not observed in the additives 
study with 2-phenylethanol 45.  Just the addition of tert-butanol to the DHEA 
O-(carboxymethyl)oxime 116 reaction doubled the reaction rate compared to 
when no additives were present.  Conversely, a decrease in reaction rate (46-
88% of control) was observed in the reaction of 2-phenylethanol 45.  Perhaps 
tert-butanol has some way of overcoming the substrate inhibition observed 
with DHEA O-(carboxymethyl)oxime 116.  This could easily be determined by 
repeating a study of initial rate vs. concentration of DHEA O-
(carboxymethyl)oxime 116 in the presence of tert-butanol.  Unfortunately, time 
restrictions did not allow for this study to take place.  If proven however, it 
would be of considerable interest to see if the substrate inhibition is alleviated 
in the other substrates demonstrating substrate inhibition. 
The conclusion from the addition of co-solvents and detergents to the DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reactions is unambiguous.  
The addition of DDM, DMSO, glycerol and TX-100 to the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction to aid with solubility 
provided no additional benefits.  Reaction rates and yields were similar for all 
cases.  The addition of tert-butanol however, drastically improves the reaction 
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rate and yields of the DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase 
reaction.  Greater concentrations of DHEA O-(carboxymethyl)oxime 116 
dissolved in tert-butanol had enhanced reaction rates and yields.  The 
influence that tert-butanol has on the DHEA O-(carboxymethyl)oxime 116 
glucuronylsynthase reactions is unknown. 
5.3 Additives Conclusion 
With the three step steroid solubilisation strategy not applicable to every 
steroid, a study on the effects of additives to the glucuronylsynthase reaction 
was explored on the DHEA O-(carboxymethyl)oxime 116 glucuronylsynthase 
reaction.  Monitoring the reaction with HPLC, it was observed that the yield and 
reaction rate were not greatly improved nor reduced by the addition of co-
solvents and detergents.  The exception being tert-butanol, which doubled the 
reaction rate compared to when no additives were present.  This enhancement 
of enzyme activity as the concentration of organic solvent is increased is a 
phenomenon being studied by numerous research groups.  Research by 
Dordick and Klibanov has seen the integration of enzymes into pure organic 
solvents with enzyme activities and thermostability beyond what is capable in a 
aqueous media.179,180   Furthermore, as the concentration of DHEA O-
(carboxymethyl)oxime 116 was increased in the presence of tert-butanol, the 
reaction rate and yield improved further.  The concentration of tert-butanol did 
not seem to affect the reaction with similar reaction profiles being observed 
with both 5% and 10% tert-butanol.  It is proposed that the addition of tert-
butanol alleviates substrate inhibition.  Kinetic studies of the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction in the presence of tert-
butanol would be able to validate the statement.  If true, the removal of 
substrate inhibition imposed on other acceptor alcohols may be possible.  With 
an understanding of some of the additional variables in the glucuronylsynthase 
reactions, it was now time to expand the application of the methodology by 
investigating more steroid substrates. 
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5.4  Expansion of the steroid library 
The optimum conditions for the glucuronylsynthase reactions have been 
determined and the solubility of steroids has been enhanced by the addition of 
tert-butanol.  The substrate repertoire for the glucuronylsynthase enzyme was 
ready to be expanded by screening against a library of steroids.  But the task 
of purifying each reaction would still be a lengthy process.  To save time in this 
area, the use of solid-phase extraction cartridges were explored to quickly 
separate the components of the glucuronylsynthase reactions. 
5.4.1 Principles of solid-phase extraction 
Solid-phase extraction (SPE) is similar to chromatography in which a mixture 
of components is adsorbed onto a stationary phase.  However, unlike 
chromatography which separates the components based on their retention 
through a column of solid media, SPE elutes one or more components from a 
small amount of sorbent using different types of mobile phases.  As a result, 
structurally and chemically similar molecules (e.g. DHEA 55 and testosterone 
7) would elute in the same portion whilst chemically different molecules (e.g. 
DHEA 55 and DHEA -D-glucuronide 77) would be quickly and easily 
separated by different washes.  The sorbent can be comprised of normal-
phase, reverse-phase, ion-exchange or a combination of each media.  The 
strategy behind SPE is to assess the chemical make-up of your desired 
product and how it differs from the other components in your mixture, just as 
you would in a liquid-liquid separation.  
Solid phase extraction is routinely used in the sports drug testing industry to 
isolate the unconjugated steroids, steroid glucuronides and steroid sulphates 
from a competitor’s urine sample.  The Australian Racing Forensic Laboratory 
utilise Waters Oasis® WAX branded SPE cartridges to analyse steroid 
metabolites in urine samples.181  The WAX cartridge is a reverse phase 
sorbent with polar and weak anion exchange residues capable of separating 
unconjugated steroids, steroid glucuronides, and steroid sulphates from a urine 
matrix consisting of salts and other renal waste.  Piperazine residues provide 
the weak anion exchange used to selectively elute the weakly acidic 
glucuronides over the strong acidic sulphates.  The successful isolation of 
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steroid glucuronides from such a complex mixture would suggest the isolation 
of the steroid glucuronide from the limited components in the 
glucuronylsynthase reactions would be easily achieved by SPE. 
The components of the glucuronylsynthase reactions comprise of the steroid 
glucuronide, unreacted steroid, unreacted -D-glucuronyl fluoride 51, 
phosphate buffer salts and possibly some glucuronic acid 3 from the 
degradation of 51.  Assessing the chemical properties of each of these 
components (Figure 5.6), it can be seen that a combination of ionic and 
lipophilic interactions can be used to isolate steroid glucuronides from the 
crude reactions.  With the absence of steroid sulphates from the reaction 
mixture, the use of the Waters Oasis® MAX SPE cartridges could also be used.  
Oasis® MAX cartridges are similar to the WAX cartridges but differ only by the 
ionic residue.  The MAX cartridges have a quaternary amine (instead of the 
ionisable piperazine residue in the WAX) to produce a stronger ionic 
interaction that provides a better retention. 
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Figure 5.6.  The interactions of the components from the DHEA 55 
glucuronylsynthase reaction with the Waters Oasis® WAX sorbent.  Lipophilic residues 
are coloured green, hydrophilic residues are red and ionic residues are coloured blue. 
An investigation was undertaken to assess if solid phase extraction 
cartridges could separate the individual components of the glucuronylsynthase 
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to quickly isolate the steroid glucuronide.  A quantitative study was also 
undertaken to measure the recovery of material from these extractions. 
5.4.2 Method development 
The Australian Racing Forensics Laboratory (ARFL) have isolated steroid 
glucuronides using the Oasis® WAX SPE cartridges and have developed their 
own method for glucuronide extraction (Figure 5.7).  This procedure differs 
from the manufacturer’s method (Figure 5.8) and so it was of interest to know 
which procedure worked best at isolating pure glucuronide with the highest 
recovery.  Both Oasis® SPE cartridges (WAX and MAX) were tested with each 
extraction procedure to determine which combination provided the best 
separation and recovery.  To establish these results, the isolation of DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 from the crude DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction was used. 
The HPLC conditions to separate and quantify the components of the DHEA 
O-(carboxymethyl)oxime 116 glucuronylsynthase reaction have already been 
developed (chapter 4.5).  As a result, HPLC was utilised as a quantitative tool 
to determine the recovery of DHEA O-(carboxymethyl)oxime -D-glucuronide 
118 from SPE extraction.  A glucuronylsynthase reaction of DHEA O-
(carboxymethyl)oxime 116 was performed and after 5 days, the crude reaction 
was analysed by HPLC.  Equal known volumes of the reaction were loaded 
onto two Oasis® WAX and two Oasis® MAX SPE cartridges.  From HPLC 
analysis, it was determined that 2.72 mol of DHEA O-(carboxymethyl)oxime 
-D-glucuronide 118 was loaded onto each cartridge. 
The manufacturer’s recommended extraction procedure (Figure 5.8) was 
performed on one of the Oasis® WAX cartridges and one of the Oasis® MAX 
cartridges.  The ARFL’s extraction procedure (Figure 5.7) was performed on 
the remaining WAX and MAX cartridge.  Every fraction from the two SPE 
procedures were collected and subjected to HPLC analysis to determine the 
quantity of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 in each 
fraction (Table 7.2, Table 7.3, Table 7.4 and Table 7.5). 
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Figure 5.7. Schematic diagram of the ARFL SPE procedure used for both Oasis MAX 
and WAX SPE cartridges. 
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Figure 5.8.  Schematic diagram of the Oasis SPE procedure for a) MAX and b) WAX 
cartridges 
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The manufacturer’s extraction procedure worked very well for both cartridges 
with 96% and 97% of the glucuronide recovered from the Oasis® WAX and 
MAX cartridges respectively in the final elution.  A small quantity (1%) of the 
glucuronide 118 leached out in the methanol wash from the Oasis WAX 
cartridge.  The methanol wash is supposed to extract out the unconjugated 
steroid whilst the glucuronide remains bound to the resin through ionic 
interactions.  The weak anion exchange of the WAX cartridge failed to retain all 
of the glucuronide whereas the strong ionic interaction of the MAX cartridge 
successfully withheld all of the glucuronide. 
The ARFL’s extraction procedure worked the best for the Oasis MAX SPE 
cartridge.  Approximately 99% of the DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 was recovered from the MAX cartridge.  Unfortunately, when 
the same procedure was applied to the Oasis WAX SPE cartridge, 83% of 
glucuronide 118 was washed out in the initial basic aqueous wash used to 
wash out the sugars and salts from the resin.  This high loss is probably the 
result of using DHEA O-(carboxymethyl)oxime 116 as the steroid.  The basic 
wash would have deprotonated the carboxylic acid of the oxime and 
glucuronide making the molecule 118 di-anionic and therefore highly 
hydrophilic.  The di-anion 118 would not retain well in the lipophilic resin, which 
would normally retain steroid glucuronides, and was washed out from the 
cartridge.  The remainder of the glucuronide 118 (14%) was reclaimed in the 
appropriate glucuronide wash which still accounts for a total recovery of 97% 
for the glucuronide 118.  Unfortunately, the majority of the glucuronide 118 
which eluted in the first fraction would contain buffer salts and sugars.  It is 
unlikely that the same would happen to a non-ionisable steroid nucleus such 
as DHEA 55. 
Reviewing the four different extraction combinations it appears that all are 
feasible procedures with greater than 97% recovery for all.  The exception 
being the ARFL extraction procedure with the Oasis WAX cartridge which did 
not work well with DHEA O-(carboxymethyl)oxime 116.  But this is likely due to 
the ionisation of this steroid with literature evidence pointing to the success of 
this protocol.  SPE has been successfully applied to workup small scale 
glucuronylsynthase reactions and isolate pure steroid glucuronide.  The use of 
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SPE will save time in glucuronylsynthase steroid screens by providing a rapid 
and universal means of isolating steroid glucuronides. 
5.4.3 Initial steroid screen 
The optimum glucuronylsynthase reaction conditions have been identified 
and solid phase extraction has provided a rapid means of isolating the steroid 
glucuronides.  Accordingly, a small steroid screen was performed to illustrate 
the practicality of the screen on a selection of different steroids. 
DHEA 55, testosterone 7, boldenone 122, epitestosterone 123, estrone 9, 
methandriol 58, and 6-hydroxystanozolol 124 were used in the screen 
(Scheme 5.1).  Using the optimised glucuronylsynthase conditions, a milligram 
of steroid was dissolved in phosphate buffer pH 7.5 with 5% tert-butanol to aid 
solubility.  Five equivalents of -D-glucuronyl fluoride 51 were added and the 
reaction incubated with 0.2 mg mL-1 glucuronylsynthase at 37 C.  After 3 days, 
each of the crude reactions were analysed by HPLC and the peak area ratios 
were used to estimate a yield for the reaction.  The glucuronides were isolated 
by solid phase extraction and then re-analysed by HPLC.  The purified 
samples were also analysed by ESI-MS. 
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Scheme 5.1.  Screening of steroid substrates for the glucuronylsynthase reaction.  
Yields were determined from HPLC peak ratios and are reported below the structures. 
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A remarkable improvement on the direct glucuronylsynthesis of DHEA 55 
was observed (71%) with an almost tripling of the yield previously achieved by 
direct glucuronylsynthesis (26%).  This yield even exceeds the 67% yield 
achieved over the three steps of the steroid solubilisation strategy.  The 
purification of the DHEA -D-glucuronide 77 can be visually observed by the 
HPLC chromatograms before (Figure 5.9) and after (Figure 5.10) solid phase 
extraction. 
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Figure 5.9.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
DHEA 55. 
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Figure 5.10.  HPLC chromatogram of the purified DHEA -D-glucuronide 77 using SPE
The testosterone -D-glucuronide 6 was only achieved in 6% yield which is 
lo
  
wer than the 12% yield achieved from the direct glucuronylsynthesis with 
DMSO co-solvent present.  But this may just be an abnormality as the 
boldenone -D-glucuronide 125, which is structurally similar, was achieved in a 
yield of 15%.  The less sterically-hindered epimer of testosterone 7, 
epitestosterone 123, provided a good yield of 38% for its respective 
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glucuronide 126.  The glucuronylsynthesis of phenols has been proven to 
occur in low yields.  It was therefore remarkable to obtain a yield of 24% for the 
estrone 9 glucuronylsynthase reaction. 
The methandriol -D-glucuronide 127 was observed in the high resolution 
m
sites at which 
g
lsynthase enzyme catalysed the glucuronylation of all the 
st
ass spectrum and HPLC, but its yield could not be determined by HPLC due 
to the absence of a chromophore in the aglycon.  An alternative means of 
detection, such as evaporative light scattering detection (ELSD), is needed to 
quantify the conversion of methandriol 58 and related steroids screened in 
glucuronylsynthase reactions. The 6-hydroxystanozolol -D-glucuronide 128 
was also seen in the high resolution mass spectrum, but due to the ionisable 
pyrazole ring, both the glucuronide 128 and aglycon 124 co-eluted in the 
solvent front of the HPLC chromatogram.  A normal phase HPLC method is 
required to analyse this steroid and other ionisable analogues. 
Methandriol 58 and 6-hydroxystanozolol 124 have two 
lucuronylation can occur.  The mass spectrum did not show any evidence of 
glucuronylation occurring twice on these steroids.  But the regioselectivity 
could not be determined either given such small quantities of glucuronide were 
available.  Larger scale glucuronylsynthase reactions with methandriol 58 and 
6-hydroxystanozolol 124 would have to be conducted to determine yields and 
regioselectivity. 
The glucurony
eroids subjected to the screen.  Yields varied from exceptional to poor, but it 
is the universal application of this enzyme that is of most interest.  The large 
range of substrate tolerance may open the doors for previously unachievable 
syntheses of glucuronides and provide the means of creating glucuronides for 
novel steroids always emerging in the sports drug testing.  Subjecting the 
glucuronylsynthase enzyme to a larger screen of steroids will help build a 
profile for the enzyme and determine limitations of the enzyme. 
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6.1 Comparative study 
The glucuronylsynthase-mediated reaction provides is a novel procedure for 
glucuronide synthesis.  The alternative procedures for glucuronide synthesis 
(using the UDP-glucuronosyltransferase, Koenigs-Knorr reaction and related 
reactions) were introduced earlier (chapter 1.5) and the characteristics of each 
were highlighted.  In light of the results from this research, it seemed 
appropriate to re-evaluate the optimised methodology with the other 
glucuronylation procedures available in greater detail.  In this comparative 
review, the procedure for preparing the substrates and enzyme/catalyst will be 
disclosed and the details of the reactions (yield, selectivity, reaction time, etc) 
will be scrutinised. 
6.1.1 Preparation of the glucuronyl donors 
A common attribute of all the glucuronylation procedures is the use of an 
activated glucuronyl donor.  The glycosyl donor for the glucuronylsynthase 
reaction is the -D-glucuronyl fluoride 51.  As discussed previously (chapter 
2.4), it is prepared from cheap and commercially available D-glucose 82 in 39% 
(over 4 steps) or 69% (over 3 steps) from the per-acetylated glucose 83 
(Scheme 2.2).  A crystal structure (Figure 2.8) was obtained during this study 
which validated its preparation and relative stereochemistry. 
The glucuronyl donor for the UDP-glucuronosyltransferase is the uridine 5′-
diphosphate -D-glucuronic acid 22.  With the exception of the synthesis by 
Roseman,182 every reported synthesis of UDP -D-glucuronic acid 22 
incorporates at least one enzymatic step in the synthetic sequence.  The 
enzymatic step is commonly used for the oxidation of UDP -D-glucose 129 to 
UDP -D-glucuronic acid 22 or the phosphorylation of glucose.183,184  One of the 
latest reported synthesis of UDP-glucose 129 was published by Meier et al 
(Scheme 6.1).185  Meier incorporates 5-nitro-cycloSal-uridine monophosphate 
130 to synthesise UDP-glucose 129.  The UDP-glucose 129 obtained from the 
Meier’s synthesis could be oxidised by lactate dehydrogenase.184  This 
synthetic sequence is seven steps with an overall yield of 30% from the per-
acetylated glucose 83.  A similar synthesis of UDP-glucose 129 has also been 
reported by Timmons.186  It follows a similar sequence to the Meier sequence 
albeit the use of trifluoroacetic anhydride and N-methylimidazole to activate 
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uridine mono-phosphate instead of the cycloSal reagent 130 to achieve UDP-
glucose 129 in 35% yield in that single coupling step. 
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Scheme 6.1.  Synthesis of UDP-glucuronic acid 22. 
Unlike the enzymatic procedures, the Koenigs-Knorr reaction and its related 
reactions do not require a specific glucuronyl donor.  They only require an 
activated glucuronyl donor with protected alcohols.  These protected glucuronyl 
donors come in the form of a -D-glucuronyl halide (e.g. 10)12,15, -D-glucuronyl 
trichloroacetimidate (e.g. 19)26 or -D-glucuronyl silyl ether (produced in situ 
from 20)28.  The synthesis of the glucuronyl donors (Scheme 6.2) range from 
39% (over 4 steps) for the trichloroacetimidate sugar 19 to 71% (over 3 steps) 
for the glucuronyl bromide 10. 
The synthesis of the glucuronyl donor for the glucuronylsynthase and the 
Koenigs-Knorr procedure are similar in the synthetic route, yield and number of 
steps.  Both procedures achieve the final glucuronyl donor in a short synthesis 
(3-4 steps) and high yields (~70% overall).  The synthesis of UDP-glucuronic 
acid 22 required for UDP-glucuronosyltransferase is clearly the most 
complicated synthesis with only 30% achieved over 7 steps which usually 
179 
Conclusions and future work 
incorporates an enzymatic step.  This challenging synthesis makes the UDP-
glucuronic acid 22 an expensive substrate to purchase (Sigma-Aldrich price for 
100 mg of the tri-sodium salt is in excess of USD200)187.  The synthesis of the 
-D-glucuronyl fluoride 51, required for the glucuronylsynthase reactions, is 
therefore equally the highest yielding and easiest prepared substrate of the 
glucuronylation procedures. 
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Scheme 6.2.  Synthesis of the glucuronyl donors for the Koenigs-Knorr reaction.15,28,188 
6.1.2 Preparation and properties of the reaction activator 
Each glucuronylation procedure requires activation to promote the reaction 
between the acceptor alcohol and the glucuronyl donor.  In the 
glucuronylsynthase and UDP-glucuronosyltransferases procedures, activation is 
achieved catalytically with the aid of an enzyme.  The Koenigs-Knorr reaction 
uses stoichiometric amounts of metal salts whereas the trichloroacetimidate 
only uses catalytic protic or Lewis acids.  The preparation of the reaction 
activator will be compared for each glucuronylation procedure. 
The glucuronylsynthase enzyme is expressed in high yields (2.5% w/w cell) 
from a -glucuronidase-deficient strain of E. coli and is easily purified by nickel-
affinity chromatography.  It takes approximately a week to obtain purified 
glucuronylsynthase enzyme from a sample of plasmid DNA.  On average, 50 
mg of purified enzyme is obtained from a litre of broth.  At present, the 
glucuronylsynthase enzyme is not commercially available or expressed from a 
natural source which limits the accessibility of the enzyme to other researchers.  
However, given the widespread commercial availability of the WT -
glucuronidase enzyme, it can be assumed that the glucuronylsynthase enzyme 
could be made equally available.  The low cost and high availability of the E. 
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coli WT -glucuronidase enzyme can be attributed to the properties of the 
enzyme.  The water-soluble enzyme allows easy preparation and handling and 
its homotetrameric quaternary structure provides robust thermal, pH and 
storage stability.  These properties were reflected in this study for the 
glucuronylsynthase enzyme. 
The UDP-glucuronosyltransferase is not expressed in prokaryotic cells and as 
a result animal sacrifice is usually required to obtain the enzyme.   The purified 
UDP-glucuronosyltransferase is isolated in a yield of only 0.27% w/w from rat 
liver.189  UDP-glucuronosyltransferases have many isoforms that are selective 
towards different classes of acceptor alcohols and phenols so it is essential that 
the correct isoform is isolated for the substrate glucuronylation.  To avoid this 
complication, the enzyme is usually used from a crude microsomal extract from 
bovine, porcine, rabbit or rat liver.  However, to complicate matters further, 
research shows that the UDP-glucuronosyltransferase activity also varies 
amongst different organisms.190  So the UDP-glucuronosyltransferase obtained 
from a certain species may provide low yields of the required glucuronide, if any 
at all. 
The purified, recombinant human UDP-glucuronosyltransferase enzyme 
expressed from insect cells is commercially available, but is valued at over 50 
times the price of the E. coli WT -glucuronidase for an identical mass.187  The 
cost of this enzyme is due to difficulties in its preparation, expression and 
handling.  The UDP-glucuronosyltransferase enzyme is membrane bound so 
the purified enzyme requires the use of co-solvents or detergents for stability.191  
Most forms of the enzyme exhibit low stability towards pH and heat with a 
moderate pH range of 6.0-8.5 reported for the human UGT1A7 enzyme.192  The 
common optimum temperature of the enzyme across all species is 37 C, 
however, the long-term stability of the enzyme is poor with the rat UDP-
glucuronosyltransferase enzyme losing over 10% activity after only a week 
stored at 0-4 C.193  Finally, a divalent metal such as calcium or magnesium is 
required as a co-factor to activate the enzyme.191,194  
The Koenigs-Knorr reaction uses a different activator for each class of 
glycosyl donor used.  When glycosyl halides are utilised (e.g. 10), various 
halophilic metal salts are used to promote the activation of the halide leaving 
group.  The most common metals include silver, cadmium and mercury which 
are typically used as the carbonates, oxides or perchlorates.  When the triflate 
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procedure is used for glucuronylation, trimethylsilyl triflate is used to silylate the 
anomeric alcohol of the glucuronyl donor 20 which provides a better leaving 
group.  When the trichloroimidate glucuronyl donor 19 is used, a strong Lewis 
acid such as boron trifluoride etherate is used to promote the reaction.  All these 
activators are commercially available (albeit most are expensive) or easily 
prepared in the laboratory within minutes.195  However, these activators are 
moisture-sensitive so their storage stability is dependent on their exposure to 
water. 
In terms of the complexity and duration of the preparation, the activator in the 
Koenigs-Knorr procedure is the simplest.  The only disadvantages present are 
the high costs and poor stability of the Koenigs-Knorr activators.  The UDP-
glucuronosyltransferase is the worse activator to prepare due to the difficulties 
in expressing and purifying a membrane-bound enzyme that is harvested from 
animals.  The glucuronylsynthase enzyme appears to be the most stable 
activator out of the glucuronylation procedures.  It has a long storage stability 
and tolerates high temperatures and a wide range pHs over an extended 
amount of time.  Its preparation appears to only be inferior to the Koenigs-Knorr 
preparation due to the time taken to express and purify the enzyme (~ 1 week).  
This is a small drawback that is outweighed by the many other advantages of 
this system. 
6.1.3 The Reaction 
The glucuronylation reactions can be sorted into two classes of reactions.  
The Koenigs-Knorr and its related reactions are a chemical synthesis approach 
whereas the UDP-glucuronosyltransferase and glucuronylsynthase procedures 
can be classed as enzyme-assisted reactions.  There are pros and cons 
associated with each procedure which will be weighed up against the respective 
yields from these reactions. 
The optimised conditions for the glucuronylsynthase reaction were determined 
in this study (Scheme 6.3).  The ideal reaction conditions call for a pH 7.5 
buffered solution at 37 C for 3-5 days depending on the concentration of 
enzyme and turnover of the substrate (e.g. phenols and sterically-hindered 
alcohols react slowly).  A concentration of 0.2 mg mL-1 of glucuronylsynthase 
enzyme was frequently used in this research and found to be more than 
sufficient to catalyse glucuronide conjugation of any substrate within 5 days, 
especially at 37 C. 
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Scheme 6.3.  Optimised reaction conditions for the glucuronylsynthase reaction 
At least three equivalents of -D-glucuronyl fluoride 51 is required to 
sufficiently overcome the possibility of product inhibition.  From the product 
inhibition study on DHEA O-(carboxymethyl)oxime 116, it was shown that >3 
equivalents of -D-glucuronyl fluoride 51 would further improve yield but by 
smaller quantities with each addition. 
The addition of tert-butanol (up to 10% v/v) aids the solubility of hydrophobic 
substrates.  However, further investigation into the effects of tert-butanol is 
needed to explain its effect on enhancing the reaction with DHEA O-
(carboxymethyl)oxime 116 whilst hindering the reaction involving 2-
phenylethanol 45. 
With the exception of the -D-glucuronyl fluoride 51 hydrolysis (analogous to 
Scheme 3.7), no by-products have been observed in the glucuronylsynthase 
reaction to date.  The resulting reaction mixture consists of the -glucuronide 
product, glucuronic acid 3 (from the hydrolysis of -D-glucuronyl fluoride 51) 
and unreacted starting materials.  The stereochemical outcome of the 
glucuronylsynthase reaction is stereospecific for the -anomer as determined by 
its mechanism (Scheme 1.9). 
The reaction conditions for the UDP-glucuronosyltransferase are very similar 
to the glucuronylsynthase (Scheme 6.4).40,190,196-199  Briefly, the UDP-
glucuronosyltransferase is added to a buffered solution of alcohol and excess 
glucuronyl donor (UDP-glucuronic acid 22) at 37 C for a few days.  Also 
essential to the reaction is magnesium chloride (activity modulator)200 and a co-
solvent or detergent (to aid the solubility of the enzyme).  DMSO is most 
commonly used but dimethylformamide, ethanol and Triton X-100 have also 
been used.  When liver microsomal extracts are used, it can contain other 
metabolising enzymes such as cytochromes or -glucuronidase.  To maximise 
yields, D-saccharic acid 1,4-lactone 131 (a -glucuronidase inhibitor) is added 
to the microsomal extracts.120 
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Scheme 6.4.  General reaction conditions for the UDP-glucuronosyltransferase 
Once again, the reaction time is dependent on the amount of enzyme added 
to the reaction with a typical reaction (> 1 mg mL-1) using over 5 times the 
concentration of glucuronylsynthase enzyme used (0.2 mg mL-1).  It is difficult to 
accurately compare the enzyme kinetic parameters between UDP-
glucuronosyltransferase (Table 6.1) and the glucuronylsynthase enzyme (Table 
6.2) due to the large number of isoforms and species from which UDP-
glucuronosyltransferase can be obtained from.  In addition to this, kinetic data 
was not available for the aglycons investigated in this research.  Nevertheless, 
a general comparison of the kinetic parameters does provide some insight into 
the catalytic performance of these two enzymes.  From the specific activity, it 
can be observed that the glucuronylsynthase catalyses the glucuronylation 
reaction of alkyl alcohols faster than the UDP-glucuronosyltransferase.   
However, UDP-glucuronosyltransferases are able to catalyse the conjugation of 
phenolic aglycons more rapidly.  The glucuronylsynthase has a lower Km for its 
glucuronyl donor (Kmapp 15 M) than UDP-glucuronosyltransferase (Km 260 
M).  This binding affinity does not change much between different 
glucuronosyltransferase isoforms or between species with most Michaelis 
constants falling in the range of 0.2-0.7 mM.201  It is interesting to note that the 
UDP-glucuronosyltransferase Km values for the aglycon substrates are 
approximately three orders of magnitude lower than for glucuronylsynthase.  
This illustrates, once again, the role of -glucuronidase in hydrolysing the 
glucuronic acid 3 residue non-selectively from a wide range of aglycons.  
Conversely, UDP-glucuronosyltransferases are a superfamily of enzymes with 
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each isoform being selective towards certain classes of aglycons.  Therefore, a 
moderate affinity for the aglycon substrates is required for this selectivity. 
Table 6.1.  Examples of kinetic parameters for UDP-glucuronosyltransferase. 
Substrate Enzyme origin 
Km 
(mM) 
Specific activity 
(nmol-1 min-1 [mg protein]-1) 
UDP-glucuronic 
acid 22202 
Recombinant 
human 1A6 WT 
0.26a) 2.46a) 
phenol  52203 
Rat liver 
microsome 
N/A 10.6 
DHEA 55199 
Recombinant 
human 2B7 WT 
N/A 0.0021 
Testosterone 7198 
Recombinant 
human 2B17 WT
0.010 1.0 
Estrone 9204 
Recombinant 
human 1A10 WT
0.042 7.9 
a) Reaction with 1-naphthol (50 mM) 
Table 6.2.  Kinetic parameters for the glucuronylsynthase enzyme 
Substrate 
Km 
(mM) 
Specific activity 
(nmol-1 min-1 [mg protein]-1) 
-D-glucuronyl fluoride 51 0.015a) 20.3a) 
2-phenylethanol 45 144 42.8 
3-methoxybenzyl alcohol 47 43 64 
4-fluorobenzyl alcohol 50 40 27 
DHEA O-(carboxymethyl)oxime 116 7 32 
phenol 52 20 5 
a) Apparent parameter from the reaction with 2-phenylethanol 45 (107 mM) 
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The mechanism for UDP-glucuronosyltransferase is stereospecific and 
involves an SN2 reaction facilitated by the enzyme (similar to the 
glucuronylsynthase mechanism).205  Reactions utilising pure UDP-
glucuronosyltransferase do not report any by-products except for D-glucuronic 
acid 3 from the hydrolysis of the UDP-glucuronic acid 22.  However, when liver 
microsomes are used in reactions, the presence of other metabolising enzymes 
(such as cytochromes) can produce phase 1 by-products by oxidation (e.g. 
Scheme 1.1).  The UDP-glucuronosyltransferase procedure requires more 
exertion to set-up than the glucuronylsynthase reactions.  Additional 
components (such as detergent, magnesium chloride and D-saccharic acid 1,4-
lactone 131) are essential for the operation of the UDP-glucuronosyltransferase 
compared to the glucuronylsynthase system which only requires the substrates 
and buffer to operate in. 
Only a small number of reaction components are required for the Koenigs-
Knorr procedure.  It essentially involves stirring or refluxing the glucuronyl donor 
and acceptor alcohol in the presence of a heavy metal salt, Lewis acid or 
phase-transfer catalyst (Scheme 6.5a).13-18,20 Despite the large range of 
reaction conditions, there is no generalised rule that states what conditions (i.e. 
which metal salts) should be used for certain substrates.  Unless the reaction 
has been previously reported, conditions are usually chosen on a “trial-by-error” 
basis. 
In the trichloroacetimidate procedure, the glucuronyl trichloroacetimidate 19 is 
stirred with the acceptor alcohol and boron trifluoride etherate under inert 
conditions at sub-zero to room temperatures (Scheme 6.5b).18,25-27  Longer and 
warmer reactions generally provide the -anomer selectively (thermodynamic 
product), whereas short and chilled reactions are selective for -glucuronide 
formation (kinetic).26  The reaction conditions for the triflate procedure are 
similar to the imidate procedure albeit the addition of trimethylsilyl triflate to 
produce the activated glucuronyl donor in situ (Scheme 6.5c).18,28 
Despite the simplicity of the reaction components required, the presence of 
water is detrimental to the yields obtained from the Koenigs-Knorr reaction.  As 
a result, laborious measures must be made to ensure that substrates, metal 
salts, solvents and glassware are all dry prior to use; an unnecessary step in 
the UDP-glucuronosyltransferase and glucuronylsynthase procedures.  Special 
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care must also be taken for the handling and disposal of the toxic heavy metals 
employed in this procedure. 
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Scheme 6.5. General procedures for the a) Koenigs-Knorr, b) trichloroacetimidate and 
c) triflate glucuronylation reactions. 
Unlike the stereospecific mechanism of the enzyme-assisted glucuronylation 
procedure, the Koenigs-Knorr reaction (and its derivatives) is only 
stereoselective (Scheme 1.4).21  The  linkage can result from the SN1 pathway 
and the presence of anchimeric assistance can lead to a formation of the ortho 
ester 17 by-product.  The profusion of mechanistic pathways is responsible for 
the majority of low yields reported for the Koenigs-Knorr reaction.  The overall 
yield of the glucuronide product is reduced further by a deprotection step that is 
not present for the enzyme-assisted procedures. 
The deprotection step generally involves saponification of acyl-protecting 
groups in a water-miscible solvent, such as methanol or ethanol, to aid the 
solubility of the protected glucuronide (Scheme 6.6).13-16,20,25,27,206  Dilute 
concentrations of hydroxide and low temperatures are used to prevent 
hydrolysis of the glycosidic linkage and/or base promoted elimination within the 
pyranose ring.  The extra step in the Koenigs-Knorr reaction means that 2-3 
days are required to go from the steroid aglycon to the final steroid glucuronide.  
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Therefore, the Koenigs-Knorr and enzyme-mediated glucuronylation procedures 
are similar in preparation time. 
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Scheme 6.6.  Saponification of the glucuronide triacetate 13 and possible side-
reactions. 
Possibly the most important factor to compare amongst the different 
glucuronylation procedures is the reaction yield.  The yields obtained from the 
glucuronylation of various steroids (With the exception of estrone 9, the UDP-
glucuronosyltransferase provided consistently good yields (77%).  However, it is 
important to note that in each UDP-glucuronosyltransferase synthesis that less 
than 10 mg of product is obtained which illustrates a major limitation of this 
procedure.  The yields of the Koenigs-Knorr reaction are reported as yields over 
two steps and rarely achieve yields greater than 50%.  This is due to the 
production of by-products (such as the ortho ester 17) formed in the reaction 
(Scheme 1.4) and the additional deprotection step required after conjugation. 
Table 6.3) were compared due to the lack of data available for the simple 
alcohols.  The glucuronylsynthase provides the highest yields for the direct 
glucuronylsynthesis of DHEA 55 and epiandrosterone 56.  However, the yields 
for the more sterically hindered 17-positioned steroids were either on par with 
the other procedures (e.g. testosterone 7 and epitestosterone 123) or worse off 
(e.g. nandrolone 108 and boldenone 118).  The yield of nandrolone -D-
glucuronide 110 was obtained from un-optimised conditions.  The yield of 
epiandrosterone -D-glucuronide 109 almost doubled (from 21% to 38%) when 
subjected to the optimised conditions.  Alternatively, the use of the 3-step 
solubility strategy vastly improved the yields of DHEA 55 and testosterone 7 
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and would be envisaged to have the same effects on the other 17-hydroxy 
steroid series. 
With the exception of estrone 9, the UDP-glucuronosyltransferase provided 
consistently good yields (77%).  However, it is important to note that in each 
UDP-glucuronosyltransferase synthesis that less than 10 mg of product is 
obtained which illustrates a major limitation of this procedure.  The yields of the 
Koenigs-Knorr reaction are reported as yields over two steps and rarely achieve 
yields greater than 50%.  This is due to the production of by-products (such as 
the ortho ester 17) formed in the reaction (Scheme 1.4) and the additional 
deprotection step required after conjugation. 
Table 6.3.  Yields for the glucuronylation of various steroid aglycons using different 
glucuronylation procedures. 
yields (%) 
Substrate direct 
glucuronylsynthase 
UDP-glucuronosyl-
transferase Koenigs-Knorra
DHEA 55 71% (86%)b N/A 20%20 
testosterone 7 12% (69%)b 77% (6.5 mg)d,196 17%20 
epiandrosterone 56 21% (38%)c N/A 19%13 
nandrolone 108 6% 77% (3.5 mg)d,196 N/A 
estrone 9 24%c 17%207 45%14 (39%)e,27
epitestosterone 123 38%c N/A 21-41%206 
boldenone 118 15%c N/A 77%16 
a) Yield over two steps; b) yield from 3-step solubility strategy; c) yield from HPLC trace; 
d) isolated mass; e) yield obtained from the trichloroimidate procedure. 
The three glucuronylation procedures (glucuronylsynthase, UDP-
glucuronosyltransferase and Koenigs-Knorr) were reviewed on their use for 
glucuronide preparation.  The procedures were scrutinised from substrate costs 
and preparation through to reaction procedures and yield.  Overall, it appears 
the glucuronylsynthase has many advantages over the alternative means of 
glucuronylation.  The substrates and enzyme are easier to prepare than the 
UDP-glucuronosyltransferase procedure and it can be scaled up to multi-gram 
scale.  The reaction conditions for the glucuronylsynthase reaction are milder 
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and safer than the Koenigs-Knorr reaction which allows recovery of 
unconsumed starting material and avoids the additional deprotection step 
afterwards.  But possibly the most significant advantage is the large diversity of 
substrates that have been applied without the need of modifying the reaction 
conditions albeit the addition of tert-butanol to aid solubility.  The 
glucuronylsynthase has matched and surpassed the attractive attributes of 
these procedures and secured its role as a novel procedure for glucuronide 
synthesis. 
6.2 Conclusions 
The glucuronylsynthase is the latest glycosynthase engineered from the E. 
coli -glucuronidase.  The methodology for its expression and its application in 
glucuronylsynthase reactions was developed and optimised in this study.  This 
was achieved through enzyme kinetic investigations performed with HPLC. 
The enzyme kinetic studies (chapter 3.5) revealed a low Kmapp for the -D-
glucuronyl fluoride 51 (15 M) and higher Km (millimolar) for the alcohol 
acceptors.  The presence of substrate inhibition was observed for all acceptor 
substrates except for 2-phenylethanol 45.  In addition to this, mixed 
predominately competitive product inhibition (K ic 71 M, K iu 190 M) was 
observed in the 2-phenylethanol 45 glucuronylsynthase reaction with DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 as the inhibitor (chapter 4.6).  The 
inhibition is two orders of magnitude stronger than the estimated substrate 
inhibition constant for DHEA O-(carboxymethyl)oxime 116 alone (Ksi 0.1 mM).  
This is consistent with the -glucuronidase’s substrate promiscuity.  The primary 
recognition of a glucuronide conjugate by β-glucuronidase is expected for the 
target carbohydrate moiety over the variable aglycon portion.  Overcoming this 
predominately competitive product inhibition and maintaining high 
concentrations of -D-glucuronyl fluoride 51 (>Kmapp) saw yields for the 
glucuronylation of DHEA O-(carboxymethyl)oxime 116 (section 4.5.2) rise 
dramatically from 48% (1 equiv) to 98% (5 equiv). 
Further optimisation of the glucuronylsynthase reaction was achieved by 
scrutinising the reaction variables (chapter 3.6 and 5.2).  The effect of reaction 
pH, temperature enzyme concentration and additives in the glucuronylsynthase 
kinetics were investigated by enzyme kinetics.  The results of the study were 
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combined to develop the ideal reaction conditions for the glucuronylsynthase 
reaction (Scheme 6.3).  The optimisation of reaction variables saw a marked 
improvement in yields.  For example, phenyl -D-glucuronide 76 was isolated in 
43% yield compared to the previously un-optimised reaction yield of 13% and 
epiandrosterone 56 obtained in 38% HPLC yield from its un-optimised yield of 
21%. 
With a deeper understanding of the enzyme kinetics and the optimised 
conditions identified, the research was directed towards the glucuronylsynthesis 
of steroids which is the anticipated role for this enzyme in industry.   The 
glucuronides of DHEA 55, epiandrosterone 56, testosterone 7, and nandrolone 
108 were successfully synthesised from glucuronylsynthase reactions (chapter 
4.2).  But the solubility of steroids in water required high concentrations of co-
solvents or detergents which were harmful to the enzyme and very dilute 
reactions which required large quantities of enzyme.  To overcome this 
problem, the steroids were made more water soluble through a temporary 
chemical modification. 
Carboxymethoxylamine 115 was reacted with DHEA 55 and testosterone 7 to 
synthesise ionisable oxime analogues that were 100 and 500 times more water 
soluble than the parent steroid respectively (chapters 4.3 and 4.7).  These 
steroid oximes were then subjected to glucuronylsynthase reactions under 
optimised conditions to achieve 98% yield of the DHEA O-
(carboxymethyl)oxime -D-glucuronide 118 and 72% yield of the testosterone 
O-(carboxymethyl)oxime -D-glucuronide 121.  The oxime moiety was removed 
via a titanium(III)-mediated reduction of the N-O bond in the presence of the 
glucuronyl residue.  The subsequent imine was hydrolysed in situ to form the 
DHEA -D-glucuronide 77 in quantitative yields, but the testosterone -D-
glucuronide 6 in only 38% yield (81% brsm). 
With the optimised reaction conditions determined for steroid 
glucuronylsynthesis, a small screen was trailed with the glucuronylsynthase 
enzyme (chapter 5.4).  Solid phase extraction was used to quickly isolate the 
products from this screen.  The screen contained steroids of different structural 
configurations, including phenols, pyrazoles and diols.  Evidence of glucuronide 
formation was observed for all of the steroids subjected to the screen. 
The growing substrate repertoire demonstrates the universal application of the 
glucuronylsynthase enzyme which is one of many aspects that makes it such an 
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attractive method of glucuronylation.  Another important attribute is the 
scalability of the reaction which was demonstrated by the large scale 
glucuronylsynthesis on 2-phenylethanol 45 (300 mg, refer to section 2.5.2) and 
DHEA O-(carboxymethyl)oxime 116 (500 mg, refer to section 4.3.3).  In many 
ways, the glucuronylsynthase surpasses the attributes of the alternative means 
of glucuronylation and simultaneously overcomes many of their downfalls. 
6.3 Future work 
This research determined the optimised reaction conditions for the 
glucuronylsynthase reactions (Scheme 6.3).  It would be valuable to repeat the 
glucuronylsynthase reactions on previously attempted substrates to see what 
improvement could be made on the un-optimised yields.  In addition to this, the 
optimised conditions could be used to expand the collection of substrates that 
successfully undergo the glucuronylsynthase reaction.  Glucuronide formation 
was observed for all substrates involved in the small steroid screen (although 
no yield was determined for some of the steroids).  A larger library will present 
the true value of the glucuronylsynthase system in terms of its universal 
application as well as pose any limitations the procedure may have.  The 
reaction with pharmaceutical substrates could also be re-explored with the 
glucuronylsynthesis of morphine 2, codeine 1 and chloramphenicol 87 
producing no glucuronide under un-optimised conditions. 
During the reaction optimisation with additives, the use of tert-butanol was 
determined to aid the solubility of hydrophobic substrates (chapter 5.2).  It also 
demonstrated an unusual effect of enhancing the reaction rate for DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthesis.  It is still unknown whether tert-
butanol imparts allosteric activation, represses substrate inhibition or has 
another role altogether at enhancing the reaction rate.  Temperature was 
another variable changed in these investigations (21 C vs. 37 C) and may be 
responsible for the apparent altered kinetic parameters.  Further investigations 
into the effects of tert-butanol and temperature on the glucuronylsynthase 
reactions needs to be explored with a kinetic study. 
The existence of product inhibition by DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 in the 2-phenylethanol 45 glucuronylsynthase reaction was 
proven in this research (refer to section 4.6.2).  The yields achieved in the 
glucuronylsynthase reactions using one equivalent of -D-glucuronyl fluoride 51 
192 
Conclusions and future work 
may be related to the binding affinity of the product.  This could be investigated 
by the addition of the glucuronides derived from other alcohols (e.g. 3-
methoxybenzyl alcohol 47 and 4-fluorobenzyl alcohol 50) to a single 
glucuronylsynthase reaction (e.g. DHEA O-(carboxymethyl)oxime 116 or 2-
phenylethanol 45 glucuronylsynthase reaction) to indirectly investigate the 
existence and extent of product inhibition.  A relationship may exist between the 
binding affinity of the product (K i) and the yield of the reactions given a single 
equivalent of -D-glucuronyl fluoride 51. 
A simple means of detecting product inhibition would also be to repeat the 
same glucuronylsynthase reaction with increasing quantities of -D-glucuronyl 
fluoride 51 and determine the yield from each (analogous to section 4.5.2).  This 
would not provide the inhibition parameters but would provide a pointer toward 
competitive product inhibition that would warrant further investigation. 
A three step steroid solubilisation strategy was developed that improved the 
overall synthesis of DHEA -D-glucuronide 77 and testosterone -D-glucuronide 
6 (chapters 4.3 and 4.7).  The synthesis sequence worked well for DHEA 55, 
but the de-oximation of testosterone O-(carboxymethyl)oxime -D-glucuronide 
121 did not go to completion.  Oxidation of titanium(III) was observed over the 
extended reaction time needed to cleave the oxime moiety.  A greater excess of 
titanium(III) may be needed or its continuous addition over time may improve 
conversions. Alternately, improved reaction conditions such as the degassing of 
solvents, the use of argon gas or optimising the buffer concentration and pH 
may help reduce the degradation of titanium(III).  Optimisation of this step will 
drastically improve the synthesis of testosterone -D-glucuronide 6 via the three 
step steroid sequence.   
The largest problem that exists for the glucuronylsynthase is its slow catalytic 
turnover.  Despite its apparent catalytic superiority over UDP-
glucuronosyltransferase (refer to section 6.1.3), the glucuronylsynthase is 
possibly the slowest glycosynthase reported to date.  Reaction times extend for 
days for a glucuronylsynthase reaction unless large quantities of enzyme are 
used.  The 3-methoxybenzyl alcohol 47 glucuronylsynthase recorded the fastest 
observed catalytic turnover of only 0.023 s-1. 
Previously reported glycosynthase activities have been improved through the 
use of directed evolution.91,96,121,124,134  Progress has already been made in this 
field with multiple high-throughput assays already been developed and trialled.  
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Assays such as the fluoride-selective assay (refer to section 3.7.4) and the pH-
dependent assay (refer to section 3.7.5) failed to work due to the minute 
amount of enzyme activity available in the cell lysate studies.  Future work 
involves the directed evolution of the WT -glucuronidase which has an 
appreciable and readily detectable activity.  Site-directed mutagenesis of the 
catalytic residue would then be applied to the evolved WT gene to create the 
glucuronylsynthase gene.  A marginally improved glucuronylsynthase enzyme 
could then be subjected to previously attempted directed evolution to improve 
the activity further.  The ELISA assay (refer to section 3.7.6) is also an option 
but requires extensive biochemical procedures to develop the antibodies for the 
assay. 
Further to this molecular biology work, the enzyme crystal structure of -
glucuronidase and glucuronylsynthase has not been determined.  The crystal 
structure would help rationalise the findings in the mutagenic studies as well as 
provide structure-activity relationships to determine why some substrates react 
better than others.  Attempts at growing an enzyme crystal (chapter 1.1) has 
achieved no sizable crystal to date. 
The yields of the glucuronylsynthase reactions are continually improving as 
more is understood about the glucuronylsynthase system such as the findings 
presented in this research.  Enzyme kinetic studies and complimentary 
strategies, such as the three step steroid solubilisation strategy, have aided the 
yields of steroid glucuronylation with the glucuronylsynthase enzyme.  The 
future success of the enzyme relies on the improved catalytic turnover through 
the use of directed evolution technology.  This would lead to more efficient 
syntheses and increased accessibility of glucuronide conjugates required in 
analytical studies such as sports drug testing and the pharmaceutical industry.  
The glucuronylsynthase shows great promise for the rapid synthesis of a variety 
of known glucuronide conjugates and those not yet obtainable via current 
methodologies. 
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Experimental 
Experimental 
7.1 General Experimental 
7.1.1 Equipment 
Melting points were determined using a Reichart heating stage with 
microscope (USyd) or an Optimelt Automated Melting Point System MPA100 
(ANU) and are uncorrected. 
Optical activity was measured on a PolAAr 2001 polarimeter (USyd) or Perkin-
Elmer Polarimeter 241MC (ANU) set at the 589.3 nm sodium D line, in a 0.25 
dm or 1.00 dm cell.  Data is expressed as []  R (C, S), where T is temperature 
(C), R is the calculated degree of rotation (10
T
D
-1 deg cm2 g-1), C is the 
concentration of solution (g 100 mL-1), and S is the solvent used. 
Infrared absorption (IR) spectra were obtained using with a Biorad FTS-40 
series (USyd), Perkin Elmer 1600 series (USyd) or Perkin-Elmer Spectrum One 
(ANU) FTIR spectrometer.  Compounds were homogenised (10% w/w) in 
anhydrous potassium bromide and measured directly from IR cups (KBr 
powder) or pressed into a disc (KBr disc).  Alternatively, the compound was 
dried as a thin film onto sodium chloride plates (NaCl).  Significant absorbance 
bands are reported in wavenumbers (cm-1) and are described by the 
abbreviations: br = broad, s = strong, m = medium, w = weak.  Where 
applicable, bands are also assigned their respective functional group. 
1H Nuclear Magnetic Resonance (1H NMR) spectra were obtained on a Bruker 
Avance 200 (200 MHz, USyd), Bruker Avance 300 (300 MHz, USyd), Mercury 
300 (300 MHz, ANU), Mercury 400 (400 MHz, ANU) or Bruker Avance 800 (800 
MHz, ANU) at 300 K unless otherwise stated.  Chemical shift data is expressed 
in ppm relative to TMS = 0, using residual protons in deuterated solvent as an 
internal reference.  The data is reported as chemical shift (), relative integral, 
multiplicity (s = singlet, d = doublet, dd = doublet of doublets, ddd = doublet of 
doublet of doublets, dt = doublet of triplets, quint = quintet, m = multiplet), 
coupling constant(s) (J Hz) and assignment.  All multiplicities and coupling 
constants are apparent.  
13C Nuclear Magnetic Resonance (13C NMR) spectra were obtained on a 
Bruker Avance 200 (50 MHz, USyd), Bruker Avance 300 (75 MHz, USyd), 
Mercury 300 (75 MHz, ANU), Mercury 400 (100 MHz, ANU) or Bruker Avance 
800 (200 MHz, ANU) at 300 K with complete proton decoupling unless 
otherwise stated.  Chemical shift data is expressed in ppm relative to TMS = 0, 
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using deuterated solvent as an internal reference.  13C spectra acquired in 
deuterium oxide were calibrated by the addition of a drop of methanol.  The 
data is reported as chemical shift () and assignment.  Heteronuclear 13C-19F 
coupling, where present, are denoted with multiplicity (d = doublet) and coupling 
constant (J Hz).  The protonicity (CH3 = primary, CH2 = secondary, CH = 
tertiary, Cq = quaternary carbon) is provided where supported by a DEPT135 
experiment. 
Low resolution mass spectra (LRMS) was obtained from a ThermoQuest 
Finnigan LCQ Deca ion trap (USyd) or Micromass–Waters LC-ZMD single-
stage quadrupole (ANU) mass spectrometer with electro-spray ionisation in 
either positive (+ESI) or negative (-ESI) mode.  A VG Autospec Quattro II triple 
quadrupole mass spectrometer (ANU) was used to obtain electron impact 
spectra.  Data is expressed as observed mass (m/z), assignment (M = 
molecular ion), and relative intensity (%). 
High resolution mass spectroscopy (HRMS) was recorded on a Spectrospin 
7T FTICR (UNSW) or Waters LCT Premier XE (ANU) mass spectrometer, using 
positive (+ESI) or negative (-ESI) electro-spray ionisation.  Data is expressed as 
observed mass (m/z), assignment (M = molecular ion), and relative intensity 
(%). 
Elemental analysis was determined using a Carlo Erba CE1106 automatic 
analyser (carbon, hydrogen and nitrogen), Diowex DX-120 ion-chromatograph 
(sulfur) and Varian spectraAA-30 (metals) and are uncorrected. 
Isothermal Titration Calorimetry (ITC) experiments were performed on a 
MicroCal VP-ITC® Microcalorimeter.  MicroCal® Origin software was used to 
determine the equilibrium constant (KA).  Solutions were made with identical 
degassed buffer. 
Fast Protein Liquid Chromatography (FPLC) for protein purification was 
performed on a Waters ATKA purifier 10 series equipped with a P-900 pump, 
UV-900 UV detector (280 nm) and Frac-900 Fractionator.  Eluting solvents and 
samples were filtered through a 0.45 m membrane prior to use. 
Centrifugal filtration was performed with Millipore Amicon Ultra 15 mL 10,000 
MW cut-off centrifugal filter devices centrifuged at 5000g until acquiring the 
appropriate volume. 
SDS-PAGE was run at 40 mV for ~3 h in glycine running buffer.  Mark 12 
wide-range protein standard was used as a reference standard.  The gel was 
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stained with glycine “Coomassie Blue” gel stain (1 h) then de-stained with 
glycine destain solution. 
High Performance Liquid Chromatography with Ultra Violet detection (HPLC-
UV) for the glucuronylsynthase assay was performed on Waters 2695 
Separations module equipped with the Waters Alliance Series Column Heater 
(set at 30 °C) and Water 2996 Photodiode Array (PDA) Detector.  Data 
acquisition and processing was performed with the Waters Empower 2 
software. 
UV spectroscopy was performed on a Cary 1 UV-VIS spectrometer set at 280 
nm using Eppendorf UVettes with a path length of 1 cm.  Enzyme solutions 
were centrifuged at 12,000 rpm for two minutes prior to reading. 
Fluorescence was performed on a Cary Eclipse spectrometer with quartz 
cuvettes and at ambient temperatures.  Fluorescence was measured using the 
Cary Eclipse Kinetics Application version 1.1. 
Analytical thin layer chromatography (TLC) was performed using 0.2 mm 
thick, aluminium-backed, pre-coated silica gel plates (Merck Silica gel 60 F254).  
Compounds were visualised by short and long wavelength ultra-violet 
fluorescence and by staining with 10% sulfuric acid in methanol or Goofy’s dip 
(15 g phosphomolybdic acid, 15 mL conc. sulfuric acid, 485 mL water and 2.5 g 
cerium sulfate). 
Normal-phase Flash chromatography was performed using Merck Silica gel 
60 (230 – 400 mesh ASTM), under a positive pressure of nitrogen, with the 
indicated solvents.  Solvent compositions were mixed volume per volume (v/v) 
as specified. 
Reversed-phase Flash Chromatography was performed with Davisil C18 silica 
(cat #633NC18E), under a positive pressure of air, with the indicated solvents. 
Solvent compositions were mixed volume per volume (v/v) as specified. 
Ion exchange chromatography was preformed using Dowex 1x8, 200-400, 
MeshCl resin.  All solutions were made from MilliQ water and the resin was re-
conditioned before every use.  Resin was re-conditioned with 1 M hydrochloric 
acid (2 column volumes), then water until neutral, 1 M sodium hydroxide (2 
column volumes), then water until neutral, 1 M ammonium bicarbonate (2 
column volumes), then finally water (≥5 column volumes). 
Evaporation or concentration under reduced pressure refers to evaporation 
using a rotary evaporator connected to a vacuum pump.  Removal of residual 
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solvent when necessary was achieved by evacuation (0.01 - 0.1 mm Hg) with a 
high stage oil sealed vacuum pump. 
All solvents and reagents were dried and purified when necessary according 
to published standard procedures.195  Hexanes refers to hexanes (bp 65 – 69 
°C) and brine refers to saturated aqueous sodium chloride solution.  Moisture 
sensitive reactions were carried out in oven dried glassware under a dry inert 
atmosphere of nitrogen or argon.  Reaction temperatures were controlled using 
ice : water (0 – 5 °C) cooling baths or oil heating baths (> room temperature).  
Room temperature ranges from 18-25 C. 
7.1.2 Biochemical solutions 
Formulae for biochemical solutions are as follows.  Solutions are made with 
MilliQ water with % concentration in g (100 mL)-1 unless otherwise stated. 
Binding Buffer 
Sodium dihydrogen phosphate (20 mM), sodium chloride (0.5 M), imidazole 
(20 mM), MilliQ water, adjusted to pH 7.4. 
Bromophenol Blue (BPB) loading buffer 
Bromophenol blue (0.05%), glycerol (75%), Tris buffer (2.5 mM, pH 8.0) 
Buffer H (10X) 
Tris-HCl (0.5 M), sodium chloride (1 M), magnesium chloride (100 mM), 
dithioerythritol (10 mM), pH 7.5 (at 37 C). 
Eluting Buffer 
Sodium phosphate (20 mM), sodium chloride (0.5 M), imidazole (500 mM), 
MilliQ water, adjusted to pH 7.4. 
Extraction Buffer 
Sodium dihydrogen phosphate (50 mM), -mercaptoethanol (10 mM), Triton 
X-100 (0.1%), water (MilliQ), adjusted to pH 7.4. 
Glycine “Coomassie Blue” Gel Stain 
Coomassie Brilliant Blue R (0.125%), methanol (40% v/v), acetic acid (7% 
v/v), water (MilliQ). 
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Glycine Destain Solution 
Acetic acid (10% v/v), methanol (30% v/v), water (MilliQ). 
Glycine Running Buffer 
Tris Buffer (0.25 M), glycine (1.92 M), sodium dodecyl sulfate (SDS, 1%), 
water (MilliQ), adjusted to pH 8.3. 
Glycine SDS-PAGE Resolving Gel 
Acrylamide (15%), Tris buffer pH 8.8 (0.36 M), sodium dodecyl sulfate (SDS, 
0.10%), ammonium persulfate (APS, 0.05%), water (MilliQ), N,N,N′,N′-
tetramethylethylenediamine (TEMED, 0.10%). 
Glycine SDS-PAGE Stacking Gel 
Acrylamide (4%), Tris buffer pH 8.8 (0.19 M), sodium dodecyl sulfate (SDS, 
0.05%), ammonium persulfate (APS, 0.03%), water (MilliQ), N,N,N′,N′-
tetramethylethylenediamine (TEMED, 0.07%). 
KCM 
Potassium chloride (100 mM), calcium chloride (30 mM), magnesium chloride 
(50 mM) 
Luria Burtani (LB) Media 
Peptone (1%), yeast extract (0.5%), sodium chloride (0.5%), water (MilliQ). 
Luria Burtani (LB) Agar Media 
Agar (1.5%), peptone (1%), yeast extract (0.5%), sodium chloride (0.5%), 
water (MilliQ). 
Luria Burtani with Kanamycin 78 (LBkan) Media 
Peptone (1%), yeast extract (0.5%), sodium chloride (0.5%), kanamycin 78 
(0.005%), water (MilliQ). 
Lysis Buffer 
Tris buffer pH 8.0 (50 mM), sodium chloride (50 mM), Triton X-100 (1%), 
phenylmethanesulfonyl fluoride (PMSF, 1.4 mM), -mercaptoethanol (1.4 mM), 
water (MilliQ). 
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Phosphate Buffered Saline (PBS) Buffer 
Sodium chloride (0.8%), potassium chloride (0.02%), sodium hydrogen 
phosphate (0.144%), potassium dihydrogen phosphate (0.024%), water (MilliQ), 
adjusted to pH 7.4, autoclaved. 
Resuspension buffer 
LB media (pH 6.1), PEG 3350 or PEG 8000 (10%), DMSO (5% v/v), 
magnesium chloride (10 mM), magnesium sulfate (10 mM), glycerol (10%). 
SDS-PAGE Loading Buffer (Glycine Gel) 
Tris buffer pH 6.8 (0.31 M), sodium dodecyl sulfate (SDS, 10%), glycerol 
(50%), -mercaptoethanol (25%), bromophenol blue (0.5%), water (MilliQ). 
SOC Media 
Yeast (0.5%), tryptone (2%), sodium chloride (10 mM), potassium chloride 
(2.5 mM), magnesium chloride (10 mM), magnesium sulfate (10 mM), 
autoclaved, then glucose 82 (20 mM). 
Sodium Borate Buffer 
Sodium hydroxide (0.04%), boric acid (0.225%) 
YenB Media 
Yeast extract (0.75%), nutrient broth (0.8%), water (MilliQ). 
7.2 Glucuronylsynthase expression 
7.2.1 DNA SDS-PAGE 
The DNA sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) gels were prepared by using heat and stirring to dissolve agarose (0.8% 
w/v) in sodium borate buffer (refer to section 7.1.2).  Once the molten agarose 
had cooled to pouring temperature (50-55 C), ethidium bromide (final 
concentration 5 g mL-1) was added.  Gels were poured onto 125 mm wide by 
80 mm long flat glass plates, with surface tension allowing gels of up to 5 mm 
thickness to be cast.  Wells (5mm wide x 1 mm long x 4 mm deep) were cast 
with a 20-lane comb during the pouring process, resulting in wells capable of 
holding 15 L of sample.  Samples (7.5 L) were prepared for loading by the 
addition of Bromophenol Blue (BPB) loading buffer (2.5 L, 3.3) unless 
otherwise stated.  A 1 kB DNA ladder (New England Biolabs) was used as a 
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standard and prepared to the manufacturer’s instructions by dilution with BPB 
loading buffer. 
Electrophoresis occurred with the gel slightly submerged in sodium borate 
buffer (refer to section 7.1.2) in a Wide Mini Sub tank at a constant current of 
150 mA and voltage of 150 V.  DNA was visualised by use of 254 nm UV light 
and images captured by UVI Pro electronic photography system. 
7.2.2 Protein SDS-PAGE 
The protein SDS-PAGE protocol208 consisted of hand-casted mini-gels (0.75 
mm) with a 50 mm glycine SDS-PAGE resolving gel region (refer to section 
7.1.2) and a 10 mm glycine SDS-PAGE stacking gel region (refer to section 
7.1.2). 
The acrylamide, Tris buffer pH 8.8, and sodium dodecyl sulfate, were 
prepared in advanced and stored at 4C with fresh batches made monthly.  
Polymerisation of the gel was initiated by the addition of ammonium persulfate 
(APS) and N,N,N’,N’-tetramethylethylenediamine (TEMED). 
Gels were cast with either 10 or 15 lanes. When cast with 10 lanes each lane 
was approximately 5 mm wide and was loaded with 15 L of sample. In 15 lane 
gels each lanes was approximately 3.5 mm wide and was loaded with 10 L of 
sample. 
The low-range molecular weight standard (Bio-Rad) provided 100 ng L-1 of 
protein in each of six bands:  97.4, 66.2, 45.0, 31.0, 21.5 and 14.4 kDa.  
Alternatively, the Mark 12TM wide-range protein standard (Invitrogen) provided 
twelve bands:  200, 116.3, 97.4, 66.3, 55.4, 36.5, 31.0, 21.5, 14.4, 6.0, 3.5, and 
2.5 kDa.  Protein standards were prepared according to manufacturers 
instructions. 
Gels were immersed in glycine running buffer (refer to section 7.1.2) in 
water-cooled Mighty Small gel tanks with a current maintained at 40 mV (~3 h).  
The gel was stained with glycine “Coomassie Blue” gel stain (1 h, refer to 
section 7.1.2) then de-stained with glycine destain solution (refer to section 
7.1.2). 
7.2.3 Optical Density Measurements 
The optical density to determine culture size was performed at 600 nm 
(A600nm).  For the pre-induction aliquots, the A600nm was measured on the 
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undiluted aliquot.  The post-induction samples underwent a 1:4 dilution with LB 
media prior to the A600nm measurement. 
7.2.4 Determining protein concentration 
Enzyme concentrations were estimated from UV absorption (280 nm) using 
the extinction coefficient of wild-type E. coli -glucuronidase ( = 2.049 (mg 
mL-1)-1 cm-1).209  Concentrations were determined from assays run as duplicates 
or triplicates. 
7.2.5 Selection for the recombinant E. coli 
LB agar media (100 mL, refer to section 7.1.2) was autoclaved then allowed to 
cool to ~55 C at which point kanamycin 78 (100 L, 50 mg mL-1), X-gluc 79 (8 
mg), and IPTG 81 (1 M, 50 L) were added.  The media was immediately 
distributed into four Petri dishes and allowed to cool.  The four GMS407(DE3) 
E. coli strains with the recombinant glucuronidase enzyme (E504A, E504G, 
E504S, and WT) were streaked separately onto each of the dishes which were 
then incubated (37 C) overnight.  The WT strain was selected from a blue-
coloured colony whilst the E504A, E504G, and E504S mutants were selected 
from colonies free from blue discolouration. 
7.2.6 Heat-shock competent cells general procedure 
A single host colony is picked from an LB AGAR plate (refer to section 7.1.2) 
and grown overnight (37 C) in sterile LB media (10 mL, refer to section 7.1.2).  
An aliquot of the overnight broth (4 mL) was used to inoculate SOC media (400 
mL, refer to section 7.1.2) and the culture grown (37 C) to A600 0.4.  All 
subsequent steps were undertaken at 4 C.  The culture was centrifuged (4000 
rpm, 5 min, 4 C) with the cell pellet resuspended in a resuspension buffer (20 
mL, refer to section 7.1.2).  The resuspended culture was distributed into 
aliquots (220 L), snap-frozen with liquid nitrogen and stored at -80 C until 
transformation. 
7.2.7 Heat-shock general procedure 
Heat-shock competent E. coli host cells (50 L, refer to section 7.2.6) were 
thawed on ice then added to concentrated pET28a(+) vector (1 L) in KCM (50 
L, refer to section 7.1.2).  The solution was mixed gently and kept on ice (15 
min) before subjecting to heat shock (42 °C, 90 s).  LB media (200 L, refer to 
section 7.1.2) was immediately added to the culture and then incubated (37 C, 
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1 h) without agitation.  The culture was plated on LB agar plates (refer to 
section 7.2.5) with a sterile loop and incubated (37 °C) overnight. 
7.2.8 Electro-competent cells general procedure63 
A single host colony is picked from an LB AGAR plate (refer to section 7.1.2) 
and grown overnight (37 C) in sterile YENB media (2 mL, refer to section 
7.1.2).  An aliquot of the overnight broth (1 mL) was used to inoculate YENB 
media (100 mL, refer to section 7.1.2) and the culture grown (37 C) to A600 0.8 
(~3 h).  All steps subsequent were undertaken at 4 C.  Cells were harvested by 
centrifugation (4,000 g, 10 min, 4 C) with the cell pellet washed with water (2 x 
40 mL) then sterile glycerol (10% v/v, 40 mL).  The cell pellet was resuspended 
in a sterile glycerol (10% v/v, 200 L), distributed into aliquots (50 L), snap-
frozen with liquid nitrogen and stored at -80 C until transformation. 
7.2.9 Electroporation transformation general procedure 
Electro-competent E. coli host cells (50 L, refer to section 7.2.6) were thawed 
on ice before the addition of concentrated pET28a(+)-E504G vector (1 L).  The 
mixture was left to stand (1 min) before being transferred into a 0.2 mm 
electrode cuvette and subjected to an electric field potential (2.5 kV, 5 ms) using 
a Micropulser.  
YENB media (1 mL, refer to section 7.1.2) was immediately added to the cells 
which were then incubated (37 C, 1 h) without agitation.  Cells were streaked 
onto LB agar plates (refer to section 7.2.5) with a sterile loop and incubated (37 
°C) overnight. 
7.2.10 Plasmid Amplification in E. coli NEB5 cells 
The pET28a(+)-E504G vector (0.5 L) was diluted with water (25 L) before 
its addition to E. coli NEB5[fhuA2Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17]  cells (40 L) in 10% 
glycerol.  The cells were transformed via electroporation (4.2.5).  A single 
colony from the agar plate was used to inoculate sterile LBkan media (2 mL, 
refer to section 7.1.2) which was then incubated (37 C) overnight.  The culture 
was centrifuged (13000 rpm, 2 min) and the supernatant was removed.  
Plasmid was isolated and purified using a QIAprep Spin Miniprep Kit (Qiagen) 
as per the manufacturer’s instructions.210  
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7.2.11 Plasmid sequencing 
A single digestion solution was created by combining Buffer H (10X, 1 L, 
refer to section 7.1.2), XhoI restriction enzyme (0.5 L, Roche) and water (3.5 
L).  A double digestion solution was created by combining Buffer H (10X, 1 L, 
refer to section 7.1.2), XhoI restriction enzyme (0.5 L, Roche), NdeI restriction 
enzyme (0.5 L, Roche) and water (3 L).  Concentrated plasmid (5 L, refer to 
section 7.2.10) was combined with a single digestion mixture (5 L) or double 
digestion mixture (5 L) and incubated (37 C) for 2 h.  The reaction was 
ceased by the addition of Bromophenol Blue (BPB) loading buffer (2 L, refer to 
section 7.1.2).  The samples were subjected to DNA SDS-PAGE (refer to 
section 7.2.1).  Single digestion lanes showed a single band at approximately 6 
kB.  Double digestion lanes exhibited a band at 5 kB and 1-2 kB. 
7.2.12 Induction 
A colony of transformed E. coli GMS407(DE3) cells (refer to section 7.2.7 or 
section 7.2.9) was picked from the selection LB agar plate and placed in an 
aliquot of LBkan media (10 mL, refer to section 7.1.2).  The samples were 
incubated (37 C) overnight with shaking at 180 rpm. 
The overnight culture (5 mL) was used to inoculate sterile LBkan media (500 
mL, refer to section 7.1.2) and cultures were incubated (37 °C) with shaking.  At 
A600nm ~0.7 (3 h), cells were induced with IPTG 81 (1 M, 200 L, 0.2 mol) and 
incubated further (37 C, 3 h).  Cultures were harvested by centrifugation (5000 
rpm, 10 min, 4 °C).  The pellet was resuspended in PBS buffer (100 mL, refer to 
section 7.1.2) and centrifugation was repeated.  The cell pellet (~1 g) was 
stored at -80 °C until required. 
7.2.13 Chemical Bacterial Cell Lysis 
Bacterial cells (~1 g) were resuspended in lysis buffer (10 mL, refer to section 
7.1.2) and DNAse (100 L, 10 mg mL-1) and lysosymes (100 L, 100 mg mL-1) 
were added.  The solution was subjected to five cycles of snap-freezing in liquid 
nitrogen and warming to room temperature.  The cell suspension was 
centrifuged (13000 rpm, 10 min, 4 C) and the supernatant was collected and 
stored at -80 °C until required. 
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7.2.14 Pressurised Bacterial Cell Lysis 
All subsequent steps were done at 4 °C. Bacterial cells (~1 g) were 
resuspended in binding buffer (15 mL, refer to section 7.1.2), lysed three times 
using a French Pressure Cell Press (20,000 kPa) and centrifuged (40,000 g, 
45 min, 4 C). The supernatant was immediately subjected to FPLC. 
7.2.15 FPLC Enzyme purification 
Lysed bacterial extracts were purified by FPLC equipped with a 5 mL 
HisTrapTM column (GE Healthcare).  The backpressure controlled flow rate was 
used at 0.3 MPa with a maximum flow rate of 5 mL min-1 used.  The  HisTrapTM 
was pre-conditioned with water (5 column volumes) and then binding buffer (5 
column volumes) prior to loading the sample directly onto the column via 
syringe equipped with a 0.45 M membrane filter.  The sample was washed 
with binding buffer until a baseline response was observed (~10 column 
volumes) by UV (A280nm).  A linear gradient to 100% eluting buffer over 25 
column volumes was applied and then maintained until a baseline response 
was regained.    A retention time for mutant strains was first determined by 
purifying the His-tagged WT glucuronidase.  A strong UV absorbing peak (280 
nm) was observed and verified by mixing a droplet from the UV peak fractions 
with a droplet of p-nitrophenyl--D-glucuronide 25 (10 mM) - a rapid yellow 
colour change confirming WT -glucuronidase.  A strong UV absorbing peak 
with an equal retention time was observed for the other glucuronylsynthase 
strains.  Fractions were concentrated and the buffer solution changed to 50 mM 
phosphate buffer pH 7.4 using centrifugal filtration. 
Samples were tested for purity by diluting an aliquot (5 L) from each sample 
with SDS-PAGE loading buffer (glycine gel) (10 L, refer to section 7.1.2) and 
subjecting them to glycine SDS-PAGE (refer to section 7.2.2). 
After use, the HisTrapTM was washed with water (5 column volumes) and then 
aqueous ethanol (20%, 5 column volumes) before being stored at 4 C. 
7.2.16 Enzyme crystallisation screens 
High through-put screening for appropriate protein crystallisation conditions 
were performed with a Cartesian Honeybee Crystallisation Robot (Genomic 
Solutions) using the Hampton Research® Crystal ScreenTM (Hampton 
Research, Laguna Hills, CA), Hampton Research® Index ScreenTM (Hampton 
Research, Laguna Hills, CA) and QIAGEN® PEGS SuiteTM (QIAGEN Sciences, 
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Germantown, MD).  Crystal screens were performed as microbatches in Intelli-
platesTM 96-3 LVR 96-well plates (Hampton Research, Laguna Hills, CA).  Each 
well consisted of three reservoirs.  In the first reservoir, screening solutions 
were mixed with a droplet of glucuronylsynthase (41 mg mL-1).  In the second 
reservoir, screening solutions were mixed with a droplet of glucuronylsynthase 
(41 mg mL-1) and -D-glucuronyl fluoride 51 (350 mM). In the final reservoir, 
screening solutions were mixed with glucuronylsynthase (41 mg mL-1) and p-
nitrophenyl--D-glucuronide 25 (10 mM).  Wells were covered with para-filmTM 
and stored at 4 C.   Reservoirs were examined under microscope for the 
presence of crystallisation.  Crystals were observed in the following conditions: 
Hampton Research Crystal Screen (Well B2.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM)
Conditions: 
 
calcium chloride dehydrate (0.2 M), 
Tris.HCl (0.1 M, pH 8.5), polyethylene glycol 400 (30% v/v).
Qiagen PEG Screen (Well G1.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM)
Conditions: 
 magnesium acetate (0.2 M), 
polyethylene glycol 3350 (20% w/v) 
Qiagen PEG Screen (Well H4.1) 
Contents: 
E504G (41 mg mL-1) 
Conditions: 
 
di-sodium phosphate (0.2 M),  
polyethylene glycol 3350 (20% w/v) 
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Qiagen PEG Screen (Well F8.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
magnesium formate (0.2 M), 
polyethylene glycol 3350 (20% w/v) 
Hampton Research Index Screen (Well G1.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
sodium chloride (0.2 M), Tris (0.1 M, pH 8.5), 
polyethylene glycol 3350 (25% w/v) 
Hampton Research Index Screen (Well G2.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
lithium sulfate monohydrate (0.2 M),  
bis-Tris (0.1 M, pH 5.5), polyethylene glycol 3350 (25% w/v) 
Hampton Research Index Screen (Well B6.2 + B6.3) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
(top) 
41 mg mL-1 E504G + p-nitrophenyl--D-glucuronide 25 (10 
mM) (bottom) 
Conditions: 
 
Tris (0.1 M, pH 6.9), di-potassium phosphate (0.91 M), 
mono-sodium phosphate monohydrate (0.49 M)  
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Hampton Research Index Screen (Well D8.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
HEPES (0.1 M, pH 7.5), polyethylene glycol 3350 (25% w/v)
Hampton Research Index Screen (Well D9.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
Tris (0.1 M, pH 8.5), polyethylene glycol 3350 (25% w/v) 
Hampton Research Index Screen (Well B9.1) 
Contents: 
E504G (41 mg mL-1) 
Conditions: 
 
Tri-ammonium citrate (1.8 M, pH 7.0) 
Hampton Research Index Screen (Well B9.2) 
Contents: 
E504G (41 mg mL-1) + -D-glucuronyl fluoride 51 (350 mM) 
Conditions: 
 
Tri-ammonium citrate (1.8 M, pH 7.0) 
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7.3 Synthesis of -D-glucuronyl fluoride 51 
7.3.1 1,2,3,4,6-Penta-O-acetyl -D-glucopyranoside 83211 
OAcO
OAc
AcO
OAc
OAc1
23
4
6
5
 
Acetic anhydride (100 mL, 1.06 mol) was added to D-glucose 82 (20.0 g, 
0.111 mol) and sodium acetate (16.0 g, 0.195 mol) and the solution heated to 
100 °C for 2.5 h.  The reaction was cooled to RT and poured onto ice with 
stirring to give a colourless suspension in water.  The solid was filtered, washed 
with water (1 L) and dried at the pump, then overnight over potassium 
hydroxide.  Recrystallisation from methanol yielded the title compound 83 as 
white crystals (24.4 g, 56.4%, : 1:17). 
mp 164-167C (Lit. mp 176-178C); [] +7.8 (4.5, CHCl24D 3) [lit.212 []  +4.5 
(4.6, CHCl
23
D
3)]; IR (NaCl):  2958 (m, C-H), 1747 (s, C=O), 1433, 1367, 1220, 
1078, 1039, 910 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.70 (1H, d, JH1-H2 8.2, 
H1), 5.24 (1H, t, JH1-H2≈JH2-H3 9.3, H2), 5.19-5.05 (2H, m, H3, H4), 4.28 (1H, dd, 
2JH6a-H6b 12.5, 3JH5-H6a 4.4, H6a), 4.09 (1H, dd, 2JH6a-H6b 12.5, 2JH5-H6b 1.7, H6b), 
3.84 (1H, ddd, JH4-H5 9.9, JH5-H6a 4.2, JH5-H6b 2.0, H5), 2.17-2.01 (15H, m, 5 x 
CH3); 13C NMR (300 MHz CDCl3): δ 170.7 (C=O), 170.2 (C=O), 169.5 (C=O), 
169.3 (C=O), 169.0 (C=O), 91.83 (C1), 72.9, 70.4, 70.0, 67.9, 61.6, 20.9 (2 x 
CH3), 20.7 (3 x CH3). 
7.3.2 2,3,4,6-Tetra-O-acetyl -D-glucopyranosyl fluoride 8469,213 
OAcO
FAcO
AcO
OAc
2
5
3
4
6
1
 
Hydrogen fluoride-pyridine (70%, 7.0 mL) was added to 1,2,3,4,6-penta-O-
acetyl -D-glucopyranoside 83 (3.500 g, 8.967 mmol) in dichloromethane (5.5 
mL) at RT and under nitrogen atmosphere.  The reaction was stirred for 7 h at 
RT, then poured into a solution of ether (30 mL) and aqueous potassium 
fluoride (10%, 80 mL).  The organic layer was collected and the aqueous layer 
was washed with ether: hexane (3:1, 3 x 90 mL).  The organic layers were 
combined and washed with aqueous potassium fluoride (10%, 2 x 60 mL), 
saturated sodium bicarbonate (30 mL) and then brine (30 mL).  The solvent was 
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dried over anhydrous magnesium sulphate, filtered and removed under reduced 
pressure at 40 ºC.  The residue was dissolved in minimal chloroform and 
subjected to flash chromatography (chloroform : ethyl acetate, 9:1) to yield the 
target compound 84 (2.576 g, 82%) as a white crystalline solid. 
mp 95-98 C (lit.213 mp 108 C); []  +86.0 (3.0, CHCl24D 3) [lit.213 []  +90.1 
(3.0, CHCl
20
D
3)]; Rf 0.71 (5:2 ethyl acetate : ethanol); IR (KBr powder): 2963 (C-
H), 1755 (C=O), 1370, 1224, 1162, 1043, 924, 771; 1H NMR (300 MHz, CDCl3): 
δ 5.75 (1H, dd, JH1-F 52.9, JH1-H2 2.7, H1), 5.49 (1H, t, JH3-H4≈JH4-H5 9.9, H4), 
5.15 (1H, t, JH2-H3≈JH3-H4 10.0, H3), 4.95 (1H, ddd, JH2-F 24.2, JH1-H2 2.8, JH2-H3 
10.2, H2), 4.31-4.12 (3H, m, H5, H6), 2.10 (3H, s, Ac), 2.09 (3H, s, Ac), 2.04 
(3H, s, Ac), 2.02 (3H, s, Ac); 13C NMR (75 MHz, CDCl3): δ 170.7 (C=O), 170.1 
(C=O), 170.0 (C=O), 169.5 (C=O), 103.9 (d, 1JC1-F 229.6, C1), 70.4 (d, 2JC2-F 
24.6, C2), 69.9 (d, 3JC3-F 4.2, C3), 69.6 (C5), 67.5 (C4), 61.4 (C6), 20.8 (Ac), 
20.7 (3C, 3 x Ac). 
7.3.3 -D-Glucopyranosyl fluoride 32214 
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Sodium methoxide in methanol (0.6 mL, 1 M, 0.6 mmol) was added dropwise 
to 2,3,4,6-tetra-O-acetyl--D-glucopyranosyl fluoride 84 (1.02 g, 2.91 mmol) 
dissolved in dry methanol (28.5 mL) on ice under nitrogen atmosphere.  The 
reaction was stored overnight (18 h) at 4 C then quenched by the addition of 
silica gel (4.5 g).  The solvent was evaporated at 30 ºC and the resulting 
residue dry-loaded onto a flash silica column.  Flash chromatography (ethyl 
acetate: ethanol 5:2) afforded the target compound 32 (0.512 g, 96.6%) as a 
white powder. 
 mp 190-200 C (decomp); []  +91.4 (1.0, H22D 2O) [lit.215 []  +90 (1 H25D 2O)]; 
Rf 0.40 (5:2 ethyl acetate : ethanol); IR (KBr powder): 3313 (broad, OH), 2935 
(C-H), 1344, 1236, 1167, 894, 775; 1H NMR (300 MHz, D2O): δ 5.72 (1H, dd, 
JH1-F 53.5, JH1-H2 2.8, H1), 3.92-3.37 (6H, m, H2, H3, H4, H5, H6); 13C NMR (75 
MHz, D2O): δ 107.8 (d, JC1-F 223, C1), 74.6, (C5), 72.8 (C3), 71.4 (d, 2JC2-F 25, 
C2), 69.0 (C4), 60.5 (C6). 
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7.3.4  Ammonium -D-glucopyranuronyl fluoride 51216 
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TEMPO (77 mg, 0.49 mmol) was added to -D-glucopyranosyl fluoride 32 
(1.67 g, 9.15 mmol) dissolved in MilliQ water (80 mL) on ice.  The pH was 
adjusted to ~9 before the drop wise addition of sodium hypochlorite (1 M, 18.5 
mL, 18.5 mmol).  The addition of sodium hypochlorite was maintained at a rate 
such that the reaction pH was maintained at 9.5 ± 0.5.  After the addition of 
sodium hypochlorite, the pH of the reaction was maintained at 9.5 ± 0.5 by the 
addition of sodium hydroxide (1 M) until pH was steady.  Upon completion (~3 
h), the pH was lowered to 7 by the addition hydrochloric acid (1 M), and the 
crude reaction subjected to anion-exchange chromatography (Dowex® 1x8, 
200-400, meshCl resin).  The column was eluted with MilliQ water (4 column 
volumes), then 0.1 M ammonium bicarbonate (2 column volumes), then 0.2 M 
ammonium bicarbonate until complete elution of target compound 51.  Fractions 
were combined and evaporated under reduced pressure at 30 C.  The white 
residue was stored overnight under vacuum to remove residual ammonium 
bicarbonate, resulting in the off-white powder of the target compound 51 (1.87 
g, 96%).  Rapid recrystallisation from aqueous ethanol (70%) afforded the target 
compound 51 as colourless, dendritic crystals (1.70 g, 87%). 
mp 97-150 C (decomp), []  +46.6 (c 1.1, H24D 2O); Rf 0.47 (5:2:1 ethyl 
acetate : methanol : water); IR (NaCl): 3219 (broad, OH), 1597 (CO2-), 1422 
(CO2-), 1310, 1162, 1109, 1077, 1034, 1011, 946, 880, 622; 1H NMR (300 MHz, 
D2O): δ 5.72 (1H, dd, JH1-F 53.4, JH1-H2 2.5, H1), 4.10 (1H, d, JH4-H5 10.1, H5), 
3.81-3.50 (3H, m, H2, H3, H4); 13C NMR (75 MHz, D2O): δ 176.1 (C6), 107.8, 
(d, JC2-F 223.8, C1), 74.6 (C5), 72.9 (C3), 71.7 (C4), 71.3 (C2). 
Crystals for single crystal x-ray diffraction (Figure 2.8) were grown by 
dissolving the crude product in boiling 70% aqueous ethanol, and then adding 
acetone drop wise until cloudiness was almost persistent.  The solution was 
allowed to cool slowly to room temperature before chilling at 4 C overnight. 
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7.4 Revised glucuronylsynthase reactions 
7.4.1   trans-2-Methylcyclohexyl -D-glucuronide 64 
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Glucuronylsynthase (E504G, 25 mg mL-1, 280 L, final concentration 0.40 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (187 mg, 0.877 mmol, final 
concentration 50 mM), trans-2-methylcyclohexanol 39 (100 mg, 0.876 mmol, 
final concentration 50 mM) and DMSO (876 L, final concentration 5.0% v/v) in 
sodium phosphate buffer (100 mM, 16.36 mL, pH 7.5).  The reaction was 
swirled continuously (100 rpm) under ambient conditions for 4 days then dried 
onto silica.  The residue was subjected to flash chromatography (ethyl acetate : 
methanol : water, 7:2:1) to obtain the glucuronide product 64 as a mixture of 
diastereomers (103.4 mg, 40.7%). 
mp decomposes; [] 20D  -59 (c 0.78, MeOH); Rf 0.37 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3358 (broad, OH), 2928 (C-H), 2857 (C-H), 1605 
(CO2H), 1418 (CO2H), 1376, 1297, 1167, 1038; 1H NMR (800 MHz, MeOD): δ 
4.40 (2H, d, JH1-H2 7.8, H8), 3.77 (1H, d, JH11-H12 9.8, H5 minor isomer), 3.75 
(1H, d, JH11-H12 9.8, H5 major isomer), 3.55 (1H, t, J 9.4, major isomer), 3.52 
(1H, t, J 9.5, minor isomer), 3.40 (1H, t, J 9.2, major isomer), 3.55 (1H, 
obstructed, minor isomer),  3.26-3.20 (3H, m), 3.12 (1H, m, minor isomer), 2.11 
(1H, m, minor isomer), 2.06 (1H, m, major isomer), 1.80-1.68 (4H, m), 1.60 (2H, 
m), 1.50-1.39 (2H, m), 1.34-1.15 (6H, m), 1.05 (3H, d, JH6-H7 6.4, H7 minor 
isomer), 1.02 (2H, obstructed), 0.98 (3H, d, JH6-H7 6.6, H7 major isomer); 13C 
NMR (75 MHz, D2O): 176.3 (C6), 100.0 (C1), 84.3 (C1’), 76.7, 76.4, 73.6, 72.5, 
37.7, 33.9, 31.6, 25.4, 24.9, 18.8 (C7’); LRMS (+ESI) m/z: 959 ([3M-3H+4Na]+, 
52.5), 647 ([2M-2H+3Na]+, 100), 335 ([M-H+2Na]+, 51.5), 313 ([M+Na]+, 17); 
HRMS (+ESI) m/z: 335.1081 ([M-H+2Na]+, C13H21O7Na2+ gives 335.1078); 
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7.4.2   cis-2-Methylcyclohexyl -D-glucuronide 65 
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Glucuronylsynthase (E504G, 27 mg mL-1, 60 L, final concentration 0.2 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (104 mg, 0.488 mmol, final 
concentration 59.5 mM), cis-2-methylcyclohexanol 38 (50 L, 46.8 mg, 0.410 
mmol, final concentration 50 mM) and DMSO (820 L, final concentration 
10.0% v/v) in sodium phosphate buffer (100 mM, 7.27 mL, pH 7.5).  The 
reaction was swirled continuously (100 rpm) under ambient conditions for 4 
days then dried onto silica.  The residue was subjected to flash chromatography 
(ethyl acetate : methanol : water, 7:2:1) to obtain the glucuronide product 65 as 
a mixture of diastereomers (71.3 mg, 59.9%). 
mp decomposes; Rf 0.15 (7:2:1 ethyl acetate : methanol : water); IR (neat): 
3370 (broad, OH), 2928 (C-H), 2863 (C-H), 1607 (CO2H), 1416 (CO2H), 1376, 
1298, 1163, 1028, 935; 1H NMR (300 MHz, D2O): δ 4.55 (1H, m, H8), 3.90 (1H, 
m, H12), 3.90 (1H, m, H11), 3.60-3.45 (2H, m, H10, H1), 3.45-3.25 (1H, m, H9), 
2.1-1.2 (10H, m, H2-H6), 0.96 (3H, d, JH2-H7 6.9, H7); 13C NMR (75 MHz, D2O): 
176.4 (C13), 100.7 (C8), 80.2 (C1), 76.7, 76.3, 73.5, 72.5, 34.7, 30.1, 27.7, 
23.1, 22.2, 15.5 (C7); LRMS (+ESI) m/z: 959 ([3M-3H+4Na]+, 74), 647 ([2M-
2H+3Na]+, 100), 335 ([M-H+2Na]+, 46), 313 ([M+Na]+, 10); HRMS (+ESI) m/z: 
335.1076 ([M-H+2Na]+, C13H21O7Na2+ gives 335.1078); 
7.4.3   trans-4-Methylcyclohexyl -D-glucuronide 66 
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Glucuronylsynthase (E504G, 27 mg mL-1, 52 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (45 mg, 0.21 mmol, final 
concentration 30 mM), trans-4-methylcyclohexanol 41 (22 L, 20 mg, 0.18 
mmol, final concentration 26 mM) and DDM (39 mg, final concentration 0.56% 
w/v) in sodium phosphate buffer (100 mM, 6.95mL, pH 7.5).  The reaction was 
swirled continuously (100 rpm) under ambient conditions for 4 days then dried 
onto silica.  The residue was subjected to flash chromatography (ethyl acetate : 
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methanol : water, 7:2:1) to obtain the glucuronide product 66 as a mixture of 
diastereomers (71.3 mg, 59.9%). 
mp decomposes; [] 19  -72 (c 0.52, MeOH); RD f 0.28 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3358 (broad, OH), 2948 (C-H), 2926 (C-H), 2866 
(C-H), 1607 (CO2H), 1451, 1418 (CO2H), 1372, 1297, 1162, 1107, 1034, 941, 
890; 1H NMR (300 MHz, D2O): δ 4.60 (1H, d, JH6-H7 8.0, H6), 3.81-3.68 (2H, m, 
H10, H1), 3.53 (1H, m, H9), 3.50 (1H, m, H8), 3.27 (1H, m, H7), 2.04 (2H, m, 
H2), 1.74 (2H, m, H2), 1.44-1.21 (3H, m, H3, H4), 1.07-0.94 (2H, m, H3), 0.88 
(3H, d, JH4-H5 6.5, H5); 13C NMR (75 MHz, D2O): 176.4 (C11), 100.8 (C6), 79.9 
(C10), 76.8, 76.3, 73.6, 72.5, 33.5, 33.4, 33.2, 32.0, 31.9 (C4), 21.8 (C5); LRMS 
(+ESI) m/z: 647 (100), 641 (79.5), 393 (81), 335 ([M-H+2Na]+, 56), 313 
([M+Na]+, 43); HRMS (+ESI) m/z: 313.1267 ([M+Na]+, C13H22O7Na+ gives 
313.1258). 
7.4.4 Benzyl -D-glucuronide 6957 
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Glycosynthase (E504G, 27 mg mL-1, 41 L, final concentration 0.20 mg mL-1) 
was added to -D-glucuronyl fluoride 51 (72 mg, 0.33 mmol, final concentration 
59 mM), benzyl alcohol 46 (30 mg, 0.28 mmol, final concentration 50 mM) in 
sodium phosphate buffer (100 mM, 5.51 mL, pH 7.5).  The reaction was swirled 
continuously under ambient conditions for 4 days then dried onto silica.  The 
residue was subjected to flash chromatography (ethyl acetate : methanol : 
water, 7:2:1) to obtain benzyl -D-glucuronide 69 (46 mg, 58%) as a white 
powder. 
mp decomposes; []  -89 (c 0.53, MeOH); R20D f 0.19 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3389 (broad, O-H), 2892 (C-H), 1605 (C=O), 1418, 
1370, 1285, 1158, 1046, 946, 795, 737, 701; 1H NMR (400 MHz, MeOD): δ 
7.47-7.23 (5H, m, H2-4), 5.00 (1H, d, 2JH5a-H5b 11.6, H5a), 4.66 (1H, d, JH5a-H5b 
12.0, H5b), 4.38 (1H, d, JH6-H7 7.6, H6), 3.62  (1H, d, JH9-H10 9.6, H10), 3.49 (1H, 
t, JH8-H9≈JH9-H10 9.2, H9), 3.41 (1H, t, JH7-H8≈JH8-H9 9.0, H8), 3.50-3.27 (1H, 
obscured, H7); 13C NMR (75 MHz, D2O): 176.3 (Cq, C11), 137.2 (Cq, C1), 
129.4 (2 x CH), 129.3 (2 x CH), 129.0 (CH, C4), 101.6 (CH, C6), 76.6 (CH, 
C20), 76.2 (CH), 73.6 (CH), 72.4 (CH), 71.9 (CH2, C5); LRMS (+ESI) m/z: 941 
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([3M-3H+4Na]+, 100), 635 ([2M-2H+3Na]+, 95), 329 ([M-H+2Na]+, 31); HRMS 
(+ESI) m/z: 329.0602 ([M-H+2Na]+, C13H15O7Na2 gives 329.0608). 
7.4.5   3-Methoxybenzyl -D-glucuronide 71 
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Glycosynthase (E504G, 14.5 mg mL-1, 50 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (77 mg, 0.36 mmol, final 
concentration 100 mM), 3-methoxybenzyl alcohol 47 (50 mg, 0.36 mmol, final 
concentration 100 mM) in sodium phosphate buffer (100 mM, 3.57 mL, pH 7.5).  
The reaction was swirled continuously under ambient conditions for 4 days then 
dried onto silica.  The residue was subjected to flash chromatography (ethyl 
acetate : methanol : water, 7:2:1) to obtain benzyl -D-glucuronide 71 (73 mg, 
64%) as a white powder. 
mp decomposes; []  -72 (c 1.0, MeOH); R20D f 0.19 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3355 (broad, OH), 2914 (C-H), 1597 (CO2H), 1433 
(CO2H), 1267, 1157, 1038; 1H NMR (300 MHz, MeOD): δ 7.22 (1H, t, JH4-
H5≈JH5-H6 7.8, H5), 7.05 (1H, d, 2JH2-H4 1.8, H2), 6.97 (1H, d, JH5-H6 7.5, H6), 6.82 
(1H, dd, JH4-H5 8.0, JH2-H4 2.3, H4), 4.95 (1H, d, 2JH7-H7 12.0, H7), 4.65 (1H, d, 
2JH7-H7 12.0, H7), 4.38 (1H, d, JH9-H10 7.8, H9), 3.79 (3H, s, H8), 3.63 (1H, d, 
JH12-H13 9.3, H13), 3.50 (1H, t, H12), 3.42 (1H, t, H11), 3.35-3.23 (1H, obscured 
by solvent peak, H10); 13C NMR (75 MHz, MeOD): 176.7 (C14), 161.2 (C3), 
140.6 (C1), 130.2 (C5), 121.3 (C6), 114.5, 114.4, 103.3 (C9), 77.8, 76.2 (C13), 
74.9, 73.7, 71.7 (C7) 55.7 (C8); LRMS (-ESI) m/z: 649 ([2M-2H+Na]-, 12), 627 
([2M-H]-, 10.5), 313 ([M-H]-, 100); HRMS (+ESI) m/z: 359.0699 ([M-H+2Na]+, 
C14H17O8Na2+ gives 359.0713), 337.0898 ([M+Na]+, C14H18O8Na+ gives 
337.0894); HRMS (-ESI) m/z: 313.0920 ([M-H]-, C14H17O7- gives 313.0929). 
7.4.6    4-Fluorobenzyl -D-glucuronide 7357 
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Glucuronylsynthase (E504G, 27 mg mL-1, 47.0 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (41 mg, 0.19 mmol, final 
concentration 30 mM), 4-fluorobenzyl alcohol 50 (20 mg, 0.16 mmol, final 
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concentration 25 mM) and n-dodecyl -maltoside (32 mg, final concentration 
0.5% w/v) in sodium phosphate buffer (50 mM, 6.34 mL, pH 7.5).  The reaction 
was swirled continuously under ambient conditions for 4 days then dried onto 
silica.  The residue was subjected to flash chromatography (ethyl acetate : 
methanol : water, 7:2:1) to obtain the glucuronide product 73 (24.1 mg, 50%) as 
a white powder. 
mp decomposes; []  -91 (c 0.52, MeOH); R20D f 0.24 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3362 (broad, O-H), 2887 (C-H), 1605 (C=O), 1512, 
1418, 1367, 1292, 1227, 1155, 1038, 947, 827; 1H NMR (300 MHz, D2O): δ 
7.50 (2H, dd, 3JH2-H3 8.3, 2JH2-F 5.9, H2), 7.19 (2H, t, 4JH3-F≈3JH2-H3 8.9, H2), 4.95 
(1H, d, 2JH5a-H5b 11.7, H5a), 4.73 (1H, d, 2JH5a-H5b 11.7, H5b), 4.54 (1H, d, JH6-H7 
8.1, H6), 3.73 (1H, d, JH9-H10 9.0, H10), 3.53 (2H, m, H8, H9), 3.36 (1H, t, JH7-
H8≈JH6-H7 8.3, H7); 13C NMR (100 MHz, MeOD): 176.9 (Cq, C11), 163.8 (Cq, d, 
1JC4-F 244.0, C4), 135.2 (Cq, d, 4JC1-F 2.8, C1), 131.2 (2xCH, d, 3JC2-F 8.0, C2), 
115.9 (2xCH, d, 2JC3-F 21.5, C3), 103.3 (CH, C6), 77.8 (CH, C8), 76.0 (CH, 
C10), 74.9 (CH, C7), 73.7 (CH, C9), 71.1 (CH2, C5); LRMS (+ESI) m/z: 671 
([2M-2H+3Na]+, 100), 347 ([M-H+2Na]+, 73); HRMS (+ESI) m/z: 347.0519 ([M-
H+2Na]+, C13H14FO7Na2 gives 347.0514). 
7.4.7 4-Methoxybenzyl -D-glucuronide 7257 
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Glycosynthase (E504G, 27 mg mL-1, 42.9 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (37 mg, 0.17 mmol, final 
concentration 29 mM), 4-methoxybenzyl alcohol 48 (20 mg, 0.14 mmol, final 
concentration 26 mM) and n-dodecyl -maltoside (119 mg, final concentration 
2.1% w/v) in sodium phosphate buffer (50 mM, 5.79 mL, pH 7.5).  The reaction 
was swirled continuously under ambient conditions for 4 days then dried onto 
silica.  The residue was subjected to flash chromatography (ethyl acetate : 
methanol : water, 7:2:1) to obtain 4-methoxybenzyl -D-glucuronide 72 (20 mg, 
45%) as a white powder. 
 mp decomposes; [] 20  -90 (c 0.56, MeOH); RD f 0.22 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3360 (broad, O-H), 2909 (C-H), 2838 (C-H), 1613 
(C=O), 1514, 1416, 1368, 1302, 1250, 1158, 1032, 822; 1H NMR (300 MHz, 
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D2O): δ 7.45 (2H, d, JH2-H3 8.4, H2), 7.05 (2H, d, JH2-H3 8.7, H3) 4.92 (1H, d, 
2JH5a-H5b 11.4, H5a), 4.69 (1H, d, 2JH5a-H5b 11.1, H5b), 4.52 (1H, d, JH7-H8 7.8, 
H7), 3.87 (3H, s, H6), 3.72 (1H, d, JH10-H11 9.2, H11), 3.52 (2H, m, H9, H10), 
3.35 (1H, t, JH8-H9≈JH7-H8 8.1, H8); 13C NMR (75 MHz, D2O): 176.3 (Cq, C12), 
159.5 (Cq, C4), 131.2 (2 x CH, C2), 129.8 (Cq, C1), 114.7 (2 x CH, C3), 101.4 
(CH, C7), 76.7 (CH, C11), 76.3 (CH), 73.6 (CH), 72.5 (CH), 71.5 (CH2, C5), 
56.0 (CH3, C6); LRMS (+ESI) m/z: 714 (100), 695 ([2M-2H+3Na]+, 47), 359 ([M-
H+2Na]+, 17.5); HRMS (+ESI) m/z: 359.0705 ([M-H+2Na]+, C14H17O8Na2 gives 
359.0714). 
7.4.8   1-Napthalenemethyl -D-glucuronide 7557 
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Glycosynthase (E504G, 33 mg mL-1, 65 L, final concentration 0.20 mg mL-1) 
was added to -D-glucuronyl fluoride 51 (32 mg, 0.15 mmol, final concentration 
14 mM), 1-naphthalenemethanol 43 (21 mg, 0.13 mmol, final concentration 12 
mM) and n-dodecyl -maltoside (107 mg, final concentration 1% w/v) in sodium 
phosphate buffer (50 mM, 10.7 mL, pH 7.5).  The reaction was swirled 
continuously under ambient conditions for 4 days then dried onto silica.  The 
residue was subjected to flash chromatography (ethyl acetate : methanol : 
water, 7:2:1) to obtain 1-O-(1’-napthalenemethyl) -D-glucopyranuronic acid 75 
(21 mg, 48%) as a white powder. 
mp decomposes; []  -65 (c 0.63, MeOH); R20D f 0.30 (7:2:1 ethyl acetate : 
methanol : water); IR (neat): 3370 (broad, O-H), 3050 (C-H), 2922 (C-H), 1613 
(C=H), 1422, 1289, 1169, 1063, 1034, 946, 793, 777; 1H NMR (300 MHz, D2O): 
δ 8.15 (1H, d, J 7.8), 7.99-7.84 (2H, m), 7.68-7.44 (4H, m), 5.33 (1H, d, 2JH11a-
H11b 11.7, H11a),  5.04 (1H, d, 2JH11a-H11b 11.7, H11b), 4.50 (1H, d, JH12-H13 7.8, 
H12), 3.71 (1H, d, JH15-H16 9.6, H16), 3.56 (1H, t, JH14-H15≈JH15-H16 7.2, H15), 
3.45 (1H, t, JH13-H14≈JH14-H15 9.0, H14), 3.34 (1H, t, JH12-H13≈JH13-H14 8.6, H13); 
13C NMR (75 MHz, D2O): 176.4 (C17), 134.0 (C1), 132.5 (Cq), 132.0 (Cq), 
129.9 (CH), 129.1 (CH), 128.7 (CH), 127.3 (CH), 126.8 (CH), 126.1 (CH), 124.6 
(CH), 101.5 (C12), 76.7 (C16), 76.2 (C14), 73.5 (C13), 72.4 (C15), 70.0 (C11); 
LRMS (+ESI) m/z: 735 ([2M-2H+3Na]+, 100), 379 ([M-H+2Na]+, 55), 356 
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([M+Na]+, 20); HRMS (+ESI) m/z: 379.0762 ([M-H+2Na]+, C17H17O7Na2 gives 
379.0765). 
7.4.9 Phenyl -D-glucuronide 7657 
OHO
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O
O
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Glycosynthase (E504G, 1.35 mg mL-1, 4.89 mL, final concentration 0.50 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (113 mg, 0.53 mmol, final 
concentration 40 mM), phenol 52 (50 mg, 0.53 mmol, final concentration 40 
mM) in sodium phosphate buffer (100 mM, 4.89 mL pH 7.5).  The reaction was 
incubated at 30 C without agitation for 3 days then acidified to pH 2 and dried 
onto reverse-phase flash silica.  The residue was subjected to reverse-phase 
flash chromatography (18% aqueous acetonitrile + 0.1% acetic acid) to obtain 
phenyl -D-glucopyranuronic acid 76 (61 mg, 43%) as a white powder. 
mp 158-160 C (lit. 160-161 C)217; []  -78.4 (c 1.9, MeOH) [lit. [] 20  -87.5 
(c 2.10, H
20
D D
2O)]217; Rf 0.27 (7:2:1 ethyl acetate : methanol : water); IR (NaCl): 
3351 (broad, OH), 2922 (C-H), 1601 (C=O), 1495, 1416, 1295, 1229, 1109, 
1063, 755, 693; 1H NMR (400 MHz, D2O+AcOH spike): δ 7.38 (2H, t, J 8.0), 
7.17-7.06 (3H, m), 5.10 (1H, d, JH5-H6 7.0, H5), 3.86 (1H, d, JH8-H9 9.1, H9), 
3.64-3.53 (3H, m, H2-H4); 13C NMR (100 MHz, D2O+AcOH spike):  173.4 
(C10), 154.6 (C1), 127.9 (2C, C3), 121.3 (C4), 114.6 (2C, C2), 98.1 (C5), 74.2, 
73.3, 70.7, 69.7; LRMS (+ESI) m/z: 899 ([3M-3H+4Na]+, 76), 607 ([2M-
2H+3Na]+, 88), 315 ([M-H+2Na]+, 100); HRMS (+ESI) m/z: 315.0446 ([M-
H+2Na]+, C12H13O7Na2 gives 315.0452). 
7.5 Large scale glucuronylsynthase reaction 
7.5.1  Large scale synthesis of 2-phenylethyl -D-glucuronide 6857 
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Glycosynthase (E504G, 27 mg mL-1, 185 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (0.63 g, 3.0 mmol, final 
concentration 120 mM), 2-phenylethanol 45 (0.30 g, 2.5 mmol, final 
concentration 100 mM) in sodium phosphate buffer (100 mM, 24.8 mL, pH 7.5).  
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The reaction was swirled continuously under ambient conditions for 4 days then 
dried onto silica.  The residue was subjected to flash chromatography (ethyl 
acetate : methanol : water, 7:2:1) to obtain 2-phenylethyl -D-glucuronide 68 
(718 mg, 96%) as a white powder.  Characterisation data was identical to 
previously characterised material. 
Rf 0.22 (ethyl acetate : methanol : water, 7:2:1); 1H NMR (300MHz, D2O): δ 
7.47-7.28 (5H, m, H4-H6), 4.49 (1H, d, JH7-H8 8.1, H7), 4.20, (1H, dt, 2JH1a-H1b 
10.2, 3JH1a-H2 6.9, H1a), 3.94 (1H, dt, 2JH1a-H1b 10.2, 3JH1b-H2 7.0, H1b), 3.70 (1H, 
m, H11), 3.53 (1H, m, H10), 3.50 (1H, m, H9), 3.30 (1H, m, H8), 3.00 (2H, t, 
JH1-H2 6.9, H2); 13C NMR (75 MHz, D2O): 176.4 (Cq, C12), 139.4 (Cq, C3), 
129.7 (2xCH), 129.3 (2xCH), 127.2 (CH, C6), 102.7 (CH, C7), 76.7 (CH, C11), 
76.2 (CH), 73.5 (CH), 72.4 (CH), 71.3 (CH2, C1), 35.7  (CH2, C2). 
7.6 Kinetic resolution of racemic trans-2-
methylcyclohexanol 39 
7.6.1  Glucuronylsynthesis of trans-2-methylcyclohexanol 3957 
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trans-2-Methylcyclohexanol 39 (50 mg, 0.44 mmol, final concentration 50 mM) 
and -D-glucuronyl fluoride 51 (93 mg, 0.44 mmol, final concentration 50 mM) 
were dissolved in 100 mM sodium phosphate buffer (100 mM, 8.3 mL, pH 7.5) 
and DMSO (400 L, final concentration 4.5% v/v).  Glucuronylsynthase (32.6 
mg mL-1, 53.7 L, final concentration 0.2 mg mL-1) was added to the solution 
and the mixture was swirled (120 rpm) at RT for 7 d.  The unreacted alcohol 
was extracted from the crude reaction with ethyl acetate (3 x 20 mL), and 
washed with saturated sodium bicarbonate (20 mL).  The organic layer was 
dried over sodium sulphate and evaporated to dryness under weak vacuum 
(>100 mm Hg, 30 C) to reclaim crude unreacted trans-2-methylcyclohexanol 
39 (23 mg, 46%) as a colourless oil. 
The aqueous crude reaction layer and sodium bicarbonate washes were 
combined and silica (~0.5 g) was added.  The water was removed under 
reduced pressure (40 C) and the resulting white residue was dry loaded on top 
of a flash silica column.  Ethyl acetate : methanol (5:2) was used to elute the 
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DMSO, then ethyl acetate : methanol : water (7:2:1) was used to elute the target 
compound.  Removal of the solvent by evaporation yielded trans-2-
methylcyclohexyl -D-glucuronide 64 (44 mg, 34%) as a mixture of 
diastereomers. 
Spectra was identical to previously synthesised material (refer to section 
7.4.1). 
7.6.2 Enzymatic hydrolysis of the trans-2-methylcyclohexyl -D-glucuronide 64 
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39  
trans-2-Methylcyclohexyl -D-glucuronide 64 (44 mg, 0.15 mmol) was 
dissolved in sodium phosphate buffer (100 mM, 1 mL, pH 7.5) and wild-type -
D-glucuronidase (1.2 mg mL-1, 200 L, final concentration 0.2 mg mL-1) was 
added.  The reaction was swirled (150 rpm) under ambient conditions until 
complete hydrolysis was observed (2 h) by TLC (ethyl acetate: methanol : 
water, 7:2:1). 
The free alcohol was extracted with ethyl acetate (3 x 5 mL), washed with 
sodium hydroxide (1 M, 5 mL), and dried over sodium sulphate.  The solvent 
was removed under gentle vacuum (>100 mm Hg, 30 C) to yield trans-2-
methylcyclohexanol 39 (11.7 mg, 68%) as a colourless oil. 
7.6.3  General Mosher’s esterification procedure71 
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Freshly distilled oxalyl chloride (4 mmol) was added to a stirring solution of 
(R)-(+)--methoxy--(trifluoromethyl)phenylacetic acid (3.9 mmol) in 
dichloromethane (15 mL) on ice.  Dimethylformamide was added drop wise until 
effervescence commenced and the reaction was warmed to RT and stirred for a 
further 30 min. 
This solution was then transferred via cannula (14 mL dichloromethane 
washing) to a stirred solution of trans-2-methylcyclohexanol 39 (1 mmol), 
diisopropylethylamine (8 mmol) and 4-N’,N’-dimethylaminopyridine (1 mmol) in 
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dichloromethane (15 mL).  The reaction was stirred at RT until complete 
consumption was observed (18 h) by TLC analysis (ethyl acetate : hexane, 
1 : 19).  The reaction was quenched with saturated sodium bicarbonate (275 
mL) and extracted with diethyl ether (3 x 275 mL).  The organic extracts were 
combined and washed with brine (275 mL), dried over anhydrous magnesium 
sulphate, filtered, and concentrated under reduced pressure to a colourless oil.  
The crude oil was subjected to flash chromatography (ethyl acetate : hexane, 
1:19) to yield the pure trans Mosher esters 86. 
1H NMR (300 MHz, CDCl3): δ 7.73-5.33 (10H, m, H13-H15), 5.35-5.12 (2H, 
m, H1), 3.69-3.46 (6H, m, H10), 2.12-1.87 (2H, m, H2), 1.86-1.15 (16H, m, H3-
H6), 0.94 (3H, d, JH2-H7 6.4, H7), 0.78 (3H, d, JH2-H7 6.5, H7); 13C NMR (75 MHz, 
CDCl3)75: δ 166.0 (C8), 165.9 (C8), 132.3 (C12), 132.1 (C12), 129.2 (2C, s, 
C15), 128.04 (C14), 128.01 (C14), 127.1 (C13), 126.90 (C13), 123.13 (d, JC11-F 
287, C11), 123.07 (d, JC11-F 287, C11), 81.3 (C1), 81.2 (C1), 76.5 (2C, d, 3JC9-F 
34, C9), 55.2 (C10), 55.1 (C10), 36.5 (C2), 35.3 (C2), 33.14 (C6), 33.08 (C6), 
31.2 (C3), 30.6 (C3), 24.77 (C4), 24.67 (C4), 24.30 (C5), 24.16 (C5), 18.3 (C7), 
17.9 (C7). 
7.6.4  Determination of the diastereomeric ratio 
Analytical normal-phase HPLC was used to determine the diastereomeric 
ratio using a Waters Sunfire column (5 M, 4.4 x 150 mm) and an ethyl 
acetate : hexane (0.2% v/v, 0.5 mL min-1) solvent system.  The column module 
was heated at 30 C and the detection of the trans Mosher esters 86 (11.7 min 
and 12.2 min) was measured by UV (A260nm).  Peak areas were determined 
using Empower 2 software. 
7.6.5  Mosher’s esterification on the starting material 
The general procedure (refer to section 7.6.3) was used with commercially 
supplied trans-2-methylcyclohexanol 39 (25 mg, 0.22 mmol) to generate the (2-
methylcyclohexyl) (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 86 (61 mg, 
84%).  Ratio of diastereomers was 1.0 : 1.1 by HPLC, equating to 4.8% ee. 
7.6.6  Mosher’s esterification on the hydrolysed glucuronide product 
The general procedure (refer to section 7.6.3) was used with trans-2-
methylcyclohexanol 39 (12 mg, 0.11 mmol) obtained from 4.3.2 to generate the 
(2-methylcyclohexyl) (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate 86 (4.0 
mg, 11%).  Ratio of diastereomers was 1.0 : 13.2 by HPLC, equating to 86% ee. 
222 
Experimental 
7.7 1H NMR assay 
7.7.1  1H NMR General 
NMR spectra were taken with a Bruker Avance 800 instrument (800.1 MHz for 
1H).  Kinetic experiments were run simultaneously through the use of an 
autosampler and conducted at room temperature (21 ± 1 C).  A “Jump and 
Return” sequence103 was used with a delay d2 of 160 s. 
The baseline was corrected at the regions 5.9-5.4 ppm (anomeric proton of -
D-glucuronyl fluoride 51), 4.5-4.3 ppm (anomeric proton of the glucuronide 
product 68) and 3.1-2.7 ppm (benzylic protons of 2-phenylethanol 45 and the 
glucuronide product 68). 
7.7.2  1H NMR Michaelis-Menten kinetics of -D-glucuronyl fluoride 51 
Glucuronylsynthase (32.6 mg mL-1, 15.3 L, final concentration 1.0 mg mL-1) 
was added to 2-phenylethanol 45 (final concentration 100 mM), deuterium oxide 
(final concentration 10% v/v) and -D-glucuronyl fluoride 51 (final 
concentrations 2.4 mM, 12 mM, 24 mM, 60 mM, 119 mM, 239 mM, and 500 
mM) pre-incubated at 21 C in sodium phosphate buffer (50 mM, 485 L, pH 
7.5).  The reaction was immediately subjected to 1H NMR analysis.  Seven 
scans were made to monitor the initial velocity of the reactions at 22.5 min 
intervals on average (Figure 3.4).  Data points (minimum 4 points, 0.6-15% 
conversion) that encompassed the initial linear velocity were used to plot initial 
velocities against the -D-glucuronyl fluoride 51 concentration to provide the 
Michaelis-Menten plot (Figure 3.5).  The result from the reaction with -D-
glucuronyl fluoride 51 at 2.4 mM was not used due to the reaction reaching 23% 
conversion at the second data point. 
7.7.3  1H NMR Michaelis-Menten kinetics of 2-phenylethanol 45 
Glucuronylsynthase (32.6 mg mL-1, 18 L, final concentration 1.0 mg mL-1) 
was added to -D-glucuronyl fluoride 51 (final concentration 100 mM), 
deuterium oxide (final concentration 10% v/v) and 2-phenylethanol 45 (final 
concentrations 1 mM, 5 mM, 10 mM, 25 mM, 50 mM, 77 mM, and 104 mM) pre-
incubated at 21 C in sodium phosphate buffer (50 mM, 482 L, pH 7.5).  The 
reaction was immediately subjected to 1H NMR analysis.  Eight scans were 
made to monitor the initial velocity of the reactions at 18.7 min intervals on 
average (Figure 3.6).  Data points (8 points, 1.8-3.5% conversion) that 
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encompassed the initial linear velocity were used to plot initial velocities against 
the 2-phenylethanol 45 concentration to provide the Michaelis-Menten plot 
(Figure 3.7). 
7.8  Isothermal titration calorimetry (ITC) assay 
7.8.1  Isothermal titration calorimetry for -D-glucuronyl fluoride 51 
Isothermal microcalorimetry experiments were performed on a MicroCal VP-
ITC® microcalorimeter and were conducted at 21 C with each titration 
consisting of 59 successive injections (1 × 0.5 L, 60 × 5 L) of a degassed 
solution of -D-glucuronyl fluoride 51 (3 mM) in sodium phosphate buffer (100 
mM, pH 7.5).  The titrant was injected into a thermostatted reaction cell 
containing a known volume (1.44 mL) of the E504G (50 M) in identical 
degassed buffer. Injection duration was 5.4 s every 240 s and the solutions 
were stirred at 300 rpm. Independent heat of dilution experiments were 
conducted and used to correct the binding experiments.  The equilibrium 
constant (KA) of 1130 M-1 was obtained which equates to a dissociation 
constant (KD) of 0.88 mM.  The experiment was repeated with -D-glucuronyl 
fluoride 51 (6.7 mM) and E504G (125 M) to obtain a KA of 780 M-1 equating to 
KD of 1.3 mM. 
7.8.2  Isothermal titration calorimetry for 2-phenylethyl -D-glucuronide 68 
Isothermal microcalorimetry experiments were performed on a MicroCal VP-
ITC® microcalorimeter and were conducted at 21 C with each titration 
consisting of 59 successive injections (1 × 0.5 L, 60 × 5 L) of a degassed 
solution of 2-phenylethyl -D-glucuronide 68 (1 mM) in sodium phosphate buffer 
(100 mM, pH 7.5).  The titrant was injected into a thermostatted reaction cell 
containing a known volume (1.44 mL) of the E504G (50 M) in identical 
degassed buffer. Injection duration was 5.4 s every 240 s and the solutions 
were stirred at 450 rpm. Independent heat of dilution experiments were 
conducted and used to correct the binding experiments.  An equilibrium 
constant (KA) could not be determined from this experiment.  The experiment 
was repeated with 2-phenylethyl -D-glucuronide 68 (10 mM and 100 mM) and 
E504G (50 M) with no equilibrium constant resulting. 
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7.9 HPLC-UV assay 
7.9.1  HPLC general 
Enzyme kinetics was directly and continuously monitored by HPLC using a 
Waters Alliance E2695 Separations Module equipped with thermostatted 
autosampler and a Waters 2998 Photodiode Array detector.  Reaction injections 
(25 L unless otherwise stated) were resolved on a Waters XterraMS C18 5 m 
column (2.1 x 150 mm) using an acetonitrile : sodium phosphate buffer (100 
mM, pH 2.0) mobile phase.  The column module was heated at 30 ºC whilst the 
sample compartment was kept at 21 ºC unless otherwise stated.  Detection of 
product glucuronide was measured at 211 nm unless otherwise stated.  
Reactions were performed in sodium phosphate buffer (100 mM, pH 7.5) unless 
otherwise stated. Reactions rates were extrapolated using Empower 2 software 
and data analysis was performed with Microsoft Excel and Kleidograph 4.0.2. 
7.9.2  Internal Standard Screen 
Compounds trialled as potential internal standards include 1-naphthoic acid 
132, 2-naphthoic acid 133, naphthalenamine 134, N-phenylnaphthalen-2-amine 
135, 1,2-naphthoquinone-4-sulfonic acid 90, 2,6-diacetoxynaphthalene 136, 
2,6-naphthalenedisulfonic acid 137, 2,3-dimethylbenzoic acid 138, 3,5-
dimethylbenzoic acid 139, 4-ethylbenzoic acid 140, 4-propylbenzoic acid 141, 
4-tert-butylbenzoic acid 142, 2-acetylbenzoic acid 143, 2-methoxybenzoic acid 
91, 4-methoxybenzoic acid 92, 3,4-dimethoxybenzoic acid 93, 2-nitrobenzoic 
acid 94, 3-nitrobenzoic acid 95, and 4-nitrobenzoic acid 144.  The compound 
(~1 mg) was added to sodium phosphate buffer (50 mM, 1 mL, pH 7.5) and 
sonicated (5 min, 30 C) before being filtered (0.45 m membrane) into a HPLC 
vial.  Samples were subjected to the reported HPLC conditions (refer to section 
7.9) using a mobile phase of 23% acetonitrile in sodium phosphate buffer (100 
mM, pH 2.0).  Their retention times and λmax are reported in Table 7.1. 
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Table 7.1 Library of compounds to potentially use as an internal standard for monitoring 
the glucuronylsynthesis of 2-phenylethanol 45 via HPLC. 
Compound Structure 
Retention 
time (min) λmax (nm) 
solvent front N/A ~2  
2-phenylethyl -D-glucuronide 68 OHO
HO
HO
OH
O
O
 
4.2 260 
2-phenylethanol 45 
HO  
7.2 260 
1-naphthoic acid 132 
OHO
 
32.1 217, 294 
2-naphthoic acid 133 OH
O
 
37.7 236, 281 
naphthalenamine 134 
NH2
 
2.0 221, 285 
N-phenylnaphthalen-2-amine 135 
H
N
 
2.0 & 3.0 227, 275 
1,2-naphthoquinone-4-sulfonic 
acid 90 
SO3H
O
O
 
2.5 252, 361 
2,3-dimethylbenzoic acid 138 OH
O
 
19.7 254, 281 
3,5-dimethylbenzoic acid 139 
OH
O
 
31.0 239, 287 
4-ethylbenzoic acid 140 
OH
O
 
30.7 241 
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Compound Structure 
Retention 
time (min) λmax (nm) 
4-propylbenzoic acid 141 
OH
O
 
75.9 241 
4-tert-butylbenzoic acid 142 
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2-acetylbenzoic acid 143 OH
OO
 
4.7 232, 272 
2-methoxybenzoic acid 91 OH
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1.8 225, 275 
7.9.3  Effect of internal standard 
A solution of 2-phenylethanol 45 (final concentration 100 mM) and -D-
glucuronyl fluoride 51 (final concentration 100 mM) in sodium phosphate buffer 
Experimental 
(100 mM, pH 7.5) was divided (1460 L each) into two separate vials.  To the 
first vial (the control), sodium phosphate buffer (100 mM, 20 L, pH 7.5) was 
added.  To the second vial (internal standard), 2-methoxybenzoic acid 91 (75 
mM) in sodium phosphate buffer (100 mM, 20 L, pH 7.5) was added.  
Glucuronylsynthase (15 mg mL-1, 20 L) was added to each vial and the 
reaction rate monitored by the HPLC assay (refer to section 7.9) at 22 min 
intervals over 27 h (~ 6% conversion).  A mobile phase of 23% acetonitrile in 
sodium phosphate buffer (100 mM, pH 2.0) provided a retention time of 4.8 min 
for 2-phenylethanol 45 and 5.8 min for 2-methoxybenzoic acid 91.  The plot of 
the glucuronide product peak area against time was linear (R2 > 0.99) over the 
studied time frame (Figure 3.12).  The reaction without 2-methoxybenzoic acid 
91 (control) provided an initial velocity of 15865 arbitrary units (au) min-1 whilst 
the reaction containing 1 mM 2-methoxybenzoic acid 91 (internal standard) 
provided an initial velocity of 15401 arbitrary units (au) min-1 (97% of control).  
At concentrations below 1 mM, 2-methoxybenzoic acid 91 did not affect the rate 
of the glucuronylsynthase reactions and so was adopted at 0.5 mM as an 
internal standard for monitoring the kinetics of these reactions by HPLC. 
Raw
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Figure 7.1.  Reaction profiles for the glucuronylsynthase reaction between 2-
phenylethanol 45 acceptor (100 mM) with α-D-glucuronyl fluoride 51 donor (100 mM) in the 
presence of 2-methoxybenzoic acid 91 raw data ( ) and corrected with the internal data  
( ) (21C in 100 mM phosphate buffer, pH 7.5).  Line represents line of best fit with its 
linear regression analysis. 
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7.9.4  Calibration of 2-phenylethyl -D-glucuronide 68 
OHO
OH
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OH
O
O
 
A solution of 2-phenylethyl -D-glucuronide 68 (final concentrations 2 M, 4 
M, 6 M, 8 M, 10 M, 15 M, 20 M, 25 M, 30 M, 40 M, 50 M, 75 M, 
and 100 M) in sodium phosphate buffer (100 mM, pH 7.5) was prepared and 
subjected to the HPLC assay (refer to section 7.9) in duplicate.  A mobile phase 
of 23% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0) provided a 
retention time of 4.8 min.  The area was plotted against the concentration to 
provide the absorption co-efficient of 42846 au M-1 for 2-phenylethyl -D-
glucuronide 68 under the specified conditions.  
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Figure 7.2. Calibration curve of 2-phenylethyl -D-glucuronide 68 (211 nm, 21 ºC, 100 
mM sodium phosphate, pH 7.5).  R2 was calculated using linear regression analysis. 
7.9.5  Michaelis-Menten kinetics of -D-glucuronyl fluoride 51 
OHO
FHO
HO
O
O
OHO
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HO
O
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O
0.02 mg/mL E504G
pH 7.5, 21°C
OH
+
4551 68  
Glucuronylsynthase (1.2 mg mL-1, 20 L) was added to 2-phenylethanol 45 
(final concentration 97 mM) and -D-glucuronyl fluoride 51 (final concentrations 
0 M, 2 M, 4 M, 6 M, 8 M, 10 M, 15 M, 20 M, 25 M, 30 M, 40 M, 50 
M, 75 M, and 100 M) pre-incubated at 21 C in sodium phosphate buffer 
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(100 mM, 1480 L, pH 7.5).  The reaction was immediately subjected to HPLC 
(refer to section 7.9) with a mobile phase of 23% acetonitrile in sodium 
phosphate (100 mM, pH 2.0).  Six injections were made to monitor the initial 
velocity of the reactions at 11 min intervals.  Data points (minimum 3 points, 15-
34% conversion) that encompassed the initial linear velocity (R2 > 0.99) were 
used to plot initial velocities against the -D-glucuronyl fluoride 51 concentration 
to provide the Michaelis-Menten plot (Figure 3.13). 
7.9.6  Michaelis-Menten kinetics of 2-phenylethanol 45 
OHO
FHO
HO
O
O
OHO
OH
HO
O
O
O
0.02 mg/mL E504G
pH 7.5, 21°C
OH
+
4551 68  
Glucuronylsynthase (2.8 mg mL-1, 20 L,) was added to -D-glucuronyl 
fluoride 51 (final concentration 1 mM) and 2-phenylethanol 45 (final 
concentrations 0 mM, 2 mM, 6 mM, 10 mM, 15 mM, 37 mM, 55 mM, 73 mM, 92 
mM, and 107 mM) pre-incubated at 21 C in sodium phosphate buffer (100 mM, 
1480 L, pH 7.5).  The reaction was immediately subjected to HPLC (refer to 
section 7.9) with a mobile phase of 23% acetonitrile in sodium phosphate buffer 
(100 mM, pH 2.0).  Five injections were made to monitor the initial velocity of 
the reactions (<4% conversion) at 14 min intervals.  Data points (5 points) that 
encompassed the initial linear velocity (R2 > 0.99) were used to plot initial 
velocities against the 2-phenylethanol 45 concentration to provide the 
Michaelis-Menten plot (Figure 3.14). 
7.9.7  Calibration of 3-methoxybenzyl -D-glucuronide 71 
OHO
OH
HO
O
O
O
O
 
A solution of 3-methoxybenzyl -D-glucuronide 71 (final concentration 5 M, 
10 M, 20 M, 30 M, 40 M, 50 M, 75 M, and 100 M) in sodium phosphate 
buffer (100 mM, pH 7.5) was prepared and subjected to the HPLC assay (refer 
to section 7.9) in duplicate.  A mobile phase of 23% acetonitrile in sodium 
phosphate buffer (100 mM, pH 2.0) provided a retention time of 3.7 min.  The 
peak area was plotted against the concentration to provide the absorption co-
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efficient as 48062 au M-1 for 3-methoxybenzyl -D-glucuronide 71 under the 
specified conditions. 
y = 48062x + 22484
R2 = 0.9999
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Figure 7.3. Calibration curve of 3-methoxybenzyl -D-glucuronide 71 (211 nm, 21 ºC, 
100 mM sodium phosphate, pH 7.5). R2 was calculated using linear regression analysis. 
7.9.8  Michaelis-Menten kinetics of 3-methoxybenzyl alcohol 47 
47
OHO
FHO
HO
O
O
OHO
OH
HO
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O
0.04 mg/mL E504G
pH 7.5, 21°C
+
O
OH
O
51 71  
Glucuronylsynthase (2.9 mg mL-1, 20 L) was added to -D-glucuronyl fluoride 
51 (final concentration 1 mM) and 3-methoxybenzyl alcohol 47 (final 
concentrations 0 mM, 2 mM, 6 mM, 10 mM, 15 mM, 22 mM, 37 mM, 55 mM, 73 
mM, 90 mM, and 107 mM) pre-incubated at 21 C in sodium phosphate buffer 
(100 mM, 1480 L, pH 7.5).  The reaction was immediately subjected to HPLC 
(refer to section 7.9) with a mobile phase of 23% acetonitrile in sodium 
phosphate (100 mM, pH 2.0).  Five injections were made to monitor the initial 
velocity of the reactions (<4% conversion) at 13 min intervals.  Data points (5 
points) that encompassed the initial linear velocity (R2 > 0.99) were used to plot 
initial velocities against the 3-methoxybenzyl alcohol 47 concentration to 
provide the Michaelis-Menten model (Figure 3.15).  The data did not fit a 
standard Michaelis-Menten curve, so the kinetic parameters were determined 
by taking the tangent of the initial slope (kcat/Km = 1.25 M-1 s-1) and the local 
maximum velocity (max kcat = 0.022 s-1 at 55 mM) from the Michaelis-Menten 
plot. 
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7.9.9  Calibration of 4-fluorobenzyl -D-glucuronide 73 
OHO
OH
HO
O
O
O
F
 
A solution of 4-fluorobenzyl -D-glucuronide 73 (final concentration 1 M, 2.5 
M, 5 M, 7.5 M, 10 M, 22.5 M, 35 M, 47.5 M, 60 M and 74 M) in 
sodium phosphate buffer (100 mM, pH 7.5) was prepared and subjected to the 
HPLC assay (refer to section 7.9) in duplicate.  A mobile phase of 23% 
acetonitrile in sodium phosphate buffer (100 mM, pH 2.0) provided a retention 
time of 4.9 min.  The peak area was plotted against the concentration to provide 
the absorption co-efficient of 39739 au M-1 for 4-fluorobenzyl -D-glucuronide 
73 for the specified conditions. 
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Figure 7.4. Calibration curve of 4-fluorobenzyl -D-glucuronide 73 (211 nm, 21 ºC, 100 
mM sodium phosphate, pH 7.5). R2 was calculated using linear regression analysis. 
7.9.10    Michaelis-Menten kinetics of 4-fluorobenzyl alcohol 50 
50
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pH 7.5, 21°C
+
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51 73  
Glucuronylsynthase (6.5 mg mL-1, 20 L) was added to -D-glucuronyl fluoride 
51 (final concentration 1 mM) and 4-fluorobenzyl alcohol 50 (final 
concentrations 0 mM, 2 mM, 4 mM, 6 mM, 10 mM, 15 mM, 26 mM, 37 mM, 55 
mM, 73 mM and 107 mM) pre-incubated at 21 C in sodium phosphate buffer 
(100 mM, 1480 L, pH 7.5).  The reaction was immediately subjected to HPLC 
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(refer to section 7.9) with a mobile phase of 23% acetonitrile in sodium 
phosphate buffer (100 mM, pH 2.0).  Five injections were made to monitor the 
initial velocity of the reactions (<4% conversion) at 15 min intervals.  Data points 
(5 points) that encompassed the initial linear velocity (R2 > 0.99) were used to 
plot initial velocities against the 4-fluorobenzyl alcohol 50 concentration to 
provide the Michaelis-Menten plot (Figure 3.16).  The data did not fit a standard 
Michaelis-Menten model, so the kinetic parameters were determined by taking 
the tangent of the initial slope (kcat/Km = 0.59 M-1 s-1) and the local maximum 
velocity (max kcat = 0.081 s-1 at 37 mM) from the Michaelis-Menten plot. 
7.9.11    Calibration of phenyl -D-glucuronide 76 
OHO
OH
HO
OH
O
O
 
A solution of phenyl -D-glucuronide 76 (final concentration 2 M, 4 M, 6 M, 
8 M, 10 M, 20 M, 40 M, 60 M, 80 M and 100 M) in sodium phosphate 
buffer (100 mM, pH 7.5) was prepared and subjected to the HPLC assay (refer 
to section 7.9) in duplicate.  A mobile phase of 18% acetonitrile in sodium 
phosphate buffer (100 mM, pH 2.0) provided a retention time of 4.2 min.  The 
area was plotted against the concentration to provide the absorption co-efficient 
of 30292 au M-1 for phenyl -D-glucuronide 76 for the specified conditions. 
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Figure 7.5. Calibration curve of phenyl -D-glucuronide 76 (211 nm, 21 ºC, 100 mM 
sodium phosphate, pH 7.5). R2 was calculated using linear regression analysis. 
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7.9.12    Michaelis-Menten kinetics of phenol 52 
52
OHO
FHO
HO
O
O
OHO
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O
0.05 mg/mL E504G
pH 7.5, 21°C
OH
+
51 76  
Glucuronylsynthase (1.45 mg mL-1, 50 L) was added to -D-glucuronyl 
fluoride 51 (final concentration 1 mM) and phenol 52 (final concentrations 0 mM, 
2 mM, 4 mM, 6 mM, 8 mM, 10 mM, 12 mM, 16 mM, 20 mM, 30 mM, 40 mM, 80 
mM, 160 mM and 240 mM) pre-incubated at 21 C in sodium phosphate buffer 
(100 mM, 1450 L, pH 7.5).  The reaction was immediately subjected to HPLC 
(refer to section 7.9) with a mobile phase of 18% acetonitrile in sodium 
phosphate buffer (100 mM, pH 2.0).  Five injections were made to monitor the 
initial velocity of the reactions (<1% conversion) at 16 min intervals.  Data points 
(5 points) that encompassed the initial linear velocity (R2 > 0.99) were used to 
plot initial velocities against the phenol 52 concentration to provide the 
Michaelis-Menten plot (Figure 3.17).  The data did not fit a standard Michaelis-
Menten model, so the kinetic parameters were determined by taking the tangent 
of the initial slope (kcat/Km = 0.21 M-1 s-1) and the local maximum velocity (max 
kcat = 0.0029 s-1 at 30 mM) from the Michaelis-Menten plot. 
7.10 Reaction optimisation 
7.10.1   pH optimisation 
Glucuronylsynthase (2.0 mg mL-1, 20 L,) was added to -D-glucuronyl 
fluoride 51 (final concentration 1 mM) and 2-phenylethanol 45 (final 
concentration 107 mM) pre-incubated at 21 C in sodium phosphate buffer (100 
mM, 1480 L) adjusted to pH 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, or 11.0.  The 
reaction was immediately subjected to HPLC (refer to section 7.9) with a mobile 
phase of 23% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0).  Five 
injections were made at 16 min intervals to determine the initial reaction 
velocity.  After 5 days, the reactions were re-subjected to HPLC to determine 
the yield of the reactions based on the limiting amount of -D-glucuronyl fluoride 
51 added (Figure 3.18). 
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7.10.2   Temperature optimisation 
Glucuronylsynthase (1.7 mg mL-1, 20 L) was added to -D-glucuronyl fluoride 
51 (final concentration 89 mM) and 3-methoxybenzyl alcohol 47 (final 
concentration 89 mM) pre-incubated at either 4 C, 11 C, 18 C, 24 C, 30 C, 
or 37 C in sodium phosphate buffer (100 mM, 1480 L, pH 7.5).  The reaction 
was immediately subjected to HPLC (refer to section 7.9) with a mobile phase 
of 23% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0).  Five 
injections were made at 16 min intervals to determine the initial reaction 
velocity.  Reactions were stored at their corresponding temperatures and re-
tested after day 4 and 13.  Reaction yields were determined by the removal of 
aliquots (20 L) which were diluted in sodium phosphate buffer (100 mM, 180 
L, pH 7.5) then subjected to the HPLC assay (Figure 3.19). 
7.10.3   Effect of Enzyme Concentration 
A solution of 2-phenylethanol 45 (final concentration 94 mM) and -D-
glucuronyl fluoride 51 (final concentration 1 mM) in sodium phosphate buffer 
(100 mM, 1350 L, pH 7.5) was distributed into six separate HPLC vials.  The 
solutions were equilibrated at 21 C for 5 min then glucuronylsynthase (150 L, 
final concentrations 0.0257 mg mL-1, 0.129 mg mL-1, 0.257 mg mL-1, 0.643 mg 
mL-1, 1.29 mg mL-1, and 1.93 mg mL-1) was added and the reactions were 
immediately subjected to HPLC (refer to section 7.9) with a mobile phase of 
23% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0).  The reactions 
were monitored individually by HPLC by a further 4 injections at 16 min 
intervals. Data points (2-5 points, 4-42% conversion) that encompassed the 
initial linear velocity (R2 > 0.99 where applicable) were used to plot initial 
velocities per mg enzyme against the glucuronylsynthase concentration (Figure 
3.20).  A linear relationship (R2 > 99%) exists between the initial velocity per mg 
enzyme and the concentration of glucuronylsynthase. 
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7.11 In vitro chromo-ablative assay for directed 
evolution 
7.11.1   Small scale p-nitrophenyl--D-glucuronide 2540 
OHO
HO
HO
OH
O
O NO2
 
Glucuronylsynthase (22.5 mg mL-1, 8 L, final concentration 0.5 mg mL-1) was 
added to p-nitrophenol 54 (5 mg, 36 mol, final concentration 100 mM) and -D-
glucuronyl fluoride 51 (7.7 mg, 36 mol, final concentration 100 mM) in sodium 
phosphate buffer (100 mM, 351 L, pH 7.5) and swirled at RT for 4 d.  No 
product was observed by TLC analysis (ethyl acetate : methanol : water, 7 : 2 : 
1) but a weak signal consistent with the formation of product 25 was detected 
by LRMS (-ESI); LRMS (-ESI): m/z 314 ([M-H]-, <10%) 
7.11.2   Small scale fluorescein--D-glucuronide 
OHO
HO
HO
OH
O
O O
O
O
OH
 
Glucuronylsynthase (22.5 mg mL-1, 10 L, final concentration 0.2 mg mL-1) 
was added to fluorescein sodium salt 96 (2 mg, 5 mol, final concentration 5 
mM) and -D-glucuronyl fluoride 51 (1.1 mg, 5 mol, final concentration 5 mM) 
in sodium phosphate buffer (100 mM, 1.069 mL, pH 7.5) and swirled at RT for 4 
d.  No product was observed by TLC analysis (ethyl acetate : methanol : water, 
7 : 2 : 1) or LRMS (-ESI). 
7.11.3   Synthesis of 7-hydroxy-4-methylumbelliferone 97127 
HO O O
4 3
8
1
6
5
7
29
10
 
Resorcinol 99 (2.236g, 20.31 mmol), ethyl acetoacetate (2.70 g, 20.7 mmol) 
and Amberlite IR-120+ resin (2.0 g) in toluene (20 mL) were refluxed (2 h) under 
Dean-Stark conditions.  The mixture was cooled to RT, then warm methanol (40 
mL) was added and the Amberlite resin removed by filtration.  The filtrate was 
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evaporated under reduced pressure and the residue was recrystallised from 
methanol/water and dried overnight under vacuum to produce the white crystals 
of 7-hydroxy-4-methylumbelliferone 97 (1.36 g, 38.0%). 
mp 183-185 C [lit.218 mp 186-187 C]; IR (KBr disc): 3497 (m, O-H), 3127 (Ar 
C-H), 1673 (s, O-H), 1604 (C=C), 1453, 1392, 1276, 1068, 846, 806, 583, 477; 
1H NMR (400 MHz, MeOD): δ 10.42 (1H, singlet, O-H), 7.45 (1H, d, JH4-H5 8.7, 
H4), 6.68 (1H, dd, 3JH4-H5 8.7, 4JH5-H7 2.4, H5), 6.58 (1H, d, 4JH5-H7 2.3, H7), 5.99 
(1H, d, JH2-H10 1.0, H2), 2.23 (3H, d, 4JH2-H10 1.0, H10); 13C NMR (100 MHz, 
MeOD):  170.7 (C1), 169.8, 164.3, 163.0, 136.1, 122.4, 121.5, 119.8, 111.7, 
27.6 (C10); LRMS (+ESI) m/z: 199 ([M+Na]+, 10%), 177 ([M+H]+, 100%); HRMS 
(+ESI) m/z: 177.0552 (C10H9O3 gives 177.0552).  
7.11.4   Small scale 4-methylumbellifer-7-yl -D-glucuronide 100 
OHO
HO
HO
OH
O
O O O
 
Glucuronylsynthase (22.5 mg mL-1, 63 L, final concentration 0.5 mg mL-1) 
was added to 7-hydroxy-4-methylumbelliferone 97 (5 mg, 28 mol, final 
concentration 10 mM), -D-glucuronyl fluoride 51 (6.0 mg, 28 mol, final 
concentration 10 mM) and DMSO (284 L, final concentration 10% v/v) in 
sodium phosphate buffer (100 mM, 2.491 mL, pH 7.5) and swirled at RT for 4 d.  
Product was observed by TLC analysis (ethyl acetate : methanol : water, 7 : 2 : 
1) and confirmed by LRMS (-ESI). 
LRMS (-ESI): m/z 351 ([M-H]-, 25%) 
7.11.5   Preparative scale 4-methylumbellifer-7-yl--D-glucuronide 100219,220 
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Glucuronylsynthase (22.5 mg mL-1, 757 L, final concentration 0.48 mg mL-1) 
was added to 7-hydroxy-4-methylumbelliferone 97 (60 mg, 0.34 mmol, final 
concentration 10 mM), -D-glucuronyl fluoride 51 (72 mg, 0.34 mmol, final 
concentration 10 mM) and DMSO (3.4 mL, final concentration 9.7% v/v) in 
sodium phosphate buffer (100 mM, 31.04 mL, pH 7.5) and swirled at RT for 5 d.  
The crude reaction was dried onto silica which was subjected to flash 
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chromatography (ethyl acetate : methanol : water, 7 : 2 : 1).  The 4-
methylumbellifer-7-yl -D-glucuronide 100 (49 mg, 41%) was obtained as a 
white powder.  Spectral data was identical to reported literature.221 
1H NMR (300 MHz, D2O): δ 7.06 (1H, d, JH4-H5 9.0, H4), 6.63 (1H, d, JH4-H5 
8.7, H5), 6.47 (1H, s, H7), 5.64 (1H, s, H2), 4.88 (1H, d, JH11-H12 6.3, H11), 3.71 
(1H, d, JH14-H15 8.7, H15), 4.10-3.20 (3H, m, obscured, H12-14), 1.90 (3H, s, 
H10). 
7.11.6   Small scale 6-bromo-2-naphthyl -D-glucuronide 101222 
OHO
HO
HO
OH
O
O
Br
 
Glucuronylsynthase (22.5 mg mL-1, 50 L, final concentration 0.5 mg mL-1) 
was added to 6-bromo-2-naphthol 98 (6 mg, 27 mol, final concentration 12 
mM), -D-glucuronyl fluoride 51 (6 mg, 28 mol, 12 mM) and DMSO (224 L, 
final concentration 10% v/v) in sodium phosphate buffer (100 mM, 1.972 mL, pH 
7.5) and swirled at RT for 4 d.  Product was observed by TLC analysis (ethyl 
acetate : methanol : water, 7 : 2 : 1) and confirmed by LRMS (-ESI). 
LRMS (-ESI): m/z 397 ([M-H]-, 25%), 399 ([M-H]-, 25%). 
7.11.7   Preparative scale 6-bromo-2-naphthyl -D-glucuronide 101222 
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Glucuronylsynthase (22.5 mg mL-1, 598 L, final concentration 0.48 mg mL-1) 
was added to 6-bromo-2-naphthol 98 (61 mg, 0.27 mmol, final concentration 9.7 
mM), -D-glucuronyl fluoride 51 (58 mg, 0.27 mmol, final concentration 9.7 mM) 
and DMSO (2.69 mL, final concentration 9.7% v/v) in sodium phosphate buffer 
(100 mM, 24.47 mL, pH 7.5) and swirled at RT for 5 d.  The crude reaction was 
dried onto silica which was subjected to flash chromatography (ethyl acetate : 
methanol : water, 7 : 2 : 1).  The 6-bromo-2-naphthyl -D-glucuronide 101 (74 
mg, 69%) was obtained as a white powder. 
1H NMR (300 MHz, D2O): δ 7.10-6.70 (6H, m, H1, H3-H5, H7, H8), 4.76 (1H, 
obscured, H11), 3.80-3.30 (4H, m, H12-H15). 
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7.11.8   Excitation and emission of 7-hydroxy-4-methylumbelliferone 97223 and 
6-bromo-2-naphthol 98224 
Fluorescence was carried out at room temperature (25 ± 5 C) with an 
excitation slit of 2.5 nm and an emission slit of 2.5 mM.  Data was collected at a 
rate of 600 nm min-1 with a resolution of 1 nm.  The excitation spectra (Figure 
3.23 and Figure 3.24) were collected between 280-440 nm and the emission 
spectra was collected between 400-700 nm.  Sodium phosphate (100 mM, pH 
7.5) was used to blank the instrument prior to solutions (1 mM) of 7-hydroxy-4-
methylumbelliferone 97 and 6-bromo-2-naphthol 98 in sodium phosphate (100 
mM, pH 7.5) being scanned.  7-Hydroxy-4-methylumbelliferone 97 showed an 
excitation maximum (λex) of 389 nm and an emission maximum (λem) of 447 nm 
(Figure 7.6).  6-Bromo-2-naphthol 98 showed an excitation maximum (λex) of 
257 nm and an emission maximum (λem) of 367 nm (Figure 7.7). 
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Figure 7.6. Excitation and emissions spectrum of 1 mM 7-hydroxy-4-
methylumbelliferone 97 in 100 mM sodium phosphate, pH 7.5 
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Figure 7.7. Excitation and emissions spectrum of 1 mM 6-bromo-2-naphthol 98 in 100 
mM sodium phosphate, pH 7.5 
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7.11.9   Calibration of 7-hydroxy-4-methylumbelliferone 97 
A solution of 7-hydroxy-4-methylumbelliferone 97 (final concentration 0.1 mM, 
0.2 mM, 0.3 mM, 0.4 mM, and 0.5 mM) in sodium phosphate buffer (100 mM, 
pH 7.5) was analysed by fluorometry.  An excitation of 389 nm was used with 
the emission intensity observed at 449 nm plotted against the concentration 
(Figure 7.8) to provide the absorption co-efficient of 805 au mM-1.  
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Figure 7.8.  Calibration curve of 7-hydroxy-4-methyl-umbelliferone 97 in 100 mM 
sodium phosphate, pH 7.5 obtained from fluorometry (λex = 389 nm, λem = 449 nm). R2 
was calculated using linear regression analysis. 
7.11.10   Calibration of 6-bromo-2-naphthol 98 
A solution of 6-bromo-2-naphthol 98 (final concentration 0.04 mM, 0.08 mM, 
0.12 mM, 0.16 mM, and 0.20 mM) in sodium phosphate buffer (100 mM, pH 
7.5) was analysed by fluorometry.  An excitation of 257 nm was used with the 
emission intensity observed at 367 nm plotted against the concentration (Figure 
7.9) to provide the absorption co-efficient of 1691 au mM-1.  
y = 1691.3x + 32.205
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Figure 7.9. Calibration curve of 6-bromo-2-naphthol 98 in 100 mM sodium phosphate, 
pH 7.5 obtained from fluorometry (λex = 257 nm, λem = 367 nm). R2 was calculated using 
linear regression analysis. 
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7.11.11   In vitro assay of 7-hydroxy-4-methylumbelliferone 97 
OHO
OH
HO
OH
O
O O OHO O O
1FGlucA 51,
E504G
RT, 5 d,
pH 7.597 100  
Glucuronylsynthase (22.5 mg mL-1, 113 L, final concentration 0.85 mg mL-1) 
was added to 7-hydroxy-4-methylumbelliferone 97 (0.26 mg, 1.5 µmol, final 
concentration 0.5 mM) and -D-glucuronyl fluoride 51 (6.4 mg, 0.03 mmol, final 
concentration 10 mM) in sodium phosphate buffer (100 mM, 2.887 mL, pH 7.5) 
in a quartz cuvette.  The reaction was left untouched for 5 days in the 
fluorometer with the emission at 449 nm (excitation 389 nm) scanned every 10 
min.  The reaction was repeated in the absence of enzyme. 
7.11.12   In vitro assay of 6-bromo-2-naphthol 98 
OHO
OH
HO
OH
O
OHO
1FGlucA 51,
E504G
RT, 5 d,
pH 7.5
Br Br
10198  
Glucuronylsynthase (22.5 mg mL-1, 113 L, final concentration 0.85 mg mL-1) 
was added to 6-bromo-2-naphthol 98 (0.13 mg, 0.57 mol, final concentration 
0.19 mM) and -D-glucuronyl fluoride 51 (6.4 mg, 0.03 mmol, final concentration 
10 mM) in sodium phosphate buffer (100 mM, 2.887 mL, pH 7.5) in a quartz 
cuvette.  The reaction was left untouched for 5 days in the fluorometer with the 
emission at 367 nm (excitation 257 nm) scanned every 10 min.  The reaction 
was repeated in the absence of enzyme. 
7.12 In vitro fluoride-selective assay for directed 
evolution 
7.12.1   Synthesis of potassium 2’-hydroxychalcone-2-sulfonate 105225 
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Potassium hydroxide (5 M, 7.5 mL, 37.5 mmol) was added to 
o-hydroxyacetophenone 103 (1.36 g, 10.0 mmol) in methanol (9 mL).  Sodium 
2-formylbenzenesulfonate 104 (2.09 g, 10.0 mmol) was dissolved in a minimal 
volume of water (~10 mL) and added dropwise to the stirring, basic 
acetophenone solution at RT.  After stirring at RT for 30 h, a yellow-orange 
241 
Experimental 
precipitate had formed and a new spot was visible by TLC (ethyl acetate : 
methanol, 5 : 2 + 0.1% formic acid).  The reaction mixture was acidified to pH 2 
with concentrated hydrochloric acid and the yellow precipitate was collected by 
filtration.  Recrystallisation from aqueous methanol (50% v/v) produced shiny, 
yellow flakes of 2’-hydroxychalcone-2-sulfuric acid hemihydrate 105 (3.47 g, 
99%). 
mp 307-311 C (decomp.); IR (KBr): 3480 (O-H), 3077 (Ar-H), 3057 (Ar-H), 
1650 (C=O), 1593 (C=C), 1490, 1343 (vasSO2), 1205 (vsSO2), 1017, 750, 744 
(C-S); 1H NMR (800 MHz, d6-DMSO): δ 12.58 (1H, s, OH), 8.96 (1H, d, JH7-H8 
15.7, H7), 8.26 (1H, d, J 7.8), 8.06 (1H, d, J 7.0), 7.92-7.84 (2H, m, H8), 7.57 
(1H, t, J 7.5), 7.43 (2H, m,), 7.04-6.97 (2H, m,); 13C NMR (100 MHz, d6-DMSO):  
194.0 (C9), 162.0, 147.9, 144.81, 136.3, 131.8, 131.0, 129.8, 129.1, 127.4, 
127.2, 121.9, 120.7, 119.2, 117.8; LRMS (-ESI) m/z: 303 ([M-K]-, 100); HRMS 
(-ESI) m/z: 303.0324 (C15H11O5S gives 303.0327); Anal. Calcd. for 
C15H11KO5S.½H2O: C, 51.27; H, 3.44; K, 11.13; S, 9.12.  Found: C, 51.21; H, 
3.58; K, 11.73; S 9.15. 
7.12.2   Synthesis of potassium flavonol-2-sulfate 102225 
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Potassium hydroxide (40% m/v, 3.7 mL) was added to potassium 
2’-hydroxychalcone-2-sulfate hemihydrate 105 (1.13 g, 3.22 mmol) dissolved in 
aqueous methanol (50% v/v, 37 mL).  The mixture was cooled on ice and then 
hydrogen peroxide (30% w/w, 1.11 mL) was added.  After 2 h stirring on ice, the 
solution was neutralised with hydrochloric acid (1 M) and solvent removed 
under reduced pressure.  The residue was subjected to reverse-phase flash 
chromatography (100% water to 100% methanol gradient).  Recrystallisation 
from water produced tan crystals of potassium flavonol-2-sulfate hydrate 102  
(0.43 g, 36%). 
mp 311-321 C (decomp.); IR (KBr): 3438 (O-H), 1629 (C=O), 1611, 1565 
(C=C), 1469, 1421, 1345 (vasSO2), 1201 (vsSO2), 1129, 1095, 1023, 901, 766, 
757 (C-S), 615; 1H NMR (800 MHz, d6-DMSO): δ 8.79 (1H, s, OH), 8.12 (1H, 
dd, 3J 7.9, 4J 1.0), 7.94 (1H, d, J 7.8), 7.74 (1H, dt, J 7.7, 4J 1.3), 7.59-7.48 (4H, 
m), 7.45 (1H, t, J 7.5); 13C NMR (200 MHz, d6-DMSO):  169.3 (C9), 151.0, 
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147.7, 142.6, 133.9, 129.1, 126.7, 125.7, 124.8, 124.2, 123.5, 120.8, 120.2, 
118.8, 114.5; LRMS (-ESI) m/z: 317 ([M-K]-, 100); HRMS (-ESI) m/z: 317.0120 
(C15H9O6S gives 317.0120). 
7.13  Steroid glucuronylsynthase reactions 
7.13.1   Epiandrosterone -D-glucuronide 10913 
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Glycosynthase (E504G, 27 mg mL-1, 204 L, final concentration 0.22 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (36 mg, 0.17 mmol, final 
concentration 7 mM), epiandrosterone 56 (40 mg, 0.14 mmol, final 
concentration 5.7 mM) and n-dodecyl -maltoside (490 mg, final concentration 
2% w/v) in sodium phosphate buffer (50 mM, pH 7.5, final volume 24.5 mL).  
The reaction was swirled continuously under ambient conditions for 4 days then 
dried onto silica.  The crude product over silica was subjected to flash 
chromatography (ethyl acetate : methanol : water, 7:2:1) to reclaim unreacted 
epiandrosterone 56 (30 mg, 75%) and obtain 17-oxo-androst-5-an-3-yl 
-D-glucuronide 109 (14 mg, 21%) as a white powder. 
mp >200 C (decomp); Rf 0.26 (ethyl acetate : methanol : water, 7:2:1); IR 
(NaCl): 3339 (O-H), 2924, C-H), 2850 (C-H), 1728 (C=O), 1607, 1415, 1031, 
562; 1H NMR (400 MHz, MeOD): δ 4.44 (1H, d, JH20-H21 7.8, H20), 3.73 (1H, m, 
H3), 3.65 (1H, d, JH23-H24 8.3, H24), 3.54-3.37 (2H, m, H22, H23), 3.19, (1H, t, 
JH20-H21≈JH21-H22 8.1, H21), 2.43 (1H, dd, J 19.1, J 8.6) 2.21-0.68 (21H, m), 0.88 
(3H, s, CH3), 0.87 (3H, s, CH3); 13C NMR (100 MHz, MeOD): 224.1 (C17), 
102.0 (C20), 79.2, 77.7, 76.2, 74.8, 73.6, 55.9, 52.7, 46.0, 38.2, 36.9, 36.7, 
36.4, 35.3, 32.8, 32.1, 30.2, 29.7, 22.7, 21.6, 14.2, 12.7, C25 is unresolved and 
one carbon obscured; LRMS (+ESI) m/z: 511 ([M-H+2Na]+, 70%), 489 
([M+Na]+, 100%); HRMS (+ESI) m/z: 489.2463 ([M+Na]+, C25H38O8Na gives 
489.2464). 
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7.13.2   Testosterone -D-glucuronide 620,206  
18
19
4
3
8
1
6
5 7
2 9
10
1311
12 17
16
14 15
21
20
O
O
OH
OH
O
HO
COOH24
23
22
25
 
Glycosynthase (E504G, 33 mg mL-1, 175 L, final concentration 0.22 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (36 mg, 0.17 mmol, final 
concentration 6 mM), testosterone 7 (42 mg, 0.15 mmol, final concentration 5 
mM) and n-dodecyl -maltoside (568 mg, final concentration 2% w/v) in sodium 
phosphate buffer (50 mM, 28.9 mL, pH 7.5).  The suspension was swirled 
continuously under ambient conditions for 4 days then dried onto silica.  The 
crude product over silica was subjected to flash chromatography (ethyl acetate : 
methanol : water, 7:2:1) to reclaim unreacted testosterone 7 (30 mg, 71%) and 
obtain 3-oxo-androst-4-en-17-yl -D-glucopyranosiduronic acid 6 (8 mg, 12%) 
as a white powder. 
mp 240 C (decomp); []D20 +4.5 (c 0.22, MeOH); Rf 0.28 (ethyl acetate : 
methanol : water, 7:2:1); IR (KBr disc): 3416 (O-H), 2933 (C-H), 2848 (C-H), 
1666 (unsat. C=O), 1614 (C=O), 1430, 1162, 1069, 1053, 1027, 958, 684; 1H 
NMR (800 MHz, MeOD): δ 5.71, (1H, s, H4), 4.36 (1H, d, JH20-H21 7.8, H20), 
3.83 (1H, t, JH16-H17 8.6, H17), 3.52 (1H, d, JH23-H24 8.7, H24), 3.42 (1H, t, JH22-
H23≈JH23-H24 9.0, H23), 3.37 (1H, JH21-H22≈JH22-H23 8.7, H22), 3.20 (1H, t, JH20-
H21≈JH21-H22 8.3, H21), 2.51-2.44 (2H, m), 2.33-2.25 (2H, m), 2.13-2.01 (3H, m, 
H16a), 1.89 (1H, m), 1.73-1.55 (4H, m, H16b), 1.51 (1H, ddd, 2J 26.1, 3J 13.0, 
3J 3.8), 1.39-1.20 (3H, m, obscured), 1.24 (3H, s, CH3), 1.06-0.93 (3H, m), 0.91 
(3H, s, CH3); 13C NMR (200 MHz, MeOD): 202.4 (C3), 175.3 (C25), 170.4 (C5) 
124.1 (C4), 104.5 (C20), 89.2 (C17), 77.9 (C22), 76.4 (C24), 75.3 (C21), 73.7 
(C23), 55.4, 51.7, 44.2, 40.0, 38.5, 36.8, 36.7, 34.7, 33.9, 32.8, 29.5, 24.1, 21.8, 
17.7, 12.0; LRMS (-ESI) m/z: 463 ([M-H]-, 100%); HRMS (-ESI) m/z: 463.2329 
([M-H]-, C25H35O8 gives 463.2332) 
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7.13.3   Nandrolone -D-glucuronide 110206 
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Glycosynthase (E504G, 33 mg mL-1, 89 L, final concentration 0.22 mg mL-1) 
was added to -D-glucuronyl fluoride 51 (38 mg, 0.18 mmol, final concentration 
12 mM), nandrolone 108 (40 mg, 0.15 mmol, final concentration 10 mM) and 
n-dodecyl -maltoside (294 mg, final concentration 2% w/v) in sodium 
phosphate buffer (50 mM, pH 7.5, final volume 14.7 mL).  The reaction was 
swirled continuously under ambient conditions for 4 days then dried onto silica.  
The crude product over silica was subjected to flash chromatography (ethyl 
acetate : methanol : water, 7:2:1) to reclaim unreacted nandrolone 108 (37 mg, 
93%) and obtain the 3-oxo-estr-4-en-17-yl -D-glucopyranosiduronic acid 110 
(4 mg, 6%) as a white powder. 
mp >200 C (decomp); Rf 0.28 (ethyl acetate : methanol : water, 7:2:1); ); IR 
(NaCl): 3369 (O-H), 2916 (C-H), 2850 (C-H), 1661 (C=O), 1610 (C=O), 1415, 
1051, 1028;  1H NMR (400 MHz, MeOD): δ 5.80, (1H, s, H4), 4.36 (1H, d, JH19-
H20 7.8, H19), 3.85 (1H, t, JH16-H17 8.6, H17), 3.65-3.35 (3H, m, H21-23), 3.20 
(1H, t, JH19-H20≈JH20-H21 8.3, H20), 2.50 (1H, m), 2.41-2.25 (4H, m), 2.25-2.00 
(3H, m), 1.91-1.82 (2H, m), 1.73-1.25 (7H, m),  1.15-1.00 (2H, m), 0.92 (3H, s, 
H18), 0.87 (1H, m); LRMS (+ESI) m/z: 495 ([M-H+2Na]+, 50%), 473 ([M+Na]+, 
100%); HRMS (+ESI) m/z: 473.2151 ([M+Na]+, C24H34O8Na gives 473.2151). 
7.13.4   Direct glucuronylsynthesis of DHEA 55 with DMSO57 
OHO
OH
HO
OH
O
O
25
20
21
24
23
1
22
3
4
2
O
8
7
12
1319 16
18
5
10
9
15
6
11
14
17
 
Glycosynthase (E504G, 28 mg mL-1, 200 L, final concentration 0.20 mg 
mL-1) was added to -D-glucuronyl fluoride 51 (36 mg, 0.17 mmol, final 
concentration 6 mM), DHEA 55 (41 mg, 0.14 mmol, final concentration 5 mM) 
and DMSO (6.8 mL, final concentration 25% v/v) in sodium phosphate buffer 
(50 mM, 27.5 mL, pH 7.5).  The reaction was swirled continuously under 
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ambient conditions for 4 days then filtered prior to drying onto silica.  The 
filtration residue was washed with ethyl acetate (2 x 5 mL) to reclaim unreacted 
DHEA 55 (19 mg, 46%).  The crude product over silica was subjected to flash 
chromatography (ethyl acetate : methanol : water, 7:2:1) to reclaim further 
unreacted DHEA 55 (8 mg, 20%) and obtain 17-oxo-androst-5-en-3-yl -D-
glucuronide 77 (11 mg, 17%) as a white powder. 
mp 188 C (dec.); []  -29 (0.70, MeOH), [lit.20D 20 []  -35.5 (1, EtOH)]; R25D f 0.25 
(7:2:1 ethyl acetate : methanol : water); IR (NaCl): 3369 (O-H), 2938 (C-H), 
2903 (C-H), 1733 (C=O), 1636, 1436, 1373, 1259, 1218, 1161, 1089, 1049, 
1020; 1H NMR (300 MHz, MeOD): δ 5.43 (1H, d, JH6-H7 4.2, H6), 4.45 (1H, d, 
JH20-H21 7.7, H20), 3.80 (1H, d, JH23-H24 9.6, H24), 3.64-3.44 (2H, m, H3, H23), 
3.38 (1H, t, JH21-H22≈JH22-H23 9.1, H22), 3.20 (1H, t, JH21-H22=JH20-H21 8.3, H21), 
2.60-1.44 (15H, m), 1.43-1.20 (2H, m), 1.19-0.82 (2H, m), 1.05 (3H, s), 0.90 
(3H, s); 13C NMR (100 MHz, MeOD): 223.9 (C17), 177.1 (C25), 142.2 (C5), 
122.2 (C6), 102.2 (C20), 79.5 (C3), 77.8, 76.3, 74.9, 73.7, 53.0, 51.8, 39.6, 
38.5, 38.0, 36.7, 32.8, 32.7, 31.9, 30.5, 22.8, 21.5, 19.9, 13.9, one carbon 
overlapping or obscured; LRMS (-ESI) m/z: 927 ([2M-H]-, 43%), 463 ([M-H]-, 
100%); HRMS (-ESI) m/z: 463.2342 ([M-H]-, C25H35O8 gives 463.2338). 
7.14 DHEA Derivatives 
7.14.1   DHEA hydrazone 112144 
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Triethylamine (400 L, 2.9 mmol) and aqueous hydrazine hydrate solution 
(~25%, 80 L, 0.41 mmol) were added to a solution of DHEA 55 (103 mg, 0.36 
mmol) in aqueous ethanol (95%, 1.0 mL).  The mixture was refluxed with stirring 
for 4 h, cooled to RT, and then precipitated from solution by the addition of 
water (6 mL).  The precipitate was collected by filtration and washed with water 
(5 x 1 mL) to afford 3-hydroxy-androst-5-en-17-one hydrazone 112 (88 mg, 
81%) as white prisms. 
mp 206-211 C (decomp) [lit.144 mp 208-213 C]; []  -45 (1.0, CHCl20D 3); IR 
(NaCl): 3369 (broad, O-H), 2938, 2903 (C-H), 1733 (C=N), 1636, 1436, 1373, 
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1259, 1089, 1049, 1020; 1H NMR (800 MHz, DMSO-d6): δ 5.33 (2H, s, broad, 
NH2), 5.28 (1H, d, JH6-H7 5.0, H6), 4.63 (1H, s, broad, OH), 3.25 (1H, m, H3), 
2.19 (2H, m), 2.07 (2H, m), 1.99 (1H, m, H7), 1.77 (3H, m), 1.67 (1H, m), 1.57 
(2H, m), 1.48 (1H, ddt, J 10.7, J 10.7, J 5.2), 1.41 (1H, ddt, J 13.2, J 13.0, J 
4.0), 1.33 (2H, m), 1.21 (1H, dt, J 13.1, J 4.0), 0.98 (3H, m), 0.96 (3H, s, CH3), 
0.75 (3H, s, CH3); 13C NMR (200 MHz, DMSO-d6): δ 161.4 (C17), 141.5 (C5), 
120.3 (C6), 70.0 (C3), 53.8, 50.1, 43.1, 42.3, 36.9, 36.3, 34.4, 31.5, 31.0, 30.9, 
24.3, 23.1, 20.3, 19.2, 17.0; LRMS (+ESI) m/z: 303 ([M+H]+, 100%); HRMS 
(+ESI) m/z: 303.2436 (C19H31N2O gives 303.2436). 
7.14.2   DHEA 2’-pyridylhydrazone 113 
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Triethylamine (171 L, 1.2 mmol) and 2-pyridylhydrazine (88 mg, 0.81 mmol) 
were added to a solution of DHEA 55 (101 mg, 0.350 mmol) in absolute ethanol 
(1.0 mL).  The mixture was refluxed with stirring for 4 h, then cooled to RT, and 
finally precipitated from solution by the addition of water (6 mL).  The precipitate 
was collected by filtration and washed with water (5 x 1 mL) to afford 3-
hydroxy-androst-5-en-17-one 2-(2-pyridyl)hydrazone 113 (98 mg, 74%) as off-
white prisms and a single diastereomer. 
mp 271-274 C (decomp); [] 20D  +15 (1.0, CHCl3); IR (NaCl): 3312 (O-H), 
2926 (C-H), 1598 (C=N), 1577 (C=C), 1522, 1444, 1373, 1324, 1273, 1136, 
1060, 771; 1H NMR (800 MHz, DMSO-d6): δ 8.85 (1H, s, NH), 7.97 (1H, d, 
3JH23-H24’ 4.1, 4JH22-H24 0.8, H24), 7.48 (1H, dt, 3JH21-H22 ≈ 3JH22-H23 7.7, 4JH22-H24 
1.3 H22), 6.96 (1H, d, JH21-H22 8.4, H21), 6.60 (1H, dd, JH22-H23 6.4, JH23-H24 5.4, 
H23), 5.23 (1H, d, JH6-H7 4.8, H6), 4.59 (1H, d, J 4.6, O-H), 3.19 (1H, m, H3), 
2.47-2.42 (1H obscured, m), 2.22 (1H, quin, J 9.1), 2.10 (1H, m), 2.03 (1H, m), 
1.94 (1H, m), 1.87 (1H, m), 1.78-1.69 (2H, m), 1.62 (1H, m), 1.59-1.49 (2H, m), 
1.46 (1H, ddt, J 10.7, J 10.7, J 5.1); 1.40 (1H, ddt, J 13.1, J 13.0, J 4.1), 1.36-
1.23 (3H, m), 1.04 (1H, m), 0.97-0.87 (2H, m), 0.91 (3H, s, CH3), 0.78 (3H, s, 
CH3); 13C NMR (200 MHz, DMSO-d6): δ 162.9 (C17), 158.2 (C20), 147.5 (C24), 
141.5 (C5), 137.6 (C22), 120.3 (C6), 114.3 (C23), 106.1 (C21), 70.1 (C3), 53.5, 
50.1, 43.7, 42.3, 37.0, 36.3, 31.2, 31.5, 31.0, 30.9, 26.0, 23.3, 20.3, 19.3, 17.0; 
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LRMS (+ESI) m/z: 380 ([M+H]+, 100%), 402 ([M+Na]+, 15%); HRMS (+ESI) m/z: 
380.2701 ([M+H]+, C24H34N3O gives 380.2702). 
7.14.3   DHEA oxime 114145 
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Sodium acetate (98 mg, 1.2 mmol) and hydroxylamine hydrochloride (43 mg, 
0.62 mmol) were dissolved in methanol (100 mL) and refluxed for 10 min.  
DHEA 55 (173 mg, 0.60 mmol) was added to the hot solution and the reaction 
was stirred for 2 h at 4 °C. The reaction mixture was then diluted with water (65 
mL) and extracted with ethyl acetate (4 x 65 mL). The organic phase was 
washed with brine (2 x 65 mL) then dried over magnesium sulphate.  The 
solution was filtered and evaporated to dryness, resulting in an off-white solid.  
Recrystallisation from aqueous ethanol (50%) produced 3-hydroxy-androst-5-
en-17-one oxime 114 (94 mg, 52%) as a mixture of E and Z diastereomers (1.9 
: 1.0 respectively). 
mp 192-195 C (decomp) [lit.145 mp 200-202 C]; [] 20D  -60 (0.47, CHCl3); IR 
(NaCl): 3252 (O-H), 2930 (C-H), 1679 (C=N), 1429, 1373, 1019, 948, 923, 797, 
725; 1H NMR (800 MHz, DMSO-d6): δ  10.06 (1H, s N-OH E-isomer), 9.78 (1H, 
s N-OH Z-isomer), 5.28 (2H, s, H6), 4.72-4.51 (2H, m, C3-OH), 3.25 (2H, m, 
H3), 2.39-2.22 (4H, m), 2.20-2.04 (4H, m), 2.02-1.92 (2H, m), 1.87-1.63 (8H, 
m), 1.62-1.39 (8H, m), 1.38-1.19 (7H, m), 1.09 (1H, dt, J 11.9, J 6), 1.01-0.89 
(13H, m), 0.83 (3H, s, E-isomer); 13C NMR (200 MHz, DMSO-d6): δ 167.9 (C17, 
E-isomer), 165.6 (C17, Z-isomer), 141.4 (C5, both isomers), 120.2 (C6, both 
isomers), 70.0 (C3, both isomers), 54.7 (Z-isomer), 53.7 (E-isomer), 49.9 (E-
isomer), 49.7 (Z-isomer), 44.5 (Z-isomer), 42.9 (E-isomer), 42.24 (E-isomer), 
42.22 (Z-isomer), 36.91 (E-isomer), 36.87 (Z-isomer), 36.25 (E-isomer), 36.22 
(Z-isomer), 34.9 (Z-isomer), 34.1 (E-isomer), 31.44 (E-isomer), 31.43 (Z-
isomer), 30.87 (E-isomer), 30.85 (Z-isomer), 30.83 (E-isomer), 30.4 (Z-isomer), 
28.4 (Z-isomer), 24.9 (E-isomer), 23.6 (Z-isomer), 22.9 (E-isomer), 20.3 (Z-
isomer), 20.2 (E-isomer), 19.2 (E-isomer), 19.1 (Z-isomer), 17.0 (E-isomer), 
13.3 (Z-isomer); LRMS (+ESI) m/z: 304 ([M+H]+, 100%); HRMS (+ESI) m/z: 
304.2275 ([M+H]+, C19H30NO2 gives 304.2277). 
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7.14.4   DHEA O-(carboxymethyl)oxime 116148 
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Pyrrolidine (600 L, 7.19 mmol) was added to DHEA 55 (1.00 g, 3.47 mmol) 
dissolved in dry methanol (40 mL) on ice under a nitrogen atmosphere in the 
dark.  After one hour, the solution had turned yellow.  Carboxymethoxylamine 
hemihydrochloride 115 (800 mg, 7.32 mmol) was dissolved in a dry solution of 
methanol (10 mL) and pyrrolidine (600 L, 7.19 mmol) under nitrogen 
atmosphere and transferred to the DHEA 55 reaction via cannula with methanol 
washing (5 mL).  The solution went immediately clear and was heated to reflux.  
The reaction was monitored by TLC (methanol : dichloromethane, 1 : 9) and 
was complete after 6 h.  The solvent was evaporated under reduced pressure 
and water (100 mL) was added to the residue.  The pH was adjusted to 2 with 
hydrochloric acid (2 M) and the white precipitate was extracted with ethyl 
acetate until all precipitate had dissolved (5 x 150 mL with sonication required).  
The organic extracts were combined, washed with water (200 mL), dried over 
magnesium sulphate, and then evaporated under reduced pressure. 
The yellow-white residue (1.15 g) was washed with cold chloroform (5 mL, 
then 2 x 3 mL) to afford 3-hydroxy-androst-5-en-17-one O-
(carboxymethyl)oxime 116 (1.10 g, 88%) as a colourless solid. 
mp 215-217 C (decomp.); []  -36 (1.0, DMSO) [lit.20D 148 []  -37.9 (1, 
EtOH)]; R
24
D
f 0.38 (7:2:1 ethyl acetate : methanol : water); IR (KBr): 3351 (broad, 
O-H), 2946, 2910, 2865, 2505 (C-H), 1680 (s, C=O), 1377, 1348, 1284, 1090, 
1071, 1040, 849; 1H NMR (800 MHz, d6-DMSO): δ 5.28 (1H, s, H6), 4.61 (1H, 
s, broad, OH), 4.42 (2H, s, OCH2COO), 3.26 (1H, obscured, m, H3), 2.46 (1H, 
dd, 2JH16a-H16b 18.9, 3JH15-H16a 9.0, H16a), 2.38 (1H, m, H16b), 2.16 (1H, dd, 
2JH4a-H4b 12.8, 3JH3-H4a 2.3, H4a), 2.09 (1H, t, 2JH4a-H4b≈ 3JH3-H4b 12.1, H4b), 1.98 
(1H, m, H7a), 1.82-1.70 (3H, m), 1.67 (1H, d, J 12.2), 1.58 (2H, m, H7b), 1.51 
(1H, dquart, J 10.5, J 5.2), 1.42 (1H, dquart, J 13.2, J 3.4), 1.38-1.28 (3H, m), 
1.12 (1H, m), 1.02-0.91 (2H, m), 0.96 (3H, s, CH3), 0.85 (3H, s, CH3), COOH 
not observed; 13C NMR (200 MHz, d6-DMSO):  171.3 (C21), 170.6 (C17), 141.4 
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(C5), 120.1 (C6), 70.0 (C3), 69.8 (C20), 53.5, 49.8, 43.5, 42.2 (C4), 36.9, 36.2, 
33.8, 31.4, 30.82, 30.78, 25.7 (C16), 22.8, 20.2, 19.2 (CH3), 16.8 (CH3); LRMS 
(+ESI) m/z: 384 ([M+Na]+, 100); LRMS (-ESI) m/z: 360 ([M-H]-, 100); HRMS 
(+ESI) m/z: 384.2151 ([M+Na]+, C21H31NO4Na gives 384.2151). 
7.14.5   Solubility of DHEA derivatives 
Solutions (10 mM) of DHEA 55, DHEA hydrazone 112, DHEA 2’-
pyridylhydrazone 113, DHEA oxime 114, and DHEA O-(carboxymethyl)oxime 
116 were made with sodium phosphate buffer (100 mM, pH 7.5).  Solutions 
were sonicated (10 min, 30 C) prior to solubility being determined by eye.  If 
complete dissolution was not achieved, the solution was diluted further with 
sodium phosphate (100 mM, pH 7.5).  Dilutions were made such that the final 
concentration employed were 5 mM, 2 mM, 1 mM, 0.75 mM, 0.5 mM, 0.3 mM, 
0.1 mM and 0.05 mM. 
7.14.6   DHEA O-(carboxymethyl)oxime-D-glucuronide 118 
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Reaction at room temperature 
Glucuronylsynthase (22.5 mg mL-1, 521 L, final concentration 0.42 mg mL-1) 
was added to a solution containing DHEA O-(carboxymethyl)oxime 116 (20.1 
mg, 0.056 mmol, final concentration 2.0 mM) and -D-glucuronyl fluoride 51 
(11.9 mg, 0.056 mmol, final concentration 2.0 mM) in sodium phosphate buffer 
(100 mM, 27.1 mL, pH 7.5).  The reaction was swirled at room temperature for 2 
days then a further addition of -D-glucuronyl fluoride 51 (11.9 mg, 0.056 mmol) 
was added.  Silica gel (~100 mg) was added and the solution was evaporated 
to dryness by rotary evaporation.  The dried residue was subjected to flash 
chromatography with ethyl acetate : ethanol (5:2) to recover unreacted oxime 
116, then ethyl acetate : methanol : water (7:2:1) to isolate pure 17-
carboxymethoximino-androst-5-en-3-yl -D-glucuronide 118 (22.8 mg, 76%) as 
a colourless solid. 
250 
Experimental 
Large scale reaction 
Glucuronylsynthase (110 mg, final concentration 0.32 mg mL-1) was added to 
a solution containing DHEA O-(carboxymethyl)oxime 116 (500 mg, 1.38 mmol, 
final concentration 3.97 mM), -D-glucuronyl fluoride 51 (298 mg, 1.40 mmol, 
final concentration 4.03 mM) and DMSO (15 mL, final concentration 4.3% v/v)  
in sodium phosphate buffer (100 mM, 27.1 mL, pH 7.5).  Silica gel (~1 g) was 
added and the solution was evaporated to dryness by rotary evaporation.  The 
dried residue was subjected to flash chromatography with ethyl acetate : 
ethanol (5:2) to recover unreacted oxime 116, then ethyl acetate : methanol : 
water (7:2:1) to isolate pure 17-carboxymethoximino-androst-5-en-3-yl 
-D-glucuronide 118 (0.293 mg, 41%) as a colourless solid.  
Reaction at 37 C 
Glucuronylsynthase (1.45 mg mL-1, 4.14 mL, final concentration 0.21 mg mL-1) 
was added to a solution containing DHEA O-(carboxymethyl)oxime 116 (20 mg, 
0.055 mmol, final concentration 1.9 mM) and -D-glucuronyl fluoride 51 (57.5 
mg, 0.270 mmol, final concentration 9.3 mM) in sodium phosphate buffer (100 
mM, 25 mL, pH 7.5).  The reaction was incubated at 37 ºC without agitation for 
3 days then dried onto reverse-phase silica.  The dried residue was subjected to 
reverse-phase flash chromatography (25% aqueous acetonitrile + 0.1% formic 
acid) to isolate pure 17-carboxymethoximino-androst-5-en-3-yl -D-glucuronide 
118 (29 mg, 98%) as a colourless solid. 
mp decomp.; []  -62 (1.0, DMSO); R20D f 0.02 (ethyl acetate : methanol : water, 
7:2:1); IR (KBr): 3423 (O-H), 2942 (C-H), 1745 (C=O), 1436, 1373, 1367, 1226, 
1167, 1109, 1092, 1070, 1049, 1021; 1H NMR (800 MHz, D2O): δ 5.51 (1H, s, 
H6), 4.59 (1H, d, JH22-H23 7.3, H22), 4.38 (2H, s, H20), 3.73-3.64 (2H, m, H3, 
H26), 3.54-3.47 (2H, m, H24, H25), 3.27 (1H, t, JH22-H23≈JH23-H24 7.1, H23),  2.63 
(1H, dd, JH16a-H16b 19.2, JH15-H16 8.3, H16a), 2.52 (1H, m, H16b), 2.47 (1H, d, 
JH4a-H4b 12.6, H4a), 2.29 (1H, t, JH3-H4≈JH4a-H4b 12.0, H4b), 2.10 (1H, d, J 11.3, 
H7a), 1.99-1.91 (2H obscured, m, H2a), 1.91-1.81 (2H, m, H14), 1.72-1.60 (4H, 
m, H2b, H7b), 1.55 (1H, quart, J 13.0), 1.48-1.38 (2H, m, H15), 1.27 (1H, m), 
1.10 (1H, t, J 13.0), 1.06 (3H, s, CH3), 1.04 (1H, m,), 0.95 (3H, s, CH3); 13C 
NMR (200 MHz, D2O): 181.7 (C21), 178.4 (C27), 176.8 (C17), 142.7 (C5), 
122.9 (C6), 101.2 (C22), 80.6 (C26), 77.2 (C3), 76.6 (C24), 73.9 (C23), 72.8 
(C20), 72.4 (C25), 54.5, 50.7, 45.1 (quart. C), 39.0 (C4), 37.6, 37.5 (quart. C), 
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34.4, 31.8 (C7), 29.8 (C2), 27.3 (C16), 23.8, 23.7, 21.1, 19.8, 17.2; LRMS 
(-ESI) m/z: 536 ([M-H]-, 100%), 558 ([M-2H+Na]-, 30%); HRMS (-ESI) m/z: 
536.2495 ([M-H]-, C27H38NO10] gives 536.2496), 558.2302 ([M-2H+Na]-, 
C27H37NO10Na gives 558.2315). 
Recrystallisation was obtained from ethyl acetate & methanol with water used 
sparingly to achieve complete dissolution.  Upon cooling overnight at 4 C, the 
translucent crystals of disodium DHEA O-(carboxymethyl)oxime -D-
glucuronate were observed that were suitable for single crystal x-ray structure 
determination (Figure 4.3). 
7.14.7   DHEA 55 from the deoximation of DHEA O-(carboxymethyl)oxime 116 
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DHEA O-(carboxymethyl)oxime 116 (20 mg, 0.055 mmol) and ammonium 
acetate (55 mg, 0.71 mmol) were dried under vacuum, then purged with 
nitrogen, and dissolved in dioxane (0.5 mL) and aqueous acetic acid (50% v/v, 
22 L).  Aqueous titanium trichloride (9 mM) was freshly prepared and added 
(14 mL) dropwise to the reaction to which the solution turned violet-black.  After 
one hour, the solution had lightened in colour to a light blue with a white-grey 
precipitate.  TLC analysis (ethyl acetate : methanol : water, 50:2:1) showed 
significant conversion to a product with an equivalent Rf of DHEA 55.  The 
solution was filtered, and the residue washed with ethyl acetate (20 mL).  The 
filtrate was washed with brine (10 mL), then saturated sodium bicarbonate (10 
mL) and then water (10 mL).  The organic layer was dried over anhydrous 
magnesium sulfate, then evaporated to dryness to yield crude DHEA 55 (5 mg, 
33%). 
Spectral data confirmed the removal of the oxime group and was identical to a 
DHEA 55 reference sample. 
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7.14.8   Dehydroepiandrosterone -D-glucuronide 7720 
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DHEA O-(carboxymethyl)oxime -D-glucuronide 118 (50 mg, 0.093 mmol) and 
ammonium acetate (96 mg, 1.2 mmol) were purged with nitrogen gas, then 
dioxane (0.5 mL) and aqueous acetic acid (50%, 38 L) were added.  In a 
second flask, anhydrous titanium trichloride (36 mg, 0.23 mmol) was purged 
with nitrogen gas before water (6 mL) was added.  The aqueous titanium 
trichloride was added via cannula to the stirred DHEA O-(carboxymethyl)oxime 
-D-glucuronide 118 solution at room temperature and under a nitrogen 
atmosphere.  The reaction instantly turned black-violet upon addition and 
gradually changed to a white-grey as the reaction proceeded.  After 2 h, the 
reaction was deemed complete by TLC (ethyl acetate : methanol : water, 7:2:1) 
so the reaction was acidified to pH 2 and dried onto silica.  The dry residue was 
subjected to flash chromatography (ethyl acetate : methanol : water, 7:2:1  + 
0.1% formic acid) to isolate pure 17-oxo-androst-5-en-3-yl -D-glucopyranuronic 
acid 77 (44.8 mg, 100%) as a white solid. 
Spectral data was identical to literature and previously synthesised material 
(refer to section 7.13.4).20,57 
7.15 Kinetics with DHEA O-(carboxymethyl)oxime 
7.15.1   Calibration of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
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A solution of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 (final 
concentration 0.2 M, 0.4 M, 0.6 M, 0.8 M, and 10 M) in sodium phosphate 
buffer (100 mM, pH 7.5) was prepared and subjected to the HPLC assay (refer 
to section 7.9) in duplicate.  A mobile phase of 30% acetonitrile in sodium 
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phosphate buffer (100 mM, pH 2.0) provided a retention time of 5.7 min.  The 
area was plotted against the concentration (Figure 7.10) to provide the 
absorption co-efficient of 10083 au M-1 for DHEA O-(carboxymethyl)oxime -D-
glucuronide 118 for the specified conditions. 
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R2 = 0.9993
0
20000
40000
60000
80000
100000
0 2 4 6 8 1
DHEA O -(carboxymethyl)oxime
-D-glucuronide (M)
pe
ak
 a
re
a 
(a
u)
0
 
Figure 7.10. Calibration curve of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
(211 nm, 21 ºC, 100 mM sodium phosphate, pH 7.5).  R2 was calculated using linear 
regression analysis. 
7.15.2   Michaelis-Menten kinetics of DHEA O-(carboxymethyl)oxime 116 
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Glucuronylsynthase (1.77 mg mL-1, 50 L) was added to -D-glucuronyl 
fluoride 51 (final concentration 1 mM) and DHEA O-(carboxymethyl)oxime 116 
(final concentrations 0 mM, 0.14 mM, 0.27 mM, 0.41 mM, 0.55 mM, 0.68 mM, 
0.82 mM, 1.09 mM, 1.37 mM, 1.5 mM, 1.64 mM, 1.78 mM, and 1.95 mM) pre-
incubated at 21 C in sodium phosphate buffer (100 mM, 1450 L, pH 7.5).  The 
reaction was immediately subjected to HPLC (refer to section 7.9) with a mobile 
phase of 30% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0). Five 
injections were made to monitor the initial velocity of the reactions (<1% 
conversion) at 21 min intervals.  Data points (5 points) that encompassed the 
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initial linear velocity (R2 > 0.99) were used to plot initial velocities against the 
DHEA O-(carboxymethyl)oxime 116 concentration to provide the Michaelis-
Menten plot (Figure 4.5).  The data did not fit a standard Michaelis-Menten 
model, so the kinetic parameters were determined by taking the tangent of the 
initial slope (kcat/Km = 5.0 M-1 s-1) and the local maximum velocity (max kcat = 
0.0014 s-1 at 0.55 mM) from the Michaelis-Menten plot. 
7.15.3   Equivalents of -D-glucuronyl fluoride 51 in the DHEA O-
(carboxymethyl)oxime 116 glucuronylsynthase reaction 
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A stock solution of DHEA O-(carboxymethyl)oxime 116 (1.6 mM) in sodium 
phosphate buffer (100 mM, pH 7.5) was distributed into five separate HPLC 
vials (1.28 mL each).  An aliquot (200 L, 160L, 120L, 80L, and 40L) of 
-D-glucuronyl fluoride 51 (52.5 mM) in sodium phosphate buffer (100 mM, pH 
7.5) was added to each vial.  The volume of the vial was made up to 1.48 mL 
using sodium phosphate buffer (100 mM, pH 7.5) and then equilibrated at 37 C 
for 5 min.  Glucuronylsynthase (22.5 mg mL-1, 20 L, final concentration 0.3 mg 
mL-1) was added to each vial and the reactions were immediately subjected to 
HPLC (refer to section 7.9) with a mobile phase of 30% acetonitrile in sodium 
phosphate buffer (100 mM, pH 2.0).  The reactions were monitored 
simultaneously by HPLC over 30 h with an injection taken every 2h. 
7.15.4   Non-enzymatic hydrolysis of the -D-glucuronyl fluoride 51 donor 
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D2O, 37 °C + DF(aq)
51 3  -D-Glucuronyl fluoride 51 (20 mg, 94 mol) was dissolved in deuterium oxide 
(700 L) at 37 C and subjected to a timescale NMR (500 MHz) experiment 
whereby a proton spectrum was recorded every hour over a 21 h period (Figure 
4.7).  The hydrolysis was quantified through the integration of the anomeric 
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proton of -D-glucuronyl fluoride 51 (5.72 ppm) and the hydrolysis products -
glucuronic acid 3 (5.50 ppm) and -glucuronic acid 3 (5.38 ppm).  The rate of 
hydrolysis (Figure 4.8) was determined as a proportion to the sum of the 
integrations to provide a hydrolysis rate of 600 nmol h-1.  Assuming first-order 
kinetics, the rate constant of hydrolysis (kH) is 1.8 x 10-6 s-1. 
7.15.5   Estimation of inhibition constant for DHEA O-(carboxymethyl)oxime -
D-glucuronide 118 
Glucuronylsynthase (1.9 mg mL-1, 20 L) was added to 2-phenylethanol 45 
(final concentration 88 mM), -D-glucuronyl fluoride 51 (final concentration 20 
M) and DHEA O-(carboxymethyl)oxime -D-glucuronide 118 (final 
concentration 0 M, 10 M, 20 M, 50 M, 76 M, or 101 M) pre-incubated at 
21 C in sodium phosphate buffer (100 mM, 1480 L, pH 7.5).  The reaction 
was immediately subjected to HPLC (refer to section 7.9) with a mobile phase 
of 23% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0).  Three 
injections were made at 26 min intervals to determine the initial reaction 
velocity.  The procedure was repeated with 5 M and 10 M final 
concentrations of -D-glucuronyl fluoride 51. 
7.15.6   Estimation of inhibition for 2-phenylethyl glucuronide 68 
Glucuronylsynthase (1.9 mg mL-1, 20 L) was added to DHEA O-
(carboxymethyl)oxime 116 (final concentration 0.6 mM), -D-glucuronyl fluoride 
51 (final concentration 20 M) and 2-phenylethyl glucuronide 68 (final 
concentration 0 mM, 25 M, 50 M, or 75 M, 100 M, 25 mM, 50 mM, 75 mM 
or 100 mM) pre-incubated at 21 C in sodium phosphate buffer (100 mM, 1480 
L, pH 7.5).  The reaction was immediately subjected to HPLC (refer to section 
7.9) with a mobile phase of 30% acetonitrile in sodium phosphate buffer (100 
mM, pH 2.0).  Three injections were made at 23 min intervals to determine the 
initial reaction velocity. 
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7.16 Steroid solubility strategy with testosterone 
7.16.1   Testosterone O-(carboxymethyl)oxime 120177 
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Pyrrolidine (85 L, 1.0 mmol) was added to testosterone 7 (146 mg, 0.506 
mmol) dissolved in dry methanol (8 mL) on ice under a nitrogen atmosphere in 
the dark.  Within 5 min, the solution had turned yellow.  The solution was heated 
to 50 ºC and further pyrrolidine (85 L, 1.0 mmol) was added followed by 
carboxymethoxylamine hemihydrochloride 115 (117 mg, 1.07 mmol).  The 
solution turned immediately clear and was monitored by TLC (methanol : 
dichloromethane, 1 : 9).  After 1 h, the solvent was removed under reduced 
pressure and water (20 mL) was added to the residue.  The pH was adjusted to 
2 with hydrochloric acid (2 M) and the white precipitate was extracted with ethyl 
acetate until all precipitate had dissolved (3 x 15 mL with sonication required).  
The organic extracts were combined, washed with water (30 mL), dried over 
magnesium sulphate, and then evaporated to dryness by rotary evaporation.  
The yellow residue was subjected to flash chromatography (methanol : 
dichloromethane, 1:9) to yield an off-white solid.  Discolouration was removed 
by washing with cold chloroform (2-3 mL), followed by filtration to yield the white 
powder of 17-hydroxy-androst-4-en-3-one O-(carboxymethyl)oxime 120 (166 
mg, 91%) as a mixture of E and Z isomers (1.7:1.0 respectively). 
 mp 173-175 ºC (decomp.) [lit.177 mp 179-181 ºC]; []  +119 (1.0, MeOH) 
[lit.
20
D
177 []  +144 (1.3, EtOH)]; R25D f 0.38 (ethyl acetate : methanol : water, 7:2:1); 
IR (KBr): 3392 (O-H), 2934 (C-H), 1739 (C=O), 1689 (C=N), 1286, 1204, 1094, 
1055, 1028, 753, 663; 1H NMR (800 MHz, MeOD): δ 6.45 (1H, s, H4 Z-isomer), 
5.74 (1H, s, H4 E-isomer), 4.54 (2H, s, H20 E-isomer), 4.51 (2H, s, H20 Z-
isomer), 3.57 (2H, t, JH16-H17 8.7, H17), 3.05 (2H, d, JH6a-H6b 17.3, H6a), 2.42-
2.15 (6H, m, H6b), 2.01-1.75 (8H, m, H16a), 1.65-1.25 (14H, m, H16b), 1.20-
0.70 (8H, m), 1.11 (6H, s, CH3), 0.78 (6H, s, CH3); 13C NMR (200 MHz, MeOD):  
174.07 (C21, Z-isomer), 173.99 (C21 E-isomer), 161.9 (C5, Z-isomer), 159.1 
(C5, E-isomer), 158.4 (C3, E-isomer), 156.0 (C3, Z-isomer), 117.6 (C4, E-
isomer), 112.0 (C4, Z-isomer), 82.4 (C17, E-isomer), 82.3 (C17, Z-isomer), 71.0 
257 
Experimental 
(C20, E-isomer), 70.8 (C20, Z-isomer), 55.8 (Z-isomer), 55.5 (E-isomer), 52.0 
(E-isomer), 51.9 (Z-isomer), 44.0 (Z-isomer), 43.9 (E-isomer), 40.1 (Z-isomer), 
39.2 (E-isomer), 37.9 (E-isomer), 37.8 (Z-isomer), 37.4 (Z-isomer), 37.2 (E-
isomer), 37.1 (Z-isomer), 35.9 (E-isomer), 34.0 (Z-isomer), 33.52 (E-isomer), 
33.46 (Z-isomer), 33.1 (E-isomer), 30.6 (C16, E-isomer), 25.4 (Z-isomer), 24.29 
(E-isomer), 24.27 (Z-isomer), 22.1, (E-isomer), 21.9 (Z-isomer), 20.5 (C6, E-
isomer), 18.4 (Z-isomer), 18.2 (E-isomer), 11.59 (Z-isomer), 11.58 (E-isomer), 
one C obscured or overlapping; LRMS (-ESI) m/z: 360 ([M-H]-, 100); HRMS (-
ESI) m/z: 360.2175 ([M-H]-, C21H30NO4 gives 360.2175). 
7.16.2   Solubility of testosterone O-(carboxymethyl)oxime 120 
Solutions (28 mM) of testosterone 7 and testosterone O-
(carboxymethyl)oxime 120 were made with sodium phosphate buffer (100 mM, 
pH 7.5).  Solutions were sonicated (10 min, 30 C) prior to solubility being 
determined by eye.  If complete dissolution was not achieved, the solution was 
diluted further with sodium phosphate (100 mM, pH 7.5).  Dilutions were made 
such that the final concentration employed were 14 mM, 9.3 mM, 4.7 mM, 2.3 
mM, 1.2 mM, 0.58 mM, 0.29 mM. 
7.16.3   Testosterone O-(carboxymethyl)oxime -D-glucuronide 121 
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Glucuronylsynthase (21.6 mg mL-1, 128 L, final concentration 0.21 mg mL-1) 
was added to a solution containing testosterone O-(carboxymethyl)oxime 120 
(52 mg, 0.14 mmol, final concentration 11 mM) and -D-glucuronyl fluoride 51 
(145 mg, 0.680 mmol, final concentration 38 mM) in sodium phosphate buffer 
7.5 (100 mM, 13 mL, pH 7.5).  The reaction was incubated at 30 ºC without 
agitation for 3 days before being acidified to pH 2 and then dried onto reverse-
phase silica.  The dried residue was subjected to reverse-phase flash 
chromatography (25% aqueous acetonitrile + 0.1% formic acid) to isolate 3-
carboxymethoximino-androst-4-en-17-yl -D-glucuronide acid 121 (54 mg, 72%) 
as a colourless solid and a mixture of anti and syn isomers (2.0 : 1.0 
respectively).  Unreacted testosterone O-(carboxymethyl)oxime 120 was also 
recovered (12 mg, 23%). 
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mp decomp.; []  +50.3 (1.0, MeOH); IR (NaCl): 3370 (O-H), 2935 (C-H), 
1732 (C=O), 1630 (C=N), 1434, 1375, 1243, 1168, 1097, 1055, 1024; 
20
D
1H NMR 
(800 MHz, MeOD): δ 6.45 (1H, s, H4 Z-isomer), 5.71 (1H, s, H4 E-isomer), 4.54 
(2H, s, C20 E-isomer), 4.52 (2H, s, H20 Z-isomer), 4.38 (2H, d, JH22-H23 7.2, 
H22), 3.73 (2H, m H26), 3.68 (2H, t, JH16-H17 8.1, H17), 3.51 (2H, t, JH24-H25≈JH25-
H26 8.8, H25), 3.36 (2H, t, JH23-H24≈JH24-H25 9.3, H24), 3.22 (2H, t, JH22-H23≈JH23-
H24 8.1, H23), 3.04 (1H, d, JH6a-H6b 17.0, H6a), 2.42-2.12 (7H, m, H6b), 2.06-
1.89 (6H, m, H16a), 1.87-1.76 (2H, m), 1.71-1.52 (8H, m, H16b), 1.51-1.25 (6H, 
m), 1.19 (2H, t, J 11.6), 1.14 (3H, s, H19 Z-isomer), 1.10 (3H, s, H19 E-isomer), 
1.04-0.82 (6H, m), 0.88 (6H, s, H18); 13C NMR (200 MHz, MeOD):  174.0 (2C, 
C21, E+Z-isomer), 172.7 (2C, C27, E+Z-isomer), 161.9 (C5, Z-isomer), 159.1 
(C5, E-isomer), 158.3 (C3 E-isomer), 156.0 (C3, Z-isomer), 117.6 (C4 E-
isomer), 112.0 (C4 Z-isomer), 105.1 (2C, C22, E+Z-isomer), 90.29 (C17, E-
isomer), 90.24 (C17, Z-isomer), 77.5 (2C, C24, E+Z-isomer), 76.6 (2C, C26, 
E+Z-isomer), 75.0 (2C, C23, E+Z-isomer), 73.2 (2C, C25, E+Z-isomer), 71.0 (E-
isomer), 70.8 (Z-isomer), 55.6 (Z-isomer), 55.3 (E-isomer), 51.73 (E-isomer), 
51.67 (Z-isomer), 44.17 (Z-isomer), 44.13 (E-isomer), 40.1 (Z-isomer), 39.2 (E-
isomer), 38.5 (E-isomer), 38.4 (Z-isomer), 37.4 (Z-isomer), 36.93 (E-isomer), 
36.87 (Z-isomer), 35.8 (E-isomer), 34.0 (Z-isomer), 33.5 (E-isomer), 33.4 (Z-
isomer), 33.0 (E-isomer), 29.8 (E-isomer), 25.3 (Z-isomer), 24.26 (E-isomer), 
24.25 (Z-isomer), 22.1 (E-isomer), 21.9 (Z-isomer), 20.5 (E-isomer), 18.4 (C19, 
Z-isomer), 18.2 (C19, E-isomer), 11.99 (C18, Z-isomer), 11.98 (C18, E-isomer), 
one carbon obscured or overlapping; LRMS (-ESI) m/z: 558 ([M-2H+Na]-, 94), 
536 ([M-H]-, 100); HRMS (-ESI) m/z: 558.2314 ([M-2H+Na]-, C27H37NO10Na 
gives 558.2315), 536.2496 ([M-H]-, C27H38NO10 gives 536.2496). 
7.16.4   Testosterone -D-glucuronide 6 
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Testosterone O-(carboxymethyl)oxime -D-glucuronide 121 (30 mg, 0.056 
mmol) and ammonium acetate (117 mg, 1.52 mmol) were purged with nitrogen 
gas, then dioxane (0.5 mL) and aqueous acetic acid (50%, 90 L) were added.  
Aqueous titanium trichloride (40 mg mL-1, 0.54 mL, 0.18 mmol) was added to 
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the stirred testosterone O-(carboxymethyl)oxime -D-glucuronide 121 solution 
at room temperature and under a nitrogen atmosphere.  The reaction instantly 
turned black-violet upon addition and gradually changed to a white-grey as the 
reaction proceeded.  After 24 h, the reaction was acidified to pH 2 and dried 
onto silica.  The dry residue was subjected to flash chromatography (ethyl 
acetate : methanol : water, 7:2:1 + 0.1% formic acid) to isolate a mixture of 
testosterone -D-glucopyranuronic acid 6 and unreacted testosterone O-
(carboxymethyl)oxime -D-glucopyranuronic acid 121.  These were separated 
by prep TLC (ethyl acetate : methanol : water, 7:2:1  + 0.1% formic acid) to 
recover flash chromatography (25% aqueous acetonitrile + 0.1% formic acid) to 
isolate testosterone O-(carboxymethyl)oxime -D-glucuronide 121 (16 mg, 53%) 
and obtain pure 3-oxo-androst-4-en-17-yl -D-glucuronide 6 (10 mg, 38%) as a 
white solid. 
Spectral data was identical to literature and previously synthesised material 
(refer to section 7.13.2).20,206 
7.17 Effect of additives on the glucuronylsynthase 
reactions 
7.17.1   Effect of co-solvents on initial velocity 
Co-solvents investigated include ethanol, DMSO, tert-butanol, and glycerol at 
a final concentration of 5% v/v and 10% v/v.  Glucuronylsynthase (1.4 mg mL-1, 
50 L) was added to -D-glucuronyl fluoride 51 (final concentration 1 mM), 2-
phenylethanol 45 (final concentration 94 mM) and co-solvent pre-incubated at 
21 C in sodium phosphate buffer (100 mM, 1450 L, pH 7.5).  The reaction 
was immediately subjected to HPLC (refer to section 7.9) with a mobile phase 
of 23% acetonitrile in sodium phosphate (100 mM, pH 2.0).  An additional 3 
injections were made at 16 min intervals. 
7.17.2   Effect of detergents on initial velocity 
Detergents investigated include dodecyl maltoside, Triton X-100, Bug Buster, 
and Brij-56 at a final concentration of 1% w/v and 2% w/v.  Glucuronylsynthase 
(1.4 mg mL-1, 50 L) was added to -D-glucuronyl fluoride 51 (final 
concentration 1 mM), 2-phenylethanol 45 (final concentration 94 mM) and 
detergent pre-incubated at 21 C in sodium phosphate buffer (100 mM, 1450 
L, pH 7.5).  The reaction was immediately subjected to HPLC (refer to section 
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7.9) with a mobile phase of 23% acetonitrile in sodium phosphate buffer (100 
mM, pH 2.0).  An additional 3 injections were made at 16 min intervals. 
7.17.3   Effect of co-solvents on reaction yield 
Co-solvents investigated include DMSO (5% v/v), tert-butanol (5% v/v and 
10% v/v), and glycerol (5% v/v).  Glucuronylsynthase (21.7 mg mL-1, 20 L, final 
concentration 0.4 mg mL-1) was added to DHEA O-(carboxymethyl)oxime 116 
(final concentration 2 mM, 5 mM or 10 mM), -D-glucuronyl fluoride 51 (3 
equiv), and co-solvent pre-incubated at 37 C in sodium phosphate buffer (100 
mM, 980 L, pH 7.5).  The reaction was immediately subjected to HPLC (5 L 
injections, refer to section 7.9) with a mobile phase of 30% acetonitrile in 
sodium phosphate buffer (100 mM, pH 2.0).  The reaction was monitored by 
injections (5 L) every 5 h for 60 h.  The reaction endpoint was determined to 
be 48 h. 
7.17.4   Effect of detergents on reaction yield 
Detergents investigated include dodecyl maltoside (1% w/v) and Triton X-100 
(1% w/v).  Glucuronylsynthase (21.7 mg mL-1, 20 L, final concentration 0.4 mg 
mL-1) was added to DHEA O-(carboxymethyl)oxime 116 (final concentration 2 
mM and 5 mM), -D-glucuronyl fluoride 51 (3 equiv), and detergent pre-
incubated at 37 C in sodium phosphate buffer (100 mM, 980 L, pH 7.5).  The 
reaction was immediately subjected to HPLC (5 L injection, refer to section 
7.9) with a mobile phase of 30% acetonitrile in sodium phosphate buffer (100 
mM, pH 2.0).  The reaction was monitored by injections (5 L) every 5 h for 60 
h. 
A reaction with DHEA O-(carboxymethyl)oxime 116 (5 mM) dissolved in a 
Triton X-100 (1% w/v) solution was also trialled, but due to the HPLC 
autosampler rupturing the vial seal, it was omitted from the study. 
7.18  SPE methodology 
7.18.1   Australian Racing Forensic Laboratories solid phase extraction 
procedure181 
Solid phase extraction cartridge (3 cc, Oasis® MAX or Oasis® WAX, Waters 
Co.) was pre-conditioned with methanol (1 mL), then water (3 mL). The crude 
reaction was loaded into the cartridge and washed with sodium hydroxide 
(0.1 M, 3 mL), sodium phosphate buffer (0.05 M, 3 mL, pH 7.5), then water 
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(3 mL). The cartridge was dried briefly under pressure and subsequently eluted 
with methanol (3 mL) and then a solution of methanol, ethyl acetate and formic 
acid (25:25:1 respectively, 3 mL). 
7.18.2   Waters Oasis® MAX extraction procedure226 
The Oasis® MAX solid-phase extraction cartridge (3 cc, Waters Co.) was pre-
conditioned with methanol (1 mL), then water (3 mL). The crude reaction was 
loaded into the cartridge and washed with ammonium hydroxide (5% v/v, 3 mL), 
methanol (3 mL), then formic acid in methanol (2% v/v, 3 mL). 
7.18.3   Waters Oasis® WAX extraction procedure226 
The Oasis® WAX solid-phase extraction cartridge (3 cc, Waters Co.) was pre-
conditioned with methanol (1 mL), then water (3 mL). The crude reaction was 
loaded into the cartridge and washed with formic acid (2% v/v, 3 mL), methanol 
(3 mL), then ammonium hydroxide in methanol (5% v/v, 3 mL). 
7.18.4   Assessing the optimum SPE cartridge and SPE procedure. 
Glucuronylsynthase (final concentration 0.3 mg mL-1) was added to -D-
glucuronyl fluoride 51 (final concentration 10 mM) and DHEA O-
(carboxymethyl)oxime 116 (final concentration 2 mM) in sodium phosphate 
buffer (50 mM, pH 7.5, final volume 5 mL).  The reaction was incubated at 37 C 
for 5 d without agitation.  An aliquot (1 mL each) was loaded onto four SPE 
cartridges (2 x Oasis® MAX, 2 x Oasis® WAX) with the remainder used to 
determine the quantity of DHEA O-(carboxymethyl)oxime -D-glucuronide 118 
(2.7 mol) loaded onto each cartridge by HPLC (see section 5.2.12 for 
conditions). 
The ARFL extraction procedure (refer to section 7.18.1) was applied to an 
Oasis® MAX and Oasis® WAX SPE cartridge and the remaining SPE cartridges 
were extracted with their respective protocols.  Each procedure was eluted with 
the final wash twice more to ensure complete elution.  Non-aqueous solutions 
were evaporated to dryness by a nitrogen jet, and then re-dissolved in sodium 
phosphate buffer (50 mM, pH 7.5) to their original volume.  The quantity of 
DHEA O-(carboxymethyl)oxime -D-glucuronide 118 (5.7 min) and DHEA O-
(carboxymethyl)oxime 116 (13.7 min) were determined in every fraction by 
HPLC analysis (see section 7.15 for conditions). 
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Table 7.2.  Recovery of DHEA O-(carboxymethyl)oxime -D-glucuronide (CMO-DHEA 
Gluc) 118 and DHEA O-(carboxymethyl)oxime (CMO-DHEA) 116 (determined by HPLC) 
from Oasis® MAX SPE cartridge using the ARFL extraction procedure.  Recovery is a 
percentage based on the amount of CMO-DHEA Gluc 118 loaded on the cartridge. 
Reaction component CMO-DHEA Gluc 118 CMO-DHEA 116 
Fraction Quantity 
(mol) 
Recovery 
(%) 
Response 
(au) 
Recovery 
(%) 
Loading 2.72 100 3874233 100 
NaOH 0 0 0 0 
Phosphate buffer 0 0 0 0 
Water 0 0 0 0 
MeOH 0 0 0 0 
MeOH/EtOAc/HCO2H (Wash 1) 2.68 98.5 3251745 83.9 
MeOH/EtOAc/HCO2H (Wash 2) 0 0 0 0 
MeOH/EtOAc/HCO2H (Wash 3) 0 0 0 0 
Unaccounted 0.04 1.5 622488 16.1 
 
Table 7.3.   Recovery of DHEA O-(carboxymethyl)oxime -D-glucuronide (CMO-DHEA 
Gluc) 118 and DHEA O-(carboxymethyl)oxime (CMO-DHEA) 116 (determined by HPLC) 
from Oasis® WAX SPE cartridges using the ARFL extraction procedure.  Recovery is a 
percentage based on the amount of CMO-DHEA Gluc 118 loaded on the cartridge. 
Reaction component CMO-DHEA Gluc 118 CMO-DHEA 116 
Fraction Quantity 
(mol) 
Recovery 
(%) 
Response 
(au) 
Recovery 
(%) 
Loading 2.72 100 3874233 100 
NaOH 2.26 83.1 0 0 
Phosphate buffer 0.06 2.2 0 0 
Water 0 0 0 0 
MeOH 0 0 2013942 52.0 
MeOH/EtOAc/HCO2H (Wash 1) 0.37 13.6 1239216 32.0 
MeOH/EtOAc/HCO2H (Wash 2) 0 0 0 0 
MeOH/EtOAc/HCO2H (Wash 3) 0 0 0 0 
Unaccounted 0.03 1.1 621075 16.0 
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Table 7.4. Recovery of DHEA O-(carboxymethyl)oxime -D-glucuronide (CMO-DHEA Gluc) 
118 and DHEA O-(carboxymethyl)oxime (CMO-DHEA) 116 (determined by HPLC) from 
Oasis® MAX using the Waters Oasis® MAX extraction procedure.  Recovery is a 
percentage based on the amount of CMO-DHEA Gluc 118 loaded on the cartridge. 
Reaction component CMO-DHEA Gluc 118 CMO-DHEA 116 
Fraction Quantity 
(mol) 
Recovery 
(%) 
Response 
(au) 
Recovery 
(%) 
Loading 2.72 100 3874233 100 
Aq. NH4OH 0 0 0 0 
MeOH 0 0 0 0 
HCO2H/MeOH (wash 1) 2.65 97.4 3847113 99.3 
HCO2H/MeOH (wash 1) 0.01 0.4 0 0 
HCO2H/MeOH (wash 1) 0 0 0 0 
Unaccounted 0.06 2.2 27120 0.7 
 
Table 7.5.  Recovery of DHEA O-(carboxymethyl)oxime -D-glucuronide (CMO-DHEA 
Gluc) 118 and DHEA O-(carboxymethyl)oxime (CMO-DHEA) 116 (determined by HPLC) 
from Oasis® WAX using the Waters Oasis® WAX extraction procedure.  Recovery is a 
percentage based on the amount of CMO-DHEA Gluc 118 loaded on the cartridge. 
Reaction component CMO-DHEA Gluc 118 CMO-DHEA 116 
Fraction Quantity 
(mol) 
Recovery 
(%) 
Response 
(au) 
Recovery 
(%) 
Loading 2.72 100 3874233 100 
Aq. HCO2OH 0 0 0 0 
MeOH 0.03 1.1 2349012 60.6 
NH4OH/MeOH (wash 1) 2.61 96.0 1482323 38.3 
NH4OH/MeOH (wash 1) 0 0 0 0 
NH4OH/MeOH (wash 1) 0 0 0 0 
Unaccounted 0.08 2.9 42898 1.1 
 
7.18.5   General steroid screen with SPE 
Steroid (1 mg, final concentration 0.2 mg mL-1), -D-glucuronyl fluoride 51 (5 
equiv) and tert-butanol (final concentration 5% v/v) were combined in sodium 
phosphate (50 mM, pH 7.5) and sonicated (2 min, 30 C).  Glucuronylsynthase 
(final concentration 0.2 mg mL-1) was added and the reaction was incubated at 
37 C without agitation for 3 days.  The crude reaction was analysed by TLC 
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(ethyl acetate :  methanol : water, 7 : 2 : 1) and HPLC (refer to section 7.9) with 
30% acetonitrile in sodium phosphate buffer (100 mM, pH 2.0).  The 
glucuronide product was isolated using Oasis® WAX SPE cartridge (3 cc) and 
the ARFL procedure.  The purified glucuronide product was re-subjected to 
HPLC analysis and submitted for ESI-MS analysis. 
Yields were estimated from the peak area % from HPLC analysis (where 
applicable) using the UV absorbance maximum of the largest peak common to 
steroid and steroid glucuronide and assuming equal absorbance co-efficients 
for the steroid and steroid glucuronide. 
7.18.6   SPE with DHEA 55 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
DHEA 55 to produce the DHEA -D-glucuronide 77 (76%).  The chromatogram 
was measured at 211 nm to provide a retention time of 17.2 min for DHEA 55 
and 6.4 min for the DHEA -D-glucuronide 77 (Figure 5.9). The target 
glucuronide 77 was purified by SPE (96% purity by HPLC, Figure 5.10). 
λmax 211 nm; LRMS (-ESI) m/z: 463 ([M-H]-, 100%); HRMS (-ESI) m/z: 
463.2342 ([M-H]-, C25H35O8 gives 463.2332). 
7.18.7   SPE with testosterone 7 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
testosterone 7 to produce the testosterone -D-glucuronide 6 (6%).  The 
chromatogram was measured at 248 nm to provide a retention time of 14.5 min 
for testosterone 7 and 6.1 min for the testosterone -D-glucuronide 6 (Figure 
7.11).  The target glucuronide 6 was purified by SPE (49% purity by HPLC, 
Figure 7.12).  
λmax 248 nm; LRMS (-ESI) m/z: 463 ([M-H]-, 100%); HRMS (-ESI) m/z: 
463.2332 ([M-H]-, C25H35O8 gives 463.2332). 
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Figure 7.11.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
testosterone 7. 
 
Figure 7.12.  HPLC chromatogram of the purified testosterone -D-glucuronide 6 using 
SPE 
7.18.8   SPE with epitestosterone 123 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
epitestosterone 123 to produce the epitestosterone -D-glucuronide 126 (38%). 
The chromatogram was measured at 248 nm to provide a retention time of 19.5 
min for epitestosterone 123 and 8.2 min for the epitestosterone -D-glucuronide 
126 (Figure 7.13).  The target glucuronide 126 was purified by SPE (58% purity 
by HPLC, Figure 7.14).  A second SPE step was performed to purify the 
glucuronide 126 further (96% purity by HPLC, Figure 7.15). 
λmax 248 nm; LRMS (-ESI) m/z: 463 ([M-H]-, 100%); HRMS (-ESI) m/z: 
463.2338 ([M-H]-, C25H35O8 gives 463.2332). 
266 
Experimental 
 
Figure 7.13. HPLC chromatogram of the crude glucuronylsynthase reaction of 
epitestosterone 123. 
 
Figure 7.14. HPLC chromatogram of the purified epitestosterone -D-glucuronide 126 
after one round of SPE. 
 
Figure 7.15.  HPLC chromatogram of the purified epitestosterone -D-glucuronide 126 
after two rounds of SPE. 
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7.18.9   SPE with boldenone 118 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
boldenone 118 to produce the boldenone -D-glucuronide 125 (15%).  The 
chromatogram was measured at 248 nm to provide a retention time of 9.9 min 
for boldenone 118 and 5.2 min for the boldenone -D-glucuronide 125 (Figure 
7.16).  The target glucuronide 125 was purified by SPE (75% purity by HPLC, 
Figure 7.17).  A second SPE step was performed to purify the glucuronide 125  
further (99% purity by HPLC, Figure 7.18). 
λmax 248 nm; LRMS (-ESI) m/z: 461 ([M-H]-, 80%); HRMS (-ESI) m/z: 
461.2184 ([M-H]-, C25H33O8 gives 461.2175). 
 
Figure 7.16.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
boldenone 118. 
 
Figure 7.17.  HPLC chromatogram of the purified boldenone -D-glucuronide 125 after 
one round of SPE. 
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Figure 7.18.  HPLC chromatogram of the purified boldenone -D-glucuronide 125 after 
two rounds of SPE. 
7.18.10   SPE with estrone 9 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
estrone 9 to produce the estrone -D-glucuronide 12 (24%). The chromatogram 
was measured at 254 nm to provide a retention time of 20.2 min for estrone 9 
and 6.0 min for the estrone -D-glucuronide 12 (Figure 7.19).  The target 
glucuronide 12 was purified by SPE (43% purity by HPLC, Figure 7.20). 
λmax 254nm; LRMS (-ESI) m/z: 445 ([M-H]-, 80%); HRMS (-ESI) m/z: 
445.1862 ([M-H]-, C24H29O8 gives 445.1862). 
 
Figure 7.19.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
estrone 9. 
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Figure 7.20.  HPLC chromatogram of the purified estrone -D-glucuronide 12 after one 
round of SPE. 
7.18.11   SPE with methandriol 58 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
methandriol 58 to produce the methandriol -D-glucuronide 127 (yield not 
determined).  The chromatogram was measured at 211 nm to provide a 
retention time of 5.9 min for the methandriol -D-glucuronide 127 (Figure 7.19) 
but no absorption for methandriol 58 (Figure 7.21).   
λmax N/A; LRMS (-ESI) m/z: 479 ([M-H]-, 65); HRMS (-ESI) m/z: 479.2645 
([M-H]-, C26H39O8 gives 479.2645). 
 
Figure 7.21.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
methandriol 58. 
7.18.12   SPE with 6-hydroxystanozolol 124 
The general steroid SPE procedure (refer to section 7.18.5) was applied to 
6-hydroxystanozolol 124 to produce 6-hydroxystanozolol glucuronide 128 
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(yield not determined).  The chromatogram was measured at 229 nm but no 
resolution was obtained with the given HPLC procedure (Figure 7.22). 
λmax 229 nm; LRMS (-ESI) m/z: 519 ([M-H]-, 40%); HRMS (-ESI) m/z: 
519.2691 ([M-H]-, C27H39N2O8 gives 519.2706). 
 
Figure 7.22.  HPLC chromatogram of the crude glucuronylsynthase reaction of 
6-hydroxystanozolol 124. 
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~ Chapter 9 ~  
X-Ray Crystal Data 
X-Ray crystal data 
9.1 Crystal structure of C6H12FNO6 — mcl0801 
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Abstract 
The crystal structure of C6H12FNO6 is reported. 
Comment 
The compound is enantiometrically pure but the anomolous dispersion terms 
are very low for all elements in the structure and so the absolute configuration 
can not be determined in this experiment. Consequently Friedel-pair reflections 
have been averaged and the Flack parameter has not been refined. The 
absolute configuration of the molecule has been assigned on the basis of the 
synthetic precursors. 
The crystallographic asymmetric unit consists of one NH4+ cation and one 
C6H8FO6− anion. There is extensive hydrogen-bonding between species within 
the unit cell. 
Experimental 
The compound was prepared by SMW and recrystallized from 
ethanol/water/acetone. The sample ID is SMW4B108. 
Refinement 
All hydrogen atoms were observed in difference electron density maps 
synthesized prior to their inclusion. They were included at these positions and 
then refined positionally with their displacement parameters held fixed at 
U iso(H) = 1.2×Ueq(adjacent atom). 
The final difference electron density map is essentially featureless, with the 
largest peaks being located between carbon atoms. 
Computing details 
Data collection: COLLECT (Nonius BV, 1997); cell refinement: 
DENZO/SCALEPACK (Otwinowski & Minor, 1997); data reduction: 
DENZO/SCALEPACK (Otwinowski & Minor, 1997); program(s) used to solve 
structure: SIR92 (Altomare et al.,1994); program(s) used to refine structure: 
CRYSTALS (Watkin et al. 2003); molecular graphics: ORTEPII (Johnson 1976) 
in TEXSAN (MSC, 1992-1997); software used to prepare material for 
publication: CRYSTALS (Watkin et al. 2003).  
X-Ray crystal data 
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Crystal data 
H4N+·C6H8FO6– Dx = 1.590 Mg m−3 
Mr = 213.16  
Mo Kα radiation 
λ = 0.71073 Å 
Orthorhombic, P212121 Cell parameters from 6863 reflections 
a = 7.0684 (2) Å θ = 2.6–27.5º 
b = 8.4206 (2) Å μ = 0.15 mm−1 
c = 14.9569 (5) Å T = 200 K 
V = 890.24 (4) Å3 Block, colourless 
Z = 4 0.44 × 0.33 × 0.23 mm 
F000 = 448  
Data collection 
Nonius KappaCCD diffractometer 1100 reflections with I > 2.0σ(I) 
Monochromator: graphite R int = 0.035 
T = 200 K θmax = 27.5º 
φ and ω scans with CCD θmin = 2.7º 
Absorption correction: integration via 
Gaussian method (Coppens, 1970) 
implemented in maXus (2000) 
h = −9→9 
Tmin = 0.950, Tmax = 0.977 k = −9→10 
10200 measured reflections l = −19→19 
1196 independent reflections  
Refinement 
Refinement on F2 Hydrogen site location: inferred from 
neighbouring sites 
Least-squares matrix: full Only H-atom coordinates refined 
R[F2 > 2σ(F2)] = 0.026 Method = Modified Sheldrick w = 1/[σ2(F2) + 
(0.05P)2 + 0.0P] ,where P = (max(Fo2,0) + 
2Fc2)/3 
wR(F2) = 0.073 (Δ/σ)max = 0.0003 
S = 0.99 Δρmax = 0.21 e Å−3 
1196 reflections Δρmin = −0.17 e Å−3 
163 parameters Extinction correction: None 
Primary atom site location: structure-invariant 
direct methods 
Absolute structure: The enantiomer has been 
assigned by reference to an unchanging chiral 
centre in the synthetic procedure. 
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Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) 
 x y z U iso*/Ueq 
F1 0.75092 (15) 0.57835 (13) 0.15646 (7) 0.0330 
O1 0.64661 (17) 0.38047 (15) 0.24833 (7) 0.0226 
O2 0.6403 (2) 0.41398 (18) 0.00483 (8) 0.0323 
O3 0.2445 (2) 0.38953 (15) 0.04701 (8) 0.0286 
O4 0.15035 (17) 0.50600 (17) 0.21649 (8) 0.0254 
O5 0.52940 (18) 0.35395 (15) 0.41541 (8) 0.0253 
O6 0.24880 (17) 0.46453 (14) 0.38595 (8) 0.0227 
N1 0.4209 (2) 0.23923 (19) 0.58663 (10) 0.0232 
C1 0.7153 (3) 0.4142 (2) 0.16247 (11) 0.0236 
C2 0.5746 (3) 0.36880 (19) 0.09024 (10) 0.0217 
C3 0.3841 (2) 0.44694 (18) 0.10722 (10) 0.0186 
C4 0.3160 (2) 0.41374 (19) 0.20132 (10) 0.0172 
C5 0.4715 (2) 0.45872 (18) 0.26834 (10) 0.0172 
C6 0.4159 (2) 0.41985 (18) 0.36479 (10) 0.0176 
H2 0.655 (4) 0.329 (3) −0.0171 (16) 0.0390* 
H3 0.256 (4) 0.429 (3) 0.0009 (17) 0.0340* 
H4 0.145 (3) 0.502 (3) 0.2652 (15) 0.0300* 
H5 0.417 (3) 0.318 (3) 0.6271 (14) 0.0280* 
H6 0.440 (3) 0.289 (3) 0.5364 (15) 0.0280* 
H7 0.511 (3) 0.168 (3) 0.5980 (14) 0.0280* 
H8 0.312 (3) 0.185 (3) 0.5856 (15) 0.0280* 
H11 0.846 (3) 0.351 (3) 0.1530 (13) 0.0280* 
H21 0.551 (3) 0.252 (2) 0.0917 (14) 0.0260* 
H31 0.407 (3) 0.558 (2) 0.0990 (13) 0.0220* 
H41 0.284 (3) 0.300 (2) 0.2075 (12) 0.0210* 
H51 0.490 (3) 0.574 (2) 0.2677 (13) 0.0210* 
 
Atomic displacement parameters (Å2) 
 U11 U22 U33 U12 U13 U23 
F1 0.0278 (6) 0.0346 (5) 0.0365 (6) −0.0064 (5) 0.0051 (5) 0.0030 (5) 
O1 0.0171 (6) 0.0331 (6) 0.0176 (5) 0.0068 (5) 0.0026 (4) 0.0027 (5) 
O2 0.0459 (8) 0.0325 (6) 0.0184 (6) 0.0109 (7) 0.0117 (6) 0.0046 (5) 
O3 0.0354 (8) 0.0345 (7) 0.0158 (5) −0.0109 (7) −0.0073 (5) 0.0037 (5) 
O4 0.0178 (6) 0.0396 (7) 0.0188 (5) 0.0069 (6) 0.0013 (5) 0.0048 (6) 
O5 0.0243 (6) 0.0340 (6) 0.0176 (5) 0.0017 (5) −0.0017 (5) 0.0025 (5) 
O6 0.0207 (6) 0.0297 (6) 0.0176 (5) 0.0009 (5) 0.0036 (5) −0.0026 (5) 
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N1 0.0213 (8) 0.0268 (7) 0.0215 (7) 0.0020 (7) −0.0006 (6) 0.0018 (6) 
C1 0.0214 (8) 0.0276 (8) 0.0217 (8) 0.0045 (7) 0.0057 (7) 0.0034 (7) 
C2 0.0288 (9) 0.0200 (7) 0.0164 (7) 0.0052 (7) 0.0054 (7) 0.0027 (6) 
C3 0.0223 (8) 0.0189 (7) 0.0146 (7) −0.0015 (6) −0.0018 (6) 0.0010 (5) 
C4 0.0173 (8) 0.0182 (7) 0.0160 (7) 0.0001 (6) −0.0013 (6) 0.0011 (6) 
C5 0.0148 (7) 0.0194 (7) 0.0174 (7) 0.0014 (6) −0.0002 (6) −0.0004 (6) 
C6 0.0195 (8) 0.0177 (6) 0.0155 (7) −0.0033 (6) −0.0016 (6) −0.0024 (6) 
Geometric parameters (Å, °) 
F1—C1 1.408 (2) N1—H7 0.89 (2) 
O1—C1 1.4021 (19) N1—H8 0.90 (2) 
O1—C5 1.4339 (19) C1—C2 1.517 (2) 
O2—C2 1.4114 (19) C1—H11 1.07 (2) 
O2—H2 0.79 (3) C2—C3 1.520 (2) 
O3—C3 1.4208 (19) C2—H21 1.00 (2) 
O3—H3 0.77 (3) C3—C4 1.514 (2) 
O4—C4 1.423 (2) C3—H31 0.96 (2) 
O4—H4 0.73 (2) C4—C5 1.535 (2) 
O5—C6 1.235 (2) C4—H41 0.99 (2) 
O6—C6 1.279 (2) C5—C6 1.531 (2) 
N1—H5  0.90 (2) C5—H51 0.978 (19) 
N1—H6  0.87 (2)   
F1···N1i 2.972 (2) O3···C2viii 3.223 (2) 
F1···O4ii 3.025 (2) O3···C6vii 3.360 (2) 
F1···C6iii 3.124 (2) O3···N1vii 3.390 (2) 
F1···O5iii 3.235 (2) O3···O5vii 3.506 (2) 
F1···O6iii 3.313 (2) O4···N1vii 2.937 (2) 
F1···C4iii 3.567 (2) O4···C1ix 3.272 (2) 
O1···N1iv 3.297 (2) O5···N1 2.842 (2) 
O1···O4v 3.504 (2) O5···N1iv 2.876 (2) 
O2···O3vi 2.770 (2) O5···C3v 3.498 (2) 
O2···N1iii 3.092 (2) O6···N1x 2.913 (2) 
O2···O5i 3.325 (2) O6···C3xi 3.520 (2) 
O2···O6vii 3.431 (2) N1···C3xi 3.424 (2) 
O3···O6vii 2.705 (2)   
C1—O1—C5 113.40 (12) C2—C3—O3 111.24 (13) 
C2—O2—H2 100.1 (18) C2—C3—C4 110.92 (12) 
C3—O3—H3 110.2 (18) O3—C3—C4 107.79 (13) 
C4—O4—H4 100.0 (18) C2—C3—H31 104.5 (13) 
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H5—N1—H6 103.5 (18) O3—C3—H31 111.7 (12) 
H5—N1—H7 112.9 (19) C4—C3—H31 110.7 (12) 
H6—N1—H7 112.2 (19) C3—C4—O4 108.00 (12) 
H5—N1—H8 111.1 (19) C3—C4—C5 109.52 (13) 
H6—N1—H8 111.3 (20) O4—C4—C5 110.49 (12) 
H7—N1—H8 105.8 (19) C3—C4—H41 109.9 (11) 
F1—C1—O1 108.62 (13) O4—C4—H41 108.8 (12) 
F1—C1—C2 108.60 (13) C5—C4—H41 110.1 (11) 
O1—C1—C2 111.96 (14) C4—C5—O1 111.61 (12) 
F1—C1—H11 109.0 (11) C4—C5—C6 112.26 (12) 
O1—C1—H11 108.5 (11) O1—C5—C6 108.68 (12) 
C2—C1—H11 110.1 (11) C4—C5—H51 109.6 (12) 
C1—C2—O2 111.14 (15) O1—C5—H51 109.7 (12) 
C1—C2—C3 110.65 (13) C6—C5—H51 104.8 (11) 
O2—C2—C3 109.03 (13) C5—C6—O6 114.05 (13) 
C1—C2—H21 110.0 (12) C5—C6—O5 120.46 (14) 
O2—C2—H21 109.9 (12) O6—C6—O5 125.47 (15) 
C3—C2—H21 105.9 (12)   
F1—C1—O1—C5 61.9 (2) O3—C3—C4—O4 −65.3 (2) 
F1—C1—C2—O2 55.8 (2) O3—C3—C4—C5 174.4 (1) 
F1—C1—C2—C3 −65.5 (2) O4—C4—C3—C2 172.7 (1) 
O1—C1—C2—O2 175.8 (1) O4—C4—C5—C6 64.2 (2) 
O1—C1—C2—C3 54.5 (2) O5—C6—C5—C4 134.9 (1) 
O1—C5—C4—O4 −173.5 (1) O6—C6—C5—C4 −46.6 (2) 
O1—C5—C4—C3 −54.7 (2) C1—O1—C5—C4 58.4 (2) 
O1—C5—C6—O5 10.9 (2) C1—O1—C5—C6 −177.2 (1) 
O1—C5—C6—O6 −170.5 (1) C1—C2—C3—C4 −52.4 (2) 
O2—C2—C3—O3 65.1 (2) C2—C1—O1—C5 −58.1 (2) 
O2—C2—C3—C4 −175.0 (1) C2—C3—C4—C5 52.4 (2) 
O3—C3—C2—C1 −172.4 (1) C3—C4—C5—C6 −177.0 (1) 
Symmetry codes: (i) −x+3/2, −y+1, z−1/2; (ii) x+1, y, z; (iii) −x+1, y+1/2, −z+1/2; (iv) x+1/2, 
−y+1/2, −z+1; (v) −x+1, y−1/2, −z+1/2; (vi) x+1/2, −y+1/2, −z; (vii) −x+1/2, −y+1, z−1/2; (viii) 
x−1/2, −y+1/2, −z; (ix) x−1, y, z; (x) x−1/2, −y+1/2, −z+1; (xi) −x+1/2, −y+1, z+1/2. 
Hydrogen-bond geometry (Å, °) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O3vi 0.79 (3) 2.00 (3) 2.770 (2) 165 (3) 
O3—H3···O6vii 0.77 (3) 1.94 (3) 2.705 (2) 173 (3) 
O4—H4···O6 0.73 (2) 1.97 (2) 2.651 (2) 154 (2) 
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N1—H5···O4xi 0.90 (2) 2.05 (2) 2.937 (2) 168 (2) 
N1—H6···O5 0.87 (2) 1.99 (2) 2.843 (2) 165 (2) 
N1—H7···O6iv 0.89 (2) 2.03 (2) 2.913 (2) 170 (2) 
N1—H8···O5x 0.90 (2) 2.02 (2) 2.877 (2) 159 (2) 
N1—H5···F1xii 0.90 (2) 2.54 (2) 2.972 (2) 110 (2) 
Symmetry codes: (vi) x+1/2, −y+1/2, −z; (vii) −x+1/2, −y+1, z−1/2; (xi) −x+1/2, −y+1, z+1/2; 
(iv) x+1/2, −y+1/2, −z+1; (x) x−1/2, −y+1/2, −z+1; (xii) −x+3/2, −y+1, z+1/2. 
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Abstract 
The crystal structure of Na2C27H37NO10·CH3OH is reported. 
Comment 
The compound is enantiometrically pure but the anomolous dispersion terms 
are very low for all elements in the structure and so the absolute configuration 
can not be determined in this experiment. Consequently Friedel-pair reflections 
have been averaged and the Flack parameter has not been refined. The 
absolute configuration of the molecule has been assigned on the basis of the 
synthetic precursors. 
The crystallographic asymmetric unit consists of two Na+ cations, one 
C27H37NO10 2− anion and one methanol molecule of crystallization. There is 
also a region of electron density isolated from the principal molecules which 
presumably arises from disordered solvate molecules, probably methanol 
and/or water. No sensible disordered model could be formulated which would 
match the observed electron density, so the computer program SQUEEZE 
within PLATON was used to account for the electron density in this region of 
the unit cell. [Sluis, P. van der and Spek, A·L. (1990) Acta Crystallogr., Sect. A, 
46, 194–201.] The program identified solvent accessible voids totalling 236.4 
Å3 and 52 electrons per unit cell were recovered.  The formula weight, density 
etc. listed in the Tables do not include any correction for the missing solvate. 
Experimental 
The compound was prepared by SMW and recrystallized from 
methanol/water/ethyl acetate. The sample ID is SMW34C46. 
Computing details 
Data collection: COLLECT (Nonius, 1997-2001).; cell refinement: 
DENZO/SCALEPACK (Otwinowski & Minor, 1997); data reduction: 
DENZO/SCALEPACK (Otwinowski & Minor, 1997); program(s) used to solve 
structure: SIR92 (Altomare et al., 1994); program(s) used to refine structure: 
CRYSTALS (Betteridge et al., 2003), SQUEEZE (Spek et al., 1990); molecular 
graphics: ORTEPII (Johnson 1976) in TEXSAN (MSC, 1992-1997); software 
used to prepare material for publication: CRYSTALS (Betteridge et al., 2003). 
X-Ray crystal data 
326 
Crystal data 
(Na+)2·C27H37NO102–·CH4O Dx = 1.364 Mg m−3 
Mr = 613.61 
Mo Kα radiation 
λ = 0.71073 Å 
Orthorhombic, P212121 Cell parameters from 65058 reflections 
a = 7.8722 (3) Å θ = 2.7–25º 
b = 9.2049 (3) Å μ = 0.13 mm−1 
c = 41.2201 (15) Å T = 200 K 
V = 2986.92 (19) Å3 Plate, colourless 
Z = 4  0.37 × 0.36 × 0.05 mm 
F000 = 1304  
Data collection 
Area diffractometer 2092 reflections with I > 2.0σ(I) 
Monochromator: graphite R int = 0.069 
T = 200 K θmax = 25.1º 
φ and ω scans with CCD θmin = 2.6º 
Absorption correction: integration via 
Gaussian method (Coppens, 1970) 
implemented in maXus (2000) 
h = −9→9 
Tmin = 0.956, Tmax = 0.993 k = −10→10 
3055 measured reflections l = −48→48 
3055 independent reflections  
Refinement 
Refinement on F2 Hydrogen site location: inferred from 
neighbouring sites 
Least-squares matrix: full H-atom parameters constrained 
R[F2 > 2σ(F2)] = 0.037 
 
Method = Modified Sheldrick w = 1/[σ2(F2) + 
(0.05P)2 + 0.0P], 
where P = (max(Fo2,0) + 2Fc2)/3 
wR(F2) = 0.092 (Δ/σ)max = 0.001 
S = 0.82 Δρmax = 0.59 e Å−3 
3053 reflections Δρmin = −0.38 e Å−3 
367 parameters Extinction correction: None 
Primary atom site location: structure-invariant 
direct methods 
Absolute structure: The enantiomer has been 
assigned by reference to an unchanging chiral 
centre in the synthetic procedure. 
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Special details 
Refinement. In addition to the cations, anion and solvate molecule identified, 
there is also a region of electron density isolated from the principal species 
which presumably arises from disordered solvate molecules, probably 
methanol and/or water. No sensible disordered model could be formulated 
which would match the observed electron density, so the computer program 
SQUEEZE within PLATON was used to account for the electron density in this 
region of the unit cell. [Sluis, P. van der and Spek, A·L. (1990) Acta 
Crystallogr., Sect. A, 46, 194–201.] The program identified solvent accessible 
voids totalling 236.4 Å3 and 52 electrons per unit cell were recovered. The 
formula weight, density etc. listed in the Tables do not include any correction 
for the missing solvate. 
Hydrogen atoms attached to carbon atoms of the anion were introduced at 
calculated positions, and the other H atoms were located in difference electron 
density maps. They were initially refined with soft restraints on the bond 
lengths and angles to regularize their geometry (C—H in the range 0.93–0.98, 
O—H = 0.82 Å) and with U iso(H) in the range 1.2–1.5 times Ueq of the parent 
atom, after which the positions were refined with riding constraints. 
The displacement ellipsoids of O3 and C52 are noticeably elongated, 
suggesting some disorder of their positions arising from the variable nature of 
their surroundings dependent on the disordered solvate molecules which were 
not located. The largest peaks in the final difference electron density map lie 
between C52 and the region where SQUEEZE was applied. 
Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) 
 x y z U iso*/Ueq 
Na1 0.6893 (2) 0.86909 (15) 0.54410 (3) 0.0395 
Na2 0.5896 (2) 0.20364 (15) 0.49675 (3) 0.0442 
O1 0.4075 (3) 0.8113 (2) 0.59946 (5) 0.0295 
O2 0.8537 (3) 0.6830 (3) 0.87802 (5) 0.0384 
O3 0.9002 (6) 0.6930 (4) 0.94238 (7) 0.0995 
O4 1.0695 (4) 0.5004 (3) 0.94172 (6) 0.0537 
O5 0.0878 (3) 0.7248 (3) 0.57391 (6) 0.0394 
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O6 0.1160 (3) 0.5835 (3) 0.51023 (5) 0.0359 
O7 0.3911 (3) 0.4048 (2) 0.50303 (5) 0.0305 
O8 0.7668 (4) 0.4014 (3) 0.51857 (8) 0.0681 
O9 0.8028 (3) 0.6402 (3) 0.52542 (6) 0.0387 
O10 0.5450 (3) 0.6646 (2) 0.56369 (5) 0.0280 
O51 0.4985 (4) 0.0880 (4) 0.54701 (8) 0.0668 
N1 0.9020 (4) 0.7101 (3) 0.84479 (7) 0.0349 
C1 0.7251 (5) 0.7769 (4) 0.66845 (8) 0.0296 
C2 0.6671 (5) 0.8011 (5) 0.63341 (8) 0.0338 
C3 0.4745 (5) 0.7890 (4) 0.63195 (8) 0.0277 
C4 0.3939 (5) 0.9032 (4) 0.65323 (8) 0.0303 
C5 0.4533 (5) 0.8907 (4) 0.68822 (8) 0.0250 
C6 0.3412 (5) 0.8882 (4) 0.71183 (8) 0.0263 
C7 0.3814 (4) 0.8806 (4) 0.74700 (8) 0.0278 
C8 0.5695 (5) 0.8997 (4) 0.75435 (7) 0.0254 
C9 0.6787 (4) 0.8222 (4) 0.72859 (7) 0.0230 
C10 0.6452 (4) 0.8805 (4) 0.69386 (8) 0.0235 
C11 0.8668 (5) 0.8155 (4) 0.73799 (8) 0.0311 
C12 0.8998 (5) 0.7557 (4) 0.77232 (8) 0.0320 
C13 0.8007 (5) 0.8456 (4) 0.79695 (8) 0.0273 
C14 0.6119 (5) 0.8398 (4) 0.78774 (7) 0.0241 
C15 0.5214 (5) 0.9034 (4) 0.81734 (8) 0.0347 
C16 0.6235 (5) 0.8412 (4) 0.84629 (8) 0.0370 
C17 0.7867 (5) 0.7898 (4) 0.83162 (8) 0.0293 
C18 0.7224 (5) 1.0336 (4) 0.68924 (8) 0.0316 
C19 0.8726 (5) 1.0019 (4) 0.79920 (9) 0.0419 
C20 0.9697 (6) 0.5804 (4) 0.89153 (8) 0.0397 
C21 0.9794 (6) 0.5975 (5) 0.92827 (9) 0.0417 
C22 0.3870 (5) 0.6872 (4) 0.58102 (8) 0.0254 
C23 0.2438 (4) 0.7085 (4) 0.55679 (8) 0.0262 
C24 0.2356 (4) 0.5722 (4) 0.53575 (8) 0.0259 
C25 0.4040 (5) 0.5399 (4) 0.51986 (8) 0.0240 
C26 0.5466 (5) 0.5339 (4) 0.54480 (9) 0.0268 
C27 0.7220 (5) 0.5236 (4) 0.52842 (9) 0.0324 
C52 0.5013 (12) 0.1533 (7) 0.57578 (14) 0.1545 
H1 0.0322 0.7978 0.5722 0.0595* 
H2 0.0186 0.6107 0.5166 0.0544* 
H3 0.4051 0.4268 0.4837 0.0457* 
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H4 0.3941 0.0895 0.5432 0.1012* 
H11 0.8469 0.7903 0.6694 0.0368* 
H12 0.6934 0.6765 0.6746 0.0359* 
H21 0.7035 0.8998 0.6256 0.0409* 
H22 0.7189 0.7284 0.6187 0.0413* 
H31 0.4393 0.6911 0.6396 0.0332* 
H41 0.4212 0.9995 0.6446 0.0357* 
H42 0.2724 0.8910 0.6528 0.0356* 
H61 0.2273 0.8921 0.7057 0.0316* 
H71 0.3195 0.9560 0.7584 0.0329* 
H72 0.3445 0.7856 0.7553 0.0325* 
H81 0.5963 1.0045 0.7534 0.0306* 
H91 0.6387 0.7214 0.7287 0.0278* 
H111 0.9133 0.9150 0.7368 0.0364* 
H112 0.9264 0.7552 0.7227 0.0375* 
H121 1.0220 0.7620 0.7774 0.0387* 
H122 0.8606 0.6529 0.7739 0.0383* 
H141 0.5847 0.7372 0.7867 0.0290* 
H151 0.5312 1.0071 0.8163 0.0420* 
H152 0.4023 0.8743 0.8175 0.0418* 
H161 0.6441 0.9134 0.8639 0.0441* 
H162 0.5667 0.7592 0.8553 0.0442* 
H181 0.6858 1.0954 0.7077 0.0479* 
H182 0.8440 1.0274 0.6890 0.0486* 
H183 0.6810 1.0775 0.6692 0.0474* 
H191 0.8144 1.0596 0.8158 0.0625* 
H192 0.9925 0.9964 0.8043 0.0626* 
H193 0.8610 1.0518 0.7781 0.0630* 
H201 1.0795 0.5983 0.8828 0.0484* 
H202 0.9352 0.4816 0.8855 0.0478* 
H221 0.3651 0.6013 0.5953 0.0300* 
H231 0.2639 0.7915 0.5434 0.0296* 
H241 0.2006 0.4909 0.5495 0.0302* 
H251 0.4278 0.6172 0.5037 0.0288* 
H261 0.5324 0.4504 0.5589 0.0319* 
H521 0.6155 0.2016 0.5794 0.2347* 
H522 0.4818 0.0830 0.5933 0.2340* 
H523 0.4139 0.2296 0.5775 0.2340* 
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Atomic displacement parameters (Å2) 
 U11 U22 U33 U12 U13 U23 
Na1 0.0490 0.0347 0.0348 −0.0097 0.0015 −0.0015 
Na2 0.0681 0.0308 0.0338 0.0157 0.0071 0.0014 
O1 0.0476 (16) 0.0219 (12) 0.0190 (12) 0.0008 (14) −0.0051 (12) −0.0031 (10) 
O2 0.0514 (19) 0.0415 (15) 0.0224 (13) 0.0099 (15) −0.0071 (13) 0.0064 (12) 
O3 0.192 (5) 0.071 (2) 0.0350 (17) 0.075 (3) −0.044 (2) −0.0227 (18) 
O4 0.054 (2) 0.075 (2) 0.0318 (15) 0.0292 (19) 0.0000 (16) 0.0192 (16) 
O5 0.0331 (16) 0.0419 (16) 0.0433 (16) 0.0086 (14) 0.0079 (14) −0.0127 (13) 
O6 0.0234 (14) 0.0524 (17) 0.0320 (14) 0.0013 (14) −0.0026 (12) −0.0143 (13) 
O7 0.0353 (15) 0.0276 (13) 0.0287 (13) −0.0021 (13) 0.0046 (12) −0.0113 (11) 
O8 0.0383 (19) 0.0408 (18) 0.125 (3) −0.0040 (16) 0.027 (2) −0.039 (2) 
O9 0.0256 (15) 0.0331 (16) 0.0574 (17) −0.0024 (14) 0.0063 (14) −0.0007 (14) 
O10 0.0293 (15) 0.0254 (14) 0.0292 (13) −0.0023 (12) 0.0009 (12) −0.0052 (11) 
O51 0.071 (2) 0.064 (2) 0.065 (2) 0.005 (2) 0.0164 (19) 0.019 (2) 
N1 0.045 (2) 0.0347 (18) 0.0246 (16) −0.0008 (19) −0.0045 (16) 0.0036 (15) 
C1 0.026 (2) 0.032 (2) 0.0305 (19) −0.0024 (19) 0.0000 (18) −0.0042 (17) 
C2 0.038 (2) 0.038 (2) 0.026 (2) 0.006 (2) −0.0003 (18) −0.0024 (19) 
C3 0.038 (2) 0.027 (2) 0.0181 (18) 0.000 (2) −0.0018 (17) −0.0005 (17) 
C4 0.034 (2) 0.032 (2) 0.0251 (19) 0.004 (2) −0.0019 (18) −0.0017 (17) 
C5 0.030 (2) 0.0177 (19) 0.0273 (19) 0.0030 (18) −0.0027 (19) 0.0000 (16) 
C6 0.023 (2) 0.029 (2) 0.026 (2) 0.0051 (18) −0.0013 (17) −0.0015 (17) 
C7 0.026 (2) 0.029 (2) 0.028 (2) 0.003 (2) 0.0029 (18) −0.0008 (17) 
C8 0.030 (2) 0.0234 (19) 0.0225 (18) −0.0007 (19) 0.0003 (17) 0.0011 (16) 
C9 0.026 (2) 0.0198 (19) 0.0237 (18) −0.0019 (17) 0.0004 (17) −0.0008 (15) 
C10 0.026 (2) 0.0207 (19) 0.0239 (18) 0.0007 (17) 0.0006 (16) −0.0008 (16) 
C11 0.031 (2) 0.034 (2) 0.028 (2) 0.004 (2) −0.0037 (18) 0.0030 (17) 
C12 0.029 (2) 0.036 (2) 0.031 (2) 0.003 (2) −0.0043 (18) 0.0057 (17) 
C13 0.032 (2) 0.026 (2) 0.0239 (19) 0.0011 (19) −0.0038 (17) 0.0011 (16) 
C14 0.030 (2) 0.0211 (19) 0.0212 (18) 0.0005 (18) −0.0002 (17) 0.0013 (15) 
C15 0.043 (2) 0.034 (2) 0.0274 (19) 0.009 (2) 0.0019 (19) 0.0001 (19) 
C16 0.049 (3) 0.033 (2) 0.029 (2) 0.012 (2) −0.005 (2) 0.0041 (18) 
C17 0.034 (2) 0.026 (2) 0.0284 (19) 0.002 (2) −0.0100 (18) −0.0009 (17) 
C18 0.038 (2) 0.031 (2) 0.0261 (19) −0.007 (2) −0.0019 (19) 0.0009 (16) 
C19 0.049 (3) 0.034 (2) 0.042 (2) −0.010 (2) −0.011 (2) 0.0044 (19) 
C20 0.053 (3) 0.032 (2) 0.034 (2) 0.011 (2) −0.013 (2) 0.0043 (18) 
C21 0.054 (3) 0.037 (3) 0.034 (2) −0.001 (2) −0.007 (2) 0.009 (2) 
C22 0.028 (2) 0.0221 (19) 0.0258 (19) −0.0049 (18) 0.0020 (18) −0.0049 (16) 
C23 0.031 (2) 0.0225 (18) 0.0248 (18) −0.0009 (18) 0.0015 (18) −0.0047 (17) 
C24 0.021 (2) 0.032 (2) 0.0246 (19) −0.0028 (18) 0.0030 (17) −0.0038 (17) 
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C25 0.027 (2) 0.0208 (19) 0.0243 (18) −0.0032 (18) 0.0007 (18) −0.0057 (16) 
C26  0.031 (2) 0.0200 (19) 0.0293 (19) 0.0002 (18) 0.0054 (19) −0.0053 (16) 
C27 0.027 (2) 0.034 (2) 0.036 (2) 0.001 (2) −0.0026 (19) −0.008 (2) 
C52 0.298 (12) 0.078 (5) 0.088 (5) 0.056 (7) 0.091 (6) 0.019 (4) 
Geometric parameters (Å, °) 
Na1—O4i 2.325 (3) C7—H71 0.969 
Na1—O6ii 2.353 (3) C7—H72 0.984 
Na1—O51iii 2.517 (4) C8—C9 1.541 (5) 
Na1—O9 2.414 (3) C8—C14 1.520 (4) 
Na1—O10 2.342 (3) C8—H81 0.988 
Na2—O3iv 2.436 (3) C9—C10 1.551 (4) 
Na2—O7v 2.575 (3) C9—C11 1.531 (5) 
Na2—O6v 2.667 (3) C9—H91 0.980 
Na2—O8vi 2.791 (3) C10—C18 1.547 (5) 
Na2—O7 2.437 (3) C11—C12 1.541 (4) 
Na2—O8 2.464 (3) C11—H111 0.987 
Na2—O51 2.437 (3) C11—H112 0.962 
O1—C3 1.454 (4) C12—C13 1.524 (5) 
O1—C22 1.382 (4) C12—H121 0.986 
O2—N1 1.443 (3) C12—H122 0.998 
O2—C20 1.427 (4) C13—C14 1.535 (5) 
O3—C21 1.225 (5) C13—C17 1.522 (5) 
O4—C21 1.269 (5) C13—C19 1.549 (5) 
O5—C23 1.424 (4) C14—C15 1.530 (5) 
O5—H1 0.805 C14—H141 0.969 
O6—C24 1.416 (4) C15—C16 1.549 (5) 
O6—H2 0.847 C15—H151 0.958 
O7—C25 1.428 (4) C15—H152 0.975 
O7—H3 0.830 C16—C17 1.497 (5) 
O8—C27 1.247 (4) C16—H161 0.996 
O9—C27 1.254 (4) C16—H162 0.952 
O10—C22 1.449 (4) C18—H181 0.993 
O10—C26 1.433 (4) C18—H182 0.959 
O51—C52 1.330 (6) C18—H183 0.974 
O51—H4 0.837 C19—H191 0.981 
N1—C17 1.287 (5) C19—H192 0.969 
C1—C2 1.531 (5) C19—H193 0.987 
C1—C10 1.550 (5) C20—C21 1.524 (5) 
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C1—H11 0.967 C20—H201 0.951 
C1—H12 0.990 C20—H202 0.981 
C2—C3 1.521 (5) C22—C23 1.519 (5) 
C2—H21 1.006 C22—H221 1.000 
C2—H22 0.991 C23—C24 1.526 (5) 
C3—C4 1.509 (5) C23—H231 0.956 
C3—H31 0.995 C24—C25 1.508 (5) 
C4—C5 1.520 (4) C24—H241 0.980 
C4—H41 0.978 C25—C26 1.523 (5) 
C4—H42 0.963 C25—H251 0.993 
C5—C6 1.314 (5) C26—C27 1.540 (5) 
C5—C10 1.532 (5) C26—H261 0.971 
C6—C7 1.486 (5) C52—H521 1.014 
C6—H61 0.932 C52—H522 0.982 
C7—C8 1.521 (5) C52—H523 0.985 
O2···C52vii 3.393 (9) O5···C21vii 3.472 (5) 
O2···C4viii 3.477 (4) O5···C20vii 3.598 (4) 
O3···O7ix 3.124 (4) O6···O9x 2.597 (3) 
O3···C52vii 3.27 (1) O6···O51vi 2.986 (4) 
O3···O51vii 3.313 (6) O6···O8x 3.238 (4) 
O3···O8ix 3.514 (5) O6···C27x 3.238 (5) 
O4···O7ix 2.691 (3) O6···O9xi 3.285 (4) 
O4···O5viii 2.895 (4) O7···O8vi 3.114 (3) 
O4···C25ix 3.249 (4) O9···C24xii 3.490 (4) 
O5···O9x 3.104 (3)   
O4i—Na1—O6ii 110.06 (11) C10—C9—H91 106.2 
O4i—Na1—O51iii 93.39 (12) C11—C9—H91 105.7 
O6ii—Na1—O51iii 75.55 (10) C5—C10—C1 109.6 (3) 
O4i—Na1—O9 103.39 (12) C5—C10—C9 109.2 (3) 
O6ii—Na1—O9 87.08 (9) C1—C10—C9 110.0 (3) 
O51iii—Na1—O9 159.21 (12) C5—C10—C18 108.2 (3) 
O4i—Na1—O10 136.64 (11) C1—C10—C18 108.5 (3) 
O6ii—Na1—O10 111.00 (10) C9—C10—C18 111.2 (3) 
O51iii—Na1—O10 109.75 (11) C9—C11—C12 114.2 (3) 
O9—Na1—O10 65.68 (9) C9—C11—H111 108.0 
O3iv—Na2—O7v 97.14 (13) C12—C11—H111 108.4 
O3iv—Na2—O6v 106.58 (11) C9—C11—H112 109.2 
O7v—Na2—O6v 62.90 (8) C12—C11—H112 108.2 
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O3iv—Na2—O8vi 87.54 (15) H111—C11—H112 108.7 
O7v—Na2—O8vi 134.89 (9) C11—C12—C13 109.3 (3) 
O6v—Na2—O8vi 72.73 (9) C11—C12—H121 109.8 
O3iv—Na2—O7 79.75 (11) C13—C12—H121 109.0 
O7v—Na2—O7 152.30 (10) C11—C12—H122 110.4 
O6v—Na2—O7 144.53 (11) C13—C12—H122 108.2 
O8vi—Na2—O7 72.75 (9) H121—C12—H122 110.0 
O3iv—Na2—O8 91.64 (14) C12—C13—C14 108.2 (3) 
O7v—Na2—O8 76.31 (9) C12—C13—C17 118.6 (3) 
O6v—Na2—O8 136.70 (12) C14—C13—C17 98.6 (3) 
O8vi—Na2—O8 148.66 (10) C12—C13—C19 110.9 (3) 
O7—Na2—O8 76.28 (9) C14—C13—C19 113.6 (3) 
O3iv—Na2—O51 164.21 (16) C17—C13—C19 106.5 (3) 
O7v—Na2—O51 95.70 (10) C13—C14—C8 115.1 (3) 
O6v—Na2—O51 71.45 (10) C13—C14—C15 103.9 (3) 
O8vi—Na2—O51 76.88 (12) C8—C14—C15 118.7 (3) 
O7—Na2—O51 93.01 (10) C13—C14—H141 105.0 
O8—Na2—O51 100.31 (13) C8—C14—H141 105.4 
C3—O1—C22 115.6 (3) C15—C14—H141 107.8 
N1—O2—C20 108.4 (3) C14—C15—C16 103.4 (3) 
Na2ix—O3—C21 134.5 (3) C14—C15—H151 108.0 
Na1xiii—O4—C21 158.8 (3) C16—C15—H151 111.1 
C23—O5—H1 121.0 C14—C15—H152 110.4 
Na1xi—O6—Na2vi 95.76 (9) C16—C15—H152 113.1 
Na1xi—O6—C24 123.9 (2) H151—C15—H152 110.6 
Na2vi—O6—C24 93.4 (2) C15—C16—C17 104.5 (3) 
Na1xi—O6—H2 117.4 C15—C16—H161 113.4 
Na2vi—O6—H2 104.8 C17—C16—H161 111.4 
C24—O6—H2 113.2 C15—C16—H162 110.4 
Na2—O7—Na2vi 107.28 (9) C17—C16—H162 108.1 
Na2—O7—C25 131.9 (2) H161—C16—H162 108.8 
Na2vi—O7—C25 113.7 (2) C13—C17—C16 109.6 (3) 
Na2—O7—H3 89.9 C13—C17—N1 122.5 (3) 
Na2vi—O7—H3 102.7 C16—C17—N1 127.9 (3) 
C25—O7—H3 104.1 C10—C18—H181 108.3 
Na2—O8—Na2v 100.18 (9) C10—C18—H182 109.8 
Na2—O8—C27 128.7 (3) H181—C18—H182 109.5 
Na2v—O8—C27 130.1 (3) C10—C18—H183 110.5 
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Na1—O9—C27 121.9 (2) H181—C18—H183 108.3 
Na1—O10—C22 118.1 (2) H182—C18—H183 110.4 
Na1—O10—C26 118.88 (19) C13—C19—H191 112.0 
C22—O10—C26 113.3 (3) C13—C19—H192 108.7 
Na2—O51—Na1xiv 97.67 (12) H191—C19—H192 109.2 
Na2—O51—C52 123.8 (4) C13—C19—H193 110.2 
Na1xiv—O51—C52 113.2 (4) H191—C19—H193 108.7 
Na2—O51—H4 97.0 H192—C19—H193 107.9 
Na1xiv—O51—H4 126.2 O2—C20—C21 110.6 (3) 
C52—O51—H4 100.2 O2—C20—H201 108.6 
O2—N1—C17 108.2 (3) C21—C20—H201 108.3 
C2—C1—C10 115.3 (3) O2—C20—H202 109.7 
C2—C1—H11 108.4 C21—C20—H202 111.1 
C10—C1—H11 107.2 H201—C20—H202 108.5 
C2—C1—H12 107.6 C20—C21—O4 112.9 (4) 
C10—C1—H12 107.4 C20—C21—O3 121.4 (4) 
H11—C1—H12 111.0 O4—C21—O3 125.7 (4) 
C1—C2—C3 108.9 (3) O10—C22—O1 106.8 (3) 
C1—C2—H21 110.5 O10—C22—C23 109.4 (2) 
C3—C2—H21 109.7 O1—C22—C23 110.0 (3) 
C1—C2—H22 110.8 O10—C22—H221 108.9 
C3—C2—H22 109.6 O1—C22—H221 110.5 
H21—C2—H22 107.3 C23—C22—H221 111.2 
C2—C3—O1 112.8 (3) C22—C23—O5 109.1 (3) 
C2—C3—C4 110.2 (3) C22—C23—C24 107.4 (3) 
O1—C3—C4 106.5 (3) O5—C23—C24 109.4 (3) 
C2—C3—H31 109.4 C22—C23—H231 111.1 
O1—C3—H31 108.6 O5—C23—H231 110.2 
C4—C3—H31 109.3 C24—C23—H231 109.6 
C3—C4—C5 111.7 (3) C23—C24—O6 113.0 (3) 
C3—C4—H41 109.2 C23—C24—C25 111.8 (3) 
C5—C4—H41 110.2 O6—C24—C25 106.0 (3) 
C3—C4—H42 108.9 C23—C24—H241 108.1 
C5—C4—H42 108.4 O6—C24—H241 107.5 
H41—C4—H42 108.4 C25—C24—H241 110.4 
C4—C5—C6 119.9 (3) C24—C25—O7 108.7 (3) 
C4—C5—C10 116.9 (3) C24—C25—C26 111.2 (3) 
C6—C5—C10 123.3 (3) O7—C25—C26 110.4 (3) 
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C5—C6—C7 125.5 (3) C24—C25—H251 108.4 
C5—C6—H61 116.4 O7—C25—H251 108.1 
C7—C6—H61 118.1 C26—C25—H251 109.9 
C6—C7—C8 113.3 (3) C25—C26—O10 109.3 (3) 
C6—C7—H71 109.4 C25—C26—C27 111.5 (3) 
C8—C7—H71 108.1 O10—C26—C27 107.3 (3) 
C6—C7—H72 108.6 C25—C26—H261 110.4 
C8—C7—H72 108.7 O10—C26—H261 109.7 
H71—C7—H72 108.7 C27—C26—H261 108.5 
C7—C8—C9 110.7 (3) C26—C27—O9 116.5 (3) 
C7—C8—C14 110.6 (3) C26—C27—O8 116.9 (4) 
C9—C8—C14 109.5 (3) O9—C27—O8 126.6 (4) 
C7—C8—H81 108.2 O51—C52—H521 110.1 
C9—C8—H81 107.8 O51—C52—H522 110.8 
C14—C8—H81 110.0 H521—C52—H522 108.7 
C8—C9—C10 112.4 (3) O51—C52—H523 112.0 
C8—C9—C11 112.6 (3) H521—C52—H523 107.3 
C10—C9—C11 114.3 (3) H522—C52—H523 107.9 
C8—C9—H91 104.7   
Na1—O4i—C21i—O3i −115.4 (7) O10—Na1—O6ii—C24ii −124.4 (3) 
Na1—O4i—C21i—C20i 67.7 (9) O10—Na1—O9—C27 14.1 (3) 
Na1—O6ii—C24ii—C23ii 102.1 (3) O10—C22—O1—C3 −89.8 (3) 
Na1—O6ii—C24ii—C25ii −20.7 (4) O10—C22—C23—C24 59.2 (3) 
Na1—O9—C27—O8 177.2 (3) O10—C26—C25—C24 −53.1 (4) 
Na1—O9—C27—C26 −0.3 (4) O51—Na1xiv—O4xiii—C21xiii 31.7 (7) 
Na1—O10—C22—O1 −37.7 (3) O51—Na2—O6v—C24v −158.1 (2) 
Na1—O10—C22—C23 81.3 (3) O51—Na2—O7—C25 86.4 (3) 
Na1—O10—C26—C25 −85.6 (3) O51—Na2—O7v—C25v 90.9 (2) 
Na1—O10—C26—C27 35.5 (3) O51—Na2—O8—C27 −84.2 (3) 
Na2—O6v—C24v—C23v −158.6 (2) N1—O2—C20—C21 154.3 (3) 
Na2—O6v—C24v—C25v 78.6 (2) N1—C17—C13—C12 29.2 (5) 
Na2—O7—Na2vi—O6 179.3 (1) N1—C17—C13—C14 145.4 (4) 
Na2—O7—Na2vi—O7vi −7.3 (1) N1—C17—C13—C19 −96.7 (4) 
Na2—O7—Na2vi—O8vi −15.7 (1) N1—C17—C16—C15 −168.3 (4) 
Na2—O7—Na2vi—O51vi −115.0 (1) C1—C2—C3—C4 60.8 (4) 
Na2—O7—C25—C24 −140.7 (2) C1—C10—C5—C4 −42.3 (4) 
Na2—O7—C25—C26 −18.5 (4) C1—C10—C5—C6 137.2 (4) 
Na2—O7v—Na2v—O6xii 0.4 (2) C1—C10—C9—C8 −167.0 (3) 
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Na2—O7v—Na2v—O7xii −169.5 (2) C1—C10—C9—C11 63.2 (4) 
Na2—O7v—Na2v—O8v −161.1 (1) C2—C1—C10—C5 46.2 (4) 
Na2—O7v—Na2v—O51v −61.2 (1) C2—C1—C10—C9 166.3 (3) 
Na2—O7v—C25v—C24v 5.3 (3) C2—C1—C10—C18 −71.8 (4) 
Na2—O7v—C25v—C26v 127.5 (2) C2—C3—O1—C22 92.1 (4) 
Na2—O8—C27—O9 −144.6 (3) C2—C3—C4—C5 −57.7 (4) 
Na2—O8—C27—C26 32.8 (5) C3—O1—C22—C23 151.6 (3) 
Na2—O51—Na1xiv—O4xiii 74.7 (1) C3—C2—C1—C10 −56.6 (4) 
O1—C3—C2—C1 179.7 (3) C3—C4—C5—C6 −129.9 (4) 
O1—C3—C4—C5 179.6 (3) C3—C4—C5—C10 49.7 (4) 
O1—C22—O10—C26 176.5 (2) C4—C3—O1—C22 −146.8 (3) 
O1—C22—C23—O5 −65.3 (4) C4—C5—C6—C7 −178.2 (3) 
O1—C22—C23—C24 176.2 (3) C4—C5—C10—C9 −162.9 (3) 
O2—N1—C17—C13 177.0 (3) C4—C5—C10—C18 75.9 (4) 
O2—N1—C17—C16 −3.5 (5) C5—C6—C7—C8 9.1 (5) 
O2—C20—C21—O3 −2.9 (6) C5—C10—C9—C8 −46.7 (4) 
O2—C20—C21—O4 174.2 (3) C5—C10—C9—C11 −176.5 (3) 
O4—Na1xiii—O9xiii—C27xiii 149.5 (3) C6—C5—C10—C9 16.7 (5) 
O4—Na1xiii—O10xiii—C22xiii 105.3 (2) C6—C5—C10—C18 −104.5 (4) 
O4—Na1xiii—O10xiii—C26xiii  −110.9 (2) C6—C7—C8—C9 −38.6 (4) 
O5—C23—C22—O10 177.7 (3) C6—C7—C8—C14 −160.1 (3) 
O5—C23—C24—O6 66.8 (3) C7—C6—C5—C10 2.3 (6) 
O5—C23—C24—C25 −173.7 (3) C7—C8—C9—C10 59.2 (4) 
O6—Na1xi—O9xi—C27xi −100.5 (3) C7—C8—C9—C11 −170.0 (3) 
O6—Na1xi—O10xi—C22xi −94.4 (2) C7—C8—C14—C13 176.7 (3) 
O6—Na1xi—O10xi—C26xi 49.4 (2) C7—C8—C14—C15 −59.2 (4) 
O6—Na2vi—O7—C25 25.1 (2) C8—C9—C10—C18 72.7 (4) 
O6—Na2vi—O7vi—C25vi 148.0 (2) C8—C9—C11—C12 51.0 (4) 
O6—Na2vi—O8vi—C27vi −158.0 (3) C8—C14—C13—C12 −60.3 (4) 
O6—Na2vi—O51vi—C52vi 156.0 (5) C8—C14—C13—C17 175.6 (3) 
O6—C24—C23—C22 −174.9 (3) C8—C14—C13—C19 63.3 (4) 
O6—C24—C25—O7 −61.6 (3) C8—C14—C15—C16 −168.2 (3) 
O6—C24—C25—C26 176.6 (3) C9—C8—C14—C13 54.6 (4) 
O7—Na2—O6v—C24v 133.9 (2) C9—C8—C14—C15 178.6 (3) 
O7—Na2—O7v—Na2v −7.3 (1) C9—C11—C12—C13 −55.8 (4) 
O7—Na2—O7v—C25v −161.5 (2) C10—C9—C8—C14 −178.7 (3) 
O7—Na2—O8—C27 6.5 (3) C10—C9—C11—C12 −179.2 (3) 
O7—Na2—O51—C52 −56.6 (5) C11—C9—C8—C14 −47.9 (4) 
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O7—Na2vi—O6—C24 −51.3 (2) C11—C9—C10—C18 −57.1 (4) 
O7—Na2vi—O7vi—Na2x −169.5 (2) C11—C12—C13—C14 57.5 (4) 
O7—Na2vi—O7vi—C25vi −21.9 (3) C11—C12—C13—C17 168.6 (3) 
O7—Na2vi—O8vi—C27vi −177.6 (3) C11—C12—C13—C19 −67.8 (4) 
O7—Na2vi—O51vi—C52vi 97.1 (5) C12—C13—C14—C15 168.1 (3) 
O7—C25—C24—C23 174.9 (3) C12—C13—C17—C16 −150.4 (3) 
O7—C25—C26—O10 −173.8 (3) C13—C14—C15—C16 −38.8 (3) 
O7—C25—C26—C27 67.7 (4) C13—C17—C16—C15 11.3 (4) 
O8—Na2—O6v—C24v −72.8 (2) C14—C13—C17—C16 −34.2 (4) 
O8—Na2—O7—C25 −13.5 (3) C14—C15—C16—C17 16.8 (4) 
O8—Na2—O7v—C25v −169.9 (2) C15—C14—C13—C17 44.1 (3) 
O8—Na2—O51—C52 20.0 (5) C15—C14—C13—C19 −68.2 (3) 
O8—C27—C26—O10 160.4 (3) C16—C17—C13—C19 83.7 (4) 
O8—C27—C26—C25 −80.0 (4) C17—N1—O2—C20 172.9 (3) 
O9—Na1—O4i—C21i −160.6 (7) C22—O10—C26—C25 59.8 (3) 
O9—Na1—O6ii—C24ii −61.9 (3) C22—O10—C26—C27 −179.1 (3) 
O9—Na1—O10—C22 −170.9 (2) C22—C23—C24—C25 −55.4 (4) 
O9—Na1—O10—C26 −27.1 (2) C23—C22—O10—C26 −64.5 (3) 
O9—C27—C26—O10 −21.9 (4) C23—C24—C25—C26 53.1 (4) 
O9—C27—C26—C25 97.8 (4) C24—C25—C26—C27 −171.6 (3) 
O10—Na1—O4i—C21i −92.0 (7)   
Symmetry codes: (i) −x+2, y+1/2, −z+3/2; (ii) x+1/2, −y+3/2, −z+1; (iii) x, y+1, z; (iv) −x+3/2, 
−y+1, z−1/2; (v) x+1/2, −y+1/2, −z+1; (vi) x−1/2, −y+1/2, −z+1; (vii) −x+1, y+1/2, −z+3/2; (viii) 
−x+1, y−1/2, −z+3/2; (ix) −x+3/2, −y+1, z+1/2; (x) x−1, y, z; (xi) x−1/2, −y+3/2, −z+1; (xii) x+1, 
y, z; (xiii) −x+2, y−1/2, −z+3/2; (xiv) x, y−1, z. 
Hydrogen-bond geometry (Å, °) 
D—H···A D—H H···A D···A D—H···A 
O5—H1···O4vii 0.81 2.11 2.895 (5) 165 
O6—H2···O9x 0.85 1.76 2.597 (5) 169 
O7—H3···O4iv 0.83 1.87 2.692 (5) 173 
Symmetry codes: (vii) −x+1, y+1/2, −z+3/2; (x) x−1, y, z; (iv) −x+3/2, −y+1, z−1/2. 
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ABSTRACT
The glycosynthase derived from E. coli â-glucuronidase catalyzes the glucuronylation of a range of primary, secondary, and aryl alcohols with
moderate to excellent yields. The procedure provides an efficient, stereoselective, and scalable single-step synthesis of â-glucuronides under
mild conditions.
The formation of glucuronide conjugates during phase II
metabolism is a major pathway for the elimination of xeno-
biotic and some endobiotic compounds from the body.1 The
identification, quantification, and pharmacological evaluation
of these metabolites is essential in many fields including
sports drug testing,2 the detection of agricultural residues,3
and drug development,1 leading to a significant demand for
glucuronide standards.
The preparation of glucuronides presents significant chal-
lenges for existing methods of glucuronylation.4 Chemical
methods5 of glucuronylation are based on the Koenigs-
Knorr reaction or related procedures but often suffer from
poor yields and side reactions due to the low reactivity of
glucuronic acid derived glycosyl donors4,5 and require one
or more deprotection steps to liberate free glucuronide.
Enzymatic methods6 of synthesis employ uridine 5′-diphos-
phoglucuronosyl transferases (UGTs): a superfamily of
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enzymes responsible for glucuronylation in the body.7,8 This
procedure provides a mild and stereospecific synthesis in a
single step. However, UGTs are substrate-specific to the
acceptor alcohol and practical considerations often limit this
procedure to small scale syntheses. Given the limitations
associated with existing methods, the development of
improved glucuronylation protocols is an important goal.
Escherichia coli â-glucuronidase (EC 3.2.1.31) is a
member of the retaining â-glycosidase family 2 and catalyzes
the hydrolytic cleavage of terminal â-glucuronide residues.
The enzyme has found application in the field of analytical
chemistry for the deconjugation of a broad range of glucu-
ronide metabolites. The enzyme active site contains two key
catalytic residues. The side chain of glutamic acid 504
(E504)9 acts as a nucleophile, and glutamic acid 413 (E413)
is responsible for general acid/base catalysis in a double-
displacement mechanism (Scheme 1a). As demonstrated for
a range of other retaining â-glycosidase enzymes,10,11 muta-
tion of E504 to a non-nucleophilic glycine (E504G), alanine
(E504A), or serine (E504S) residue disables the hydrolytic
pathway (Scheme 1b). However, the resulting glycosynthase
enzyme can catalyze the formation of glucuronide product
from R-D-glucuronyl fluoride (1) and an acceptor alcohol
substrate. In this paper, we report the development of a con-
ceptually distinct approach, based on the glycosynthase10,11
derived from E. coli â-glucuronidase, for the mild, single-
step synthesis of glucuronides that is liberated from the many
drawbacks associated with contemporary procedures.
The E504G, E504A, and E504S glucuronylsynthase
mutants were created using standard overlap mutagenesis,
subcloned into the pET28a(+) expression vector and trans-
formed into a â-glucuronidase-deficient strain of E. coli
(GMS407(DE3)). The wild-type (WT) E. coli â-glucu-
ronidase was also expressed in the same manner.
The aglycon specificity of E. coli glucuronidase and of
the putative glycosynthase enzymes was determined using
an established spectrophotometric screening protocol.12,13
This screen employs WT â-glucuronidase inactivated with
2-deoxy-2-fluoro-â-D-glucuronyl fluoride.14 A panel of 123
alcohol acceptors was evaluated in parallel for their ability
to reactivate this inactivated enzyme by glucuronyl trans-
fer (Scheme 2).12 Surprisingly, of the 54 carbohydrate
acceptors screened, none gave significant reactivation of
the inactivated enzyme relative to control. In contrast, thir-
teen of the 69 alcohol acceptors screened significantly
enhanced reactivation rates (2-8  control). The thirteen
alcohols identified by this screen included a range of pri-
mary and cyclic secondary aliphatic alcohols, substituted
benzyl alcohols, and isomeric naphthalene methanols (Table
1, 2a-m). The screening suggested an unusual preference
for non-carbohydrate based acceptors to occupy the aglycon
binding site of WT â-glucuronidase and glycosynthase
enzymes.
Microgram scale reactions to identify glycosynthase activ-
ity were performed with the 13 alcohols (2a-m), R-D-
glucuronyl fluoride 1,15 and the three potential glucuronyl-
(7) Mulder, G. J. Annu. ReV. Pharmacol. Toxicol. 1992, 32, 25.
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Scheme 1. Proposed Mechanism of Action of (a) E. coli WT
â-Glucuronidase and (b) the E. coli E504G
â-Glucuronylsynthase
Scheme 2. Acceptor Screening by Reactivation of Inactivated
E. coli WT â-Glucuronidase Enzyme
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synthase enzymes (E504A, E504G, and E504S). Glucuronide
products 3a-m were identified by ESI-MS for all 13
alcohols in the presence of the glycine (E504G) and alanine
(E504A) mutants. No product formation was observed in the
absence of enzyme or for the serine mutant (E504S), which
was not examined further.
To explore the synthetic potential of the glycosynthase
enzymes, reactions involving the 13 alcohol acceptors
(2a-m) were performed on a preparative scale (5-10 mg)
in the presence of the E504G or E504A glucuronylsynthase
mutants. The E504G mutant cleanly afforded the â-glucu-
ronide products 3a-m in 37-93% isolated yield (Table 1,
entries a-m), with the E504A mutant affording lower yields
in the cases examined (entries i and m). The low aqueous
solubility of a number of acceptor alcohols was overcome
in two ways. Dimethyl sulfoxide (DMSO) was used as
cosolvent in concentrations of up to 25% v/v (entries b-e,
h, j, l, m), with the enzyme retaining useful activity at these
levels. The nonionic detergent, n-dodecyl â-maltoside (DDM),
was also found to be effective at low concentrations resulting
in improved yields (entries j, k, m). No oligomer formation
was detected in these reactions, consistent with the observa-
tion that carbohydrates do not serve as efficient acceptors
in the screen of aglycon specificity. The glucuronylation of
phenylethanol 2f on a large scale afforded the desired
glucuronide 3f in 96% yield (718 mg).
The synthesis reaction was also attempted with ethanol
and phenol; two potential acceptors that formed part of the
screen but that were not identified as hits. Indeed, ethanol
failed to afford the glucuronide product (entry n), while a
small quantity of phenyl â-D-glucuronide (3m) was isolated
in 13% yield (entry o) using the E504G glucuronylsynthase.
The low yield of this reaction can be rationalized by the poor
nucleophilicity of phenol but also hints at a broader substrate
scope for the glycosynthase mutants.
To further demonstrate the scope of the engineered
glycosynthase enzyme, the reaction was performed on the
steroid hormone dehydroepiandrosterone (DHEA, 2p). This
substrate was only partially soluble in 25% DMSO or 2.5%
DDM solutions, so the reaction was performed with the
steroid as a suspension (Table 1, entry p). The glucuronide
(3p) was obtained in 5% yield in the absence of additives,
17% yield using DMSO and 26% using DDM with 73%
recovery of residual starting material. Although of modest
yield, these results illustrate the promise of the glucuronyl-
synthase enzyme for the synthesis of a range of important
glucuronide products on a scale sufficient for modern
analytical methods.
This glucuronylsynthase, the latest addition to the glyco-
synthase range, has been shown to catalyze the glucurony-
lation of a range of alcohols with moderate to excellent
yields. This new procedure provides an efficient, stereose-
lective, and scalable single-step synthesis of â-glucuronides
under mild conditions. It is envisaged that this alternative
method of synthesis will assist to meet the demand for
glucuronide standards required for analytical purposes.
Further engineering will be directed to increasing the
substrate scope and improving the catalytic efficiency of the
glucuronylsynthase enzyme.
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Conjugation with glucuronic acid during phase II metabolism
is a major pathway for the elimination of hydrophobic xenobiotic
and endogenous compounds in mammalian systems.1 The
identification, quantification, and pharmacological evaluation of
these metabolites is essential for many fields including drug
development,1 sports drug testing,2 and the detection of agri-
cultural residues.3 This creates a significant demand for the
synthesis of glucuronide conjugates 1 as standards.
The preparation of glucuronides provides a significant chal-
lenge for existing methods of glucuronylation (Scheme 1).4
Chemical methods5 of glucuronylation based on the Koenigs-
Knorr reaction or more recent procedures often suffer from poor
yields and side reactions due to the low reactivity of glucuronic
acid derived glycosyl donors4,5 and require one or more depro-
tection steps to liberate free glucuronide. Enzymatic methods6
of synthesis employ uridine 50-diphosphoglucuronosyl trans-
ferases (UGTs), a superfamily of enzymes responsible for glucur-
onylation in the body.1 This procedure provides a mild and
stereospecific synthesis in a single step. However, UGTs are
substrate-specific to the acceptor alcohol, and practical considera-
tions often limit this procedure to small scale syntheses. Given the
limitations associated with existing methods, the development of
improved glucuronylation protocols is an important goal.
Recently we reported a distinct strategy for the synthesis
of glucuronides based on the glycosynthase derived from
Escherichia coli β-glucuronidase (EC 3.2.1.31).7 Escherichia coli
β-glucuronidase is a member of the retaining β-glycosidase
family 2 and catalyzes the hydrolytic cleavage of terminal β-
glucuronide residues. The enzyme displays substrate promiscuity
and has been widely exploited in the field of analytical chemistry
for the deconjugation of glucuronide metabolites.8 The enzyme
active site contains two key catalytic residues. The side chain of
glutamic acid 504 (E504)9 acts as a nucleophile, and glutamic
acid 413 (E413) is responsible for general acid/base catalysis in a
double displacement mechanism (Scheme 2a). As demonstrated
for a range of other retaining β-glycosidase enzymes,10,11 muta-
tion of the E. coli β-glucuronidase catalytic nucleophile to a non-
nucleophilic glycine (E504G), alanine (E504A), or serine
(E504S) residue disables the hydrolytic pathway (Scheme 2b).
However, the resulting glycosynthase enzyme, or glucuronyl-
synthase, can catalyze the formation of glucuronide product 1
fromR-D-glucuronyl fluoride 2 and an acceptor alcohol substrate.
Our previous report7 detailed the application of a spectrophoto-
metric screening protocol using the wild-type E. coli β-glucur-
onidase to identify likely acceptor alcohol substrates for the
glycosynthase mediated reaction, expression of the enzyme, and
confirmation of these screening hits with the E. coli glucuronyl-
synthase mutants. In this paper we report details of the glucur-
onylsynthase development together with a kinetic study of this
enzyme mediated transformation and practical improvements to
the process for the synthesis of steroidal glucuronides.
Received: October 7, 2010
ABSTRACT:The detection and study of glucuronide metabolites is
essential in many fields including pharmaceutical development,
sports drug testing, and the detection of agricultural residues.
Therefore, the development of improved methods for the synthesis
of glucuronide conjugates is an important aim. The glycosynthase
derived from E. coli β-glucuronidase provides an efficient, scalable,
single-step synthesis of β-glucuronides under mild conditions. In
this article we report on experimental and kinetic studies of the E. coli glucuronylsynthase, including the influence of acceptor
substrate, pH, temperature, cosolvents, and detergents, leading to optimized conditions for glucuronide synthesis. Enzyme kinetics
also reveals that both substrate and product inhibition may occur in glucuronylsynthase reactions but that these effects can be
ameliorated through the judicious choice of acceptor and donor substrate concentrations. An investigation of temporary polar
substituents was conducted leading to improved aqueous solubility of hydrophobic steroidal acceptors. In this way the synthesis of
the steroidal metabolite dehydroepiandrosterone 3-β-D-glucuronide was achieved in three steps and 86% overall yield from
dehydroepiandrosterone.
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’RESULTS AND DISCUSSION
The development of the E. coli glucuronylsynthase system
required reliable access to both the mutant enzymes and the
R-D-glucuronyl fluoride 2 donor sugar. The wild-type and three
putative glycosynthase mutant enzymes, E504G, E504A, and
E504S, were overexpressed in a glucuronidase deficient strain of
E. coli (GMS407(DE3)) as previously described.7 A minor
modification of replacing the method of cell lysis from freeze-
thaw cycles to French pressure cell press improved the yield of
purified protein from 18 to 25 mg L-1 of culture. The enzymes
produced by this protocol are histidine tagged (His6), allowing
for purification by nickel affinity chromatography. To assess if
this modification has a deleterious effect on enzyme activity, the
kinetic competence of the wild-type enzyme was investigated by
colorimetric assay using p-nitrophenyl β-D-glucuronide as sub-
strate and monitoring enzyme mediated hydrolysis at 410 nm.12
The observed Km of 0.17 ( 0.02 mM and kcat of 38 ( 1 s-1
(21 C, 50 mM phosphate buffer, pH 7.5) compare well with
reported literature values determined under similar conditions
for hydrolysis by a similar histidine tagged glucuronidase con-
struct (Km = 0.20 mM, kcat = 68 s
-1, Tris-HCl buffer, pH 7.6)13
and also purified native enzyme (Km = 0.22 mM, 37 C, 76 mM
phosphate buffer, pH 7.0).14
The second key component required for the glucuronyl-
synthase system is the R-D-glucuronyl fluoride 2 donor sugar.
At the outset of this study one reported synthesis15 provided the
potassium salt of this sugar in 65% yield and employed the
TEMPO-mediated oxidation of the primary hydroxyl group of
R-D-glucosyl fluoride 3.16 Purification was achieved by ion
exchange, followed by recrystallization to remove potassium
acetate buffer salt. In our hands the recrystallization of the sugar
from significant amounts of potassium acetate salt proved
challenging. This difficulty was circumvented by the use of
ammonium hydrogen carbonate as eluting buffer in the anion
exchange chromatography, which was readily removed on lyo-
philization to afford the ammonium salt as an off-white powder.
This was further purified by recrystallization from aqueous
ethanol to give the R-D-glucuronyl fluoride 2 as the ammonium
salt7 in 87% yield on a multigram scale (Scheme 3). The identity
of sugar 2 was confirmed by single crystal X-ray analysis from
crystals grown in ethanol/water/acetone, which clearly showed
the presence of the expected ammonium counterion.17 Analysis
of the material by 13C NMR in D2O solvent confirmed the
absence of residual hydrogen carbonate buffer (δ ∼160).
In our previous investigations the aglycone specificity of the
E. coli β-glucuronidase and of the putative glycosynthase en-
zymes was determined using an established spectrophotometric
screening protocol against a panel of 123 alcohol acceptors.7,11
The 13 alcohols identified by this screen included a range of
primary and cyclic secondary aliphatic alcohols, substituted
benzyl alcohols, and isomeric naphthalene methanols. None of
the 54 carbohydrates tested in the screen were identified as
acceptors. Preparative scale synthesis of glucuronide conjugates
was conducted from each of the 13 alcohol hits shown in
Scheme 4. Of the three glucuronylsynthase mutants, the
E504G proved most effective. The E504A mutant provided
lower yields in the cases examined, and the E504S mutant did
not promote glucuronide synthesis.
Reactions conducted on a small selection of alcohols not
identified by the screen also hinted at a broader substrate scope.
Phenol, an acceptor present in the initial screen but not identified
as a hit, was glucuronylated in a low 13% yield (Scheme 4).
Ethanol, an acceptor not included in the original screen, failed to
afford detectable amounts of the glucuronide product. Of great
Scheme 1. Preparation of Glucuronide Conjugates 1 Scheme 2. ProposedMechanism of Action of (a) E. coliWild-
Type β-Glucuronidase and (b) E. coli E504G
Glucuronylsynthase
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interest, the steroid dehydroepiandrosterone (DHEA), an ac-
ceptor not included in the original screen, was observed to give a
modest 26% yield of the glucuronide product.
The isolated yields from these early experiments showed that
the enzyme provided high yields of glucuronide products for
some substrates, but this was not universal (Scheme 4). The
yields varied considerably for some closely related acceptors such
as 3-methoxybenzyl alcohol (84%) and 4-methoxybenzyl alcohol
(42%). In a number of instances cosolvents or detergents were
used to boost reaction yield for substrates with low aqueous
solubility. However, the beneficial effects of cosolvents and
detergents were not universally observed. Finally the variation
of reaction variables such as substrate concentration provided
some surprising results. In the case of 3-methoxybenzyl alcohol
doubling the substrate concentration was expected to increase
enzyme activity and therefore chemical yield. In fact doubling the
substrate concentration led to a decrease in the isolated yield of
glucuronide product from 84% to 64% based on the acceptor
alcohol. In order to understand the factors governing this process
and to optimize glucuronide synthesis, we embarked on a study
of the kinetics of this enzyme catalyst.
The enzyme kinetics of the glucuronylsynthase reaction was
conveniently investigated by an automatically sampled reverse-
phase HPLC-UV assay monitored at 211 nm. Both alcohol
acceptor and glucuronide product concentrations were deter-
mined relative to an internal standard over time to give a measure
of initial rate (ν0). The first kinetic measurements were con-
ducted at a fixed concentration of 2-phenylethanol 4 acceptor
(97 mM), due to limited solubility of this substrate in the
aqueous buffer, and a varying concentration of R-D-glucuronyl
fluoride 2. At this concentration of alcohol acceptor, the
R-D-glucuronyl fluoride 2 donor gave apparent values of Kmapp
= 15.0 ( 1 μM and kcatapp = 0.024 ( 0.01 s-1 by least-squares
fitting to theMichaelis-Menten equation (Figure 1). Because of
the kinetically subsaturating concentration of the acceptor
alcohol, the donor Km
app and kcat
app values provide an estimate
of the kinetic parameters for this substrate. Nevertheless, the
donorKm
app is low relative to other glycosynthase enzymes18 and
well below the concentration required for preparative enzyme-
mediated synthesis. The kcat
app or apparent turnover number for
this donor, although an underestimate of kcat, is also low relative
to other glycosynthases, leaving considerable scope for improv-
ing the catalytic efficiency of the enzyme.18
The kinetic parameters for 2-phenylethanol 4 donor were also
investigated at a fixed saturating concentration ofR-D-glucuronyl
fluoride 2 donor (1 mM). Under these conditions the acceptor
alcohol did not kinetically saturate the enzyme due to the limited
aqueous solubility of the acceptor alcohol. An estimate of the
kinetic parameters for 2-phenylethanol 4 was obtained by fitting
the available data to the Michaelis-Menten equation. This
indicated a Km of 140 ( 10 mM, significantly higher than the
highest acceptor substrate concentration tested (107 mM). An
estimate of the specificity constant kcat/Kmof 0.30( 0.02M
-1 s-1
was obtained from the slope of the plot of initial rate against
acceptor concentration at low acceptor concentration (Figure 2,
Table 1).
The significant difference in estimated Michaelis constants
(Km) for the donor and acceptor substrates is noteworthy. This
may reflect the binding interactions for glucuronide substrates at
the wild-type β-glucuronidase and the role of this enzyme in
Scheme 3. Synthesis of R-D-Glucuronyl Fluoride 2
Scheme 4. Product Yields for E504G Glucuronylsynthase
Mediated Synthesis
Figure 1. Plot of initial rate versus concentration for varying R-D-
glucuronyl fluoride 2 donor with fixed (97 mM) 2-phenylethanol 4
acceptor (21 C, 100mMphosphate buffer, pH 7.5). The line represents
the data fitted (least-squares) to the Michaelis-Menten equation.
D dx.doi.org/10.1021/jo101914s |J. Org. Chem. XXXX, XXX, 000–000
The Journal of Organic Chemistry ARTICLE
E. coli, the producing organism. Escherichia coli is an enteric
organism that employs a glucuronide transporter/β-glucuroni-
dase enzyme system to harvest the glucuronide residue as a
carbon source from biliary metabolites excreted in the gut.19
These glucuronide conjugates are formed from a wide variety of
xenobiotic and some endogenous compounds so the primary
recognition of the glucuronide conjugate by wild-type β-glucur-
onidase is expected for the target carbohydrate residue over the
variable aglycone portion. For the glucuronylsynthase enzyme,
the function of the wild-type enzyme is reflected in a low
apparent Km for the R-D-glucuronyl fluoride 2 donor (Km
app
15.0 ( 1 μM) and a much higher estimated Km for the
2-phenylethanol acceptor 4 (Km 140 ( 10 mM).
Kinetic investigations on four additional acceptors 5-8
(Table 1) were conducted at a saturating concentration of R-D-
glucuronyl fluoride 2 donor (1 mM). Each of these substrates
showed a negative slope of initial rate against acceptor concentration
at high acceptor concentrations, consistent with substrate inhibi-
tion. Because of substrate inhibition the data could not be fitted
to the Michaelis-Menten model. Kinetic parameters for these
reactions (Table 1) were estimated in two ways. An estimate of
acceptor specificity kcat/Km was obtained from the slope of the
plot of initial rate against acceptor concentration at low acceptor
concentration. A second measure of enzyme activity, the max-
imum observed kcat (kcat
max), was calculated from the initial
velocity at the concentration of the local maximum (concnmax).12
It was not possible to reliably estimate Km from this data.
The kinetic parameters for acceptors 4-7 give some insight
into the yields observed in previous synthetic work (Scheme 4).7
The observed yields parallel the maximum kcat observed with the
exception of 2-phenylethanol 4 (kcat
max = 0.020 s-1, 96%), which
afforded a yield greater than that of 3-methoxybenzyl alcohol 5
(kcat
max = 0.023 s-1, 84%). Comparing estimated specificity
constants (kcat/Km) for acceptor alcohols 4-7 gives 3-methoxy-
benzyl alcohol 5 (1.3 ( 0.1 M-1 s-1) highest, followed by
4-fluorobenzyl alcohol 6 (0.62 ( 0.04 M-1 s-1), 2-phenyletha-
nol 4 (0.30 ( 0.02 M-1 s-1), and then phenol 7 (0.22 ( 0.01
M-1 s-1) as lowest. Interestingly 2-phenylethanol 4 substrate
that provided the highest yield of product (96%) in previous
work has among the lowest specificity constant (kcat/Km). The
higher yield observed for 2-phenylethanol 4 can be attributed to
the absence of substrate inhibition, which was relevant for all
other acceptor alcohols under the high acceptor concentrations
(∼100 mM) used in preparative work. The kinetic observations
also explain the reduction in yield based on acceptor alcohol that
was observed on doubling the substrate concentration of accep-
tor 3-methoxybenzyl alcohol from 50 mM (84%) to 100 mM
(64%). A higher yield is afforded by the reaction performed with
substrate concentration close to the local maximum of enzyme
activity (concnmax = 55 mM). The lowest yielding acceptor
phenol 7 (13%) gave the lowest values for kcat
max and kcat/Km
of the four simple alcohol acceptors investigated. This study
highlights the potential for substrate inhibition under the high
acceptor alcohol concentrations usually employed for prepara-
tive purposes. It indicates that operating at lower substrate
concentrations or employing slow addition of substrate may be
beneficial for some glucuronylsynthase reactions.
To further improve the glucuronylsynthase reaction, variables
such as pH, temperature, and the effect of additives were also
investigated. The pH optimum of the enzyme was determined at
a fixed concentration ofR-D-glucuronyl fluoride 2 donor (1 mM)
Table 1. Estimated Kinetic Parameters for Alcohol Acceptors
4-8 with Constant Saturating (1 mM) R-D-Glucuronyl
Fluoride 2 Donora
acceptor kcat/Km (M
-1 s-1) kcat
max (s-1) concnmax (mM)
4 0.30( 0.02 0.020 107b
5 1.3( 0.1 0.023 55
6 0.62( 0.04 0.0081 37
7 0.22( 0.01 0.0029 30
8 4.3( 0.6 0.0014 0.55
a 100 mM phosphate buffer, pH 7.5, 21 C. bThe solubility limit of
2-phenylethanol 4 in aqueous buffer at 21 C.
Figure 2. Plot of initial rate versus concentration for varying 2-phenyl-
ethanol 4 acceptor with fixed saturating (1 mM)R-D-glucuronyl fluoride
2 donor (21 C, 100mMphosphate buffer, pH 7.5). Line represents data
fitted (least-squares) to the Michaelis-Menten equation.
Figure 3. Dependence of initial rate (ν0, solid bars) and HPLC yield
after 5 d (%, lined bars) on pH for reaction of 2-phenylethanol 4
acceptor (107 mM) and R-D-glucuronyl fluoride 2 donor (1 mM) (100
mM phosphate buffer, 21 C).
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and 2-phenylethanol 4 acceptor (107 mM). Two measurements
of enzyme activity were taken at each pH value. First, the initial
rate (ν0) of reaction was measured at low conversion. Second,
the reactions were incubated for 5 d, and the yield of product
formed at end point was determined by HPLC. High yields were
obtained at pH values of 5-9 with highest initial rates across a
broad plateau between pH 6 and 9 (Figure 3). The enzyme
showed an attenuated initial rate at pH 5 but maintained activity
at this pH to afford a high yield of product after 5 d. Studies on the
hydrolytic activity of wild-type β-glucuronidase shows a similar
broad pH optimum.8,20
Next, the enzyme activity was evaluated at several tempera-
tures (4, 11, 18, 24, 30, 37 C), at a fixed concentration of R-D-
glucuronyl fluoride 2 donor (89 mM) and 3-methoxybenzyl
alcohol 5 acceptor (89 mM). The use of 3-methoxybenzyl
alcohol as acceptor alcohol and a reduced enzyme concentration
(0.02 mg mL-1) relative to typical synthesis experiments was
also used to allow the observation of initial rates at higher
temperatures and more keenly assess the influence of tempera-
ture on overall yield. Twomeasurements of enzyme activity were
taken at each temperature value. First, the initial rate (ν0) of
reactionwas determined, and as expected there was an increase of
initial rate with temperature (Figure 4). Second, the reactions
were incubated for 13 d, and the yield of product formed was
determined by HPLC. The reactions maintained at 30 and 37 C
gave similar yields after 13 d, suggesting that the higher initial
reaction rate observed at the higher temperatures is attenuated
over time by a higher rate of enzyme deactivation or R-D-
glucuronly fluoride 2 hydrolysis.21,22 The study indicated a
temperature of 30-37 C was preferred for the glucuronyl-
synthase reactions.
Next the effect of different cosolvent and detergent additives
was investigated. One limitation of the glucuronylsynthase
reaction is the low solubility ofmany of the hydrophobic acceptor
alcohols relative to the glucuronide product. Additives such as
detergents or cosolvents generally offer enhancement of sub-
strate solubility but could also potentially have a deleterious
effect on enzyme activity and stability.
The effect of different additives on the initial velocity of the
enzyme was determined at a saturating concentration of R-D-
glucuronyl fluoride 2 donor (1 mM) and a fixed concentration of
2-phenylethanol 4 acceptor (94 mM). All reactions with addi-
tives demonstrated a decrease in enzyme activity (Figure 5).
Detergents maintained the highest activity with no velocities
falling below 70% of the control (no additives). Organic cosol-
vents were more detrimental to the enzyme, albeit 5% tert-
butanol and glycerol demonstrated enzymatic activities greater
than 80% of the control.23
It should be noted that in the cases where the higher acceptor
concentrations can be achieved with the aid of cosolvents, this may
occur at the cost of lower enzyme activity. Furthermore, high
substrate concentrations may not always be advantageous given
the observation of substrate inhibition. In summary, the optimal
conditions of enzyme mediated synthesis of glucuronides occur at
pH6-9 and temperatures of 30-37 C.Because of the influence of
substrate inhibition, the kinetic behavior of individual acceptors
must be investigated in order to optimize additional variables such as
acceptor concentration or cosolvent composition.
The reaction of phenol 7 as acceptor alcohol was investigated
to gauge the combined effect of the optimized conditions on the
Figure 4. Dependence of initial rate (ν0, solid bars) and HPLC yield
after 13 d (%, lined bars) on temperature for reaction of 3-methoxy-
benzyl alcohol 5 acceptor (89 mM) andR-D-glucuronyl fluoride 2 donor
(89 mM) (100 mM phosphate buffer, pH 7.5).
Figure 5. Effect of additives on the initial rate (ν0 as a percentage of the
initial velocity for the control) for reaction of 2-phenylethanol 4 acceptor
(94 mM) andR-D-glucuronyl fluoride 2 donor (1 mM) (100mMbuffer,
pH 7.5, 21 C). Brij-56, poly(ethylene glycol) hexadecyl ether; BB,
commercial protein extraction reagent; TX-100, triton X-100; DDM,
dodecyl β-D-maltoside.
Scheme 5. Synthesis of Phenyl β-D-Glucuronide 9
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reaction outcome. This substrate served as a useful benchmark, as
it was not identified by the spectrophotometric screening pro-
tocol used to identify potential acceptors and the previous
synthetic procedure had provided phenyl glucuronide in a low
13% yield. Repeating this reaction with 40 mM substrate con-
centration, just above the local maximum of enzyme activity, and
at 30 C in pH 7.5 buffer afforded a phenyl β-D-glucuronide 9 in
an improved yield of 43% (Scheme 5).
To further test the scope of the glucuronylsynthase reaction,
we turned our attention to the synthesis of steroid glucuronides.
In previous work the glucuronylation of dehydroepiandrosterone
(10, DHEA) was achieved in 5% in phosphate buffer, 17% with
25% v/v DMSO cosolvent and 26% with 2.5% w/v dodecyl
maltoside (DDM) nonionic detergent additive.7 However, in
each case the reaction was performed as a suspension of DHEA
10 in the reactionmixture due to the low aqueous solubility of the
hydrophobic steroid. The solubility of DHEA 10 has been
estimated as 90 μM in aqueous buffer.24
To address the challenge of working with hydrophobic
acceptor alcohols, the temporary introduction of polar substitu-
ents was investigated as a strategy to boost solubility into a
suitable range without the need for organic cosolvents or
detergent additives. A three-step process was envisaged involving
(1) introduction of a polar substituent, (2) enzyme catalyzed
glucuronylation, and (3) cleavage of the polar substituent to give
the steroid glucuronide. A range of derivatives were explored
with the O-(carboxymethyl)oxime derivative appearing most
suitable for this purpose.25 The oxime unit is readily generated
by condensation of commercially available O-(carboxymethyl)
hydroxylamine reagent with a carbonyl compound promoted by
pyrrolidine (Scheme 6). The charged derivative CMO-DHEA 8
thus formed in 88% had significantly greater solubility than the
parent steroid and could be fully dissolved in aqueous buffer up
to 2 mM at 21 C.
The higher aqueous solubility allowed for completion of an
enzyme kinetic study with a varying concentration of CMO-
DHEA 8 and a saturating concentration of R-D-glucuronyl
fluoride 2 donor (1 mM) (Table 1). In common with a number
of the simple acceptor alcohols, a plot of initial rate against
acceptor concentration showed a negative slope at high acceptor
concentrations, consistent with substrate inhibition.12 Relative to
the simple alcohols this substrate gave the highest estimated kcat/
Km (4.3 ( 0.6 M
-1 s-1) and smallest kcat
max (0.0014 s-1) at a
concentration of 0.55 mM, with this local maximum occurring
below the solubility limit (2 mM).
The CMO-DHEA 8 glucuronylation reaction was followed
by HPLC. Using 1 equiv ofR-D-glucuronyl fluoride 2 donor gave
a reaction profile that reached a 48% HPLC yield (Figure 6).
Increasing equivalents of R-D-glucuronyl fluoride 2 afforded
higher yields of product with 5 equiv giving 98% HPLC yield.
These observations suggested the operation of product inhibi-
tion at higher conversion, a phenomenon that could be overcome
with increasing concentrations of R-D-glucuronyl fluoride 2
donor.26
To assess this product inhibition, the influence of increasing
concentrations of CMO-DHEA 3-β-D-glucuronide 11 as in-
hibitor on the glucuronylsynthase reaction between 2-phenyl-
ethanol 4 (88 mM) and R-D-glucuronyl fluoride 2 at several
concentrations was investigated (Scheme 7). The analysis of
reciprocal plots indicated mixed, predominantly competitive
inhibition (Kic = 71 μM, Kiu = 180 μM) for CMO-DHEA
3-β-D-glucuronide 11.27,28 The observed competitive inhibition
constant is higher than the apparent Michaelis constant (Km
app =
15( 1μM) forR-D-glucuronyl fluoride 2. The implication of this
finding is that higher concentrations of R-D-glucuronyl fluoride 2
should successfully compete for occupancy of the enzyme active
site and maintain enzyme activity as product concentration in-
creases. This analysis is borne out in the results presented in
Figure 6 with 5 equiv (7 mM) of R-D-glucuronyl fluoride giving a
98% HPLC yield of CMO-DHEA 3-β-D-glucuronide 11.
To further assess the potential for product inhibition in the
glucuronylsynthase reaction, the reverse experiment was con-
ducted. The inhibition derived from increasing concentrations of
2-phenylethyl β-D-glucuronide 12 on the glucuronylsynthase
reaction involving CMO-DHEA 8 (0.6 mM) and R-D-glucur-
onyl fluoride 2 at several concentrations was investigated. In this
instance no inhibition was observed for 2-phenylethyl β-D-
glucuronide 12 between 0 and 75 mM.29 Interestingly for the
reaction of 2-phenylethanol 4 the absence of observable substrate
and product inhibition correlates to a high yield of the 2-phenylethyl
Scheme 6. Synthesis of DHEA 3-β-Glucuronide 13
Figure 6. Reaction yield against time for reaction of CMO-DHEA 8
acceptor (1.4 mM) and varying equivalents of R-D-glucuronyl fluoride 2
donor (100 mM phosphate buffer, pH 7.5, 37 C). (blue circles, 1 equiv;
green squares, 2 equiv; yellow squares, 3 equiv; orange squares, 4 equiv;
red squares, 5 equiv).
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β-D-glucuronide 12 product (96%) using 1.2 equiv of R-D-
glucuronyl fluoride donor. For the reaction of CMO-DHEA 8
both substrate and product inhibition are observed in this study.
In the former case this can be overcome by selection of a suitable
substrate concentration and in the latter case by maintaining a
high concentration of the R-D-glucuronyl fluoride donor 2.
Performing the glucuronylation of CMO-DHEA 8 on a
preparative scale under optimized conditions and using 5 equiv
of R-D-glucuronyl fluoride donor and 1.9 mM acceptor alcohol
gave the glucuronide product 11 in 98% yield (Scheme 6). A
single crystal X-ray structure of the disodium salt of the glucur-
onide 11, grown from ethyl acetate/methanol/water solution
confirmed the expected structure.30 The oxime exists solely as the
E-isomer and the glycosidic linkage presents as the β anomer.
Cleavage of the oxime unit was readily achieved using titanium-
(III) chloride in aqueous ammonium acetate buffer to regenerate
the ketone and afford DHEA 3-β-D-glucuronide 13 in quantita-
tive yield. This three-step sequence afforded the target glucur-
onide (45 mg) in 86% yield, which compares favorably with the
previously reported single-step glucuronylsynthase mediated
synthesis (26%).7 The reaction also compares favorably with
the two-step Koenigs-Knorr glycosylation followed by base-
promoted deprotection that is reported to afford DHEA 3-β-D-
glucuronide 13 in 20% yield.31 The UGT catalyzed synthesis of
DHEA 3-β-D-glucuronide 13 has not been reported.
The synthesis of testosterone 17-β-D-glucuronide 14 pro-
ceeded in a similar manner (Scheme 8). Testosterone 15 was
converted to the oxime derivative 16 in 91% yield as a 1:1.7
mixture of Z and E (major) isomers. This charged derivative 16
had a solubility significantly greater than that of the parent steroid
15 and could be fully dissolved in aqueous buffer up to 10 mM at
21 C. This smoothly underwent glucuronylation under opti-
mized conditions and using 3 equiv of R-D-glucuronyl fluoride 2
to give the glucuronide product 17 in 72% yield. Partial cleavage
of the oxime was achieved using titanium(III) chloride in
aqueous ammonium acetate buffer to regenerate the ketone
and afford testosterone 17-β-D-glucuronide 14 in 38% yield.
The mild reaction conditions allowed recovery of unreacted
oxime 17 (53%). No cleavage of the glycosidic bond was
observed under the mild reaction conditions and no byproduct
was observed from over-reduction of the unsaturated ketone or
imine functionality.32 This three-step sequence afforded the
target glucuronide in 25% yield. This contrasts with the two-
step Koenigs-Knorr glycosylation followed by base-promoted
deprotection, which is reported to afford testosterone 17-β-D-
glucuronide 14 in 17% yield.31 The method can also be com-
pared to a recent report that described the UGT-mediated
synthesis of 11 steroid glucuronides.6a The steroid glucuronides
were afforded in 13-77% yield to provide 1.1-6.5 mg of
product. Pertinent to this study was the synthesis of testosterone
17-β-D-glucuronide 14 in a yield of 77% (6.5 mg). However,
drawbacks of this method include the high levels (1 mgmL-1) of
rat liver microsomal enzyme that is obtained through animal
sacrifice. By contrast the glucuronylsynthase affords testosterone
17-β-D-glucuronide in a yield of 24% (16 mg) over three steps.
Furthermore the method uses soluble enzyme (0.2 mg mL-1)
that is readily obtained on a large scale by standard methods of
protein expression and nickel affinity purification.
’CONCLUSION
Improved procedures for the glucuronylsynthase catalyzed
synthesis of glucuronide conjugates have been developed. The
influence of acceptor substrate, pH, temperature, cosolvents, and
detergents on the enzyme activity has been investigated by
HPLC/UV. Substrate inhibition was observed for the majority
of acceptor alcohols investigated, indicating that the substrate
concentration is an important consideration for optimizing
enzyme activity. The operation of mixed, predominantly com-
petitive inhibition was observed for the product CMO-DHEA
3-β-D-glucuronide 11 in the glucuronylsynthase reaction of
2-phenylethanol 4 as acceptor. This inhibition could be over-
come through the use of higher concentrations ofR-D-glucuronyl
fluoride 2 donor. The temporary introduction of polar substit-
uents was investigated as a way to increase the solubility of
hydrophobic steroidal substrates. In this way the synthesis of
DHEA 3-β-D-glucuronide 13 was achieved in three steps and in
86% overall yield from DHEA 10. The glucuronylsynthase
reaction provides a practical alternative to existing methods for
the synthesis of glucuronide metabolites. Further engineering
Scheme 8. Synthesis of Testosterone 17-β-D-Glucuronide 14
Scheme 7. Study of Glucuronylsynthase Reaction Inhibition
by CMO-DHEA 3-β-D-Glucuronide 11
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will be directed to increasing the substrate scope and improving
the catalytic efficiency of the glucuronylsynthase enzyme.
’EXPERIMENTAL SECTION
17-Carboxymethoximino-dehydroepiandrosterone (CMO-
DHEA) 8.33 Pyrrolidine (600 μL, 7.19 mmol) was added to DHEA 10
(1.00 g, 3.47 mmol) dissolved in dry methanol (40 mL) at 4 C. After 1 h
the solution had turned yellow. Carboxymethoxylamine hemihydrochloride
(800 mg, 7.32 mmol) was dissolved in a dry solution of methanol (10 mL)
and pyrrolidine (600 μL, 7.19mmol) and transferred to theDHEAmixture
via cannula with methanol washing (5 mL). The solution immediately
cleared and was heated to reflux. The reaction was complete after 6 h. The
solvent was removed under reduced pressure, and water (100 mL) was
added to the residue. The pH was adjusted to 2 with aqueous hydrochloric
acid (2 M), and the white precipitate was extracted with ethyl acetate until
all precipitate had dissolved (5  150 mL with sonication required). The
organic extracts were combined, washed with water (200 mL), dried over
magnesium sulfate, and then evaporated to dryness. Cold chloroform
(5 mL) was added to the resulting yellow-white residue (1.15 g). The
white precipitate was filtered and washed with cold chloroform (2 3mL)
to afford 17-carboxymethoximino-dehydroepiandrosterone 8 (1.10 g,
88%); mp 215-217 C (decomp); [R]20D -36 (c 1.0, DMSO) {lit.33
[R]24D-37.9 (c 1, EtOH)};Rf 0.38 (7:2:1 ethyl acetate/methanol/water).
IR (KBr): 3351 (broad, O-H), 2946, 2910, 2865, 2505 (C-H), 1680
(CdO). 1H NMR (800 MHz, d6-DMSO): δ 5.28 (1H, s), 4.61 (1H, s,
broad), 4.42 (2H, s), 3.26 (1H, obscured, m), 2.46 (1H, dd, J = 18.9, 9.0
Hz), 2.38 (1H,m), 2.16 (1H, dd, J=12.9, 2.4Hz), 2.09 (1H, t, J= 12.1Hz),
1.98 (1H,m), 1.82-1.70 (3H,m), 1.67 (1H, d, J = 12.2Hz), 1.58 (2H,m),
1.51 (1H,m), 1.42 (1H,m), 1.38-1.28 (3H,m), 1.12 (1H,m), 1.02-0.91
(2H, m), 0.96 (3H, s), 0.85 (3H, s), COOH not observed. 13C NMR (200
MHz, d6-DMSO): δ 171.3, 170.6, 141.4, 120.1, 70.0, 69.8, 53.5, 49.8, 43.5,
42.2, 36.9, 36.2, 33.8, 31.4, 30.82, 30.78, 25.7, 22.8, 20.2, 19.2, 16.8. LRMS
(þESI) m/z: 384 ([Mþ Na]þ, 100%). LRMS (-ESI) m/z: 360 ([M-
H]-, 100%).; HRMS (þESI) calcd for C21H31NO4Naþ ([M þ Na]þ)
384.2151, found 384.2151.
CMO-DHEA 3-β-D-Glucuronide 11. Glucuronylsynthase
(4.14 mL, 1.45 mg/mL) was added to a solution containing CMO-
DHEA 8 (20 mg, 0.055 mmol, final concentration 1.9 mM) and
R-D-glucuronyl fluoride 2 (57.5 mg, 0.270 mmol) in 100 mM sodium
phosphate buffer pH 7.5 (25 mL). The reaction was incubated at 37 C
without agitation for 3 days and then dried onto reverse-phase silica. The
dried residue was subjected to reverse-phase flash chromatography (25%
aqueous acetonitrileþ 0.1% formic acid) to isolate CMO-DHEA 3-β-
D-glucuronide 11 (29 mg, 98%) as a colorless solid; [R]20D -62 (c 1.0,
DMSO); Rf 0.02 (7:2:1 ethyl acetate/methanol/water). IR (KBr): 3423
(O-H), 2942 (C-H), 1745 (CdO). 1H NMR (800 MHz, D2O): δ
5.51 (1H, s), 4.59 (1H, d, J = 7.3 Hz), 4.38 (2H, s), 3.72-3.69 (2H, m),
3.52-3.50 (2H, m), 3.27 (1H, t, J = 7.1 Hz), 2.63 (1H, dd, J = 19.2, 8.3
Hz), 2.52 (1H, m), 2.47 (1H, d, J = 12.6 Hz), 2.29 (1H, t, J = 12.0 Hz),
2.10 (1H, d, J = 11.3 Hz), 2.00-1.92 (2H, m), 1.90-1.84 (2H, m),
1.71-1.60 (4H, m), 1.55 (1H, m), 1.46-1.41 (2H, m), 1.27 (1H, m),
1.10 (1H, t, J = 13.0 Hz), 1.06 (3H, s), 1.06-1.02 (1H, m), 0.95 (3H, s).
13C NMR (200 MHz, D2O): δ 178.9, 177.3, 177.2, 143.3, 123.4, 101.7,
81.0, 77.7, 77.7, 74.4, 73.3, 72.9, 55.0, 51.2, 45.6, 39.5, 38.1, 38.0, 34.9,
32.29, 32.27, 30.3, 27.8, 24.2, 21.6, 20.3, 17.7. LRMS (-ESI) m/z: 536
([M-H]-, 100%), 558 ([M- 2HþNa]-, 30). HRMS (-ESI) calcd
for C27H38NO10 ([M - H]-) 536.2496, found 536.2495; calcd for
C27H37NO10Na ([M - 2H þ Na]-) 558.2315, found 558.2302.
DHEA 3-β-D-Glucuronide 13.31 CMO-DHEA 3-β-D-glucuro-
nide 11 (50 mg, 0.093 mmol) and ammonium acetate (96 mg, 1.2 mmol)
were purged with nitrogen, and then dioxane (0.5 mL) and aqueous acetic
acid (50%, 38 μL) were added. In a second flask, titanium trichloride (36
mg, 0.23 mmol) was purged with nitrogen before water (6 mL) was
added. The aqueous titanium trichloride was added via cannula to the
stirred CMO-DHEA 3-β-D-glucuronide solution at room temperature.
The reaction instantly turned black-violet upon addition and gradually
changed to a white-gray as the reaction proceeded. After 2 h, the reaction
was deemed complete so the solution was acidified to pH 2 and dried
onto silica. The dry residue was subjected to flash chromatography
(7:2:1 ethyl acetate/methanol/water þ0.1% formic acid) to isolate
DHEA 3-β-D-glucuronide 13 (44.8 mg, 100%) as a colorless solid;
[R]20D-29 (c 0.70, MeOH), (lit.31 [R]25D-35.5 (c 1, EtOH)); Rf 0.25
(7:2:1 ethyl acetate/methanol/water). IR (NaCl): 3369 (O-H), 2938,
2903 (C-H), 1733 (CdO), 1636. 1H NMR (800 MHz, MeOD): δ
5.42 (1H, d, J = 4.9 Hz), 4.45 (1H, d, J = 7.8 Hz), 3.80 (1H, d, J = 9.7 Hz)
3.58-3.47 (2H, m), 3.38 (1H, t, J = 9.1 Hz), 3.20 (1H, t, J = 8.4 Hz),
2.48-1.43 (2H, m), 2.29 (1H, m), 2.16-2.07 (3H, m), 2.00-1.87 (3H,
m), 1.78 (1H, m), 1.74-1.52 (5H, m), 1.40-1.23 (2H, m), 1.11-1.04
(2H, m), 1.07 (3H, s), 0.90 (3H, s). 13CNMR (75MHz, MeOD/D2O):
δ 225.5, 169.8, 142.1, 122.2, 102.1, 79.7, 77.6, 74.7, 73.5, 72.5, 52.9, 51.6,
39.5, 38.3, 37.9, 36.8, 32.7, 32.5, 31.8, 30.4, 22.7, 21.4, 19.8, 13.9, one
carbon overlapping or obscured. LRMS (-ESI)m/z: 927 ([2M-H]-,
43%), 463 ([M - H]-, 100). HRMS (-ESI) calcd for C25H35O8
([M - H]-) 463.2338, found 463.2342.
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